An investigation into the role and mechanism of action of small ubiquitin-like modifier interacting motifs in Arabidopsis thaliana proteins by Nelis, Stuart
  
 
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap  
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
http://go.warwick.ac.uk/wrap/71154 
 
 
 
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to 
cite it. Our policy information is available from the repository home page.  
 
 
 
 
An Investigation into the Role and Mechanism of Action
of Small Ubiquitin-like Modifier Interacting Motifs in
Arabidopsis thaliana Proteins.
Stuart Nelis
Thesis
Submitted to the University of Warwick
for the degree of
Doctor of Philosophy
Systems Biology Doctoral Training Centre
September 2014
Contents
List of Figures v
List of Tables vii
Acknowledgements ix
Declaration and Inclusion of Material from a Prior Thesis x
Abstract xi
Abbreviations xii
1 Introduction 1
1.1 The SUMOylation cascade . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 SUMO interacting motifs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3 Biological role of SUMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.4 Purpose of work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2 Materials and methods 10
2.1 Materials and reagents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.1.1 Antibiotics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.1.2 Antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.1.3 Enzymes, proteins and specialist reagents . . . . . . . . . . . . . . . . . . . . 13
2.1.4 Commercial molecular biology kits . . . . . . . . . . . . . . . . . . . . . . . 14
2.1.5 Plasmids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.1.6 Bacterial strains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.1.7 Yeast strains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.1.8 Plant materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.1.9 Commonly used buffers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.1.10 Commonly used culture media . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.2 Molecular biology methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.2.1 Bacterial culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.2.2 Bacterial glycerol stocks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.2.3 Preparing chemically competent E. coli . . . . . . . . . . . . . . . . . . . . . 18
2.2.4 Transformation of chemically competent E. coli . . . . . . . . . . . . . . . . 19
2.2.5 Transformation of chemically competent A. tumefaciens . . . . . . . . . . . . 20
2.2.6 DNA gel electrophoresis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.7 Analytical PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.2.8 Bacterial colony PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
i
CONTENTS
2.2.9 High fidelity PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.2.10 cDNA synthesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.2.11 Blunt end cloning into pENTR D/TOPO plasmids . . . . . . . . . . . . . . . . 23
2.2.12 Site directed mutagenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.2.13 Restriction digest cloning into pGAPZα B plasmids . . . . . . . . . . . . . . 24
2.2.14 Transformation of P. pastoris . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.3 Protein methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.3.1 E. coli protein expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.3.2 Pichia pastoris protein expression . . . . . . . . . . . . . . . . . . . . . . . . 26
2.3.3 Separation of recombinant protein fractions . . . . . . . . . . . . . . . . . . . 26
2.3.4 SDS-PAGE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.3.5 Western blotting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.3.6 Coomassie staining . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.3.7 Protein purification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.3.8 Co-immunoprecipitation of GID1a and SUMO1 . . . . . . . . . . . . . . . . 30
2.3.9 Yeast two-hybrid assay of GID1a and RGA . . . . . . . . . . . . . . . . . . . 31
2.3.10 Surface plasmon resonance of GID1a and SUMO1 . . . . . . . . . . . . . . . 33
2.3.11 Reconstituted E. coli SUMOylation assay . . . . . . . . . . . . . . . . . . . . 34
2.3.12 In vitro cell free SUMOylation assay of RGA . . . . . . . . . . . . . . . . . . 35
2.4 Peptide array methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.4.1 Large-scale cellulose peptide array screen . . . . . . . . . . . . . . . . . . . . 36
2.4.2 Cellulose array stripping . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.4.3 Cellulose array Ponceau-S staining . . . . . . . . . . . . . . . . . . . . . . . 38
2.5 Small-scale nitrocellulose peptide array screen . . . . . . . . . . . . . . . . . . . . . . 38
2.6 Plant methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.6.1 Seed sterilisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.6.2 Floral dip transformation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.6.3 Germination assay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.7 Computational methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3 Prediction of SUMO-related sequence features 40
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.1.1 SIM features . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.1.2 SUMO site features . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.1.3 Random forest classifiers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.1.4 Improving current models . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.2 Chapter aims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.3 Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.3.1 SIM peptide array design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.3.2 Interaction screen of SIM peptide arrays . . . . . . . . . . . . . . . . . . . . . 51
3.3.3 SIM array image data collection . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.3.4 SUMO site data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.3.5 Peptide and protein analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.3.6 Principal component analysis of amino acid features . . . . . . . . . . . . . . 58
3.3.7 Random forest predictors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.3.8 HyperSUMO, a graphical user interface sequence feature predictor . . . . . . 62
3.3.9 Genome-wide screen for SIMs . . . . . . . . . . . . . . . . . . . . . . . . . . 63
ii
CONTENTS
3.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
3.4.1 SIM peptide array image analysis . . . . . . . . . . . . . . . . . . . . . . . . 64
3.4.2 Sequence analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.4.3 Phosphorylated SIM peptides . . . . . . . . . . . . . . . . . . . . . . . . . . 78
3.4.4 Principal component analysis of amino acid indices . . . . . . . . . . . . . . . 79
3.4.5 SIM random forest models . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
3.4.6 SUMO site random forest models . . . . . . . . . . . . . . . . . . . . . . . . 88
3.4.7 Genome screen for SIM containing proteins . . . . . . . . . . . . . . . . . . . 92
3.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
3.5.1 Peptide array . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
3.5.2 SIM analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
3.5.3 SUMO sequence feature predictors . . . . . . . . . . . . . . . . . . . . . . . 99
3.5.4 Arabidopsis genome-wide SIM screen . . . . . . . . . . . . . . . . . . . . . . 101
4 Characterisation of SUMOylated RGA 103
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
4.2 Chapter aims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
4.3.1 Analysis of RGA protein sequences . . . . . . . . . . . . . . . . . . . . . . . 106
4.3.2 Lysine 65 in RGA is the site of SUMOylation . . . . . . . . . . . . . . . . . . 107
4.3.3 N-terminal fusion tags are not present in recombinant RGA . . . . . . . . . . 108
4.3.4 SUMOylated RGA produced in E. coli is insoluble . . . . . . . . . . . . . . . 109
4.3.5 RGA expression in Pichia pastoris . . . . . . . . . . . . . . . . . . . . . . . . 111
4.3.6 Redesigned E. coli expression vector for RGA . . . . . . . . . . . . . . . . . 115
4.3.7 Cell free in vitro enzymatic SUMOylation of RGA . . . . . . . . . . . . . . . 118
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
4.4.1 Expression of RGA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
4.4.2 Production of recombinant SUMOylated RGA . . . . . . . . . . . . . . . . . 124
5 Identification of a SIM in GID1a 126
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
5.2 Chapter aims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
5.3.1 SUMO interacts with GID1a . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
5.3.2 Bioinformatic analysis of GID1 proteins . . . . . . . . . . . . . . . . . . . . . 131
5.3.3 GID1a SIM peptides bind to AtSUM1 . . . . . . . . . . . . . . . . . . . . . . 133
5.3.4 GID1a SIM mutants maintain receptor function . . . . . . . . . . . . . . . . . 135
5.3.5 Investigating GID1a interactions using SPR . . . . . . . . . . . . . . . . . . . 136
5.3.6 Exposure of Arabidopsis to a synthetic SIM peptide . . . . . . . . . . . . . . . 140
5.3.7 Phenotype of GID1a SIM mutants in Arabidopsis . . . . . . . . . . . . . . . . 143
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
6 Discussion 151
6.1 Analysis of SIM sequences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
6.2 SUMO-related sequence predictor . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
6.3 The role of SUMOylated DELLAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
6.4 Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
iii
CONTENTS
Bibliography 157
Appendices 167
A Molecular Biology 167
A.1 DNA primers for PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
A.2 Genotyping of ots1 ots2 T-DNA insertion lines . . . . . . . . . . . . . . . . . . . . . 169
B SIM peptide arrays 170
B.1 Areas of images sampled for baseline subtraction assessment . . . . . . . . . . . . . . 171
B.2 SIM peptide sequences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
B.3 Predicted SIM containing proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
B.4 SIM containing protein gene ontology analysis . . . . . . . . . . . . . . . . . . . . . 206
C Software 210
C.1 Peptide array image analysis software . . . . . . . . . . . . . . . . . . . . . . . . . . 211
C.1.1 CalcGrid.m function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
C.1.2 discCalc.m function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
C.1.3 drawCircles.m function . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213
C.1.4 drawDots.m function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213
C.1.5 drawFigure.m function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
C.1.6 generateResults.m function . . . . . . . . . . . . . . . . . . . . . . . . . 214
C.1.7 getmidpointcircle.m function . . . . . . . . . . . . . . . . . . . . . . . . 215
C.1.8 Array_Tool.m GUI function . . . . . . . . . . . . . . . . . . . . . . . . . . 217
C.2 Sequence analysis functions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
C.2.1 Sequence similarity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
C.2.2 Preference logo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225
iv
List of Figures
1.1 The SUMOylation enzyme cascade. . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
3.1 SIM binding site in SUMO. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.2 Ponceau-S stained peptide arrays. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.3 Correction error for array spot intensity normalisation. . . . . . . . . . . . . . . . . . 66
3.4 Baseline normalisation for AtSUM1 interaction arrays. . . . . . . . . . . . . . . . . . 67
3.5 Baseline normalisation for AtSUM1 control arrays. . . . . . . . . . . . . . . . . . . . 68
3.6 Baseline normalisation for HsSUM1 interaction arrays. . . . . . . . . . . . . . . . . . 69
3.7 Baseline normalisation for HsSUM1 control arrays. . . . . . . . . . . . . . . . . . . . 70
3.8 Far-western dot blot of peptide arrays probed with AtSUM1. . . . . . . . . . . . . . . 71
3.9 Far-western dot blot of peptide arrays probed with HsSUM1. . . . . . . . . . . . . . . 72
3.10 Processing results showing before and after values of the spots. . . . . . . . . . . . . 73
3.11 Venn diagram of AtSUM1 and HsSUM1 interacting SIM peptides. . . . . . . . . . . . 75
3.12 Sequence analysis of Arabidopsis SUMO1 interacting peptides. . . . . . . . . . . . . 76
3.13 Sequence analysis of human SUMO1 interacting peptides. . . . . . . . . . . . . . . . 77
3.14 Phosphorylated SIMs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
3.15 Correlation matrix of variables from the AAindex database. . . . . . . . . . . . . . . . 81
3.16 Cumulative variance accounted for in AAindex PCA. . . . . . . . . . . . . . . . . . . 82
3.17 SIM predictor variable importance . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
3.18 SIM A model parameter optimisation. . . . . . . . . . . . . . . . . . . . . . . . . . . 84
3.19 SIM B model parameter optimisation. . . . . . . . . . . . . . . . . . . . . . . . . . . 85
3.20 SIM R model parameter optimisation. . . . . . . . . . . . . . . . . . . . . . . . . . . 86
3.21 SIM predictor ROC curves. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
3.22 SUMO site predictor variable importance. . . . . . . . . . . . . . . . . . . . . . . . . 89
3.23 SUMO site model parameter optimisation. . . . . . . . . . . . . . . . . . . . . . . . . 90
3.24 SUMO site predictor ROC curves. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4.1 Alignment of DELLA proteins showing the predicted SUMO site. . . . . . . . . . . . 106
v
LIST OF FIGURES
4.2 Reconstituted SUMOylation assay of RGA. . . . . . . . . . . . . . . . . . . . . . . . 107
4.3 No immunoreactivity against N-terminal tagged RGA proteins. . . . . . . . . . . . . . 109
4.4 SUMOylated RGA produced in the reconstituted E. coli system is insoluble. . . . . . . 110
4.5 Restriction digest of RGA constructs in pGAPZαB. . . . . . . . . . . . . . . . . . . . 112
4.6 Small scale purification of RGA proteins from P. pastoris. . . . . . . . . . . . . . . . 112
4.7 RGA expression in P. pastoris. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
4.8 Large scale purification of RGA proteins from P. pastoris. . . . . . . . . . . . . . . . 114
4.9 DNA sequences of original and new RGA pENTR D/TOPO vectors. . . . . . . . . . . 116
4.10 Expression of RGA with N-terminal His and GST tags. . . . . . . . . . . . . . . . . . 117
4.11 Expression of RGA with a C-terminal His tag. . . . . . . . . . . . . . . . . . . . . . . 118
4.12 Purified proteins for in vitro SUMOylation assay. . . . . . . . . . . . . . . . . . . . . 119
4.13 In vitro enzymatic SUMOylation of RGA. . . . . . . . . . . . . . . . . . . . . . . . . 121
4.14 Expression of new RGA clone in pET DEST 55 and pDEST15. . . . . . . . . . . . . . 122
5.1 Co-IP of AtSUM1 with GID1a. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
5.2 Mapping of SIM-like hydrophobic cores onto the 3D structure of GID1a. . . . . . . . 132
5.3 Interaction of GID1 SIMs with SUMO1. . . . . . . . . . . . . . . . . . . . . . . . . . 134
5.4 GID1a SIM mutant proteins interact the DELLA protein RGA. . . . . . . . . . . . . . 135
5.5 GID1a mutant protein purification. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
5.6 SPR senograms of GID1a binding. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
5.7 Synthetic SIM peptide does not affect plant growth under stress. . . . . . . . . . . . . 142
5.8 Protein expression analysis of transgenic GID1a over-expression plant lines. . . . . . . 144
5.9 Germination rates for over-expressing GID1a lines. . . . . . . . . . . . . . . . . . . . 145
5.10 Germination rates for over-expressing GID1a homozygous lines. . . . . . . . . . . . . 146
A.1 Confirmation of the ots1-1 ots2-1 knock-down plant line. . . . . . . . . . . . . . . . . 169
B.1 Peptide array area used to assess baseline: AtSUM1 interaction blot. . . . . . . . . . . 171
B.2 Peptide array area used to assess baseline: AtSUM1 control blot. . . . . . . . . . . . 172
B.3 Peptide array area used to assess baseline: HsSUM1 interaction blot. . . . . . . . . . 173
B.4 Peptide array area used to assess baseline: HsSUM1 control blot. . . . . . . . . . . . 174
C.1 Peptide array analysis GUI interface. . . . . . . . . . . . . . . . . . . . . . . . . . . . 211
vi
List of Tables
2.1 Antibiotics for selection of transgenic organisms. . . . . . . . . . . . . . . . . . . . . 11
2.2 Primary antibodies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.3 Secondary antibodies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.4 Purchased enzymes, proteins and specialist reagents. . . . . . . . . . . . . . . . . . . 13
2.5 Commercial molecular biology kits. . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.6 Plasmids used for protein expression. . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.7 Bacterial strains. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.8 Yeast strains. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.9 Analytical PCR program. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.10 High fidelity PCR program. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.11 SDS-PAGE gel components. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.12 Co-IP of GID1a and SUM1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.13 GID1a-RGA yeast two-hybrid clones. . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.14 GID1a SPR reactions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.15 Cell free in vitro SUMOylation assay reaction components. . . . . . . . . . . . . . . . 36
3.1 SIM class models. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.2 Percentage of peptide spots excluded from final SIM dataset. . . . . . . . . . . . . . . 74
3.3 Effect of phosphorylation on SIM peptide interaction. . . . . . . . . . . . . . . . . . . 79
3.4 SIM predictor ROC AUC values. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
3.5 Comparison of ROC AUC values for various SUMO site predictors. . . . . . . . . . . 91
3.6 Summary molecular function gene ontology analysis. . . . . . . . . . . . . . . . . . . 94
3.7 Summary biological process gene ontology analysis. . . . . . . . . . . . . . . . . . . 95
5.1 GID1a mutant protein coupling to the CM5 chip for SPR analysis. . . . . . . . . . . . 138
5.2 Interactors tested against GID1a and GID1a mutant proteins. . . . . . . . . . . . . . . 138
A.1 DNA primers used for PCR. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
vii
LIST OF TABLES
B.1 SIM peptide interaction values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
B.2 Top 500 predicted SIM containing proteins in Arabidopsis. . . . . . . . . . . . . . . . 195
B.3 Full molecular function gene ontology analysis of SIM containing proteins. . . . . . . 206
B.4 Full biological process gene ontology analysis of SIM containing proteins. . . . . . . . 208
C.1 Function files from the peptide image analysis software tool. . . . . . . . . . . . . . . 211
viii
Acknowledgements
I would like to give a special thank you to my two supervisors, Dr Ari Sadanandom and Dr Jay Moore
for their guidance, support and patience throughout this project. I would like to thank Dr Ari Sadanan-
dom for giving me the flexibility to explore novel research methods and for his support to make those
approaches a reality. I would like to thank Dr Jay Moore for his help and support with the design of the
computational aspects of this project.
Thank you to all the members of the Warwick Systems Biology Department who have helped me
over the years with a special mention for Anne Maynard for helping sort out all things administration
related, usually at the very last minute. I would like to thank the following people for their specific
support: Professor George Baillie for making the peptide arrays, Professor Richard Napier for help with
SPR, Dr Prashant Pyati at Durham University for help with Pichia pastoris and Dr Laura Baxter for
supplying plant ortholog data.
Finally, I would like to thank my family, friends and my partner for believing in me and supporting
me all the way through the Ph.D. project.
ix
Declaration and Inclusion of Material
from a Prior Thesis
This thesis is submitted to the University of Warwick in support of my application for the degree of
Doctor of Philosophy. It has been composed by myself and has not been submitted in any previous
application for any degree apart from the background material in the introductions of Chapters 4 and
5 which was previously submitted for a Master of Science in Systems Biology. The introductions to
these two chapters refer to work described in a previous thesis that the plant DELLA protein GAI can
be SUMOylated.
The work presented was carried out by the author except for the manufacture of large-scale cellulose
peptide arrays described in Chapter 3. The arrays were synthesised by Professor G. Baillie’s research
group at Glasgow University as part of a collaboration.
The work described in Chapters 4 and 5 was published in the following two articles:
Conti, L. Nelis, S. Zhang, C. Woodcock, A. Swarup, R. Galbiati, M. Tonelli, C. Napier, R. Hedden,
P. Bennett, M & Sadanandom, A. (2014) Small ubiquitin-like modifier protein SUMO enables
plants to control growth independently of the phytohormone gibberellin. Developmental Cell,
28(1): 102-10.
Nelis, S. Conti, L. Zhang, C. & Sadanandom, A. (2014) A functional Small Ubiquitin-like Modifier
(SUMO) interacting motif (SIM) in the gibberellin hormone receptor GID1 is conserved in cer-
eal crops and disrupting this motif does not abolish hormone dependency of the DELLA-GID1
interaction. Plant Signaling & Behavior. (Accepted September 2014)
x
Abstract
SUMO is a small protein that is ligated to other proteins to regulate their function. Ligation occurs at
lysine residues within a SUMO site motif. A wide range of proteins are targets of SUMOylation and in
plants SUMO plays a diverse role in many important processes. Processes including development, stress
tolerance, hormone regulation, DNA repair and chromatin remodelling are regulated by SUMOylation.
SUMO affects protein function primarily by establishing interactions through SUMO interacting motifs
(SIMs) in interacting protein partners. SUMO can also alter protein function by blocking access to
protein domains and by causing conformational changes to the target. The ability to predict SIMs
in plant proteins would be useful for research into the poorly understood mechanisms behind SUMO
regulation. Large arrays of synthetic peptides were screened with SUMO to identify SIM peptides.
These data were used to characterise the sequence composition of plant SIMs. The plant SIMs were
compared and contrasted with human SIMs to highlight the functional differences between these two
evolutionary distinct species. The data were used to build a predictor for SIMs using random forest
models. A new SUMO site predictor was built using random forest models as well. The SIM predictor
was used to identify putative SIM containing proteins in the Arabidopsis thaliana genome and the
functional enrichment of these genes was analysed. The role of SUMO in the plant gibberellin (GA)
pathway was also investigated. The DELLA protein RGA is a negative regulator of GA signalling and
this protein was shown to be SUMOylated. RGA stability is regulated by the GA receptor GID1 and it
was demonstrated that GID1a contains a SIM. It was proposed that SUMOylated RGA interacted with
GID1a through its SIM which inhibited its function. The model was tested by investigating the binding
of SUMO to GID1a and by generating mutants of GID1a that had reduced SUMO affinity. The results
demonstrate that GA signalling can be enhanced by introducing a mutation into the GID1a SIM.
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Small ubiquitin-like modifier (SUMO) is a small protein that is conserved across eukaryotes (Iyer
et al., 2006) and plays a vital role in plant physiology (Hay, 2005). SUMO belongs to the group of
ubiquitin-like proteins that all share the β-grasp fold structure of ubiquitin, the founding member of this
group. The tertiary structure of SUMO is very similar to that of ubiquitin but the sequence similarity
between the proteins is low which gives rise to very different biochemical properties (Burroughs et al.,
2007) and each protein plays a very different role in the cell.
Both ubiquitin and SUMO are ligated to other proteins as post translational modifications (PTMs)
to regulate their function. The primary role of ubiquitin is to regulate protein stability through the form-
ation of poly-ubiquitin chains. Proteins tagged with poly-ubiquitin chains are targeted for degradation
by the 26S proteasome and ubiquitin dynamically regulates protein stability in response to various mo-
lecular cues (Hershko & Ciechanover, 1998). SUMO on the other hand plays a different role unrelated
to protein stability, rather it regulates the function of proteins it is ligated to by a number mechanisms
(Miura et al., 2007). The dominant role for SUMO is to recruit interactions with other proteins by bind-
ing to short SUMO interacting motifs (SIMs) within other proteins (Hecker et al., 2006). SUMO can
also regulate protein function by blocking interactions through steric hindrance (Boyer-Guittaut et al.,
2005) or through conformational changes to modified protein (Ulrich, 2005). The modification of pro-
teins by SUMO occurs at a lysine residue and in most cases the lysine residue lies within the conserved
motif ΨKx[ED]. Additionally, like ubiquitin, poly-SUMO chains can be formed by the SUMOylation
of lysines within SUMO itself.
In Arabidopsis thaliana (Arabidopsis hereafter) there are eight SUMO paralogs though only
SUMO1,2,3 and 5 (SUM1-3 & 5) are expressed at detectable levels (Budhiraja et al., 2009), suggesting
the remaining SUMO paralogs may be pseudogenes or do not play a significant role within the cell. The
SUMO paralogs SUM1 and SUM2 are the most similar, they are expressed at the highest levels and they
have a high degree of functional redundancy. SUM3 is more divergent and SUM5 is the most dissimilar
of the four paralogs. Single mutants of either SUM1 or 2 do not show a phenotype while the double
mutant sum1 sum2 is lethal (Saracco et al., 2007). SUM1 and 2 appear to play a dominant role in plant
physiology and are preferentially conjugated to targets over SUM3 or SUM5 (Castaño-Miquel et al.,
2011). The expression profiles for the various SUMO paralogs are different suggesting that in plants the
different paralogs have distinct functional roles (van den Burg et al., 2010).
1.1 The SUMOylation cascade
Both SUMO and ubiquitin are attached to proteins by a similar cascade of enzyme reactions, with spe-
cific enzymes for both the SUMO and ubiquitin cascades (Miura & Hasegawa, 2010). SUMO proteins
are expressed as pro-peptides that undergo post-translational processing to produce the mature species
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by SUMO proteases which cleave a small fragment off the C-terminal end of the protein. Mature SUMO
terminates with a di-glycine motif at its C-terminal end and ligation to SUMO targets occurs at the ter-
minal glycine of this motif forming an isopeptide bond with a lysine side chain in the targets. The
di-glycine motif in SUMO is essential for ligation to target lysine residues. Ligation occurs through a
cascade of reactions mediated by three classes of enzyme namely E1, E2 and E3 shown in Figure 1.1.
S E1 E2
Protease Target
Target
S S
S
E3
Activation Conjugation
Ligation
Deconjugation
Figure 1.1: The SUMOylation enzyme cascade. SUMO (S) is activated by an E1 activating heterodimer
then transferred to an E2 conjugating enzyme then ligated to a target. SUMO E3 ligases may assist in
SUMOylation however, SUMOylation can still occur in the absence of an E3. SUMO proteases can
remove SUMO from conjugated targets and the SUMO is then recycled back into the pathway.
The SUMO activating enzyme (SAE) or E1 catalyses the ATP dependant process of activation
whereby the E1 captures free SUMO by forming a covalent thioester bond to the SUMO molecule,
generating activated SUMO. The E1 is a heterodimer of two proteins SAE1 and SAE2 and in Ara-
bidopsis there are two isoforms of SAE1, SAE1a and SAE1b. The activated SUMO is then passed to a
SUMO conjugating enzyme (SCE) or E2 by transfer of the thioester linkage to the E2. In the final step
E3 ligases mediate the conjugation to a target, however, while an E3 is essential for ubiquitin ligation,
SUMO ligation can occur in the absence of an E3. SUMO E3 enzymes have been shown to enhance the
rate of SUMOylation by binding to and restricting the flexibility of the thioester linkage between the
SUMO and E2 enzyme which maintains a more favourable conformation for SUMO ligation (Truong
et al., 2011). The mechanism of action for the SUMO E3 ligases is different to that of ubiquitin E3
ligases which bind to specific motifs or domains within the target proteins and thus confer substrate
specificity, something that SUMO E3s do not. It is also of interest to note that while there are at least
1400 ubiquitin E3 ligases in Arabidopsis (Sadanandom et al., 2012), only four SUMO E3 ligases have
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been found to date (Novatchkova et al., 2012). While there are only four published plant SUMO E3
ligases, it is possible that more exist as there are an appreciable number in other eukaryotes (Wilkinson
& Henley, 2010). The four plant E3s were discovered through homology searching with animal and
yeast E3s. It may be the case that there are classes of plant specific E3s that have little or no homology
with animal or yeast and have yet to be identified.
Like ubiquitin, chains of poly-SUMO can form on a target protein. In plants AtSUM1 and AtSUM2
can form chains while SUM3 cannot as it lacks a SUMOylatable lysine residue (Chosed et al., 2006)
and it has been proposed that AtSUM3 could act as a SUMO chain terminator (Ulrich, 2008) in planta.
The purpose of these chains appears to be to enhance the strength of an interaction with SUMO binding
proteins (SBPs). SBPs often contain regularly spaced repeats of SIMs in their amino acid sequence,
with each SIM binding to a SUMO molecule in a poly-SUMO chain. Poly-SUMO chains binding to
tandem repeats of SIMs in this way enhance the strength of the interaction between the two interacting
proteins and the number of SUMO units in a chain could be used to regulate interaction strengths. More
recently, hybrid poly-SUMO-ubiquitin chains have been found and these have been observed in two
distinct instances. The first is formed when SUMO targeted ubiquitin ligases attach a chain of ubiquitin
to a growing SUMO chain leading to proteasomal degradation of the target. This mechanism allows
SUMOylation to target proteins for degradation. Secondly, hybrid SUMO-ubiquitin chains can act as
distinct signals and proteins with hybrid SIM and ubiquitin interacting motif repeats have been identified
that bind specifically to these hybrid chains (Guzzo & Matunis, 2013).
After ligation of SUMO, various families of SUMO proteases can later cleave attached SUMO mo-
lecules from SUMOylated proteins, returning the SUMO protein to the pool of free SUMO (Miura et al.,
2007). These proteases, along with the ligation machinery, allows SUMO to be transiently attached to
target proteins, allowing for many levels of regulation. Antagonisation between the SUMOylation cas-
cade and SUMO deconjugation machinery allows for the level of SUMOylated targets in a cell to be
regulated and a shift in the levels of these components can lead to a shift in the levels of SUMOylated
proteins in the cell. The importance of the de-SUMOylating components has been highlighted by knock-
outs of SUMO protease genes which show strong phenotypes (Reeves et al., 2002). Double mutants of
the proteases OVERLY TOLERANT TO SALT1 and 2 (OTS1 & 2), ots1 ots2, show a dwarf phenotype
that is hypersensitive to salt stress and higher levels of SUMOylated protein levels than wild type plants
(Conti et al., 2008).
1.2 SUMO interacting motifs
The dominant mechanism by which SUMO modulates protein function is through interaction with SIMs
in other proteins. The β-grasp fold structure of SUMO consists of an α-helix and a β-sheet and this
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structure is important for forming interactions with SIMs. SIMs tend to be disordered stretches of a
peptide lacking secondary structure (Vogt & Hofmann, 2012). The SIM binds to SUMO by inserting
into a groove between the β-sheet and α-helix, extending the β-sheet in SUMO in either a parallel or
antiparallel manner (Song et al., 2004). The core amino acids of the SIM inserting into this groove
and participating in the β-sheet are mostly hydrophobic (typically valine, leucine and isoleucine). This
core is flanked by polar or charged amino acids that interact with portions of SUMO outside the groove
(Namanja et al., 2012). SIMs often show SUMO isoform specificity, binding to one isoform more
strongly than another. The differences in SIM binding between different SUMO isoforms allows the
functional specialisation of SUMO paralogs.
SIMs play an important role in progression of SUMO through the SUMOylation cascade, with
SIMs found in both E2 and E3 enzymes. The role of the SIM in the E2 is to form a complex with an
activated E1-SUMO complex which allows transfer of SUMO to the E2 (Duda et al., 2007). SUMO
E3 enzymes which can also contain SIMs, can then bind to the SUMO-E2 complexes to facilitate the
SUMOylation of a target protein (Yang & Sharrocks, 2010). SIMs also play a role in recognition of
target proteins, SIMs located near to SUMO sites in target proteins can bind to SUMO-E2 complexes
promoting SUMOylation of the target (Lin et al., 2006). SIMs in target proteins can determine SUMO
paralog selection via SIM specificity for a particular SUMO isoform (Tatham et al., 2005).
1.3 Biological role of SUMO
SUMOylation has been shown to be critical for a vast range of physiological and developmental pro-
cesses and a large number of proteins have been shown to be targets for SUMOylation. Large numbers
of proteins involved in protein stability, metabolism and transcription have been shown to be poten-
tial targets, though the function of most SUMO targets remains unknown (Elrouby & Coupland, 2010).
Mutants of components of the SUMO conjugation cascade or deconjugation enzymes show severe phen-
otypes and have been instrumental in elucidating the role of SUMOylation in plants. While double
knockouts of AtSUM1 and AtSUM2 are embryo lethal, so are knockouts of components of SUMO E1
and E2 enzymes demonstrating that SUMO conjugation is essential for plant viability (Saracco et al.,
2007). The SUMO E3s SIZ and MMS21, while not the only E3 ligases in plants, play a predominant
role. Single knockouts of either show a strong phenotype which cannot be complemented by overex-
pression of the other and the double knockout siz1 mms21 is embryo lethal (Ishida et al., 2012) showing
that these two E3s are essential for viability and have divergent roles in plant physiology. siz1 mutant
plants show a dwarf phenotype with reduced fertility and a range of other abnormalities (Ling et al.,
2012). SIZ1 has been found to negatively regulate salicylic acid (SA) signalling and the levels of this
hormone are elevated in siz1 plants. The phenotype of siz1 plants can be mostly reversed by reducing
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SA levels by expressing the bacterial SA biosynthesis inhibitor nahG, showing that the observed siz1
phenotype is predominantly due to SA accumulation (Miura et al., 2010). The phenotype seen with
mms21 mutants on the other hand is not due to accumulation of SA but rather appears to be due to
cytokinin signalling instead as cytokinin regulated genes show reduced expression in the mms21 mutant
(Huang et al., 2009). mms21 mutant plants show reduced fertility, reproductive organ deformities and
chromosome mis-segregation and fragmentation during meiosis (Liu et al., 2014).
Knockouts of the SUMO proteases also show strong phenotypes and display higher levels of
SUMOylated proteins compared to wild type plants. The higher levels of SUMOylated proteins show
that SUMOylation is a dynamic process and that transient attachment of SUMO is required for normal
cellular function. The SUMO protease mutant esd4 shows a dwarf phenotype with various develop-
mental abnormalities (Reeves et al., 2002), while double knockouts of the proteases ots1 and ots2 show
sensitivity to salt stress. Interestingly overexpression of OTS1 in wild type plants increased tolerance to
salt stress (Conti et al., 2008).
Cellular plant stresses lead to an increase in SUMOylated protein levels in the cell, indicating that
SUMO is implicated in stress response mechanisms. Stresses such as drought, salt, high temperatures
and exposure to reactive oxygen species have all been shown to induce SUMOylation in Arabidopsis
(Yoo et al., 2006; Conti et al., 2008; Kurepa et al., 2003). The E3 MMS21 appears to be a negat-
ive regulator of drought tolerance and during drought conditions the expression of MMS21 decreases.
Mutant mms21 plants show higher drought tolerance than wild type plants while overexpressors show
reduced tolerance. MMS21 acts by repressing the expression of stress genes through abscisic acid sig-
nalling (Zhang et al., 2013). Conversely the E3 ligase SIZ1 is a positive regulator of drought tolerance
and partially responsible for the large increases in SUMOylated protein levels observed during drought
stress (Miura & Nozawa, 2014). SIZ1 enhances drought tolerance by positively regulating a number
of drought tolerance related genes (Catala et al., 2007) and may regulate drought tolerance through
SA mediated stomatal closure which reduces water loss (Miura et al., 2012). Proteomic analyses of
SUMOylation during heat shock treatment has revealed that stress induces an increase in SUMOylation
of the same set of proteins that are SUMOylated under normal conditions rather than the SUMOylation
of new targets. A large proportion of the proteins that showed the highest increase in SUMOylation were
RNA and chromatin related genes as well as the heat shock protein transcription factor HSF2A. This
suggests that the observed increase in SUMOylation leads to differential gene expression (Miller et al.,
2010). The E3 SIZ1 confers tolerance to elevated levels of copper and is required for correct distribution
within plant tissues and mutant siz1 plants display copper toxicity at lower levels than wild type plants
(Chen et al., 2011). These data suggest that SUMOylation has a role in heavy metal tolerance however,
to date no research exists on the role of SUMOylation in response to metals other than copper.
The E3 ligase SIZ1 has also been implicated in nutrient assimilation processes. Phosphate starvation
6
CHAPTER 1. INTRODUCTION
leads to changes in root architecture through induction of lateral roots in order to increase phosphate
uptake. SIZ1 is a negative regulator of this process and acts by negatively regulating auxin pattern-
ing. During phosphate starvation the levels of SIZ1 protein decline and this leads to the expression
of various genes associated with root development (Miura et al., 2011) as well as genes required for
phosphate uptake, transport and assimilation (Miura et al., 2005). Conversely SIZ1 positively regulates
nitrogen assimilation. The nitrate reductase enzymes NIA1 and 2 are SUMOylated, which is mediated
by SIZ1, and SUMOylation of these nitrate reductase enzymes enhances their activity. These enzymes
are required for nitrate processing and siz1 plants show an accumulation of nitrate and reduction in other
nitrogen containing molecules as well as a nitrogen starvation phenotype compared to wild type plants
(Park et al., 2011).
While it has been shown that SIZ1 is vital for correct SA signalling, SUMO also plays a role in
abscisic acid signalling (ABA) (Lois et al., 2003).The SUMOylation of the transcription factors MYB30
and ABI5 involved in ABA signalling inhibits their activity. ABI5 is one of the many ABA responsive
transcription factors acting as a hormone receptor (Finkelstein & Lynch, 2000) which is stabilised in the
presence of ABA. SUMOylation of ABI5 also stabilises the protein leading enhanced ABA signalling
(Miura et al., 2009). MYB30 on the other hand is not involved in ABA perception but knockouts
show ABA hypersensitivity. SUMOylation of MYB30 is required for normal function and the non-
SUMOylatable myb30 K38R mutant shows a partial ABA hypersensitivity phenotype (Zheng et al.,
2012). Apart from the hormones SA and ABA, the role SUMOylation plays with the other major plant
hormones remains unclear, however, part of the work presented in this thesis in chapters 2.3.12&5
demonstrates that SUMO negatively regulates gibberellic acid signalling during stress.
A range of developmental processes are governed by SUMO and mutants of any of the SUMO cas-
cade enzymes show growth and development effects. Mutant siz1 plants show a range of developmental
abnormalities which have been investigated in detail. The increased levels of SA in this mutant lead to
reduced plant size and at least part of the reduction in growth is due to inhibition of cell elongation and
division which is governed by a number of SA regulated xyloglycan endotransglycosylase/hydrolase
genes (Miura et al., 2010). Floral development is severely affected in siz1 mutants though not all defects
are due to the increased levels of SA in these mutants. Female gametophyte development is impaired
leading to reduced seed yield and this effect is not reversed by reducing SA levels in this mutant (Ling
et al., 2012). SIZ1 regulates flowering time through the floral repressor protein FLC. The regulation
of this protein by SUMO has a rather interesting mechanism with three levels of SUMO regulation.
SUMOylation of FLC is required for the normal floral repression function of this protein. SIZ1 is able
to bind to FLC and surprisingly this reduces the rate of SUMO conjugation to FLC. Also, by binding to
FLC, SIZ1 has the effect of stabilising the FLC protein (Son et al., 2014). This complicated mechanism
in turn regulates flowering time by modulating FLC activity and stability.
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SUMOylation plays a role in defence mechanisms against plant pathogens. SIZ1 negatively regu-
lates innate immunity against biotrophic pathogens through systemic-acquired resistance (SAR) result-
ing from increased SA levels. Mutant siz1 plants, which hyperaccumulate SA, show constitutive SAR
and increased expression of pathogenesis-related genes and exhibit enhanced resistance against the bio-
trophic pathogen Pseudomonas syringae pv. tomato DC3000. Resistance to the necrotophic pathogens
mediated by the jasmonic acid pathway appears to regulated independently of SIZ1 as siz1 plants show
no change in susceptibility to the necrotrophic pathogen Botrytis cinerea (Lee et al., 2007). Whether
SUMOylation plays a role in immunity against necrotrophic pathogens is uncertain. The pathogen
Xamthamonas campestris (Xc) has evolved a SUMO protease effector protein, XopD, that is injected
into host cells through the bacterial type III secretion system and weakens the host defence against the
pathogen. XopD leads to reduced SA levels and differential gene expression however, the mechanism
of XopD function remains unclear but it is possible that XopD de-SUMOylates some as yet unidentified
protein in the plant cell to elicit its effect (Kim et al., 2008).
DNA damage is a common occurrence resulting from exposure to various mutagens including react-
ive chemical species, ultraviolet radiation, ionising radiation and replication errors. Cellular homeostasis
relies on effective DNA repair mechanisms to correct these errors which would otherwise lead to the
loss genome integrity. A multitude of repair processes have developed that repair the various kinds
of DNA damage. Various types of damage can occur and different mechanisms of repair are used to
address them. DNA double strand breaks (DSBs) are the most severe type of damage and these are
repaired either through nonhomologous end joining or homologous recombination. Nucleotides can be
modified by various mutagens leading to the formation of DNA adducts which are repaired by excision
of the faulty nucleotide leading to a single strand break which is then repaired. Nucleotide excision is
also used to repair nucleobase mismatches. Overall the process of DNA repair involves a large number
of enzymes and regulatory proteins and the posttranslational modification of these components by ubi-
quitination, phosphorylation and SUMOylation is used to regulate their activity (Jackson & Durocher,
2013). The importance of SUMO in DNA repair in mammalian systems was noted with the discovery
that HsSUM1,2 and 3 as well as SUMO E2 and E3 enzymes accumulated around DSBs (Galanty et al.,
2009; Morris et al., 2009). SUMO plays an important role in forming the protein repair complexes re-
quired for DNA repair. A mutation in one repair component in mammalian systems, BLM, that leads to
the loss of its SUMO site results in increased sensitivity to DNA damage (Ouyang et al., 2009). SUMO
regulated DNA mechanisms are also present in plants and are most important for maintaining the in-
tegrity of the meristem cell pool which develops into new plant organs during growth. The E3 ligase
MMS21 is important for the repair of DNA DSBs and mutants of this protein lead to sensitivity to DNA
damaging agents. The DNA repair targets of MMS21 remain unknown but the protein has been shown
to associate with the chromatin maintenance proteins MAINTENANCE OF CHROMOSOMES5 and 6
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(Xu et al., 2013). A number of chromatin regulation proteins have been identified that have functional
SIMs that include DNA and histone methyltransferases and demethylases suggesting that SUMO plays
a role in Arabidopsis DNA methylation processes, however, the direct role and mechanisms of these
proteins have not yet been elucidated (Elrouby et al., 2013). DNA repair mechanisms in plants are less
well understood than in animal systems and the role of SUMO even less so, however, recent research
has shown SUMO is likely to play an important role as it does in animal systems.
1.4 Purpose of work
The purpose of the work presented in this thesis was to investigate the role of SUMOylation in the
model plant Arabidopsis with a focus on the mechanisms and role of the SUMO-SIM interaction in
the plant AtSUMO1 (AtSUM1) protein. The peptide sequence requirements for the interaction were
investigated and compared a with a human homolog, HsSUMO1 (HsSUM1), to investigate to what
degree the binding properties of SUMO proteins from different species vary. A peptide library was used
to screen a large number of small SIM-like peptides for interaction with AtSUM1 and HsSUM1 and
a large dataset of interactions was generated. This dataset was used to build a predictor of AtSUM1
and HsSUM1 SIMs from the primary sequence of proteins using the random forest machine learning
algorithm. This work presents the first SUMO isoform specific SIM predictor developed to date. The
random forest algorithm has been used in the past to predict SUMO sites in proteins and an improved
method to build SUMO site predictors is presented which outperforms previous predictors.
The role of SUMOylation in the gibberellin hormone pathway will also be presented. Recently it
was discovered that DELLA repressor proteins in the gibberellin pathway are SUMOylated (Conti et al.,
2014) and a model was proposed whereby SUMOylated DELLA proteins negatively regulate gibberellin
signalling by binding to the gibberellin receptor GID1. Various aspects of this model were tested and it
was shown that the receptor GID1 can bind to SUMOylated proteins, and a potential SIM in the protein
was identified demonstrating that the proposed model is plausible.
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2.1 Materials and reagents
Basic laboratory chemicals for preparing buffers and for protein expression media were purchased from
Fisher Scientific. Antibiotics and media for plant tissue culture were purchased from Melford. Reagents
purchased from other companies will be noted throughout this chapter.
2.1.1 Antibiotics
Antibiotics were used to select transformed organisms or organisms with selection markers. Antibiotic
stock solutions were made up according to Table 2.1 and were sterilised by passing through a 0.2 μm
cellulose acetate filter. Antibiotic stock solutions were stored at -20°C. Additionally, zeocin aliquots
were wrapped in aluminium foil to protect them from light. All media requiring antibiotic supplement-
ation was prepared just before use. Agar plates supplemented with antibiotics were prepared in advance
and were stored at 0-5°C and were not kept for longer than 4 weeks. Autoclaved media was allowed to
cool to below 50°C before the addition of antibiotics to prevent degradation of heat sensitive antibiotics.
Antibiotic Working
concentration
(μg/ml)
Stock
concentration
(mg/ml)
Storage solvent
Carbenicillin 50 50 water
Chloramphenicol 34 34 100% ethanol
Gentamicin 20 20 water
Kanamycin 50 50 water
Rifampicin 25 12.5 100% methanol
Spectinomycin 50 50 water
Zeocin 100 100 water
Table 2.1: Antibiotics for selection of transgenic organisms.
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2.1.2 Antibodies
Antibodies were used in western blotting for detecting specific proteins. Newly purchased antibodies
were separated into 5 μl aliquots and stored at -80°C. Western blotting probing solutions containing
primary antibodies were recycled and the probing solutions were stored at -20°C. Solutions were reused
up to 5 times.
Epitope Type Animal raised in Company/Organisation Product code
GST Polyclonal Rabbit Sigma Aldrich G7781
6x His Monoclonal Mouse GE Life Sciences 27-4710-01
HA Monoclonal Rat Roche 11867423001
AtSUM1 Polyclonal Rabbit Abcam ab5316
HsSUM1 Polyclonal Rabbit Enzo Life Sciences BML-PW9460
RGA Polyclonal Sheep Nottingham University
Table 2.2: Primary antibodies.
Epitope Type Animal raised in Company/Organisation Product code
Rabbit IgG Polyclonal Goat Sigma Aldrich A0545
Mouse IgG Polyclonal Rabbit Sigma Aldrich A9044
Rat IgG Polyclonal Rabbit Sigma Aldrich A5795
Sheep IgG Polyclonal Goat Nottingham University
Table 2.3: Secondary antibodies. All secondary antibodies were conjugated to horse radish peroxidase
enzyme for chemiluminescent detection of the antibodies.
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2.1.3 Enzymes, proteins and specialist reagents
Product Company Product code
AvrII New England BioLabs R0174S
BugBuster® Mater Mix Merck Millipore 71456
cOmplete, Mini, EDTA-free tablets Roche 04693159001
DO Supplement –Leu/–Trp Clontech 630417
DO Supplement –His/–Leu/–Trp Clontech 630419
DpnI New England BioLabs R0176S
HsSUM1 protein Enzo Life Sciences UW0150
HyperLadder® 1 kb DNA ladder Bioline BIO-33053
Inorganic pyrophosphatase Sigma Aldrich I1891
Minimal SD Base Clontech 630411
Minimal SD Base agar Clontech 630412
PageRuler Plus Prestained Protein Ladder Thermo Scientific 26620
Phusion® Hot Start Flex DNA polymerase New England BioLabs M0535S
ReddyMix® Master Mix Thermo Scientific AB-0575/DC/LD/A
RNase H New England BioLabs M0297S
SfiI New England BioLabs R0123S
Silwet L-77 Momentive -
Surfactant P20 GE Life Sciences BR100054
T4 DNA ligase New England BioLabs M0202S
X-α-Gal Glycosynth 70039
XbaI New England BioLabs R0145S
YPD Medium Clontech 630409
YPER-Plus Thermo Scientific 78999
Table 2.4: Purchased enzymes, proteins and specialist reagents.
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2.1.4 Commercial molecular biology kits
Product name Purpose Company Product code
Amine Coupling Kit SPR chip coupling GE Life Sciences BR100050
DNeasy Plant Mini Kit DNA extraction from
plant tissue
Qiagen 69104
Gateway® LR Clonase®
II Enzyme mix
Plasmid construction Life Technologies 11791-020
pENTR™/D-TOPO®
Cloning Kit
Gene cloning Life Technologies K2400-20
Plasmid Midi Kit Plasmid extraction from
E. coli
Qiagen 12143
QIAprep Spin Miniprep
Kit
Plasmid extraction from
E. coli
Qiagen 27106
QIAquick Gel
Extraction Kit
DNA extraction from
agarose gel
Qiagen 28704
Spectrum™ Plant Total
RNA Kit
RNA extraction from
plant tissue
Sigma Aldrich STRN50
SuperScript® III
Reverse Transcriptase
cDNA synthesis Life Technologies GBP 43.70
μMACS GST Isolation
Kit
Immunoprecipitation of
GST tagged proteins
Miltenyi Biotech 130-091-370
Table 2.5: Commercial molecular biology kits.
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2.1.5 Plasmids
A range of plasmids were used to express proteins in bacteria, plants and yeast. These are shown in
Table 2.6. Most of the plasmids used the Gateway technology from Life Technologies to insert gene
fragments into the plasmids using homologous combination. A gene insert can be moved from an entry
pENTR plasmid into any destination vector using LR Clonase II enzyme mix from Life Technologies.
This system was used to generate most expression vectors.
Name Purpose N-tag C-tag Company/citation
pACYC Duet E. coli dual
protein
expression
6x His; S - Merck Millipore
pCDF Duet E. coli dual
protein
expression
6x His; S - Merck Millipore
pENTR D/TOPO cloning - - Life Technologies
pDEST 15† E. coli protein
expression
GST - Life Technologies
pDEST 17† E. coli protein
expression
6x His - Life Technologies
pDEST 22† Yeast 2-hybrid GAL4 AD - Life Technologies
pDEST 32† Yeast 2-hybrid GAL3 DBD - Life Technologies
pET DEST 55† E. coli protein
expression
Strep II 6x His Merck Millipore
pEarleyGate 201† Plant protein
expression (35S)
HA - Earley et al. (2006)
pGAPZα B P. pastoris
protein
expression
α-factor myc:6x His Life Technologies
Table 2.6: Plasmids used for protein expression. The dagger symbol (†) indicates Gateway compatible
destination plasmids.
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2.1.6 Bacterial strains
Table 2.7 shows the bacterial strains used for plasmid maintenance and protein expression and plant
transformation. Chemically competent stocks were prepared from the original commercial samples. Es-
cherichia coli and Agrobacterium tumefaciens are abbreviated to E. coli and A. tumefaciens respectively
in this chapter.
Species Bacterial strain Use Company / publication
E. coli DH5α Plasmid maintenance
E. coli BL21 (DE3) Protein expression New England BioLabs
E. coli CodonPlus RIL (DE3) Protein expression Agilent Technologies
A. tumefaciens GV3101 Plant transformation Koncz & Schell (1986)
Table 2.7: Bacterial strains.
2.1.7 Yeast strains
Yeast strains were used to perform yeast two-hybrid (Y2H) assays and for protein expression. Details
of the strains used are shown in Table 2.8.
Yeast species Strain Use Company
Saccharomyces cerevisiae AH109 Yeast two-hybrid Life Technologies
Pichia pastoris SMD1168 Protein expression Life Technologies
Table 2.8: Yeast strains.
2.1.8 Plant materials
Arabidopsis thaliana ecotype Columbia-0 (Col-0) was used for all plant work. Plants were grown under
long day conditions at 22°C. Seed collect from plants was stored either in paper bags or in 1.5 ml tubes
and were stored at room temperature in the dark.
2.1.9 Commonly used buffers
ECL
• Solution A: 200 mM Tris, pH 8.5, 800 μM p-coumaric acid, 10 mM 3-aminophthalhydrazide.
• Solution B: 0.4% w/v H2O2.
• Solutions A and B are mixed together in a 1:1 ratio just before use (final concentration: 100 mM
Tris, pH 8.5, 400 μM p-coumaric acid, 5 mM 3-aminophthalhydrazide, 0.2% w/v H2O2).
16
CHAPTER 2. MATERIALS AND METHODS
TBST
• 50 mM Tris, 150 mM NaCl, 0.1% Tween 20, pH 7.6.
TE buffer
• 10 mM Tris and 1 mM EDTA in pH 8.0.
4x SDS-PAGE sample buffer
• 200 mM Tris, 8% w/v SDS, 40% v/v glycerol, 4% v/v β-mercaptoethanol, 50 mM EDTA, 0.1%
w/v bromophenol blue.
2.1.10 Commonly used culture media
All culture media was sterilised by autoclaving at 121°C for 20 minutes.
½ MS agar
½ MS agar was used to culture Arabidopsis plants.
• 2.15 g/l Murashige and Skoog Basal Salt Mixture, 5% w/v sucrose, 0.7% phytoagar, pH 7.4.
YPG media
YPG was used for the culture of P. pastoris.
• 0.1% w/v yeast extract, 0.1% w/v peptone and 0.1% w/v glycerol.
2.2 Molecular biology methods
2.2.1 Bacterial culture
Both E. coli and Agrobacterium tumefaciens bacteria were grown on low salt Luria-Bertani (LB) 1.2%
agar plates. The agar plates were supplemented with appropriate antibiotics to select bacterial colonies
with required markers. The concentrations of antibiotics used are shown in Table 2.1. Bacteria were
streaked onto plates using a plastic loop to isolate monoclonal colonies when reviving bacteria from
cryogenic stocks and when receiving clones from other researchers. Plates were sealed using Parafilm®
to prevent drying out. E. coli were incubated for >12 hours or overnight at 37°C for colonies to grow
and were then stored at 5°C for short term storage. A. tumefaciens plates were incubated at 28°C for
2-4 days for colonies to develop and were then stored at 0-5°C for short term storage. Bacterial plates
stored at 0-5°C were not kept longer than 2 weeks.
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2.2.2 Bacterial glycerol stocks
Long-term glycerol stocks were made of all unique bacterial clones. To prepare the glycerol stocks, a
single bacterial colony was used to inoculate 10 ml of LB supplemented with appropriate antibiotics
and grown overnight with shaking at either 37°C or 28°C for E. coli or A. tumefaciens respectively. 600
μl of the bacterial culture was then transferred to a sterile 1.5 ml tube and 600 μl of sterile 50% v/v
glycerol solution was added and mixed by pipetting. The 1.5 ml glycerol stock was then flash frozen in
liquid nitrogen and then moved to a -80°C freezer for long-term storage.
To revive bacterial clones, the glycerol stock was removed from the freezer and transported in liquid
nitrogen. Glycerol stocks were opened under sterile conditions and a small piece of the frozen bacterial
culture was dislodged using a plastic pipette tip and then the stock was returned to the liquid nitrogen
container. The frozen culture on the pipette tip was then streaked onto an agar plate with appropriate
selection antibiotics and grown until colonies developed.
2.2.3 Preparing chemically competent E. coli
To transform E. coli with plasmids, chemically competent cells were prepared. To transform more than
one plasmid into E. coli, as is required for the reconstituted SUMOylation system; repeated rounds of
transformation followed by generating chemically competent cells were performed. For lines harbouring
one or more plasmids, appropriate selection antibiotics were included in the growth cultures.
Required reagents
• LB media
• Wash solution: 100 mM MgCl2
• Cryo solution: 85 mM CaCl2, 15% glycerol
All solutions were sterilised by autoclaving.
Method
A single colony from an agar plate was used to inoculate 10ml of LB, which was grown overnight at
37°C with vigorous shaking. At the start of the day of cell preparation, the wash and cryo solutions
were placed on ice to cool to around 0°C. The 2 ml of the starter culture was used to inoculate 100 ml
of LB in a 500 ml baﬄed Erlenmeyer flask which was incubated at 37°C with shaking at 180 rpm. The
bacteria were grown until the OD600 reached 0.5. The bacterial culture was then immediately placed
in an ice bath and agitated for 2 minutes to cool the bacterial culture. The culture was then transferred
into centrifuge tubes, and placed into a centrifuge rotor pre-cooled to 0°C then centrifuged at 5000 g for
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10 minutes to pellet the cells. From this point in the protocol every effort was made to ensure the cells
remained close to 0°C at all times. The supernatant from the culture was discarded and the cell pellet
was placed on ice. 100 ml of pre-cooled wash solution was added to pellet, which was then re-suspended
by agitating with a sterile plastic loop. The cells were then left on ice for 30 minutes. The cells were
then centrifuged as before and the supernatant discarded. The pellet was then suspended in 10 ml of
pre-cooled cryo solution and left to incubate on ice for 1 hour. 100 μl aliquots of the cells were pipetted
into 1.5 ml tubes pre-cooled in a -20°C freezer. The aliquots were immediately frozen in liquid nitrogen
and then moved to a -80°C freezer for long-term storage.
2.2.4 Transformation of chemically competent E. coli
The following protocol was used to transform all E. coli strains.
Required materials
• Chemically competent E. coli cells
• Plasmid DNA (10 - 200 ng/μl)
• SOC medium (SOB + 20 mM glucose:)
– First, prepare SOB (0.5% w/v yeast extract, 2% w/v tryptone, 10 mM NaCl, 2.5 mM KCl,
20 mM MgSO4, pH 7.5) and sterilise by autoclaving.
– Add 10 ml filer sterilised 2 M glucose solution per litre of SOB to make SOC.
• Agar plates with selection antibiotics for plasmid marker gene.
Method
Aliquots of competent cells in 1.5 ml tubes were first thawed on ice for 10 minutes. Up to 2 μl of
plasmid DNA was added to the competent cells. The competent cells were then flicked once to mix
the DNA and the tube was shaken to collect the cells at the bottom of the tube, which was then placed
on ice and left to incubate for 30 minutes. The competent cells were then heat shocked by placing in
a 42°C water bath for 25 seconds then promptly moved back onto ice for 5 minutes. 500 μl of sterile,
room temperature SOC medium was then added to the cells which were then moved to a 37°C incubator
heated and shaken at 220 rpm for 1 hour. 20 μl of the cell mixture was then pipetted onto one half of an
agar plate warmed to room temperature. The remaining cells were centrifuged at 5000 g for 30 seconds
to pellet the cells. The supernatant was then removed leaving around 50 μl in the tube. The pelleted
cells were then suspended in the remaining supernatant and all of the mixture was pipetted on to the
other half of the agar plate. Each drop of bacterial culture was spread over its respective half of the agar
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plate with a sterile spreader. Using dilute and concentrated mixtures on the same plate allowed single
colonies to develop irrespective of whether the transformation efficiency was high or low. Agar plates
were then sealed with Parafilm and incubated overnight at 37°C to allow colonies to grow.
2.2.5 Transformation of chemically competent A. tumefaciens
Required materials
• Chemically competent A. tumefaciens cells
• Plasmid DNA (100 - 200 ng/μl)
• LB medium
• Agar plates with selection antibiotics for plasmid marker gene.
Method
Aliquots of competent A. tumefaciens cells in 1.5 ml tubes were thawed on ice for 30 minutes. 5 μl
of plasmid DNA solution was then added to the cells. The competent cells were then flicked once to
mix the DNA and the tube was shaken to collect the cells at the bottom of the tube, which was then
placed on ice and left to incubate for 30 minutes. The cells were then placed in liquid nitrogen for 5
minutes followed by heat shock at 37°C for 5 minutes and were then placed on ice for 5 minutes. 1
ml of LB medium was then added to the cells, which were then moved to a 28°C incubator heated and
shaken at 220 rpm for 2 hours. The cells were then pelleted by centrifugation at 5000 g for 1 minute
and the supernatant was removed leaving 100 μl behind. The cells were suspended in the remaining
supernatant and all of the cell mixture was pipetted on to agar plates and spread over the agar surface
with a sterile spreader. The agar plates were then sealed with Parafilm then incubated at 28°C for 2-4
days for colonies to develop.
2.2.6 DNA gel electrophoresis
Agarose gel was prepared for DNA gel electrophoresis using commercial 1x Tris–Acetate–EDTA buffer
(TAE) and molecular biology grade agarose. Agarose gel concentrations of 0.6 - 2.0 % w/v were used
depending on the size of the DNA fragment to be resolved. The TAE buffer and agarose were mixed
in an Erlenmeyer flask and heated to boiling point using a microwave oven. The agarose gel was then
placed on a shaker for 5 minutes to cool slightly. 1 μl of 10 mg/ml ethidium bromide solution was
added per 100 ml of agarose gel. The gel was then placed in a casting tray with a well comb and
allowed to set for 30 minutes. Electrophoresis tanks with an electrode separation of 20 cm were used
and electrophoresis was carried out at 120 V. 1 kb HyperLadder® DNA ladder was used to determine
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DNA fragment size. Agarose gels were visualised using an ultraviolet transilluminator with a digital
camera. 1 μl of DNA loading buffer (0.5% w/v bromophenol blue; 0.5% w/v xylene cyanol blue; 30%
glycerol) was added per 10 μl of DNA sample before loading onto the agarose gel.
2.2.7 Analytical PCR
Step Temperature (°C) Time Number of cycles
Initial denaturation 95 1 min 1
Denaturation 95 10 s
Annealing Variable 20 s 35
Extension 72 1 min/kbp
Final extension 72 5 min 1
Table 2.9: Analytical PCR program. Used with ReddyMix and other Taq DNA polymerase enzymes.
For routine PCR for testing the presence of a DNA fragment in a sample the following protocol was
followed. 2x ReddyMix PCR Master Mix from Thermo Scientific was used. ReddyMix contains DNA
polymerase, buffer and dNTPs therefore only DNA template and primers needed to be added. 10 μl
reactions in 0.2 ml PCR tubes were used. For each reaction, the following were added: 5 μl ReddyMix,
0.5 μl of each DNA primer (10 μM), 0.5 μl DNA template and 3.5 μl water. Control reactions were
always included; water was used for the negative control and a known template for the positive control.
PCR reactions were then mixed shaking the tubes and the tubes were centrifuged briefly to collect the
PCR reaction mix at the bottom of the tubes.
The optimal annealing temperature was determined for each primer pair. The PCR was performed
in a heat cycler with a heated lid. The program used in the heat cycler is shown in Table 2.9.
2.2.8 Bacterial colony PCR
Bacterial colony PCR was used to test for the presence of a DNA fragment in both E. coli and A.
tumefaciens. This technique was used to confirm the correct recombination of vectors using the Gateway
system during plasmid construction using D_AttB-F and D_AttB-R primers (see Table A.1 in Appendix
A for primer sequences).
For each construct, 5 or more colonies were typically tested for the correct insert. For cloning 10
colonies were typically tested. For each colony a 1.5 ml tube was labelled and 20 μl of sterile water
was added. Under a Bunsen burner flame, a single bacterial colony was picked using a 0.5 μl plastic
loop and mixed with the water in the 1.5 ml tube. For A. tumefaciens half of the bacterial suspension
was transferred into a new 1.5 ml tube with identical label. The additional set of tubes was then placed
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in a boiling water bath for 5 minutes to lyse the cells. This step was not necessary for E. coli cells.
PCR reactions were set up according to the analytical PCR method using 0.5 μl of bacterial suspension
as DNA template. The PCR were products then analysed by agarose gel electrophoresis. If suitable
colonies were identified, the original bacterial suspensions in water were used to inoculate a bacterial
culture.
2.2.9 High fidelity PCR
High fidelity PCR using a DNA polymerase enzyme with proof reading was used for cloning and site
directed mutagenesis. Phusion® Hot Start Flex DNA polymerase from New England BioLabs was used
for all high fidelity PCRs. 50 μl reactions in 0.2 ml PCR tubes were used for PCRs. For each reaction the
following components were added: 10 μl of 5x Phusion HF buffer, 1 μl dNTPs (10 mM for each dNTP),
2.5 μl of each primer (10 μM), 2.5 μl DNA template and water to 50 μl. For difficult templates, DMSO
was added to a final concentration of 3%. For difficult templates with high GC content, the alternative
5x GC Phusion buffer was used. Reactions were mixed using a vortex mixer then centrifuged to collect
reaction mix at the bottom of the tube. PCRs were performed on a heat cycler with a heated lid using
the program shown in Table 2.10.
Step Temperature (°C) Time Number of cycles
Initial denaturation 98 10 s 1
Denaturation 98 5 s
Annealing Variable 10 s 35
Extension 72 15 s/kbp
Final extension 72 5 min 1
Table 2.10: High fidelity PCR program. This program was used with Phusion® DNA polymerase.
2.2.10 cDNA synthesis
RNA was collected from whole Arabidopsis plants to be used as a substrate for cDNA synthesis. Col-0
seeds were surface sterilised then spread onto sterile filter paper soaked with ½ MS media with 5% w/v
sucrose in a square petri dish. The seeds were vernalised overnight then moved to an incubator with a
long day light cycle. After 9 days of growth, the plants were removed from the surface of the filter paper
and then rinsed with distilled water. RNA was extracted from the plants using a Spectrum™ Plant Total
RNA Kit as per the kit instructions. DNase treatment of the RNA was not performed since the cDNA
was only used for cloning and not gene expression quantification. The RNA was then used as a template
for cDNA synthesis using SuperScript® III Reverse Transcriptase as per the included instructions for
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the enzyme. 20-mer oligo dT was used to prime the RNA for cDNA synthesis from mRNA. The cDNA
was eluted into 20 μl and then 65 μl of distilled water, 10 μl of 10x RNase H buffer and 5 μl of RNase
H (25 U) was added to the cDNA to digest the RNA. The cDNA was incubated with RNase H at 37°C
for 20 minutes followed by treatment at 65°C for 20 minutes to deactivate the RNase H enzyme. The
cDNA was stored at -20°C.
2.2.11 Blunt end cloning into pENTR D/TOPO plasmids
Full length coding DNA sequences (CDS) lacking a stop were cloned into pENTR D/TOPO plasmids.
Forward primers were designed that add the ’CACC’ DNA sequence onto the 5’ end of the CDS and
reverse primers were designed that exclude the stop codon at the 3’ end of the CDS. Primers used for
cloning are shown in Table A.1 in the appendices (primer prefixed with ’C_’). CDS fragments were
amplified from cDNA using the high fidelity PCR method. The amplified DNA was then separated on
an agarose gel by electrophoresis. The correct size DNA fragment was excised from the agarose gel
using a scalpel. The DNA band was illuminated during excision using a UV transilluminator with a
perspex UV shield. DNA was then extracted from the agarose gel sample using a Qiagen gel extraction
kit according to the manufacturer’s instructions, including an optional wash step to remove excess salts.
The concentration of the recovered DNA sample was measured using a NanoDrop spectrophotometer.
The purified DNA fragment was then cloned into the pENTR D/TOPO plasmid using the pENTR
D/TOPO cloning kit as per the instruction manual. The resulting product from the kit was transformed
into Top10 E. coli cells. 10 colonies for each cloned gene were screened using colony PCR to check for
colonies with the correct insert size. If suitable colonies were identified, they were used to inoculate 10
ml LB cultures which were grown overnight at 37°C with shaking. Plasmid DNA was extracted from
these cultures using a QIAprep Spin Miniprep Kit according to the manufacturer’s instructions. Isolated
plasmid DNA was then sequenced using the in house sequencing service at Durham University. M13
(-20) forward and M13 reverse primers were used to sequence the insert. If clones without errors were
not identified, more clones were screened until an error free insert was isolated.
2.2.12 Site directed mutagenesis
Site directed mutagenesis of circular plasmids was performed using PCR adapted from the method
by Weiner et al. (1994). A forward mutagenic primer was designed to include the required base pair
changes then the reverse complementary primer was created. Plasmid DNA of the target was diluted
to 2 ng/μl and PCR was set up according to the high fidelity PCR method except that the number of
cycles was reduced to 15. 1 μl of the restriction enzyme DpnI was then added directly to the PCR
reaction, which was mixed and moved to a clean 0.2ml PCR tube. The reaction was incubated at 37°C
for 1 hour and transferred to a new tube and incubated once more at 37°C for 1 hour. The enzyme was
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then deactivated by heating the reaction to 80°C for 20 minutes. 2 μl of the product was then used to
transform DH5α cells. Plasmid was prepared from the resulting colonies and sequenced to confirm the
presence of the mutation.
2.2.13 Restriction digest cloning into pGAPZα B plasmids
The DNA fragments RGA, rga K65R and S1:rga K65R were cloned into the P. pastoris expression vector
pGAPZα B. The gene fragments were amplified from pENTR D/TOPO plasmids using the high fidelity
PCR method. Forward primers introduced a SfiI restriction site onto the front of each gene. The reverse
primers for the fragments lacked a stop codon and introduced an XbaI site at the end of each gene. For
the RGA and rga K65R fragments the primers E_RGA-F and E_RGA-R were used. For S1:rga K65R
primers E_SUM1-F and E_RGA-R were used (see Table A.1 in the appendices for primer sequences).
The gene fragment and pGAPZα B were then double digested with SfiI and XbaI. 42 μl of the PCR
reactions and 20 μg of pGAPZα B in 42 μl of water had the following added to them: 1 μl SfiI, 2
μl XbaI and 5 μl 10x CutSmart buffer (New England BioLabs). The reaction was incubated at 37°C
for 4 hours followed by 50°C for 1 hour to inactivate the restriction enzymes. The restriction digests
were then gel purified using Qiagen gel extraction kit according to the manufacturer’s instructions. The
purified DNA was quantified using a NanoDrop spectrophotometer. Ligation reactions were set up using
150 ng of digested pGAPZα with each of the digested gene fragments. 247 ng of RGA and rga K65R
and 290 ng of S1:rga K65R was used. DNA plus 2 μl of 10x T4 DNA ligase buffer, 1 μl T4 DNA ligase
and water to 20 μl was mixed together for each ligation reaction. The ligation reactions were incubated
at 25°C for 2 hours. 1 μl of each ligation reaction was then used to transform competent DH5α cells and
colonies were allowed to develop on 50 μg/ml zeocin agar plates which were incubated in the dark at
37°C overnight. Colony PCR was performed on 10 colonies for each construct to select for the correct
size gene. The original primers used to amplify the DNA fragments from pENTR D/TOPO were used
in the colony PCR. 5 colonies with the correct size insert were then used to set up 10 ml LB cultures
supplemented with 50 μg/ml zeocin. The cultures were grown overnight at 37°C with shaking and then
plasmid DNA was purified. An aliquot of each sample was tested with SfiI and XbaI to check the size of
the insert and the plasmid. Plasmid DNA was then sequenced and clones with the correct DNA sequence
were isolated.
2.2.14 Transformation of P. pastoris
Plasmid DNA for the transformation was prepared using a Qiagen Midi prep kit. 10 μg of plasmid DNA
was then digested with 5 μl of AvrII (25 U) in a 250 μl reaction to linearise the plasmid DNA. The
reactions were incubated at 37°C for 4 hours and then the DNA was purified using ethanol precipitation.
To each sample 25 μl of 3M sodium acetate and 750 μl of 100% ethanol was added. The samples were
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mixed and then left overnight in freezer at -20°C to precipitate the DNA. The plasmid DNA was then
pelleted in a refrigerated centrifuge at 0°C for 30 minutes at 14000 g. The supernatant was discarded and
250 μl 70% ethanol was added to wash the DNA. The DNA was pelleted by centrifuging at 14000 g for 5
minutes and the supernatant discarded. The tubes were left open at room temperature for the remaining
ethanol to evaporate and the DNA was resuspended in 10 μl of TE buffer with a final concentration of
around 2 μg/μl.
Electrically competent P. pastoris cells were then prepared. A 5 ml P. pastoris starter culture in
YPD was grown overnight in a 50 ml Erlenmeyer flask at 30°C. This was used to inoculate a 500 ml
YPG culture in a 2 l baﬄed Erlenmeyer flask, which was grown at 30°C with shaking at 160 rpm.
When an OD600 of 1.5 was reached, the cells were chilled in an ice bath for 5 minutes then pelleted by
centrifugation in a chilled centrifuge at 1500 g for 5 minutes. The pellet was re-suspended in 500 ml of
ice-cold water. The cells were pelleted as before and then suspended in 20 ml of ice-cold 1 M sorbitol
solution. The cells were pelleted one final time and then suspended in 2 ml of ice-cold sorbitol and then
kept on ice until they were used for transformation.
For transformation 80 μl aliquots of cells were transferred to chilled electroporation cuvettes with a
gap of 0.2 cm. 10 μg of linearised plasmid DNA was then added to each cuvette and mixed by pipetting.
Cells were then placed in a BioRad MicroPulser™ Electroporator and pulsed with the default settings
for S. cerevisiae (1 pulse of 3 kV). 1 ml of ice-cold 1 M sorbitol was then added to the cuvette and
the cells were then incubated at 30°C for 2 hours. The cells were then spread on YPG agar plates with
100 μg/ml of zeocin and left to incubate at 28°C for 3 days in the dark for colonies to develop. Once
colonies had formed, 5 for each construct were selected and re-streaked onto new agar plates to isolate
monoclonal colonies.
2.3 Protein methods
2.3.1 E. coli protein expression
E. coli were cultured in LB for protein expression. An overnight starter culture inoculated from a single
colony was grown overnight at 37°C with shaking with appropriate antibiotic expression. The main
expression culture was inoculated with 1/20 media volume of starter culture. Cultures were generally
grown in baﬄed Erlenmeyer flasks with 5 times the volume of the expression media, except for 500
ml expression media, which was grown in 2 l flasks. The bacterial cells were grown at 37°C with
shaking until the OD600 reached 0.6 to 1.0. Media was then cooled on ice to the correct expression
temperature which varied depending on the protein being expressed. Media was supplemented with
0.1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) to initiate protein expression. Depending on
temperature, the cells were cultured from 1 to 12 hours. After expression, the cells were chilled in
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an ice bath then pelleted in a refrigerated centrifuge at 5000 g for 10 minutes. The supernatant was
discarded and the pellet was retained for further processing. At times the pellets were stored for later
processing, in this case they were frozen in liquid nitrogen then stored at -80°C until they were needed.
To prepare bacterial pellets for purification, the pellet was weighed and for each gram of bacterial
pellet, 5 ml of BugBuster Master Mix supplemented with 1x Complete EDTA free protease inhibitor
tablets (Roche) was used. The pellet was suspended in the BugBuster and then the cells were chemically
lysed by gently agitating for 15 minutes at room temperature. The insoluble debris was removed from
the lysate by centrifugation at 27 000 g at 0°C for 15 minutes followed by filtration through a 0.2 μm
pore size cellulose acetate filter.
2.3.2 Pichia pastoris protein expression
P. pastoris protein expression was performed using YPG media. Starter cultures inoculated from a
single colony were grown for 18 hours at 30°C with shaking. Expression cultures in Erlenmeyer flasks
were then inoculated with all of the starter cultures. Small-scale expression used 10 ml of YPG media
in 50 ml flasks. Large-scale expression used 500 ml of YPG media in 2 l flasks. Main expression
cultures were grown at 30°C for 1-2 days until a high cell density developed. After expression, the cells
were chilled in an ice bath then pelleted in a refrigerated centrifuge at 5000 g for 10 minutes. Both the
supernatant and cell pellet were retained for protein purification.
To prepare yeast pellets for purification, the pellet was weighed and for each gram of bacterial pellet,
5 ml of Y-PER Plus supplemented with 1x Complete EDTA free protease inhibitor tablets (Roche)
was used. The pellet was suspended in the Y-PER Plus and then the cells were chemically lysed by
incubating at 45 °C for 10 minutes. The insoluble debris was removed from the lysate by centrifugation
at 27 000 g at 0°C for 15 minutes followed by filtration through a 0.2 μm pore size cellulose acetate
filter.
2.3.3 Separation of recombinant protein fractions
To analyse recombinant protein solubility in E. coli protein expressions, inclusion bodies were separated
from the soluble fraction of bacterial lysates. Aliquots of expression media were collected in 1.5 ml
tubes. The volume collected was normalised to the number of cells in 2 ml of media at OD600 = 1.0.
The cells were then pelleted by centrifugation at 5000 g for 5 minutes and the supernatant discarded.
Lysis buffer consisting of a solution of BugBuster® Master Mix supplemented with 1x cOmplete, Mini,
EDTA-free protease inhibitors was prepared. Bacterial pellets were suspended in 60 μl of lysis buffer
and agitated at room temperature for 5 minutes to lyse the cells. The samples were then centrifuged at
13000 g for 10 minutes to pellet the insoluble cell debris. The supernatant was collected and transferred
to separate tubes containing 20 μl of 4x SDS-PAGE buffer and mixed. The insoluble debris pellet was
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washed by adding 100 μl of inclusion body wash buffer then centrifuged for 1 minute at 13000 g. The
wash buffer supernatant was carefully removed leaving the insoluble debris pellet in the tubes. 80 μl of
1x SDS-PAGE sample buffer was then added to the pellet and tubes were tapped against the lab bench
to dislodge the pellet. All samples were then placed on heat block at 95°C for 5 minutes, agitating the
tubes every minute or so. The samples were then centrifuged at 13000 g for 5 minutes and then either
loaded onto an SDS-PAGE gel or frozen at -20°C for later use.
2.3.4 SDS-PAGE
Required solutions
• 1x SDS-PAGE running buffer (24.8 mM Tris, 192 mM glycine, 0.1% w/v SDS)
Method
Component volume (ml)
Resolving gel Stacking gel
Component 8% 10% 12% 15% 5%
Water 4.6 4.0 3.3 2.3 6.8
30% acrylamide/bis-acrylamide mix 2.7 3.3 4.0 5.0 1.7
1.5 M Tris pH 8.8 2.5 2.5 2.5 2.5 0
1.0 M Tris pH 6.8 0 0 0 0 1.25
10% w/v SDS 0.1 0.1 0.1 0.1 0.1
10% w/v ammonium persulphate 0.1 0.1 0.1 0.1 0.1
TEMED 0.006 0.004 0.004 0.004 0.01
0.5% w/v bromophenol blue 0 0 0 0 0.01
Table 2.11: SDS-PAGE gel components for 10 ml casting solutions.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate and
resolve protein samples. The BioRad mini-gel system for gel casting and electrophoresis was used.
Casting solutions for resolving and stacking gels were prepared according to Table 2.11 depending on
the acrylamide percentage of the resolving gel. Gel casting solutions were prepared on ice to slow
polymerisation before they were added to the gel casting plates. Casting plates with a gel thickness of
1 mm were used. First 4.8 ml of resolving gel solution was added to each set of casting plates, then the
stacking gel was immediately overlaid onto resolving solution, taking care not to mix the two solutions.
A casting comb was then placed in the gel casting plates and the gels were allowed at least 15 minutes
to set. Once set, the casting combs were removed and the wells were rinsed with distilled water. The
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gels were then placed in an electrophoresis tank and SDS-PAGE running buffer added. Protein samples
in SDS-PAGE sample buffer were heated on a heat-block at 95°C immediately prior to loading onto
the gels. PageRuler Plus protein ladder was used as a molecular weight marker. Depending on the
gel percentage, electrophoresis was carried out between 80 and 140 V until the dye front reached the
bottom of the gel. Since the small protein SUMO migrated just behind the dye-front, the dye-front was
not allowed to run off the gels to ensure that SUMO protein was not lost.
2.3.5 Western blotting
Required solutions
• 1x transfer buffer (24.8 mM Tris, 192 mM glycine, 10% v/v methanol)
• TBST
• ECL solution
Method
Proteins from acrylamide gels were transferred to polyvinylidene fluoride (PVDF) membranes for west-
ern blotting. A PVDF membrane was first soaked in methanol for 5 minutes to wet the membrane. The
membrane was then transferred to transfer buffer for at least 5 minutes. An acrylamide gel was placed
on the PVDF membrane and sandwiched between filter paper and sponges pre-soaked in transfer buffer.
The sandwich was then placed in a transfer cassette and placed in a transfer tank with an ice pack. The
tank was filled with ice-cold transfer buffer. Electrophoresis was carried out overnight at 20 V in a
cold-room to transfer the proteins. The membrane was then removed and washed in TBST.
The membrane was blocked using TBST with 5% w/v Marvel milk powder for 1 hour on a rocking
platform. Primary and secondary antibody solutions were prepared in TBST or TBST milk depending
on the antibody. Primary antibody was added directly after blocking and incubated for 1-2 hours. The
membrane was then washed 3 times with TBST for 5 minutes. Secondary antibody was incubated for
1 hour and then the membrane was washed again in TBST. The membrane was then placed in 2 ml of
ECL solution for 10 seconds then sandwiched between 2 acetate sheets and then exposed to X-ray film.
X-ray film was developed in an automated film processor. For protein quantification, the membrane was
washed then stained in Coomassie stain to show the immobilised proteins in the membrane.
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2.3.6 Coomassie staining
Required solutions
• Coomassie stain (0.1% w/v Coomassie Brilliant Blue R-250, 10% v/v acetic acid, 50% v/v meth-
anol)
• Coomassie destain (10% v/v acetic acid, 40% v/v methanol)
Method
An acrylamide gel or PVDF membrane was placed in a petri dish and covered in Coomassie stain. The
gel/membrane was incubated for 30 minutes on a shaking platform then stain removed. The gel/mem-
brane was then rinsed in water until all stain was removed then the Coomassie destain was added to the
petri dish to destain overnight. Destain for PVDF membranes was changed once or twice and typically
took longer to destain than acrylamide gels.
2.3.7 Protein purification
Column buffers
All reagents were degassed and vacuum filtered through a 0.2 μm pore size cellulose acetate filter.
• His binding buffer (16.2 mM Na2HPO4, 3.8 mM NaH2PO4, 500 mM NaCl, 30 mM imidazole,
pH 7.4)
• His elution buffer (16.2 mM Na2HPO4, 3.8 mM NaH2PO4, 500 mM NaCl, 500 mM imidazole,
pH 7.4)
• GST binding buffer (15.4 mM Na2HPO4, 4.6 mM NaH2PO4, 140 mM, 2.7 mM KCl, pH 7.3)
• GST elution buffer* (15.4 mM Na2HPO4, 4.6 mM NaH2PO4, 140 mM, 2.7 mM KCl, 10 mM
reduced glutathione, pH 7.3)
• Storage buffer (20% v/v ethanol)
*The GST elution buffer differs from the GSTrap protocol as the buffer was incompatible with down-
stream SPR experiments since it contained primary amines. The alternative buffer did not contain
primary amines.
Affinity column purification
1 ml HisTrap™ HP and GSTrap™ HP sepharose columns were used for purification of recombinant
His and GST tagged proteins respectively. The columns were used with either a peristaltic pump (P1,
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GE Healthcare) or the ÄKTA FPLC system (GE Healthcare). All actions were performed at 1 ml/min
unless otherwise stated. Columns were prepared by pumping 5 ml of distilled water followed by 5 ml
of binding buffer. The NaCl and imidazole concentration of the crude protein samples were adjusted
to the same concentration as the respective binding buffer. The crude protein samples were filtered
through 0.34 μm cellulose acetate filters prior to loading onto the sepharose columns. Crude protein
samples were then pumped through the columns. For GSTrap columns, the crude protein samples were
pumped at 0.6 ml/min for room temperature purifications; for purifications performed at close to 0°C
a flow rate of 0.4 ml/ml was used. The lower flow rates for the GSTrap columns were to account for
the slow binding kinetics of the GST-glutathione interaction. Columns were then washed with 10-15 ml
of binding buffer. To elute the protein, 15 ml of elution buffer was passed through the columns and 1
ml fractions were collected. For HisTrap columns, a linear gradient elution was used instead. To clean
columns, they were washed with 10 ml of water then 5 ml of storage buffer.
The eluted protein fractions were analysed for protein by taking 20 μl aliquots and mixing these
with 80 μl Bradford reagent in a white 96 well plate. The colour of the samples was compared to an
elution buffer blank. Fractions with protein were pooled and then concentrated and buffer exchanged
using Amicon centrifugal columns (Merck Millipore). Protein sample concentrations were measured by
infrared spectroscopy using a DirectDetect spectrometer (Merck Millipore). Protein samples were then
separated into aliquots and frozen in liquid nitrogen then stored at -80°C. Aliquots were only used once
and re-frozen.
Batch affinity resin purification
Batch resin purification was performed using glutathione sepharose 4b resin and HisTrap nickel-
nitrilotriacetic acid (Ni-NTA) sepharose resin (GE Life Sciences). The bed volume of the sepharose
beads differed between experiments and between 5 and 20 μl was used. All centrifuge steps were per-
formed at 1000 g for 30 seconds. Twice the bed volume of sepharose beads was pipetted into 1.5
ml tubes. The sepharose beads were then washed 5 times with 100 μl of binding buffer, centrifuging
between each wash. The protein samples were then applied and the tubes were placed in a rotary mixer
for 30 minutes. The sepharose beads were then washed 3-5 times with binding buffer. Samples were
then mixed 1/3 bed volume of 4x SDS-PAGE sample buffer and then placed on a heat block heated to
95°C for 5 minutes and then the samples were analysed by SDS-PAGE.
2.3.8 Co-immunoprecipitation of GID1a and SUMO1
Required buffers
• 2x reaction buffer (100 mM Tris, 100 mM NaCl, 0.1% v/v IGEPAL CA-630, 2x Gamborgs B5
basal medium, pH 7.5).
30
CHAPTER 2. MATERIALS AND METHODS
Component Volume (μl)
Tube ID 2x Reaction
buffer
GST:GID1a GST His:AtSUM1 10 mM GA3 Water
1 500 390 0 100 10 0
2 500 390 0 100 0 10
3 500 0 390 100 10 0
4 500 0 390 100 0 10
Table 2.12: Co-IP of GID1a and SUM1.
Method
Protein samples of GST, GST:GID1a and His:AtSUM1 with a concentration of 1 mg/ml were used. The
proteins were in a 15 mM Tris pH 8.0 buffer. The co-immunoprecipitation (co-IP) was performed using
paramagnetic GST antibody labelled beads to precipitate free GST and GST tagged proteins. Reactions
according to Table 2.12 were set up. The reactions were incubated in ice for 30 minutes for interactions
to occur. Miltenyi μ magnetic columns were used for the co-IP. 1x reaction buffer was used as a wash
buffer. A wash buffer containing 0.1 mM GA3 was used for all wash steps with the GA3 containing
reaction (tubes 1 and 3). The columns were placed within a magnetic holder and were equilibrated with
500 μl of the 1x reaction wash buffers. The protein samples were then applied to the columns. Once all
the sample had passed through, the columns were washed 4 times with 200 μl 1x reaction wash buffer.
A final wash with 100 μl 20 mM Tris pH 7.5 (again with 0.1 mM GA3 for the respective samples) was
performed. A sample of SDS-PAGE sample buffer was then placed on a heat block at 95°C. 20 μl of hot
sample buffer was added to each column. The columns were then incubated for 5 minutes. Collection
tubes were placed under each column and the protein samples were eluted by the addition of 50 μl
of sample buffer. The elutes were then split into two equal aliquots and run two separate SDS-PAGE
gels. These gels were then analysed by western blotting with αGST and αAtSUM1 antibodies. Control
samples of the input proteins were included.
2.3.9 Yeast two-hybrid assay of GID1a and RGA
Required materials
• 50% polyethylene glycol (PEF) 3350
• 10x TE (100 mM Tris, 10 mM EDTA, pH 7.6)
• 1 M lithium acetate pH 7.6
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• 0.8% w/v NaCl
• 1 M 3-amino-1,2,4-triazole (3-AT)
• 20 mg/ml X-α-Gal in DMF
• YPD media
• SD minimal media
• -L/-W amino acid drop out powder
• -L/-W/-H amino acid drop out powder
Method
The genes for GID1a, gid1a V22A and gid1a V22S in pENTR D/TOPO were transferred to pDEST32
using Gateway cloning to make GAL4 DNA binding domain (BD) fusions. The gene for RGA in
pENTR D/TOPO was transferred to pDEST22 using Gateway cloning to make a GAL4 activation do-
main (AD) fusion. The plasmids were used to create 7 different yeast clones each with two plasmids as
per Table 2.13. Large amounts of plasmid DNA were purified using a Qiagen Midi-prep kit.
Clone ID pDEST32 pDEST22
1 RGA empty
2 empty GID1a
3 empty gid1a V22A
4 empty gid1a V22S
5 RGA GID1a
6 RGA gid1a V22A
7 RGA gid1a V22S
Table 2.13: GID1a-RGA yeast two-hybrid clones.
4 μg of each pDEST22 and pDEST32 was added to labelled 1.5 ml tubes. Transformation solution
was made by mixing the following in a separate tube: 2.4 ml 50% PEG, 300 μl 10x TE and 300 1
M Lithium acetate. A yeast suspension was made by mixing 300 μl of water with approximately the
same volume of AH109 yeast cells from an agar plate. To each plasmid containing tube 270 μl of
the transformation solution and 35 μl of the yeast suspension was added. A vortex mixer was used to
homogenise the samples. The cells were then heat shocked at 42°C for 15 minutes then pelleted by
centrifuging at 1000 g for 5 minutes. The supernatant was then discarded and the cells were suspended
in 500 μl of YPD and left at room temperature for 5 minutes. The cells were pelleted again as before
and then suspended in 500 μl of 0.8% NaCl and left overnight in the dark.
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The following day the cells were pelleted by centrifuging and 400 μl of the supernatant was removed.
The cells were suspended in the remaining 100 μl of supernatant then all of the suspension was spread
on double selection -L/-W SD agar plates. The surface of the agar was allowed to air dry then the plates
were closed and sealed with Parafilm and then incubated at 28°C for 3-5 days for colonies to develop.
Once colonies had formed, a single colony for each gene construct was mixed with 500 μl of 0.8%
NaCl. For the interaction assay 5 μl of these cultures was spotted onto various plates. Double selection
-L/-W SD agar plates were used to show that both plasmids were present. Triple selection -L/-W/-H SD
agar plates with 40 μg/ml X-α-Gal were used to show interaction and plates with and without 100 μl
GA3 and 5 mM 3-AT were used. This assay was repeated twice more with separate yeast clones.
2.3.10 Surface plasmon resonance of GID1a and SUMO1
Required buffers
• 10 acetate/acetic acid buffers at a range of pH values
• SPR binding buffer (16.2 mM Na2HPO4, 3.8 mM NaH2PO4, 150 mM NaCl, 0.005% P20, pH
7.4)
Method
Surface plasmon resonance (SPR) was performed using a CM5 amine coupling chip on a Biacore
2000 machine (GE Life Sciences). All reactions took place at 25°C. GST:GID1a, GST:gid1a V22A,
GST:gid1a V22S and GST were bound to the CM5 chip and RGA:His and His:AtSUM1 were used as
binding ligands. Scouting was performed to find the optimal pH for protein coupling. 10 mM sodium
acetate/acetic acid buffers were used for the pH scouting ranging from 4.1 to 5.2 in 0.1 pH steps. 2 μl of
each protein sample was mixed with 58 μl of each pH solution and samples were injected at a rate of 20
μl/minute for 1 minute. Once optimal pH values had been determined, each protein was immobilised to
the chip surface using an amine coupling kit. 10 μl of protein was used for the immobilisation reaction.
The target RU for the GST:GID1a proteins was 2000 response units (RU) and for the GST 800 RU so
that there was the same molar ratio between the different proteins.
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Component (μl)
Reaction ID SPR buffer RGA:His His:AtSUM 1 mM GA3
1 166 0 4 0
2 164.3 0 4 1.7
3 160 10 0 0
4 158.3 10 0 1.7
5 156 10 4 0
6 154.3 10 4 1.7
Table 2.14: GID1a SPR reactions.
Once the GID1a proteins had been immobilised ligation reactions were performed. Reactions were
set up according to Table 2.14. Reactions were injected at a rate of 20 μl/min for 2 minutes followed by
buffer only at a rate of 20 μl/min for 2 minutes. Each reaction was injected twice. Data was exported
and analysed in R. The GST channel was scaled and subtracted from the GID1a channels to subtract
non-specific binding to GST protein and the CM5 chip surface.
2.3.11 Reconstituted E. coli SUMOylation assay
The reconstituted E. coli SUMOylation assay by Okada et al. (2009) was used and the plasmids for this
assay were obtained from this group. A pACYCDuet plasmid containing S:SAE1a and His:SAE2 was
used. A second pCDFDuet plasmid contained one of two His:AtSUM1 forms and S:SCE. One form
of SUMO was functional and was denoted His:AtSUM1-GG. The other form of SUMO could not be
ligated to protein targets and was denoted His:AtSUM1-AA, this form was used as a negative control
in the SUMOylation assay. The plasmids were transformed into E. coli BL21 (DE3) strain through
repeated rounds transformation and chemically competent steps. A third plasmid containing the gene of
interest was transformed into the system. This third plasmid was transformed into both the positive and
negative control types of cell (His:AtSUM1-GG and His:AtSUM1-AA). The pDESTxx plasmids were
used in this assay and triple antibiotic selection using carbenicillin, spectinomycin and chloramphenicol
was used to maintain the plasmids.
SUMOylation assays were performed by first growing 10 ml starter cultures inoculated from a single
bacterial colony. These cultures were incubated overnight at 37°C with shaking. These cultures were
then used to inoculate 20 ml Erlenmeyer flasks containing 20 ml of Luria-Bertani LB media using 1 ml
of starter culture. Cultures were then grown at 37°C for 30 minutes and then chilled briefly. Expression
was induced by the addition of 0.1 mM IPTG. Cultures were then incubated at 28°C for 2 hours and
then bacterial cells were collected for protein analysis.
34
CHAPTER 2. MATERIALS AND METHODS
2.3.12 In vitro cell free SUMOylation assay of RGA
A cell free assay using E1 and E2 enzymes to SUMOylate RGA in vitro was used. The assay was
adapted from the method by Park-Sarge & Sarge (2009) and lacked the ATP regeneration mechanism
used in the original method.
Required reagents
• Storage buffer (50 mM Tris, pH 7.6)
• 10x reaction buffer (500 mM Tris, 500 mM KCL, 50 mM MgCl2, 10 mM DTT, pH 7.4)
• 10 mM ATP solution, pH 7.0
• Inorganic pyrophosphatase solution
Protein expression
Expression vectors for AtSUM1 and an E1 dimer consisting of a dual expression vector containing
His:SAE1a and S:SAE2 were used from the reconstituted system from Okada et al. (2009). The E2
enzyme, SCE1, was cloned from Arabidopsis cDNA into pDEST17 to create an N-terminal His fusion.
C-terminal His tagged RGA was expressed from RGA int pET DEST 55. E1, E2 and RGA vectors were
expressed in BL21 CodonPlus (DE3) RIL E. coli cells (Agilent Technologies) while the His:SUM1
was expressed in BL21 (DE3) cells. Expression cultures of 250 ml of LB media was used for the E1
and E2 vectors while for the His:AtSUM1 and RGA:His vectors, 500 ml was used. The cultures were
inoculated from starter cultures at a ratio of 1:20 and grown at 37°C with vigorous shaking until the
OD600 of cultures reached 1.0. The cultures were then briefly chilled on ice for 5 minutes to lower
their temperature to below 30°C then IPTG was added to a final concentration of 0.1 mM to induce
recombinant gene expression and were then grown at 30°C with vigorous shaking for 2 hours. Proteins
were then purified as per the method for Ni-NTA HisTrap purification described earlier. The E1 was
purified as an intact complex with S:SAE2 co-purifying with His:SAE1a.
Once the proteins had been purified, they were concentrated and buffer exchanged into storage buffer
using 0.5 ml Amicon centrifugal spin columns. RGA:His and His:AtSUM1 were concentrated to 1
mg/ml, flash frozen in liquid nitrogen and stored at -80°C until use. The E1 and E2 enzymes were
concentrated to 0.1 mg/ml and then mixed with an equal volume of glycerol to form 50% solutions with
a concentration of 0.05 mg/ml and these were stored at -20°C.
Assay
SUMOylation reactions in 20 μl were set up as in Table 2.15 below:
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Reagent Volume (μl) Amount/concentration in reaction
E1 1 50 ng
E2 1 50 ng
RGA:His 5 5 μg
His:AtSUM1 5 5 μg
Pyrophosphatase (0.1 U/μl) 1 0.01 U
10x Reaction buffer 2 1x
10 mM ATP 2 1 mM
H2O 3 -
Table 2.15: Cell free in vitro SUMOylation assay reaction components.
Four reactions were set up in 0.2 ml PCR tubes, with three lacking either one of RGA:His,
His:SUM1 or ATP as controls. The reactions mixed using a vortex mixer, then briefly centrifuged
to collect the contents at the bottom of the tube. The reaction tubes were then incubated on a heat block
at 37°C for 2 hours and the 7 μl 4x SDS PAGE sample buffer was added to tubes and they were heated
to 95°C for 2 minutes to halt the reaction and denature the proteins. The samples were then split and
loaded onto two 10% SDS-PAGE gels for analysis by western blot. One western blot was probed with
αRGA (1° 1:10 000; 2° 1:20 000) and the other with αAtSUM (1° 1:20 000; 2° 1:30 000) for two hours
and then processed as per protocol discussed previously.
2.4 Peptide array methods
2.4.1 Large-scale cellulose peptide array screen
Peptide array manufacture
The first monomer of each peptide in the array was immobilised to cellulose sheets and then fluorenyl-
methoxy-carbonyl chemistry was used to extend the polymer chains using the SPOT peptide synthesis
method described in Bolger et al. (2006). (Note: synthesis of peptide arrays was not carried out by
myself but by a collaborating group at the University of Glasgow).
His:AtSUM1 protein expression
To prepare the Arabidopsis SUM1 protein, AtSUM1 with a hexahistidine N-terminal fusion in the plas-
mid pCDFDuet was obtained from Okada et al. (2009) for expression (His:AtSUM1). The plasmid
was transformed into E. coli strain BL21 (DE3) and successful transformants were selected on LB agar
supplemented with 50 μg/ml spectinomycin. Protein expression was performed in 500 ml of LB and
expression was carried out at 37°C according to the protein expression protocol. Protein was purified
according to the purification protocol for His tagged proteins using the ÄKTA FPLC system. After puri-
fication buffer exchange into a 50 mM Tris pH 8.0 solution and protein concentration was performed
using a 500 μl Amicon selectively permeable membrane column with a 3000 kDa molecular weight
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cutoff and the final concentration of the protein was adjusted to 1 mg/ml.
Large-scale array far-western blotting
Peptide arrays were wetted by washing in 100% ethanol, rinsing in TBST 3 times then equilibrating in
TBST for 10 minutes on a rocking platform. The arrays were then blocked with blocking buffer (TBST +
5% w/v Marvel milk powder) in a rotating glass hybridisation cylinder for 2 hours at room temperature.
The arrays were then rinsed with 20 ml of TBST and then immersed in 20 ml of probing buffer (TBST
+ 1%w/v milk) with SUMO protein (0.2 μg/ml for His:AtSUM1 2.0 μg/ml for GST:HsSUM1) and
were incubated overnight in a cold room (0 - 5°C) in a rotating hybridisation cylinder. The arrays were
then rinsed 3 times with TBST then washed 3 times in TBST for 10 minutes. Primary antibody in
20 ml of TBST was then added. For AtSUM1 polyclonal αAtSUM1 antibody at a concentration of
1:20000 was used. For HsSUM1 polyclonal αGST antibody at a concentration of 1:7500 in 1% milk
TBST was used. The primary antibody was incubated for 2 hours at room temperature, after which
the arrays were washed in TBST as before. Secondary antibody in 20 ml TBST was then added. For
His:AtSUM1, α-rabbit horse radish peroxidase conjugate (HRP) at a concentration of 1:30000 was used.
For GST:HsSUM1 α-mouse HRP at a concentration of 1:20000 was used. The concentrations of the
primary and secondary antibodies were determined empirically give a similar signal strength between
the two different SUMO isoforms. The arrays were incubated in the secondary antibody for 1 hour at
room temperature then washed in TBST as before.The arrays were then immersed in 5 ml of enhanced
chemiluminescence solution for 20 seconds and then exposed to X-ray film for 2.5 minutes, which was
then developed.
The arrays were then stripped to remove interacting proteins and antibodies (see next subsection)
and a negative control far-western blot was performed. The same protocol as above was used except
that the SUMO protein was left out of the probing buffer. For the GST:HsSUM1 negative control, GST
protein was added to a concentration of 1.0 μg/ml to the probing solution. The blots were also exposed
to the X-ray film for 5 minutes, twice as long as SUMO protein probed blots. This was to ensure
that any non-specific interactions were shown clearly. The negative control blots were used to remove
non-specific interacting peptides during data processing.
2.4.2 Cellulose array stripping
The SIM arrays were stripped to prepare them for different probings. Stripping buffer (20 mM dithio-
threitol, 60 mM Tris, pH 6.8, 2% sodium dodecyl sulphate) was heated to 70°C in a microwave and then
the arrays were placed in the buffer and incubated for 30 minutes with gentle agitation over a hot plate
to maintain temperature. The arrays were then removed and washed thoroughly with distilled water,
then washed twice for 10 minutes in TBST, then washed in distilled water once more and dried. For
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long-term storage the arrays were kept in a -20°C freezer.
2.4.3 Cellulose array Ponceau-S staining
Peptide amounts in the arrays were estimated by staining with the dye Ponceau-S. Due to the short
peptide length, Ponceau-S staining does not correlate perfectly with protein amounts. This is due to
varying affinity of different amino acid groups to the Ponceau-S dye, therefore this method is only semi-
quantitative. The arrays were placed in stain solution (0.1% w/v Ponceau-S, 1% v/v acetic acid) for 30
minutes with agitation, then throughly rinsed in distilled water then washed twice more in water for 10
minutes. The arrays were then dried and photographed. The Ponceau-S stain was removed by washing
the arrays in 200 ml of distilled water with 2-3 drops of 5 M NaOH twice for 10 minutes and then
stripped using the previous stripping protocol.
2.5 Small-scale nitrocellulose peptide array screen
Synthetic peptides were manufactured by Cambridge Research Biochemicals for use in the nitrocellu-
lose arrays. Solutions of 1 mg/ml of peptide were prepared and 1 μl of the peptides were spotted onto
a nitrocellulose membrane to make the array. The array was left to stand for 5 minutes and was then
placed in a petri dish and rinsed with TBST. The array blocked with TBST with 5% w/v Marvel Milk
power for 5 minutes on a rocking platform. AtSUMO was then added to the blocking buffer to a final
concentration of 0.05 μg/ml. The array was then incubated for 1 hour. The array was then washed three
times in TBST for 5 minutes. Primary antibody (αAtSUM1, 1:30000) in TBST was incubated for 1
hour. The array was washed then the secondary antibody (αRb HRP, 1:20000) was incubated for 1 hour
then washed again. The array was then developed as per the western blotting protocol.
2.6 Plant methods
2.6.1 Seed sterilisation
The chlorine vapour phase surface sterilisation method was used. Seeds were placed in open 1.5 ml
tubes labelled with pencil and placed in a sealable plastic box in a fume hood. A flask containing 100
ml 10% sodium hypochlorite solution was placed in the plastic box then 3 ml of 37% HCl was added
and the plastic box promptly sealed. The seeds were left overnight for surface sterilisation to occur. The
next day, the box was opened and the flask removed and then closed promptly. The plastic box was then
moved to a laminar flow hood and the seeds removed.
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2.6.2 Floral dip transformation
Arabidopsis was transformed following an adapted version of the original floral dip method by Clough
& Bent (1998). Arabidopsis plants were grown in pots with 5 plants. For each construct, 4 pots of plants
were used. Plants were grown until flowers had emerged and the floral stems were cut off to promote
the development of multiple stems. Plants were then used for floral dipping once large floral stems had
grown.
Agrobacterium clones with a T-DNA plasmid containing the transformation construct were used to
inoculate 10x LB starter cultures with appropriate antibiotics and grown overnight at 28°C with shaking.
The starter cultures were used to inoculate 250 ml LB cultures with antibiotics in 1 l Erlenmeyer flasks
and these were grown overnight under the same conditions. The following day the Agrobacterium
cells were pelleted by centrifuging at 5000 g for 10 minutes. The pellets were then re-suspended in
500 ml of 5% sucrose solution then 100 μl of Silwet L77 was added. Prior to transformation, all
siliques were removed from the Arabidopsis plants. The stems of the plants were then submerged in the
Agrobacterium solutions for 20 seconds ensuring that all the flowers were submerged. The plants were
then placed flat in plastic bags and left for 24 hours. The plants were then removed from the plastic bags
and set upright and normal plant growth conditions were resumed. Seeds were collected from these
plants and were then screened for transgenic lines.
2.6.3 Germination assay
To perform the germination assay, square 15 cm petri dishes with ½ MS agar were prepared. The agar
plates were supplemented with 0, 0.1 or 0.5 μM paclobutrazol (PAC). Seeds for the lines to be tested
were surface sterilised and then seeds for each line were spread over three plates with the different PAC
concentrations. Around 100 to 250 seeds were applied to each plate. Plates were then placed in a 0-5°C
cold room for 48 hours. Plates were then moved to an incubator set to long day conditions. After 48
hours, the germination of the seeds was recorded. Seeds were viewed under a dissecting microscope.
A seed was determined to have germinated if both the seed coat had opened and the primary root had
emerged.
2.7 Computational methods
The R programming environment version 3.1.1 (R Core Team, 2013) was used for all data processing
and statistical analyses. The R programming language was used to develop random forest predictors.
MATLAB R2013b (version 8.2) was used to develop image analysis software. Full theoretical methods
for computational work are described in Chapter 3.
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3.1 Introduction
SUMO plays an important role in cellular function and is implicated in a vast number of molecular
processes (Hay, 2005). With the wealth of genomic data now available, computational methods to pre-
dict SUMOylated lysine residues (referred to as ’SUMO sites’ hereafter) and SUMO interacting motifs
(SIMs) are becoming evermore important. Predication of possible sequence features from primary se-
quence data is used both to identify new research targets and to identify the location of sequence features
in proteins that are known to have such features. SUMO sites and SIMs will be collectively referred to
as ’SUMO sequence features’ in this chapter.
A number of methods have been developed to predict SUMO-related sequence features and tools to
predict SUMO sites were the first to emerge. Currently there are three methods with online interfaces,
two of which are published. SUMOplot was the first publicly available SUMO site predictor to be
released. It was developed by Abgent but the method was not published so the strategy used to predict
SUMO sites is not known. Later SUMOsp version 1 was released, which was the first published method
and was developed by Xue et al. (2006). SUMOsp compared a query sequence with known SUMO sites
using the sum of substitution scores from the BLOSUM62 matrix. BLOSUM62 is a protein substitution
matrix developed to score amino acid similarities for protein sequence alignment (Henikoff & Henikoff,
1992), though it is often used in protein similarity scoring as well. SUMOsp was later updated to version
2 which used a novel scoring matrix that was optimised using a genetic algorithm. It also introduced
partitioning of the results into two categories of SUMO site, types I and II (Ren et al., 2009). Type I sites
conform to the canonical SUMO site motif of ΨKx[ED], while type II sites do not completely conform
and the prediction of these sites is less accurate. There is however, no functional distinction between
the two types. The methods mentioned so far all had one thing in common: they all used amino acid
factors (i.e. letters to represent the amino acid groups) in the prediction and did not directly include any
numeric variables of amino acid chemical properties in the prediction method.
The most recent SUMO site predictor, seeSUMO, took steps to address this lack of inclusion of
chemical data (Teng et al., 2012) by incorporating numerous numeric amino acid properties. seeSUMO
uses data from the AAindex, a database of hundreds of indices of amino acid properties (Kawashima
& Kanehisa, 2000). Teng et al. (2012) converted the amino acid factor levels into vectors of numeric
properties to capture the chemical information of the amino acids in order to build a random forest clas-
sifier to predict SUMO sites. Converting amino acids into numeric vectors of chemical properties and
using the more powerful random forest classifier led to the development of a predictor that outperformed
previous tools. However, the performance of seeSUMO was far from optimal as there were a number of
critical drawbacks in the methodology used byTeng et al. (2012) that negatively impacted the predictor.
The authors did not perform parameter reduction and the top performing random forest predictor used
an input of 20 amino acids, each of which was converted into a vector of 40 numeric properties. It is
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unclear whether the authors removed the central lysine from the input so the parameter space was either
760 or 800 dimensions. A large number of these parameters were highly correlated and this introduced
a large amount of redundant information into the model.
A predictor with such a high dimensionality will be subject to the Hughes phenomenon whereby pre-
dictor performance declines if more parameter dimensions are added after the optimal number (Hughes,
1968). One of the factors that contributes to the Hughes phenomenon is that as the dimensionality of
parameter space grows, the hyper-dimensional volume of that parameter space expands exponentially.
Training data projected into this large hyper-volume then becomes sparse, with similar data-points be-
coming ever more distant. To counteract this sparsity, the training data would need to grow exponentially
with the number of dimensions, something that is typically not feasible from a practical perspective. The
Hughes phenomenon suggests that there is an optimal dimensionality, where the number of dimensions
is high enough to effectively compartmentalise the different data classes but not so high that data sparsity
becomes problematic. Therefore parameter selection and model simplification should always be imple-
mented to improve predictor performance.
The seeSUMO predictor also partitioned training data into training and evaluation sets which is
generally not necessary with random forest models. Random forests, if used correctly, can calculate
an unbiased (if not pessimistic) estimate of error from the training data alone using out of the bag
(OOB) error estimation, negating the need to have a separate evaluation set for predictor performance
assessment (Breiman, 2001). Using all of the possible training data may have improved the performance
of the predictor.
While there are a number of SUMO site predictors available, prediction of SIMs in proteins is still a
very new area. Currently there is only one publicly available predictor, which was developed by the same
group that developed SUMOsp, but the method has not been published and importantly does not take
SUMO isoform differences into account. One difference between SUMO sites and SIMs is the amount of
available data for training predictors. Hundreds of SUMO sites have been published and this has allowed
researchers to build training sets of more than 1000 test sequences (these data are mostly negative, non-
SUMO site sequences). The same is not true for SIMs; while a large number of proteins have been
published that interact with SUMO, only in a small number of these publications is the site of interaction
determined, so there is a desperate need for novel training data. Another interesting aspect of SIMs
is that different SUMO isoforms within a species show SIM motif specificity, Namanja et al. (2012)
investigated the human PIASx SIM in detail and found that mutagenised versions of this SIM could
be made to interact specifically with either HsSUM1 or HsSUM3 or with both. These results showed
distinct divergence in SIM sequence and SUMO isoform interactions. This is in contrast to SUMO sites
where there has been no observed influence of motif composition on the SUMO isoform ligated. Also,
it is generally thought that there are no major species differences in SUMO site composition and SUMO
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site predictions are assumed to be applicable across species.
Since there are known SUMO isoform preferences for SIM sequences within species, it is highly
likely that there will be interspecies differences too. A predictor trained on data from one species may
not be applicable to a different species, therefore a SIM predictor will need to be designed to specifically
predict SIM binding to different SUMO isoforms and to homologous SUMO proteins in other species.
3.1.1 SIM features
                    
HsSUM1: 21-YIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQG-55
AtSUM1: 17-HINLKVKGQDGNEVFFRIKRSTQLKKLMNAYCDRQS-51
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Figure 3.1: SIM binding site in SUMO. (A) 3D structure of HsSUM1. SIMs bind to amino acids in
the groove between β-strand 2 and α-helix 1. The side chains of amino acids that have been shown to
make contact with SIM amino acids are shown in green. (B) Alignment of the HsSUM1 and AtSUM1
sequences involved in SIM binding, bars between the alignment correspond to the highlighted side
groups shown in the 3D structure. While there is a large amount of sequence divergence between the
two species, amino acids responsible for SIM binding are conserved. The bars below the amino acids
represent the conservation score. Colours of the amino acids represent the following properties: yellow:
hydrophobic, green: polar, blue: negative charge and red: positive charge. 3D structure in this figure
was solved using NMR by Song et al. (2005).
SIMs are short peptide sequences within a protein that bind to SUMO through non-covalent inter-
actions and these interactions play an important role in the assembly of protein complexes. Initially
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there had been some disagreement as to which parts of a SIM were responsible for the interaction with
early researchers incorrectly suggesting that the interaction was due to and SxS motif (Minty et al.,
2000). The actual sequence responsible for SUMO interaction was solved by nuclear magnetic reson-
ance (NMR) studies of the human RanBP2 SIM by Song et al. (2004) who showed that a short stretch
of hydrophobic amino acids fits into, and binds to, a groove within SUMO. This groove within SUMO
is flanked by an α-helix and a β-strand (Figure 3.1) and the side groups of these secondary structures
make contact with SIM side chain groups to form the interaction. When SIMs are not bound to SUMO
they are almost always unstructured polypeptide chains, but once this chain binds to the SUMO groove
it takes on a structured conformation of β-strand that extends the β-sheet within SUMO (Namanja et al.,
2012). SIMs have the rather unique property that they can bind to the SUMO groove in either peptide
chain direction, either parallel to or antiparallel to the second β-strand within SUMO (Song et al., 2005)
and some SIMs exist that can bind in both directions, though usually a particular SIM tends to bind in
the orientation with the lowest binding free energy.
Further research showed that there are three distinct classes of SIM, termed A, B and R (for re-
verse), though the overall structure with a hydrophobic core is consistent between these motifs (Vogt
& Hofmann, 2012). The most common amino acids found within the hydrophobic cores are leucine,
isoleucine and valine though other hydrophobic amino acids can also be substituted into the core. SIM
type A has a general motif structure of ΨΨxΨ and is best suited to extending the SUMO β-sheet in an
antiparallel orientation while the reverse of this SIM, type R has a motif structure of ΨxΨΨ and extends
the SUMO β-sheet in the parallel orientation (Namanja et al., 2012). The final type of SIM, type B, is
slightly different from the other two and has a core motif structure of ΨΨDLT and, like SIM A, usually
extends the SUMO β-sheet in the antiparallel orientation.
While the hydrophobic core of the SIM is responsible for the majority of the interaction with SUMO,
negatively charged sequences flanking the core also interact with SUMO and stabilise the conformation
of the two proteins. The flanking residues also determine SUMO isoform selection by promoting a
stronger interaction with a particular SUMO isoform (Hecker et al., 2006). SIMs often show specificity,
or at least higher affinity, for a particular SUMO isoform and this is partly responsible for the functional
diversification of different SUMO isoforms (Zhu et al., 2009). Since these flanking regions are respons-
ible for isoform selection, they offer the ability to predict which SUMO isoform a particular peptide is
most likely to bind to and suggests that training data used to build a predictor for a particular SUMO
isoform will not be applicable to predicting other isoforms.
Post-translational modification (PTM) plays an important role in regulating SIM-SUMO binding
and can act as a switch to rapidly modulate the behaviour of SUMO. Often SIMs contain serine residues
flanking their hydrophobic core and phosphorylation of these polar residues imparts a negative charge
on them that promotes interaction with SUMO. SIM phosphorylation has been found to both enhance
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interaction strength with SUMO (Mascle et al., 2013) and to switch the interaction between two SUMO
isoforms (Hecker et al., 2006). Acetylation of SUMO is another PTM that has been found to regulate
interaction. In HsSUM1, the positive charge of K37 is required for SIM interaction and acetylation of
this group neutralises and blocks the interaction with SIMs. Interestingly acetylation of SUMO pro-
motes interaction with bromodomain-containing proteins (Ullmann et al., 2012), which are typically
transcriptional regulators (Mazur & van den Burg, 2012), thus acetylation acts to switch SUMO inter-
action between SIMs and bromodomain containing proteins.
3.1.2 SUMO site features
Covalent attachment of SUMO occurs at lysine residues within a target protein. These SUMOylatable
lysines often conform to motif ΨKx[ED] known as a SUMO site, which is conserved across eukaryotes
(Hay, 2005). The function of the SUMO site is to attract an activated SUMO-E2 thioester linked com-
plex and promote conjugation of SUMO to the lysine residue. The motif has been shown to be important
in facilitating SUMO conjugation but about 20% of known SUMO sites do not conform to this motif.
However, these non-consensus SUMO sites have been found to have lower conjugation efficiencies
(Schwamborn et al., 2008) and so are likely to be weaker targets of SUMOylation in vivo. Alternatively,
SUMOylation at type II sites could be facilitated by some mechanism other than attraction to the core
motif. More recent research into the composition of SUMO sites has revealed complexity beyond the
core ΨKx[ED] motif. The amino acid positions immediately upstream of the motif are often enriched
for negatively charged amino acids. The role of this charged site is to facilitate interaction with the E2
part of a SUMO-E2 complex during conjugation, as the E2 enzyme contains a corresponding positively
charged patch that associates with this negatively charged site in the SUMO site motif (Yang et al.,
2006).
The amino acids in the variable parts of the ΨKx[ED] motif have significant effects on the efficiency
of SUMOylation with aromatics at the large hydrophobic position (Ψ) greatly enhancing the conjug-
ation rate. Glycine, proline or negatively charged amino acids at the third position (x) reduce SUMO
conjugation (Schwamborn et al., 2008); for proline, the steric hindrance imposed by this amino acid
may lead to less favourable conjugation conditions. The emerging understanding is that the SUMO
site motif is more complex than the originally published ΨKx[ED] motif often used in the literature to
summarise SUMO sites and using more complex amino acid features can allow efficient prediction of
SUMO sites. Phosphorylation of the SUMO sites has been found to act as a SUMO conjugation switch
with the serine in the motif ΨKxExxSP being the target of phosphorylation which imparts an enhanced
negative charge to the SUMO site and promotes interaction with the E2 via its positively charged patch
(Mohideen et al., 2009). Phosphorylation of SUMO sites however, was not investigated in this research
project.
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Apart from the interaction between the SUMO-E2 complex and a target SUMO site, E3 ligases
enhance SUMO conjugation analogous to the E3s in the ubiquitination cascade. However, unlike the
ubiquitin E3 ligases, SUMO E3 ligases are not necessary and conjugation will still occur, albeit at a
reduced rate. SUMO E3s have been shown not to recognise the target protein but rather to orientate
and restrict the flexibility of the thioester bond between SUMO and the E2 enzyme (Reverter & Lima,
2006) which reduces the activation energy of SUMO conjugation (Truong et al., 2011). Since the E3
enzymes do not directly detect target proteins, SUMO conjugation is strongly governed by the sequence
surrounding the target lysine and not detection of target protein specific features by the E3 as is the case
with ubiquitin E3 complexes (Sadanandom et al., 2012), which makes SUMO sites good candidates for
prediction.
3.1.3 Random forest classifiers
Random forests were developed by Breiman (2001) and are an ensemble machine learning method used
for classification or regression of data. For the benefit of simplicity, only the classification aspect will be
considered in this chapter. Data to be classified consist of N observations with M variables and random
forests are capable of handling large numbers of variables which can either be continuous or nominal
(alternatively referred to as factors in statistics). Ensemble methods consist of many small objects that
perform a very simple classification task and the output from these many small objects is then combined
to give a single result for the collection. In the case of random forests, the object is a decision tree
with nodes that split into exactly two branches. At each node, an input observation is split down the
tree according to the value of some of the input variables. At each node a set of m variables is used to
determine the split, with the variables and direction of the split decided during the training of the tree.
Once an observation reaches a terminal node on a decision tree, a vote for a particular class is made for
the observation.
Overall the performance of decision trees is poor. However, building an ensemble of trees and then
averaging the votes of all the tree results in significantly improved performance and the method has
a robust built in error estimation mechanism eliminating the need for a validation set during classifier
training. While some classifiers have many parameters that need to be optimised during training, such as
vector support machines, m is the only parameter that needs to optimised within random forest models,
though in practice variable selection is generally required especially when there are a large number
of input variables. Increasing the value of m up to the point m < M results in better performance of
any particular tree but also increases the correlation between trees in a random forest which causes a
decline in the overall random forest performance hence an optimal value of m should be found for best
performance. In practice the value of m is usually much smaller than the total number of variables
(m  M).
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During building of each tree in the random forest, N observations from the training data are sampled
with replacement, giving each tree a random bootstrap of the training data. Two thirds of this bootstrap
are then used to build the decision tree, randomly choosing m variables at each node to test. The
remaining third of the bootstrap or the out of bag (OOB) data is then tested on the newly built decision
tree to assess its performance. This process is repeated until the desired number of trees are built and
a global estimate of error can be calculated from the combined OOB data. Because the error for each
tree is estimated using data that was not used to build it, the tree error estimate is unbiased, thus so is
the global error estimate of the random forest (Breiman, 1996). By bootstrapping and partitioning data
separately for each tree, all data is used for training the random forest, a particular data point on average
will be used in the construction of about two thirds of the decision trees. Using this per tree bootstrap
method allows all of the training data to be used to train a random forest and allows an unbiased estimate
of predictor error to be calculated and eliminates the need to partition the training data into training and
evaluation sets. This allows the random forest to fully utilise all training data. This is especially useful
when there is limited training data.
The error estimate used internally by the random forest algorithm is the proportion of times data
from the classification with the most positive votes is not equal to the correct class, or the false positive
rate (FPR) of the classification with the most votes. Other classifier performance assessments can also
be calculated using the OOB results such as sensitivity (true positive rate; TPR) or a receiver operator
characteristic (ROC) curve. The sensitivity and the FPR of a predictor depend on the value of the
predictor cutoff, which in the case of the random forest is the value of the proportion of votes at which
an input is classified as positive. By default this cutoff is set at 0.5, that is to say an input needs to get
a positive vote from at least half of the trees in the random forest. Increasing the cutoff value reduces
the FPR of the random forest predictor but also decreases the sensitivity, thus the FPR or sensitivity can
be tuned to a specific value by varying the cutoff value. Because the values of the FPR and sensitivity
are inversely dependent on each other, either by itself is not a useful assessment of the performance of
a predictor without taking the other into account. The ROC curve on the other hand is a plot of the
FPR against the sensitivity for all values of the cutoff and gives an overview of all possible FPR and
sensitivity values achievable with a given predictor.
In a perfect predictor, the ROC curve occupies upper left bounds of the graph while a predictor
which is no better than random performance has a curve that runs diagonally across the graph. The
area under the ROC curve (AUC) can thus be used as a metric to assess the performance of a predictor
independent of the cutoff value and is a very useful metric to reliably compare different predictors. A
perfect predictor has an AUC value of 1.0 while a predictor which performs no better than random has
a value of 0.5. From a statistical perspective, the AUC value is the probability that a classifier will score
a randomly chosen true positive instance higher than a randomly chosen true negative instance (Hanley
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& McNeil, 1982). The AUC value is related to another performance metric, the Gini coefficient, which
is twice the area of the upper diagonal of a ROC curve or 2 × AUC − 1 (Fawcett, 2006). The Gini
coefficient is useful as it remaps the useful AUC interval of [0.5, 1] to [0, 1], giving a more intuitive
range of values.
The Gini coefficient is used internally by the random forest algorithm to score the importance of the
input variables and this feature can be used to identify which variables to exclude from the predictor to
reduce its complexity.
3.1.4 Improving current models
The motivation of the work described in this chapter was to build a predictor of SUMO sites and SIMs
by further developing the method of using random forest predictors. The SUMO site predictor was
trained using data from Ren et al. (2009). As there were insufficient examples of SIMs in the literature,
especially for plant models, data was generated from a library of synthetic SIM-like peptides. Predict-
ors specific to particular SUMO isoforms were built to address the issue of SUMO isoform binding
differences. To improve upon previous SUMO feature predictors, more robust variables were used to
represent the peptide sequences and rigorous variable selection was performed with the goal of minim-
ising information redundancy and model complexity in order to optimise model performance.
The predictors were used to build a graphical web-based tool that can be deployed for use to the
wider research community. The tool includes a new feature not seen in current SUMO feature models;
results are overlaid onto a multiple sequence alignment of the input sequences. This allows straight-
forward identification of conserved SUMO sequence features, which have a higher probability of being
true functional features.
Finally the completed SIM predictor was used to search for conserved predicted SIMs in ortholog-
ous proteins from multiple plant species. These predicted SUMO binding proteins (SBPs) were then
analysed to identify enrichment in any biological and biochemical functions and constitutes the first
large scale analysis of SBPs in any organism.
3.2 Chapter aims
• Generate a peptide library to screen for SUMO1 interacting peptides.
• Characterise and compare human and plant SIMs.
• Use generated SIM data and published SUMO site data to build random forest models to predict
these features.
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• Incorporate amino acid chemical features from the AAindex database, and evolutionary informa-
tion into the models.
• Screen the Arabidopsis proteome for predicted SIMs and analyse the results.
• Develop a web-based user interface for the sequence feature predictor.
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3.3 Materials and methods
3.3.1 SIM peptide array design
To generate the SIM data to be used to train random forest predictors and for feature analysis, a library
of synthetic SIM-like sequences was created. 11-mer SIM-like peptide sequences were designed, using
published SIM motifs from Vogt & Hofmann (2012) as a template. These motifs were generated from
the limited SIM data collected from animal and yeast research and were not specific to any SUMO
isoform. The published SIM motifs were used to generate sequence models using regular expressions
for each SIM type, A, B and R. The regular expressions encoded which amino acids were allowable
at a particular position along the 11-mer peptide. The core regions of the SIM models only permitted
hydrophobic amino acids for example. For each SIM type there was a stringent regular expression
model, conforming strongly to the published motif, and a number of more variable expressions allowing
more amino acid sequence diversity. The models, written as Perl style regular expressions, are shown in
Table 3.1. The purpose of these SIM models with varying stringency was to generate a set of peptides
with a large amount of sequence variety and to sample peptides with evermore divergence from the
published motifs.
Class Perl style class model
A1 ..[IVLMP][IVLM].[IVLM][^VLIMFYWAP][^VLIMFYWAP][^VLIMFYWAP]....
A2 ..[IVLMP][IVLM].[IVLM][DSE][DSE][DSE]....
A3 ..[IVLMPFYW][IVLMFYWP].[IVLMFYWP][DSE][DSE][DSE]....
B1 ..[^GDN][IVY]DL[TY]......
B2 ..[^GDN][IVYLMFWCAP]DL[TY]......
B3 ..[^GDN][IVY]DL[TYDEFSC]......
B4 ..[^GDN][IVYLMFWCAP]DL[TYDEFSC]......
R1 ....[^VLIMFYWAP][^VLIMFYWAP][^VLIMFYWAP][IVLM].[IVLM][IVLM]..
R2 ....[DSE][DSE][DSE][IVLM].[IVLM][IVLM]..
R3 ....[DSE][DSE][DSE][IVLMPFYW].[IVLMPFYW][IVLMPFYW]..
Table 3.1: SIM class models used to search the Arabidopsis proteome for test sequences. Models are
encoded with Perl style regular expressions. Full stop (.) = any amino acid. Square brackets ([ ]) =
any one of those amino acids inside brackets. Caret (^) inside square brackets = any amino acids except
those inside the brackets.
To generate sequences from the SIM models, the models were used to search translated represent-
ative Arabidopsis gene sequences (from the TAIR10 genome assembly; translated representative gene
models). Sequences were searched against the Arabidopsis translated genome to ensure that natural
amino acid frequencies were sampled and that any known or unknown natural sequence restrictions
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were adhered to. There was concern that using a stochastic model to randomly generate sequences
would likely violate underlying sequence composition restrictions. Duplicate sequences were removed
and then sequences were randomly selected for inclusion in the SIM library. For each of the three
SIM types, around 200 peptides were chosen. 8 control peptides were included of known interactors or
non-interactors and in total the library contained 600 peptides.
To investigate the role of phosphorylation on the binding of SIMs to SUMO, a second library of
phosphorylated SIM-like peptides was designed. The amino acids serine, threonine and tyrosine are all
targets for phosphorylation in vivo and SIM peptides with phosphorylated versions of all three of these
amino acids were designed. The phosphorylated peptides were not used to train the SUMO predictor
models, rather they were used to identify important phosphorylation sites in SIMs. For this library, tem-
plate non-phosphorylated peptides were designed using the same strategy as the first library, however
only one SIM model per class was used, the model generating the highest number of positive interac-
tions, the models A1, B4 and R1. These models were identified by performing a preliminary screen of
the first array to calculate the rates of positive interactions from peptides designed using the various SIM
models. Template peptides without any phosphorylations were include in this array to act as negative
controls. The template peptides were also selected so that they were unique from any peptides in the first
library; this allowed integrating these template peptides into the dataset from the first library, allowing
more peptides to be used for training the SIM predictors.
To generate the phosphorylated peptides, the template SIMs were used to design multiple phos-
phorylated versions of the template. Once this was complete, the template peptide and the phos-
phorylated versions were added to the second library. Eight control sequences were added to the array
and a total of 600 peptides were included. The pseudocode for generating the phosphorylated SIMs is
shown in Algorithm 1.
Once the peptide libraries were designed, data were prepared for synthesis on 30 x 20 spot arrays.
Control sequences were placed on their respective arrays in a pattern that allowed unambiguous identi-
fication of array orientation. For the non-phosphorylated array, the order of the remaining peptides was
completely randomised to accommodate for any possible array positional effects in peptide synthesis
quality. The peptides in the phosphorylation array were grouped by template peptide and then the order
of the groups was randomised. The peptide arrays were synthesised using an automated system.
3.3.2 Interaction screen of SIM peptide arrays
The peptide arrays were synthesised using an automated system. To identify peptides with affinity for
SUMO, far-western blotting using Arabidopsis SUM1 (AtSUM1) and human SUM1 (HsSUM1) was
performed. Recombinant HsSUM1 fused to glutathione S-transferase (GST:HsSUM1) was purchased
from Enzo life sciences (product code:UW0150) and AtSUM1 was prepared using recombinant expres-
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Algorithm 1 Pseudocode for phosphorylated SIM generating algorithm
For each SIM model, find all matching peptides in translated Arabidopsis genome
Remove all duplicate sequences
Randomise order of peptides
for Each SIM do
if SIM has no S, T or Y groups then
Discard SIM and choose next SIM
end
if SIM has 1 or 2 phosphorylatable amino acids then
Generate all possible phosphorylation combinations
end
if SIM has 3 or more phosphorylatable amino acids then
Randomly generate 2 SIMs with 1 phosphorylation
and
Randomly generate 2 SIMs with 2 phosphorylations
and
Randomly generate 1 SIM with 3 phosphorylations
end
Add peptide sequences to library
end
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sion in Escherichia coli (E. coli). Interaction with peptides in the arrays was screened using far-western
blotting. The quantity of peptide in the arrays was estimated by staining with Ponceau-S. See Chapter 2
for full molecular biology methods. Due to the peptide synthesiser being used by multiple researchers
and synthesis runs being queued, the unmodified peptide library split over in two parts.
3.3.3 SIM array image data collection
The far-western film images and the dried Ponceau-S stained arrays were imaged with a Nikon di-
gital camera to collect peptide spot intensity data. This section describes the methods used to measure
and normalise the intensity data from the images of the SIM peptide arrays. As the far-western im-
ages represent interaction data, they will be referred to as simply the interaction images hereafter. The
Ponceau-S stained images on the other had show total protein levels in the arrays and will be referred to
as the protein quantity images hereafter.
3.3.3.1 Image preprocessing
All preprocessing work was carried out in the image processing software Fiji (Schindelin et al., 2012),
a distribution of ImageJ for biological image processing. The colour images were converted to tagged
image file format (TIFF) and then converted to 32 bit greyscale (floating point) images. Artefacts such
as dust and speckling were locally removed using a noise filter. The images were then rotated so that the
peptide spots aligned with the x and y axes of the image, this was required for correct spot identification
in subsequent processing. The images were then scaled by 0.5 in both the x and y direction (75%
reduction in area) using bilinear interpolation.
The background of the interaction images (but not the protein quantity images) was then normalised
by first generating an approximation image of the background and subtracting this from the original
image. To generate the background, the intense regions from the interacting spots were filtered out
using a low-pass noise filter and then the resulting image was smoothed using a Gaussian kernel with
a radius of 50 pixels. These images, along with the protein quantity images were then reduced to 8 bit
greyscale images (256 integer scale values) and were saved for further processing.
3.3.3.2 Intensity data collection
The processed array images were analysed using a MATLAB tool with a graphical user interface written
specifically for the purpose (see appendix C.1 for source code). Centre points for each peptide spot
were calculated based on the grid size and spacing. Discs of the same size as the peptide spots were
then drawn over each spot and the average intensity of the pixels beneath the discs was calculated. To
calculate which pixels to include in the mean calculation for a particular peptide spot, any pixel in the
image, (Xi, Y j), had to satisfy the inequality
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(Xi − x)2 + (Y j − y)2 ≤ r2
to be included, where (x, y) is the centre of the disc over a peptide spot and r is the radius. The intensity
data for each spot was then matched with its corresponding peptide sequence and annotation.
Background data were also collected from the arrays for use in later normalisation steps. The inter-
action images and quantity images were treated differently in this process as the interaction images had
signal that bled into the inter-spot space on the arrays. For the interaction images 10 evenly distributed
points in areas of the image with no interaction signal were selected and the mean and standard deviation
of the intensities was calculated. For the quantity images, the intensity of an area next to each spot was
measured so that each peptide value had a corresponding background value.
3.3.3.3 Data normalisation, scaling and correction
Once the numeric data had been extracted from the array images, all further processing and analysis
was performed in R (R Core Team, 2013) and the R package and package ggplot2 (Wickham, 2009)
was used to generate figures.
To remove discontinuities between the different parts of the arrays, intensities were normalised
against the background values and rescaled. The approach differed for the intensity and quantity ar-
ray values. For each part of the interaction arrays, the mean background value, µ, was subtracted from
the matrix of intensity values, I, and then the data was rescaled between 0 and 1 using the 0th and
97.5th percentile. The 97.5th percentile was used to prevent extreme values distorting the data. The
normalisation and rescaling steps are given by:
Inormalised = Ioriginal − µ
Iscaled =
Inormalised
P97.5(Inormalised)
Normalisation and scaling of the quantity image parts was performed slightly differently. Rather
than subtracting some global background mean, the background intensities for each spot that had been
estimated earlier were subtracted from the peptide intensities, Q. The resulting values were then scaled
between 0 and 1, again using the 0th and 97.5th percentile. These steps are given by:
Qnormalised = Qoriginal −Qbackground
Qscaled =
Qnormalised
P97.5(Qnormalised)
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The peptide quantity data were then used to rescale the interaction data, essentially correcting in-
tensity values for spots with low peptide levels or no peptide. Spots with peptide levels close to 0 were
removed from the data as these could not be used to extrapolate interaction levels.
3.3.3.4 Error estimation and data exclusion
Correcting the interaction values by dividing by the quantity values introduces error into the final result.
The 95% confidence interval for this error, ˆ, was estimated as
ˆi =
1.96σ
Qscaledi
where σ is the calculated standard deviation of the background of the scaled intensity images. A cutoff
for Iscaled by ˆ was chosen since ˆ becomes large for small values of Qscaled, as
lim
Qscaled→0
1.96σ
Qscaled
= lim
Qscaled→0
ˆ = ∞
As the error associated with any particular intensity value increases, the uncertainty about the true
value of the intensity increases and a suitable error calculation to exclude values was determined. Rather
than using a single threshold to decide which data to exclude, the intensity was taken into account as
some values with high error may have such a high intensity value that they can still be assumed to be a
true interacting spot. An example of this would be a spot with a very low peptide amount that interacts
very strongly with SUMO.
As well as the estimated error, the peptide spot intensities from the negative controls had to be
included in the criteria for removing data. The intensity of the control data, which was processed
in the same manner as the interaction data, is given by C. The Arabidopsis and human data were
analysed using two different methods due to very high noise in the human data and a high number of
non-specific interactions. For the Arabidopsis data, three thresholds were defined: maximum negative
control intensity threshold (TC), interaction intensity threshold (TI) and error threshold (T). For any
particular spot to be retained, the negative control value had to be less than TC and either the intensity
value had to be greater than TI or the error value had to be less than T . More formally these criteria are
given by the formula:
(C < TC) ∧ [(Ii > TI) ∨ (ˆi < T)]
The criteria for determining which human data to retain were more complicated. Rather than only
using a cutoff for the negative control values, a spot which has a negative control value above TC could
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still be retained if the interaction value was higher than the negative control value, within an acceptable
margin given by the constant α where α > 1. This gives the formula for deciding which human data to
keep:
[(Ci < TC) ∨ (Ii > αCi)] ∧ [(Ii > TI) ∨ (ˆi < T)]
3.3.3.5 Partitioning data
Once data had been normalised and unreliable values removed, the data was partitioned into SIMs and
non-SIMs by taking an interaction threshold and defining all peptides above this threshold as interactors.
This threshold was set above a large cluster of peptide interaction values near 0. For the Arabidopsis
data this value was 0.125 and for the human data 0.15.
3.3.4 SUMO site data
Training data to build the SUMO site predictors was gathered from Ren et al. (2009) and included the
data used to train SUMOsp version 2. The authors provided Uniprot database identifiers and the indices
of the SUMOylated lysines but not any sequence data. These identifiers were collected, however, a
number of the database entries had been retired and replaced with more accurate sequences. These
updated IDs and corresponding protein sequences were first checked with an R script to ensure all
lysine indices given by Ren et al. (2009) still matched lysines in the new sequences. For a number of the
new sequences, the given indices did not match lysines but were within a few amino acids of one. For
each of these index mismatches, the index was corrected to the nearest lysine. As had been done by Ren
et al. (2009) and Teng et al. (2012), all lysines not identified as SUMO sites were used as negative data
for training predictors. Sequences were then collected which included 5 amino acids both downstream
and upstream of the central lysine. Redundant sequences were then removed so that every training
sequence was unique. In total 8318 sequences were collected, 332 SUMOylated sequences and 7986
non-SUMOylated sequences. It is likely that the non-SUMOylated set will contain some false negatives
since a fraction of the non-surface exposed motifs would still be suitable substrates for SUMOylation.
This issue however, has not had a significant effect in previous predictors and random forest models are
resistant to incorrectly labeled training data.
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3.3.5 Peptide and protein analysis
3.3.5.1 Amino acid conservation scoring
To calculate the similarity between a number of sequences, the sum of pairs method was used as this
takes amino acid properties into account by giving a score to each possible substitution (Pei & Grishin,
2001). To score substitutions, the homologous structure derived substitution (HSDS) matrix from Prlic´
et al. (2000) was used. The HSDS matrix was derived from comparisons of domains with similar struc-
ture but with low sequence identity with intent to develop a scoring matrix that is applicable for scoring
distantly related sequences. The rationale for using this matrix was that this work is more concerned
with the structure and function of peptides than the evolutionary relationship between sequences. One
modification was made to the matrix: since it was intended to be used for sequence alignment it did
not penalise gaps in an alignment heavily, the score for pairs with a gap was reduced to 0. The penalty
was changed as, for the purposes of scoring structural similarity, gaps do not represent conservation of
amino acids.
To calculate the similarity of a set of n aligned sequences, which are represented by a two-
dimensional matrix A, the similarity, S , at the kth aligned amino acid position is given by
S k =
n−1∑
i=1
n∑
j=i+1
H(Ak,i, Ak, j)
/
(
n
2
)
where H is the substitution matrix.
The computational time for this algorithm grows at rate of O(n2) for the number of sequences and
the algorithm becomes computationally intensive for multiple full length proteins. An R implementa-
tion of this calculation was too inefficient for the sequence predictor and was instead written in C and
compiled as a shared library to be called in R (on Unix type systems only). The source code for the C
and R functions are shown in Appendix C.2.1. Multiple sequence alignment was performed using the
MUSCLE algorithm (Edgar, 2004).
3.3.5.2 Preference logos
Sequence logos are often used to analyse alignments of amino acids and nucleic acids. Sequence logos
show which residues at which position are present at a rate above random chance, measured as a com-
bination of Shannon entropy and residue frequency (Schneider & Stephens, 1990). While these graphs
are useful for showing which residues are important, they do not show residues which are found at a
lower than expected frequency at a position. To analyse SIM sequences, a more robust method was
required that measured both over- and under-representation of amino acids at each position. Berry et al.
(2006) developed a method to overcome the limitations of sequence logos by representing DNA letters
on a graph whose height was the quotient of the observed and expected frequency.
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The method from Berry et al. (2006) was taken as a starting template and adapted to make a method
suitable for analysing SIMs, known as preference logos. One issue that this new method had to address
was the low number of observations and large alphabet size, often leading to small numbers for counts
of rare amino acids. To address this issue, the frequencies of the observed amino acids were subtracted
from, rather than divided by the expected frequency. This reduced amplification of noise in the results,
especially for under-represented amino acids. In addition, amino acids that did not show significant
difference to the expected distribution were removed from the figure, leading to a figure that shows
only the amino acids which deviate from the expected frequency. The Poisson exact test was used to
determine which amino acids were not significantly different from the expected frequency and only
amino acids with a p < 0.05 were kept. The Poisson exact exclusion method also had the benefit of
removing data points with too few observations to show statistical significance. A multiple comparison
correction for the p values was initially included using the Benjamini and Hochberg method but this
was found to be too restrictive and was not used on the results presented in the chapter though ideally if
the number of observations were higher, a multiple comparison correction should be used. The R source
code for this function is shown in Appendix C.2.2.
3.3.6 Principal component analysis of amino acid features
To improve the performance of the SIM models, amino acid factors (i.e. the amino acid letters) were
converted into numeric variables that describe the chemical properties of the different amino acids.
These variables were generated from a principal component analysis (PCA) of amino acid chemical
data. Amino acid chemical data were used from the AAindex database by Kawashima & Kanehisa
(2000), accessed from the seqinR R package (Charif & Lobry, 2007), and PCA was performed using
the FactoMineR R package (Husson et al., 2013). The AAindex contained 544 different indices of
properties for amino acids, 13 of these indices were excluded because they did not contain data for all
20 amino acids. The first 5 principal component dimensions were then saved for later use in machine
learning models.
3.3.7 Random forest predictors
Training data collected for SIMs and SUMO sites were used to train random forest predictors. For
each feature, data was divided into multiple subsets and a different random forest model was trained for
each set. The R implementation of the random forest algorithm by Breiman (2001) was used (Liaw &
Wiener, 2002).
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3.3.7.1 Data treatment
The processed SIM data was split into six training sets, splitting by the two species (Arabidopsis &
human) and by the three SIM types, A, B and R. The synthetic SIM sequences were sampled from a
limited set of peptides with different amino acid distributions compared to natural peptide sequences. To
prevent the models being biased by this, random sequences with natural amino acid frequencies were ad-
ded to the training sets as negative data. For each SIM type, random sequences were generated by using
natural amino frequencies as probabilities to randomly sample each amino acid in a 13-mer sequence.
The same number of these randomly generated sequences was added to each SIM type set as there were
non-interacting peptides. For the B type SIM random sequences, position 5 and 6 corresponding to the
highly conserved DL motif was constrained to these amino acids as sequences tested with the random
forest predictors for this motif would be prescreened to contain this conserved DL motif. If the amino
acids in the random negative set were not constrained to DL at position 5 and 6, the random forest would
select these amino acids as the most important variables, which would lead to poor performance as the
important features outside the DL motif would not be prioritised.
For the SUMO site data, the positive training data was partitioned into type I and II sites, and all
the negative data was added to each set. The SUMO site type was not known and was determined by
performing k-means clustering on the positive data, with k = 2. To perform the clustering, a distance
matrix was calculated by taking three amino acids downstream and upstream of the central lysine (K± 3)
and converting these to the numerical values from the first dimension of the PCA of amino acid features.
The Euclidian distance was then calculated for each pair of vectors to generate the distance values. To
determine the SUMO site type of the sets of data from the cluster analysis, the resulting groups were
analysed for conformity to the canonical ΨKx[E/D] motif, with the closest to the group being designated
as type I.
Next the datasets were prepared for the random forest models by converting the amino acid factors
into numeric vectors from the PCA of amino acid indices. Each amino acid in the 13-mer SIM sequences
was converted into 5 PCA dimensions resulting in a vector of 65 dimensions for each SIM sequence in
all of the SIM subsets. For the SUMO site data, 11-mers consisting of five amino acids downstream and
upstream of the central lysine (K± 5) were converted into the 3 PCA dimensions, resulting in vectors of
33 dimensions for each SUMO site sequence in each subgroup.
3.3.7.2 Building and optimising random forest predictors
A multistep approach was taken to build the random forests for each data subset. Since each sub-dataset
contained many times more negative training data than positive (for both the SIM and SUMO site data),
subsampling of the data was required to prevent the random forest models optimising for the prediction
of the negative data at the expense of positive data, i.e. the random forest models would tend to a
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specificity of 100% and a sensitivity of 0% without subsampling. The internal random forest sampling
method was used, maintaining the integrity of the OOB error estimation. An approximate sampling ratio
was determined by exhaustive searching to find the ratio where the OOB error estimate of positives and
negatives was the most similar, which was generally close to a ratio of 1:1.
Once the optimal subsampling ratios had been determined, a very large random forest with 10 000
trees was trained on the full datasets for each training subset with purpose of calculating variable im-
portance. The resulting variable importance, measured in mean decrease in the Gini coefficient, was
used to rank the importance of each variable in the input vector.
Next parameter selection was performed with another exhaustive search. A parameter search with
two variables, v and m was performed with each data subset. The variable v is the number of highest
ranked variables to be used and m is the number of variables used at each node in each tree. The range
for m was 1 to 10, and for v 1 to the maximum number of variables in the training data, where m ≤ v in
all cases. A small random forest of 250 trees was trained and the performance of the random forest was
estimated by calculating the OOB estimate of the AUC using the R package ROCR (Sing et al., 2005).
The score parameter used in the AUC calculation was the proportion of trees predicting a positive value.
This was then repeated 25 times and the mean AUC value with the 95% confidence interval for each
combination m and v was calculated. Algorithm 2 details this process. 10 performance curves were
generated for each training data subset, with a specific curve for each m value. The m and v pairs that
generated the maximum mean AUC values were then taken as the optimal parameters for each data
subset to use to train each random forest predictor.
Algorithm 2 Algorithm for finding optimal random forest parameters. RF is the random forest function;
v is the number of variables with a maximum of Nv; m is the number of variables to use at each tree
node with a maximum of Nm and T is a matrix of training data.
For each training data subset perform the following to calculate a vector of means and confidence inter-
vals.
for v in 1 to Nv do
for m in 1 to min(v, Nm) do
µv,m = mean AUC of RF(T, v, m)
CIv,m = 95% confidence interval of RF(T, v, m)
end
end
The final random forest predictors were then trained with the calculated optimal m value and the
v most important variables, adding trees until the OOB estimate of error could not be improved any
further, which in all cases was around 2000 trees. The resulting RF models, along with metadata about
the sequence features, was encapsulated into a sequence feature object. The metadata included which
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variables were used, the type of sequence feature, the indices of the core and a search mask. These
metadata were used to correctly configure the predicator for each sequence feature. For SIMs the core
corresponds to the central hydrophobic patch and in SUMO sites the central lysine. The mask is a
short regular expression that determines which subsequences of a full length protein are tested with
the sequence feature predictor. For the SUMO sites, the mask only allowed sequences with a lysine at
position 6 within the subsequence, the same position as the SUMOylatable lysine in the training data.
For the SIM prediction models the mask matches core features; the SIM type A and R mask matches
three hydrophobic residues in the 4 residue cores (ΨΨxΨ or ΨxΨΨ) while for SIM type R the core
matches the immutable DL amino acid pair. The masks were used to decide which subsequences to
test within a protein sequence and this method dramatically reduces the number of subsequences tested,
reducing the computational time required for the predictor to run. Sequences that do not contain the
core features in these masks are very unlikely to be SIMs.
3.3.7.3 Quantifying and comparing random forest performance
Once optimal random forest model parameters had been found for each data subset, the performance
of those models was assessed by calculating the OOB ROC statistics. RFs were trained 25 times and
the mean OOB AUC and 95% confidence intervals were calculated. The SUMO site predictors were
compared with the other published predictors, SUMOsp 2 and seeSUMO. The full training set used to
build the random forests was queried against both predictors, using their web interfaces. For SUMOsp,
the training data were split into type I and II sites, as the output of this model distinguishes between
these two types of site. The score thresholds were set to their lowest values so that the predictors would
return score values for all training data. The resulting score values and their corresponding interaction
values were used to generate ROC curves and calculate the AUC for each predictor.
The score used from the random forest models is the proportion of trees giving a positive prediction
for a given peptide sequence. These score values do not however provide any useful information about
the accuracy of the prediction these models give, and using OOB ROC data the false positive rate (FPR)
was modelled using an inverse sigmoid for each random forest model. The FPR function is given by
FPR(score) =
1
1+ e(α·score+β)
with the constants α and β estimated by performing Gauss-Newton non-linear least squares regression
on the estimated ROC data. An inverse FPR model was used to calculate score cutoffs for the random
forest models. This function is given by
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score(FPR) =
ln( 1FPR − 1) − β
α

if FPR > 1eβ+1 , FPR =
1
eβ+1
if 1
e(α+β)+1
≤ FPR ≤ 1eβ+1 , FPR = FPR
if FPR < 1
e(α+β)+1
, FPR = 1
e(α+β)+1
and uses the same α and β constant values calculated for the FPR model.
3.3.8 HyperSUMO, a graphical user interface sequence feature predictor
A web-based tool called HyperSUMO was developed to release the SUMO-related sequence feature
(i.e. both SUMO sites and SIMs) predictor to the wider research community. The shiny application
framework (RStudio, 2014) was used to develop the web tool, which was designed to run on a 64 bit
linux server. HyperSUMO takes a set of FASTA formatted sequences and first aligns these, plots a
graphical representation of the alignment and then over-lays predicted SUMO sites and SIMs onto the
alignment. The graphical representation also contains a graph of sequence similarity along the alignment
calculated. The results are also displayed in a table, with the location, sequence, type and confidence.
The tool has the option to select one of three cutoff thresholds to control the FPR of the prediction as
well as select between Arabidopsis and human SIM predictors.
To manage and align the protein sequence data, the bio3d R package (Grant et al., 2006) was used.
To read data from the text input box in the graphical user interface (GUI) a modified version of the
bio3d FASTA format sequence reader was developed. The sequence reader first checks that the correct
format is used and flags issues such as the use of ambiguous characters which were not supported or for
presence of nucleic acid sequences. A sequence is determined to be a nucleic acid if it contains at least
one of each nucleobase letter and no amino acid specific letters. If multiple sequences are uploaded they
are aligned with the MUSCLE algorithm (Edgar, 2004) and a conservation graph is calculated using the
sum of pairs method described earlier.
After query sequences are submitted, HyperSUMO uses the RF predictors to scan along each se-
quence in the input and generate sub-sequences that match the masks encapsulated within the RF mod-
els. The amino acids in these sequences are then converted into the numeric PCA dimensions and the
required variables for the model are selected. Converted sub-sequences are then sent to the RF predict-
ors which return prediction scores for all sub-sequences. Any subsequences with a score above the user
selected threshold are then indicated on the graphical alignment and the sequence data is added to the
output table. For the SUMO site predictors, if both the type I and II RFs predict a positive result at the
same lysine, the type I site overrides the type II, which is discarded; this is done as the type II predictor
can predict both types of site but has worse accuracy than the type I site predictor. For each positive
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result, an approximate confidence value is calculated corresponding to the specificity. Using the sigmoid
FPR models, the specificity is calculated as S p = 1 − FPR(score). Source code for HyperSUMO will
be provided on request.
3.3.9 Genome-wide screen for SIMs
The random forest SIM predictors were used to perform a genome-wide screen for likely SIM containing
proteins in Arabidopsis, integrating multiple sources of information to improve the accuracy of the
predictions. The SIM screen used evolutionary information to find candidate SIMs that were conserved
and did not lie within any predicted functional protein domains. Domain sequences were removed
as these tend to be structured while SIM sequences most often occur within unstructured regions of
proteins.
To incorporate the evolutionary information into the screen, predicted Arabidopsis orthologous
genes were used from the work by Baxter et al. (2012) which defined reciprocal BLAST hit gene pairs
as orthologs. Orthologs from the following 7 species were used: Populus trichocarpa (poplar tree),
Medicago truncatula, Vitis vinifera (grape), Phoenix dactylifera (date palm), Musa acuminata (banana),
Sorghum bicolor and Oryza sativa (rice). From those data, Arabidopsis proteins with at least 2 orthologs
with non-ambiguous sequences were grouped and then aligned using the MUSCLE multiple sequence
alignment algorithm (Edgar, 2004). Each set of aligned proteins, corresponding to an Arabidopsis gene,
was then analysed. Each sequence in the alignment was then scanned with each SIM predictor, resulting
in a SIM score matrix for each SIM type. For each SIM score matrix, the values were converted into
FPRs using the sigmoid model discussed earlier. The mean of the FPR was then calculated at each
amino acid position. The score values of gaps in the aligned sequence were set to 0, or an FPR of
1.0, giving a very high penalty to these sequences. Once the mean SIM FPR scores and conservation
scores at each position in the alignment were calculated, values that corresponded to alignment gaps in
the Arabidopsis sequence were removed from the dataset as they were not meaningful in the context of
screening the Arabidopsis genome.
Next, amino acids that were within predicted protein domains were identified. The entire Arabidop-
sis translated genome was uploaded to the NCBI conserved domains database batch processor with a
cutoff of p < 0.01 (Marchler-Bauer et al., 2013). Any amino acids in Arabidopsis proteins that were pre-
dicted to be within a domain superfamily were flagged. Then for each protein, the number of predicted
SIMs outside a domain region and with mean FPR ≤ 0.2 were counted. From these data, 500 proteins
with the lowest FPR SIM scores were used, with the FPR cutoff of 0.1021. The top 500 predicted
SIM-containing genes were then analysed for gene ontology (GO) term enrichment using the Virtual
Plant internet interface (Katari et al., 2010). Biological function and molecular process ontologies were
analysed. To generate an overview of the results from the GO term analysis, the terminal node keywords
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in the GO term hierarchy were used with a cutoff of p < 0.001.
3.4 Results
3.4.1 SIM peptide array image analysis
To generate the SIM data, three separate SIM arrays were manufactured with a total of 1200 peptide
spots. The first two arrays (SIM array parts I and II) contained 600 non-modified peptide sequences
for all three SIM types while a third (phosphorylated SIM array) contained 600 peptides with various
combinations of phosphorylated serine, threonine and tyrosine residues. The unmodified and phos-
phorylated arrays were manufactured on different runs on the peptide array synthesiser and staining
with Ponceau-S (Figure 3.2) showed that there were fewer successfully manufactured peptide spots on
the first two arrays (SIM array parts I and II) compared to the phosphorylated peptide array. This differ-
ence in efficiency was most likely due to differences in manufacturing conditions rather than differences
in the peptide sequence as the same templates for generating peptides were used to design the peptides.
Due to the lower peptide manufacture efficiency in the first two arrays, many more peptide spots were
excluded from the processed dataset than from the phosphorylated array.
The intensities of the Ponceau-S stained peptide spots were used to normalise the intensities of the
spots from the SUMO far-western blots. The associated error for each correction was calculated based
on the intensity of the Ponceau-S peptide spot and is shown in Figure 3.3. This correction error was
used as the basis to decide which peptide spots to exclude from the data to ensure that false negatives
were not included in the final dataset. Without this error correction, peptides that would have interacted
with SUMO but that were not synthesised in sufficient amounts would have shown no signal in the far-
western blots and would have been labeled as non-interacting peptides. Having such false negatives in
the predictor training data would have resulted in reduced performance.
The images of the SUMO far-western blots had uneven backgrounds in both the x and y directions
of the images and without correction, measured intensity values would have been spatially biased. The
method to flatten the base line successfully corrected the spatial background defects and set the baseline
values of the images to 0. Figures 3.4 to 3.7 show the results of the baseline flattening from samples
taken in the x and y directions of all far-western blots. The areas where these samples were taken from
are shown in the Appendix figures B.1 to B.4. The data for the HsSUM1 far-western blots (Figures 3.6
& 3.7) was noisier and the baseline flattening was less effective than that of the AtSUM1 far-western
blots (Figures 3.4 & 3.5). Some regions of the baseline under- or over-shot the 0 line however, the
magnitude of these errors was small enough not to have a significant effect on the intensity values.
The normalised far-western blot images of the AtSUM1 arrays are shown in Figure 3.8. Of the two
SUMO isoforms screened, these arrays produced less noisy data as there was very little signal outside
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SIM array 
part 1
SIM array 
part 2
Phosphorylated 
SIM array
Peptide arrays stained with Ponceau-S 
Figure 3.2: Ponceau-S stained peptide arrays. Staining shows the approximate amount of peptide at
each spot. Staining shows that a large number of peptide spots were not synthesised effectively and
the original SIM array (in two parts) had a worse efficiency than the later phosphorylation array. The
intensities of the peptide spots were used to normalise far-western blot results. Data for spots with little
or no peptide were excluded from the dataset.
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Figure 3.3: Correction error. Shows the 95% confidence interval of the error for the final interaction
value after normalisation with peptide amount.
of the peptide spots and there were very few non-specific interactions in the control images. The control
array was exposed to X-ray film for twice as long to ensure that any non-specific interactions were
detected. Five non-specific were interactions identified in total, along with one spot that was determined
to be an artefact (control SIM array part II).
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Figure 3.4: Results of baseline normalisation for AtSUM1 interaction array images. Normalisation
flattened undulations and centred the baseline on zero. A sample of the baseline was taken in the x and
y direction with the width of 1 peptide spot. The peaks in the data are caused by interacting spots in the
array.
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Figure 3.5: Results of baseline normalisation for AtSUM1 control array images. Normalisation flattened
undulations and centred the baseline on zero. A sample of the baseline was taken in the x and y direction
with the width of 1 peptide spot. The peaks in the data are caused by interacting spots in the array.
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Figure 3.6: Results of baseline normalisation for HsSUM1 interaction array images. Normalisation
flattened undulations and centred the baseline on zero. A sample of the baseline was taken in the x and
y direction with the width of 1 peptide spot. The peaks in the data are caused by interacting spots in the
array.
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Figure 3.7: Results of baseline normalisation for HsSUM1 control array images. Normalisation flattened
undulations and centred the baseline on zero. A sample of the baseline was taken in the x and y direction
with the width of 1 peptide spot. The peaks in the data are caused by interacting spots in the array.
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SIM array part 1
SIM array part 2
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AtSUM1 interaction
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 1° antibody: αAtSUM1 (Rb)
 2° antibody: αRb HRP
Negative control
 Probe:           buﬀer
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 2° antibody: αRb HRP
Peptide arrays probed with Arabidopsis SUMO1 
Figure 3.8: Far-western blot of peptide arrays probed with AtSUM1. For the negative control, the
arrays were probed with buffer without AtSUM1 protein. Dark spots indicate an interaction. Only a few
peptides showed interaction in the negative control blot and were removed from further analyses. The
negative control blot was also exposed for twice as long to ensure that false positives were amplified.
The dark spot in the negative control array actually corresponds to a very weak spot in the interaction
array; this could be explained by less competition by the peptide for antibodies than the interaction
array. This shows that the negative control blot was very sensitive to false positives providing a high
level of confidence that the detected interactions were genuine.
Of the 5 non-specific spots, only one had a strong signal (control SIM array part I) and the intensity
of this signal was many times that of the corresponding spot in the interaction far-western blot, showing
that the controls were highly sensitive to non-specific interactions and giving a high confidence that any
non-specific interactions were detected. The purpose of the control far-western blots was to exclude
false positives from the SIM interaction datasets.
The HsSUM1 far-western blot images (Figure 3.9) were much noisier as there was signal in the
inter-peptide spot space and a very large number of peptides had signal in the negative control blots.
The most likely reason for the poor quality of the data was the primary antibody used in the assay,
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αGST, which had a high level of non-specific binding.
SIM array part 1
SIM array part 2
Phosphorylated SIM array 
HsSUM1 interaction
 Probe:           GST:HsSUM1
 1° antibody: αGST (mouse)
 2° antibody: αMouse HRP
Negative control
 Probe:           GST
 1° antibody: αGST (mouse)
 2° antibody: αMouse HRP
Peptide arrays probed with human SUMO1
Figure 3.9: Far-western blot of peptide arrays probed with HsSUM1. For the negative control, the arrays
were probed with GST protein, as the HsSUM1 used in the interaction array was fused to GST. Both
array images were exposed to X-ray film for 5 minutes. There were a high number of non-specific
interactions in these images.
Initially αHsSUM1 antibodies were used but these produced such a high signal in the control blots
that no genuine interacting peptides could be identified (data not shown). αGST antibodies performed
better, allowing identification of some genuine interacting peptides but the performance of the antibody
was still far from ideal as about a third of the peptides had to be excluded.
The final results of the data processing and peptide exclusion are shown in Figure 3.10. Data-points
that were excluded from the final dataset due to either too low peptide amount or signal in the neg-
ative control blots are shown in red. Overall a significant proportion of the peptides in the HsSUM1
far-western blots were excluded and, for both SUMO isoforms, more data was excluded in the unmod-
ified peptide arrays (see Table 3.2). For the full list of peptides after processing see Table B.1 in the
Appendices.
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Figure 3.10: Processing results showing before and after values of the spots. Spots above the error
thresholds that were removed from the dataset are shown in red, as well as exclusions by negative
control. Each graph is partitioned into the three separate array pieces. Before processing the baselines
of the different array sections were not aligned, after processing they are aligned and centred on zero.
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Number of
peptide spots
AtSUM1 data
excluded (%)
HsSUM1 data
excluded (%)
SIM array part I 240 27.9 42.9
SIM array part II 360 25.6 38.6
Phosphorylated SIM array 600 3.8 23.5
Total 1200 15.2 31.9
Table 3.2: Percentage of peptide spots excluded from final SIM datasets.
3.4.2 Sequence analysis
In total there were 598 non-phosphorylated peptides (both interacting and non-interacting) for the At-
SUM1 set and 484 for the HsSUM1 set. Between these two sets, there were 472 common peptides
and the number that bound to the two SUMO isoforms is shown in Figure 3.11. Remarkably, only a
small number of peptides, 16, bound to both AtSUM1 and HsSUM1, with the majority of the interacting
peptides binding to only one SUMO isoform. More than twice as many peptides bound to AtSUM1,
suggesting that the Arabidopsis isoform has less stringent requirements for the peptides it binds to.
These data suggest that human and plant SUMO proteins may have diverged in their function and they
now have different binding preferences. This emphasises the need to develop specific predictors for
different SUMO homologs between species and within species too.
To analyse the sequences of the interacting peptides, the preference logo method was used that
shows which amino acids are both over- and under-represented in a peptide sequence. This method
was used to highlight which amino acids cannot be tolerated at positions along the SIM sequences. To
analyse the SIM sequences, two reference background amino acid frequencies were used, the amino
acid frequencies of non-interacting peptides and the natural frequencies of the amino acids. Using the
frequency of the non-interacting peptides as a background identified important amino acid differences
in the synthetic peptide dataset that were responsible for an interaction with the two SUMO isoforms.
On the other hand using the natural amino acid frequencies as a background shows the actual structure
of the SIM motifs.
74
CHAPTER 3. PREDICTION OF SUMO-RELATED SEQUENCE FEATURES
AtSUM1HsSUM1
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33
Figure 3.11: Venn diagram of AtSUM1 and HsSUM1 interacting SIM peptides. The data used to
generate this figure was from a subset of peptides common to the AtSUM1 and HsSUM1 datasets. Very
little overlap was seen in the sequences that the SUMO isoforms bind to, while AtSUM1 binds to about
twice as many sequences in the dataset.
Due to the large size of the amino acid alphabet, a large number of sequences should be analysed to
identify significant trends with the sequence data. For the AtSUM1 interaction set, there were enough
positive sequences to clearly identify the major amino acids responsible for an interaction with AtSUM1
(Figure 3.12) however, due to the low number of positives for the HsSUM1 dataset, fewer amino acid
features could be identified for these sequences (Figure 3.13). Overall the preference logos for AtSUM1
and HsSUM1 SIMs are very similar to SIM sequence logos published by Vogt & Hofmann (2012).
However, because the set of peptides in the arrays was already similar to the published SIMs, this result
should be considered cautiously and few if any conclusions can be drawn from it except that HsSUM1
results were more similar to the published SIM motifs than the AtSUM1 data. What is of more interest
are the differences between the AtSUM1 and HsSUM1 interacting peptides.
The different SIM binding preferences between the two different SUMO isoforms lie outside of the
hydrophobic core of these peptides. For SIMs A and B the core is from position 3 to 6 and for SIM R
it is from 8 to 11 in the array peptides. The polar or charged amino acids aspartic acid, glutamic acid
and serine are the most common amino acids upstream or downstream of SIMs A and R respectively,
and this is seen generally in the peptide array data for both SUMO isoforms. The AtSUM1 sequences
however have one very notable difference: at the position immediately next to the hydrophobic core
(position 7 for both SIM A and R) the charged amino acids aspartic acid and glutamic acid are not
tolerated, and the polar amino acid serine is much more common, which is in contrast to the HsSUM1
data and to published SIM motifs.
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Figure 3.12: Sequence analysis of Arabidopsis SUMO1 interacting peptides.
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Figure 3.13: Sequence analysis of human SUMO1 interacting peptides.
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The type B SIM again was very similar to published results for the HsSUM1 data but the AtSUM1
data showed some notable differences. The highly conserved polar threonine residue (SIM position
7), which forms part of the DLT motif, showed much greater variability in the AtSUM1 interacting
peptides. This position appeared to be strictly polar for HsSUM1 and only allowed a threonine or serine
residue, while for AtSUM1 interacting peptides also allowed a tyrosine substitution and substitutions
with the more hydrophobic residues phenylalanine and cysteine. Upstream of the conserved threonine
at position 7, the AtSUM1 interacting peptides also showed a preference for charged lysine residues
at the next four positions, which was not the case for the HsSUM1 interacting peptides which instead
appeared to favour glutamic acid, though the data for these peptides is limited due to the smaller dataset
size.
Apart from the specific amino acid differences, there were also some notable differences in the
frequencies of the amino acids in the set of interacting peptides between AtSUM1 and HsSUM1. In the
HsSUM1 interacting peptide set, the frequency for cysteine was 4.1 times higher (p = 0.063) and aspartic
acid was 1.3 times higher (p = 0.01), and in the preference logos for HsSUM1 interacting peptides a
large number of cysteine residues are present in all motifs, especially toward the amino terminal (left
hand side) of the motifs.
3.4.3 Phosphorylated SIM peptides
The effect of phosphorylation of the amino acids serine, threonine and tyrosine was investigated by
designing a number of template peptides and randomly generating phosphorylated versions the base
peptides. There are four possible outcomes to phosphorylation: activation where a noninteracting tem-
plate interacts in the phosphorylated form, sustained interaction where both the template and phos-
phorylated peptide interact, deactivation where phosphorylation abolishes an interaction, and complete
non-interacting peptides which do not interact at all. The results for the two SUMO isoforms are shown
in Table 3.3. The majority of peptides screened did not interact with SUMO at all which is in concord-
ance with previous results where only 10 - 20% of synthetic peptides showed interaction.
The effect of phosphorylation on peptide interaction was significantly different between the two
SUMO isoforms, AtSUM1 and HsSUM1 (chi squared test, p = 1.13E-10), with phosphorylation having
stronger interaction promoting effect with HsSUM1. A significantly larger number of AtSUM1 interact-
ing peptides were deactivated by phosphorylation. Figure 3.14 shows a summary of the phosphorylated
amino acid positions in SUMO interacting phosphorylated peptides. An interesting observation with
AtSUM1 SIM A peptides was that phosphorylation of position 7 (most often a serine) in the peptides
always resulted in loss of interaction, and this agrees well with the amino acid preference data which
indicated that the negatively charged amino acids glutamic acid and aspartic acid were strongly selected
against at this position as well. Phosphorylation imparts a strong -2 negative charge to modified amino
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Type Unmodified peptide
interacts?
Phosphorylated
peptide interacts?
AtSUM1 HsSUM1
Activation No Yes 21 28
Sustained Yes Yes 28 18
Deactivation Yes No 65 7
No interaction No No 304 257
Total 418 310
Table 3.3: Effect of phosphorylation on SIM peptide interaction. Table shows the number of times
phosphorylation of test peptides had one of four effects. For AtSUM1, phosphorylation of peptides
abolished interaction to a much greater extent than for HsSUM.
acids and these data suggest that position 7 of SIM A cannot tolerate a negative charge, while HsSUM1
can, though interestingly the position (8) in AtSUM SIM A can be phosphorylated without loss of in-
teraction and can act as an activator. This trend however, is not seen in the reverse AtSUM1 SIM R at
the corresponding amino acid position 7, where the negatively charged amino acids or phosphorylated
amino acids were tolerated.
Due to the low number of individual phosphorylations screened for each amino acid in the peptide
sequences, no statistically significant trends could be observed between the amino acid positions. This
is not to say that no trends exist but that rather it is a limitation of having only a few positive observations
for each position. However, what can be said is that phosphorylation of amino acids in the SIM peptides
both retains an interaction and can act as molecular switch to regulate interaction. It is also notable that
phosphorylation of amino acids either side of the hydrophobic core can maintain or activate interactions
and in some cases the variable position, x, in the cores of SIM A and R (e.g. LLxL, LxLL) can also be
phosphorylated, which was not initially expected since all phosphorylation switches currently published
are due to phosphorylation of serines upstream of the hydrophobic core (Chang et al., 2011; Hecker
et al., 2006; Percherancier et al., 2009; Stehmeier & Muller, 2009). Overall the results suggest that
there is greater diversity in the position of SIM phosphorylation than has been previously discovered.
3.4.4 Principal component analysis of amino acid indices
To build the random forest predictor models, amino acid factors were converted into numeric vectors
of variables derived from a PCA of data from the AAindex database. This was to overcome the issue
of correlation between variables in the index and to reduce the number of variables used in the random
forest models. First the correlation of the AAindex was investigated. Figure 3.15, shows the correlation
of a random sample of 50 variables out the total of 531, and quite a large number of these are highly
correlated and so contain redundant information.
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Figure 3.14: Summary of phosphorylated SIMs. Bars show counts of phosphorylated amino acids in
SUMO interacting peptides with the consensus SIM sequence below; the boxed bold letters indicate
the hydrophobic core. The amino acids specified in the consensus were not necessarily the amino acids
phosphorylated as most positions are variable. The colour of the bars indicate whether the unmodified
peptide interacted with SUMO: dark grey = no, light grey = yes. Dark grey bars indicate peptides that
were activated by phosphorylation.
By performing a PCA on the AAindex variables, the variance between the 531 variables was accoun-
ted for in 13 principal components, with the first 5 of these accounting for the majority of the variance
(Figure 3.16). To get a biological perspective on these principal components, the most similar variables
in the AAindex to these components were found. Component 1 correlates well with hydrophobicity
indices, component 2 with molecular weight, component 3 with hydrophobicity indices again but using
different methods to determine the values, component 4 with partial specific volume and component 5
with steric restriction parameters.
3.4.5 SIM random forest models
The first step in building random forest models for the SIM data was to assess variable importance of
the 65 input variables, which was generated by the algorithm, see Figure 3.17. There were very few
trends or notable features in the importance of the variables apart from position 7 for Arabidopsis SIM
type A at which aspartic acid and glutamic acid are not tolerated as they are in other species.
The difference in variable importance between AtSUM1 and HsSUM1 is probably due to the differ-
ences in size of the training sets and SUMO isoform binding preferences. The HsSUM1 models were
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Figure 3.15: Correlation matrix of a sample of 50 amino acid indices from the AAindex database. Many
of the amino acid indices are strongly correlated and so contain redundant information. The correlation
values are on an absolute scale, showing either positive or negative correlation. The data in this figure
was clustered to highlight the grouping of the amino acid indices.
more likely to be influenced by amino acid variance as the positive dataset was about half the size as
that of AtSUM1.
Once variable importance had been determined, an optimisation algorithm was used to identify the
optimal number of variables to use by assessing the performance of random forests adding one variable
at a time starting with the most important. Also the number of variables used at each tree node, m, was
optimised. The results of these optimisations are shown in Figures 3.18, 3.19 and 3.20 for SIM types A,
B and R respectively.
For all of the random forest models, there was an optimal number of variables which resulted in a
maximal performance measured as AUC; adding more variables after this point resulted in a decline in
performance in all cases. The decline in performance with the HsSUM1 SIM models was more rapid
than the AtSUM1 SIM models which is in concordance with the smaller dataset sizes for HsSUM1
positive sequences as variable scarcity is more problematic for these sets. The AtSUM1 SIM models
also converged onto performance maxima with more variables than the HsSUM1 models suggesting
that training datasets with more positives allowed more complex models to be supported than for the
HsSUM1 datasets.
The optimal performance was achieved using a value of 1 for m for all models except the Arabidopsis
SIM B model for which this parameter was 3 but there was very little difference in the performance of
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Figure 3.16: Cumulative variance accounted for in the first 5 principal components of the amino acid
indices.
models with different m values for this SIM. These data show that in general for the best performance,
sampling a single amino acid variable at each tree node results in better performance than sampling
multiple amino acids.
Once the optimal variables and model parameter m had been identified, random forest models were
constructed, adding trees until the OOB estimate of error could not be improved any further. For models
the error stabilised at around 2000 trees and this value was used for all SIM types and species. The
performance was assessed by building 25 instances of each model and calculating the AUC value for
each model. These values are shown in Table 3.4. The variance for the AUC values was very small,
showing that performance was very stable between different builds of the random forest models. For
SIM A, the Arabidopsis version performed better while the human versions for the other two SIM types
performed better, which is surprising given the smaller training dataset sizes for the human models. It
may be the case that the calculated ROC AUC or any other performance measures are biased by small
dataset sizes; while the OOB performance may be true for the training data used, it probably does not
accurately reflect performance of the models when used on actual biological data. The ROC plots for
the Arabidopsis and human data are shown in Figure 3.21 and show very jagged curves for the human
models due to the small size of the training datasets. The ROC curves for the Arabidopsis models are
more granular due to the larger size of the training datasets and should better reflect the true performance
of these models.
82
CHAPTER 3. PREDICTION OF SUMO-RELATED SEQUENCE FEATURES
1
2
3
4
5
1 3 5 7 9 11 13
Arabidopsis  SIM type A
1
2
3
4
5
1 3 5 7 9 11 13
Human SIM type A
1
2
3
4
5
1 3 5 7 9 11 13
Arabidopsis  SIM type B
1
2
3
4
5
1 3 5 7 9 11 13
Human SIM type B
1
2
3
4
5
1 3 5 7 9 11 13
Arabidopsis  SIM type R
1
2
3
4
5
1 3 5 7 9 11 13
Human SIM type R
Random forest variable importance
Amino acid position in motif
Pr
in
ci
pa
l c
om
po
ne
nt
 a
na
ly
si
s 
d
im
en
si
on
0.2 0.3 0.4 0.5 0.6 0.7
Mean
Gini
Decrease
Figure 3.17: SIM predictor variable importance
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Figure 3.18: SIM A model parameter optimisation. Performance of random forest models was assessed
by adding 1 variable at a time and testing a different number of variables sampled at each tree node.
Shaded areas show the 95% confidence intervals, n = 25.
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Figure 3.19: SIM B model parameter optimisation. Performance of random forest models was assessed
by adding 1 variable at a time and testing a different number of variables sampled at each tree node.
Shaded areas show the 95% confidence intervals, n = 25.
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Figure 3.20: SIM R model parameter optimisation. Performance of random forest models was assessed
by adding 1 variable at a time and testing a different number of variables sampled at each tree node.
Shaded areas show the 95% confidence intervals, n = 25.
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Figure 3.21: ROC curves of the performance of various SIM predictors.
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SIM type Species ROC AUC (±95% CI)
A Arabidopsis 0.887 ±0.0053
B Arabidopsis 0.762 ±0.0118
R Arabidopsis 0.869 ±0.0037
A Human 0.850 ±0.0092
B Human 0.817 ±0.0162
R Human 0.920 ±0.0074
Table 3.4: SIM predictor AUC values. Mean ROC AUC values were obtained by repeatedly training
random forests on the same data set. Random forests with 2000 trees were grown for each iteration. n
= 25.
3.4.6 SUMO site random forest models
The SUMO site sequences were converted into 33 input variables for the random forest models. Unlike
the SIM data, using 3 principal component dimensions rather than 5 resulted in better performance, sug-
gesting that SUMO site prediction is less complex than SIM prediction. The differences between type
I and II SUMO sites were notable and fit well with the understanding of these motifs, see Figure 3.22.
For type I SUMO sites, the hydrophobic residue upstream of the central lysine is the most important
followed by the [DE] feature at position 2, with other amino acids contributing a small amount of in-
formation. For the type II sites, the [DE] is most important but the strong hydrophobic feature upstream
of the central lysine is absent, with the variable importance spread over the other positions. The central
lysine contributes no information as sequences are preselected to have a lysine residue at this position
so do not contribute any information to random forest predictors, thus no variables for this position are
used in the predictor.
The optimisation algorithm was applied to the SUMO site data. As was found in the SIM optimisa-
tion, a performance maximum was found after which adding more variables reduced the performance
of the model as measured by AUC. The performance drop however, was much less than for the SIM
models. The optimal number of variables used at each tree node, m, was 1, the same as for most of the
SIM models. This is in contrast to the random forest predictor by Teng et al. (2012) which was found to
have optimal performance with m = 6, though their predictors used hundreds of input variables while
the optimal number found in this work was 11 and 6 for type I and II respectively. For random forests
using a higher number of variables, the optimal value for m starts to increase, this is especially apparent
for the type I random forest with 33 variables in Figure 3.23 where m = 1 had the worst performance.
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Figure 3.22: SUMO site predictor variable importance. The central SUMOylated lysine is at position 0
in the figure. Position 0 has no importance as sequences are prescreened to have a lysine residue at this
position and so this position contributes no information to the prediction models.
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Figure 3.23: SUMO site model parameter optimisation. Performance of random forest models was
assessed by adding 1 variable at a time and testing a different number of variables sampled at each tree
node. Shaded areas show 95% confidence intervals, n = 25.
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Once optimal parameters for the SUMO site predictors were identified, random forests were trained
with 2000 trees, the point at which the OOB estimate of error could not be improved any further. For
each SUMO site type, 25 random forests were trained and their performance was assessed by AUC
values. Like the SIM random forest predictors, the variance of the AUC values between the random
forests was very small. The performance was also compared with SUMOsp (Ren et al., 2009) and
seeSUMO (Teng et al., 2012) by querying the training data used against these two predictors and using
the resulting score values to calculate AUC values and ROC curves. The AUC for our model, known as
HyperSUMO, and the other predictors are shown in Table 3.5 and the ROC curves are shown in Figure
3.24. The results show that as expected the type I predictor (AUC = 0.986) outperforms the type II
predictor (AUC = 0.842) and the SUMO site predictors greatly outperform the SIM predictors (Table
3.4). The better performance of the SUMO site predictors is at least partly due to the much larger size
of the training dataset but may also be influenced by the quality of the data and the complexity of the
problem being addressed.
Model SUMO types ROC AUC (±95% CI)
HyperSUMO type I I 0.986 ±0.00075
HyperSUMO type II II 0.842 ±0.0039
SUMOsp type I I 0.731
SUMOsp type II II 0.725
seeSUMO I & II 0.705
Table 3.5: Comparison of ROC AUC values for various SUMO site predictors. Mean ROC AUC for
random forest models were obtained by repeatedly training random forests on the same data set (n =
25). Random forests with 2000 trees were grown for each iteration.
SUMOsp and seeSUMO were trained with the same data as was used to build the predictors and due
to technical restrictions cross validation was not possible, therefore the resulting AUC values likely over-
estimate the performance of these predictors. Despite the possible overestimation of the performance of
SUMOsp and seeSUMO, our model, HyperSUMO, greatly outperforms these models even for the less
accurate type II predictor. The results for seeSUMO disagree with those published by the author who
estimated a ROC AUC value of 0.920 for their best performing predictor while our results give a value
of 0.705, which is an enormous discrepancy. One of the major differences between HyperSUMO’s and
seeSUMO’s estimation of AUC is the validation dataset used, our method used all of the 8318 training
sequences while Teng et al. (2012) used a separate set with a total of 1338 sequences of which 48 were
SUMOylated. There may be something inherently different between these datasets that accounts for
the discrepancy in estimated AUC values where the larger dataset gives a lower value and the smaller
a higher value. Factors that could contribute to this difference include a different ratio of type I and II
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sites or different accuracy of the data resulting from the methods used to identify the SUMO sites. The
smaller dataset used for evaluation by Teng et al. (2012) was curated from publications after January
2010, whereas the data used in this work was from before this date.
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Figure 3.24: ROC curves of the performance of various SUMO site predictors. The published pre-
dictors SUMOsp and seeSUMO have comparable performance. HyperSUMO greatly outperforms the
other two published predictors for both type I and type II sites, while the performance of type I pre-
diction is markedly better. To calculate performance for HyperSUMO, FPR and TPR were calculated
using OOB estimation using the full training dataset. For the other two models, the training data were
queried against the predictors with the threshold set to 0 so that a score was generated for every lysine.
SUMOsp and seeSUMO were trained with the same datasets but cross validation was not possible due
to technical restrictions; therefore the ROC curves generated for seeSUMO and SUMOsp over-estimate
their performance. Despite this HyperSUMO outperforms these predictors.
3.4.7 Genome screen for SIM containing proteins
A genome-wide screen for SIMs in Arabidopsis was performed which incorporated evolutionary inform-
ation. Multiple orthologous genes from both eudicotyledonous and monocotyledonous plant species
were aligned with Arabidopsis genes and conserved SIM-like motifs were identified that were outside
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of predicted protein domains. The top 500 identified genes are listed in Table B.2 in the Appendices. GO
term analysis revealed that this set of genes was enriched for cell wall and sugar metabolism, DNA/RNA
homeostasis, transport and calmodulin binding. These results are in accordance with the known role of
SUMO in chromatin remodelling and a number of notable genes that were identified include ATDDM1,
CHR8 and CHR31. A summary of the molecular function GO terms is shown in Table 3.6 and biological
process GO terms are shown in Table 3.7. The full list of GO term results are shown in Tables B.3 and
B.4 in the Appendices.
Along with the DNA/RNA maintenance genes, a number of DNA repair genes were identified in-
cluding RAD5, GMI1 and ATXPD, and a wide range of stress genes including heavy metal induced genes
and heat shock protein genes were also identified. This suggests a strong role for SUMO in coping with
environmental stress and DNA damage, roles which have been cited in the literature (Mazur & van den
Burg, 2012; Castro et al., 2012).
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Molecular function GO term Observed
frequency
(%)
Expected
frequency
(%)
Ratio p-value
Cellulose synthase activity 4.09 0.57 7.24 2.59E-08
Calmodulin binding 2.50 0.15 17.09 7.04E-06
ATP binding 11.36 3.01 3.78 4.26E-05
Adenyl ribonucleotide binding 11.36 3.03 3.75 4.49E-05
ATPase activity, coupled to
transmembrane movement of ions,
phosphorylative mechanism
11.14 2.87 3.87 4.62E-05
Purine nucleoside binding 3.64 0.70 5.23 4.62E-05
Beta-galactosidase activity 11.14 2.99 3.72 4.90E-05
Helicase activity 9.55 3.55 2.69 1.59E-04
Ribonucleotide binding 20.00 11.62 1.72 2.71E-04
DNA-dependent ATPase activity 12.05 4.97 2.42 5.76E-04
Nucleotide-sugar transmembrane
transporter activity
8.18 3.05 2.68 8.17E-04
Clathrin binding 6.59 1.70 3.89 2.05E-03
Hydrolase activity, acting on acid
anhydrides, catalysing
transmembrane movement of
substances
5.00 1.26 3.96 2.05E-03
Table 3.6: Summary molecular function gene ontology analysis.
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Biological process GO term Observed
frequency
(%)
Expected
frequency
(%)
Ratio p-value
Plant-type cell wall biogenesis 2.74 0.20 13.68 1.10E-07
Cellular developmental process 5.94 1.51 3.92 1.14E-06
Cell morphogenesis involved in
differentiation
3.42 0.56 6.06 6.11E-06
Transport 14.16 6.94 2.04 8.01E-06
DNA-dependent DNA replication
initiation
1.37 0.04 31.08 1.47E-05
Carbohydrate biosynthetic process 4.11 0.96 4.29 2.80E-05
Organelle organisation 6.16 2.16 2.85 9.98E-05
Polysaccharide biosynthetic
process
2.51 0.39 6.40 1.21E-04
Disaccharide metabolic process 1.83 0.19 9.70 1.71E-04
Embryo development 5.02 1.65 3.04 2.77E-04
Cellular carbohydrate metabolic
process
5.25 1.80 2.91 3.27E-04
Oligosaccharide metabolic process 1.83 0.23 8.00 4.87E-04
Cell growth 3.65 1.01 3.63 5.46E-04
Response to light stimulus 5.25 1.91 2.75 6.64E-04
Embryo development ending in
seed dormancy
4.34 1.42 3.05 8.05E-04
Cellulose biosynthetic process 1.37 0.12 11.03 9.09E-04
Intracellular transport 4.57 1.57 2.90 9.09E-04
Table 3.7: Summary biological process gene ontology analysis.
3.5 Discussion
3.5.1 Peptide array
The use of arrays of synthetically generated peptides to screen for SUMO interacting peptides was suc-
cessful and the models used to generate those peptides produced a good balance of interacting and non-
interacting peptides, with about 20% or 10% of the total number of peptides interacting with AtSUM1
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or HsSUM1 respectively. Had the peptide generation models been too specific, too few non-interacting
peptides would have been identified; conversely, had the models been too general, too few interacting
peptides would have been identified.
There were a number of issues with the peptide arrays and the methods used to collect interaction
data. There was a large variance in the amount of peptide produced in each spot and the lack of a suit-
able method to accurately measure the peptide amount resulted in uncertainty in the amount of peptide
present which prevented any quantitative analysis of intensity signals for the peptide spots. Peptide
amounts could not be accurately quantified due to the limitation of using dye-based methods for short
peptides, where the intensity of the staining varies greatly depending on the amino acid composition of
the peptides. A similar difficulty is experienced with spectroscopic methods, where the aromatic amino
acids have a higher absorbance in the UV spectrum used for quantification (Hansen et al., 2013). For
larger protein molecules, dyes or spectroscopy are accurate methods of quantification as the propor-
tions of amino acids between proteins is usually similar. However, for short peptides the proportions of
amino acids vary significantly between peptides. It may be possible to develop a more accurate method
of quantification if the sequence of the peptides being measured is known, which is the case for peptide
arrays. For UV spectroscopy the absorbance of the different amino acids is well characterised. The se-
quence of amino acids in a peptide could be used to estimate an absorbance per quantity of peptide. Such
a method could then be used to accurately quantify the amount of peptide in array spots and differences
in interaction strength could be estimated with higher accuracy.
A confounding issue with synthetic peptide arrays is the purity of the resulting peptides as the
peptide spots are synthesised on the array, leaving any mis-formed or truncated polymers and often, as
was the case with this work, the purity of the peptides is not assessed. However, work by Frank (2002)
has shown that generally peptide spots on arrays are of high purity. Given the large number of peptides
in an array, it is likely that at least a small number will be of low purity due to variation in the synthesis
method and synthesis of difficult peptide sequences. Data generated for sequences with low purity will
be inaccurate as impurities may inhibit a true interaction or produce a false interaction; also if the amino
acid sequence is used to normalise peptide amount measurements, low purity will lead to inaccurate
results. Given the likelihood that at least some peptides in the arrays used in this work will have low
purity, it is likely that a number of the interaction results are false though as long as the number of
these false results is low, both analysis of the binding peptides and the prediction models should only be
affected to a limited degree since RF models have been shown to be very tolerant to misclassified data
(Breiman, 2001).
Western blotting was used to detect peptide interactions and significant difficulty was encountered
with HsSUM1 as the antibody used had high cross-reactivity resulting in a large number of the peptide
spots having to be excluded from analysis. The source of the cross-reactivity is not known and may
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have come from either the control GST protein binding to the peptide spots or the antibodies them-
selves binding directly to the peptides. Although different antibodies were used to detect the HsSUM1
interaction, no combination was found that did not exhibit this cross-reactivity issue. Cross-reactivity
in far-western blotting is a frequently occurring issue and arises due to the large number of different
steps in the procedure that can generate non-specific binding. These include offsite binding of the probe
protein, binding of a protein tag on the probe protein if present and binding of either the primary of
secondary antibody to the peptides (Katz et al., 2011). Using different methods, with fewer steps, can
alleviate this issue with fluorescently labelled probe proteins being a suitable alternative. Traditionally
probe proteins were labelled by non-specifically attaching a fluorescent molecule. This method had two
major drawbacks though: the sites of probe labelling varied between protein molecules and it was dif-
ficult to achieve consistent labelling between labelling reactions. The stochastic nature of the labelling
can also lead to important sites of the probe protein being modified inhibiting the interaction between
the probe and target. Newer methods such as using fluorescently labelled amino acids during protein
translation or using site specific labelling methods have alleviated these issues. The HaloTag® system
from Promega can be used to specifically label a target protein. A HaloTag® plasmid is used to express
the probe protein fused to a HaloTag® protein. The HaloTag® protein can then be modified with a
number of fluorescent ligands that the tag specifically recognises and covalently attaches to, leaving the
probe protein unmodified. The HaloTag® however is very large and there is the possibility that its large
size may interfere with the interaction between the probe and its target, though fusing the tag to the
opposite terminal may alleviate this problem (Hurst et al., 2009).
Fluorescently labelled probe methods additionally have the advantage that they are quantitative,
allowing the strength of a protein interaction to be measured. Far western blotting on the other hand
is generally semi-quantitative due the non-linear response of the chemiluminescent detection and the
number of binding steps, though methods described by Weiser et al. (2005) have been able to produce
quantitative results from peptide arrays using far-western blotting by calibrating the method with a
series of interactors with known interaction strengths. Overall though, future work would probably
benefit from using a fluorescently labelled probe to accurately measure the relative interaction strength
combined with accurate measurement of peptide amounts in the arrays to normalise the intensity results.
Having accurate interaction strength results would allow more accurate models of SIM binding to be
constructed so a distinction between strong and weakly binding SIM peptides could be made. Actual
interaction strength results would allow the use of regression models rather than the classification models
used in this work, which would allow the prediction of actual interaction affinities.
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3.5.2 SIM analysis
The SIM library was used to screen the interaction of around 1000 peptides with AtSUM and around
800 for HsSUM1. This is the first investigation that compares isoforms from two distinct organisms and
is also the first to screen such a volume and diversity of peptides, making it the first comprehensive com-
parison of SUMO isoform binding preferences. Namanja et al. (2012) used a similarly large number of
peptides to characterise the binding of two human SIMs against HsSUM1 and HsSUM3, and the tech-
nical data from their work was crucial for the design and implementation of the SIM library described
here. Overall the results agree well with other published work which has demonstrated that, depend-
ing on the amino acid composition, SIM peptides either bind specifically to one SUMO isoform (Cai
et al., 2013; Sekiyama et al., 2008) or can be more general and bind to many isoforms within a species
(Escobar-Cabrera et al., 2011). The emerging paradigm is that there are a diverse array of SIM motifs
within proteins with different binding specificities for the paralogous SUMO isoforms within a species
and these differences allow the SUMO isoforms to perform distinct roles within the cell. Thus the out-
come of SUMOylation of a target can depend on the isoform it was modified with. Further specificity is
achieved with recognition proteins containing both SIMs and target protein specific interacting domains
(Armstrong et al., 2012) allowing SUMOylation to have specific functions for different proteins.
Chain topology is another critical factor in SIM interactions, which was not explored in this work.
Often SIMs are found in tandem in proteins, with each motif interacting with a SUMO residue within
a poly-SUMO chain, and it has been shown that in some cases poly-SUMO chains rather than a single
SUMO are required for interaction (Tatham et al., 2008). It is possible that chains of mixed SUMO
isoforms may also have specific functions and investigating the role of SUMO chain topology on protein
regulation would be an interesting topic for further research.
Using the library of SIM peptides, amino acid preferences along the SIM peptide sequences were
characterised and the binding of the AtSUM1 and HsSUM1 isoforms were compared, which as expected
showed vastly different binding preferences with only a small number of peptides able to bind to both
SUMO isoforms. The differences in the SIMs that resulted in isoform selection were found to be due
to amino acids flanking the hydrophobic core, with the charge of these positions having a strong effect.
Analysis of HsSUM1 binding preferences was hampered by the small number of positive instances
of interaction which was due to a large number of peptides being excluded from analysis due to non-
specific antibody binding and due to a smaller proportion of positive interactions in the test set (10% for
HsSUM1 compared to 20% for AtSUM1).
Post translational modification of SIM peptides and SUMO adds an addition layer of complexity and
phosphorylation has been shown here to be a powerful regulator of the SIM-SUMO interaction. There
are a number of examples of SIM phospho-switches described in the literature in human systems that
demonstrate crosstalk between SUMOylation and protein kinase cascades (Percherancier et al., 2009;
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Stehmeier & Muller, 2009), however, the extent to which phosphorylation plays a role in plants remains
unknown as no examples of SIM phospho-switches have been described and the data presented here
shows that the interaction promoting effects of phosphorylation are restricted in AtSUM1 interactions.
Charged amino acids are over-represented in regions flanking the hydrophobic cores of SIMs, with
negatively charged groups very common. These charged groups play a role in stabilising the SIM
peptide within the SUMO groove and it is plausible to speculate that phosphorylation of polar residues
within SIM enhances SUMO binding by playing a role similar to that of the negatively charged amino
acids. Additionally phosphorylation imparts a -2 negative charge, twice as much as the negatively
charged amino acids, suggesting that it can have a strong effect on the electrostatic attraction of a SIM
to SUMO. The positioning of positively charged amino acids with the two SUMO isoforms studied
is different, with HsSUM1 containing more positively charged groups within the important α-helix
1 and β-strand 2. It is possible that the increased number of positively charged groups in HsSUM1
were responsible for the higher proportion of phosphorylated interacting SIMs observed, compared to
AtSUM1 where a very large proportion of interactions were abolished when the SIM peptides were
phosphorylated.
Immobilised recombinant tandem SIMs have been used to selectively purify SUMO and
SUMOylated proteins from total cell lysates and have been shown not to bind to similar ubiquitin-
like proteins, including ubiquitin itself (Da Silva-Ferrada et al., 2013). The ability to specifically purify
SUMOylated proteins can be used to identify which proteins are SUMOylated under specific condi-
tions and expand the understanding of SUMO regulated biochemical pathways. The work shown here
could hopefully be used to extend these SUMO purification methods by designing short peptides with
higher affinity to SUMO or to design peptides with specific affinity to different SUMO isoforms within
a species. Being able to specifically purify a particular SUMO isoform would be useful in studying the
divergent roles of the different isoforms.
3.5.3 SUMO sequence feature predictors
The SIM data and SUMO site data from previous publications were used to build SUMO sequence fea-
ture predictors using random forest models. The performance of the SUMO site predictors as measured
by AUC values was much better than the SIM predictors. The difference between the two is probably
due to the extensive dataset for SUMO sites and smaller dataset sizes for the SIM data. The SIM fea-
tures were also more complex (i.e. more amino acids were important for determining an interaction)
and this was exacerbated by the limited dataset size. Nevertheless the SIM predictors have a reasonable
performance and are the first example of SUMO isoform specific predictors.
One of the major aims of this work was to optimise the performance of the predictors using variable
selection and parameter optimisation. Random forests had been used earlier by Teng et al. (2012) to
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predict SUMO sites so their model, which did not utilise variable selection to an appreciable degree, was
a useful benchmark to compare with. PCA was used to reduce the multitude of amino acid indices into
a small number of variables which were used to convert amino acid factors into numeric vectors. Using
numeric variables was shown by Teng et al. (2012) and this work to improve the performance of random
forest predictors, however, Teng et al. (2012) did not use a PCA decomposition of the variables but rather
selected a number of useful amino acid indices instead. Through the course of developing the random
forest predictors, it was found that the optimal variables to use came from converting different amino
acid positions into different combinations of PCA dimensions, rather than using the same dimensions
for all amino acids positions in the predictor. For example, position two in a peptide may be converted
into the first dimension while position three may be converted into the second and third. Though this
usage of variables was rather complicated and added complexity to data processing in the predictors,
the performance of the predictors significantly benefitted. Compared with previous work, the SUMO
site predictor developed here had significantly better performance. The performance increase was so
large that initially there was concern that an error had been made in assessing the performance of the
other published predictors, however, the same set of peptides was used to assess all predictors and OOB
sampling was used for our predictor which controls for over-estimation of performance. Use of OOB
was not possible for assessing the other published predictors, seeSUMO and SUMOsp, but if anything
this should slightly overestimate the performance of these predictors as they used similar training data
to the data used to assess them.
The method of carefully optimising random forest variables and using PCA decomposition of factor
variables has shown that significant improvements can be made to predictor performance. Optimisation
and removal of redundant data reduces the complexity of the input data and it is likely that optimisation
of these factors was responsible for the observed increase in predictor performance. With the large
body of data available for SUMO sites and the high performance of the predictors for these features, it
is unlikely that large improvements in predictor performance can be achieved in future work, at least
for analysing primary sequence data alone. However, the SIM prediction models could probably be
improved significantly if more data were generated to train the predictors. Also, including SIM binding
data for other SUMO isoforms in important research organisms is a priority as there are four different
functional SUMO isoforms in both human and Arabidopsis and one in yeast. It would also be beneficial
to generate quantitative data on the affinity of the different SUMO isoforms as predictors could be
used to identify the interaction strength of a given peptide. One limitation of the work presented here
is that the peptide sequences used in the arrays were highly constrained to be similar to known SIM
peptides. This approach was used to ensure that sufficient results would be obtained from the limited
number of peptides screened, however, due to the constraints imposed, any binding peptides that were
outside of these constraints would have been missed and the features responsible for their interaction not
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captured. If a sufficiently large number of peptides could be screened, it would be beneficial to lower the
constraints imposed on peptide design to sample a more diverse range of peptides. Such peptides could
be constrained to only contain the essential hydrophobic cores while allowing every other position in
the peptides to vary freely. It is likely that this would result in fewer positive hits but may also detect
any peptide features missed in this work.
3.5.4 Arabidopsis genome-wide SIM screen
The SIM prediction models were used to predict putative SIMs within the Arabidopsis genome. To
increase the specificity of the screen, structural and evolutionary information was used to inform the
results. Since SIMs are unstructured regions of protein they tend to lie outside of functional domains
and any predicted SIMs lying within regions predicted to be functional domains using the Conserved
Domains Database (Marchler-Bauer et al., 2013) were excluded. Predicted SIMs also had to be present
within alignments of orthologous proteins from diverse species extending to the monocots to fulfil the
assumption that functionally important SIMs would be conserved in a diverse range of species. Ara-
bidopsis proteins for which orthologs were not identified were removed so any narrow, clade specific
genes resulting from gene duplication events were removed. The constraints imposed in this screen
were targeted towards detecting conserved, functionally important SIMs and would not identify any
functional SIMs that evolved more recently within a limited clade of plant species. To control the FPR,
the cutoff thresholds for various variables in the search were high and it is likely, especially given the
suboptimal sensitivity of the SIM predictors, that many genuine SIMs will have been missed by this
screen although hopefully the genes identified in this screen will provide an initial step in understanding
the genome-wide role of SUMO binding proteins (SBPs) in plants. Recent genome-wide screens for
SUMOylated proteins (Miller et al., 2010, 2012) and ubiquitinated proteins (Maor et al., 2007) have
been successful in identifying proteins that are modified by these two ubiquitin-like proteins and the
next step in unravelling the role of SUMOylation will be to identify the fate of those modified proteins.
The highest scoring 500 genes identified in the screen were selected as being likely to contain at least
one functionally relevant SIM. No estimate of the FPR for these results could be determined and sub-
sequent validation with laboratory experiments is required. However, gene ontology analysis identified
functional enrichment in a number of categories for this gene set. The genes were functionally enriched
in three broad areas: DNA/RNA maintenance, sugar and cell wall metabolism and transport with the
DNA/RNA maintenance agreeing well with published literature on the role of SUMOylation (Mazur &
van den Burg, 2012; van den Burg et al., 2010). Interestingly, the identified genes do not show nuclear
localisation enrichment which is reported widely in the literature for SUMOylated proteins, rather these
predicted SIM containing proteins showed enrichment for membrane bound localisation (both plasma
and organelle membranes) and cytoplasmic localisation. This localisation enrichment is due to the high
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number of biosynthetic and cell wall related genes in the set.
The DNA/RNA related set of genes comprise a large number of nucleotide binding proteins imply-
ing an important role in both DNA and RNA regulation. The genes DDM1, RAD5, GMI1 and UVH6
(AtXPD) are distinct DNA repair related genes that were identified. All of these genes play a role in
repairing DNA damage resulting from oxidative damage, ultraviolet radiation or gamma radiation and
play an important role in oxidative stress tolerance. RAD5 and GMI1 are both involved in repairing
DNA double strand breaks and appear to do this through homologous recombination (HR) as knock
downs of these genes alter HR patterns although the exact mechanism is unknown (Chen et al., 2008;
Böhmdorfer et al., 2011). UVH6 is an ATP dependant helicase that unwinds damaged DNA in prepar-
ation for repair by DNA repair components and this protein also appears to play a role in development
as knock downs show defects in floral development as well as sensitivity to DNA damaging agents and
heat (Ly et al., 2013). DDM1 is a cytosine methyltransferase enzyme that plays a role in chromatin re-
modelling and gene regulation (Ogrocká et al., 2014) and is important for DNA repair as knock downs
are sensitive to oxidative DNA damage though the mechanism for sensitivity is as yet unknown (Qüesta
et al., 2013). CHR8 and CHR13 were another two chromatin remodelling enzymes with helicase activ-
ity that were identified and have been also been implicated in DNA repair (Shaked et al., 2006). Such
a large number of diverse DNA repair related proteins identified is suggestive of the DNA repair pro-
cess being regulated by SUMOylation and it is likely that these proteins are the interacting partners of
SUMOylated proteins that have previously been implicated in DNA repair (Saracco et al., 2007).
Two 90 kDa heat shock proteins (HSPs) were identified fitting with the theme of the SBPs playing a
role in oxidative stress. 90 kDa heat shock proteins are chaperones which are required for both normal
protein folding and for refolding of denatured proteins. The two identified HSPs have low sequence
identity and appear to have different functions: Hsp90.4 is constitutively expressed and likely plays a
role in protein homeostasis under normal conditions while Hsp90.1 is stress-induced and probably plays
a more dominant role in protein protection and repair during stress conditions (Cha et al., 2013).
The strong enrichment for cell wall and sugar biosynthesis proteins suggests a novel role for SBPs
and there are very few examples of SUMO playing a direct role in these functions in the literature.
Miura et al. (2011) found that the SUMO E3 ligase SIZ1 regulated root growth and architecture and
mutant siz1 plants differentially expressed genes encoding cell wall loosening and cell wall biosynthesis
genes which were under the control of auxin. Interestingly, the SBP screen identified one auxin receptor
protein, AFB3 (Parry et al., 2009), and two auxin eﬄux carrier proteins, PIN1 and AGR, with the latter
expressed solely in the root (Petrásek et al., 2006). It is tantalising to speculate that these auxin related
proteins are directly regulated by some as yet unknown SUMOylated protein or proteins and that this
regulation is responsible for the reduced root growth phenotype observed during hyper-SUMOylation
under stress (Conti et al., 2008).
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4.1 Introduction
One of the major phytohormones responsible for growth regulation in plants is the gibberellin (GA)
group of hormones which regulate growth in response to a multitude of environmental cues and play an
important role in developmental processes (Schwechheimer & Willige, 2009). On a molecular level the
GAs regulate the stability of a group of transcriptional repressor proteins known as DELLAs which are
degraded by the GA receptor GIBBERELLIN INSENSITIVE1 (GID1) in the presence of GA (Ueguchi-
Tanaka et al., 2005). The primary role of the DELLA proteins in the GA pathway is to restrain growth
and developmental processes regulated by GA by inhibiting a diverse range of transcription factors. In
the presence of GA, the DELLA proteins are degraded and the repression on the transcription factors
they inhibit is released.
The DELLA proteins are nuclear localised and consist of two functional domains. The N-terminal
region of the protein consists of a ’DELLA’ domain, so called for a conserved motif with this sequence.
The DELLA domain of the protein is recognised by GID1 and is responsible for regulating the stability
of the protein. The C-terminal region contains a GRAS domain which is found in a large number of
protein classes (Bolle, 2004). The GRAS domain forms interactions with other proteins and is mostly
responsible for the repressive effects of the DELLA proteins (Sun & Gubler, 2004). While the dominant
role of the DELLA proteins is to repress transcription factors, the DELLA domain of the protein is also
a transcriptional activator that positively regulates a number of genes (Hirano et al., 2012). The DELLA
proteins regulate a diverse range of transcription factors that regulate processes including growth, floral
and seed development and crosstalk with other hormone pathways (Locascio et al., 2013).
Recent work on the SUMO protease double mutant plants ots1 ots2 first characterised by Conti et al.
(2008) lead to the discovery that the Arabidopsis DELLA proteins RGA and GAI were SUMOylated and
the SUMOylation of these proteins was elevated under stress conditions. Interestingly, plants exposed
to salt stress show a reduced growth phenotype that is not explained by GA levels alone, but rather it
was found that the DELLA proteins accumulate under the salt stress conditions, despite the presence of
GA which would normally lead to their degradation (Conti et al., 2014). Initially it was suspected that
SUMOylation of the DELLA blocked GID1 mediated degradation, however, only a small pool of the
DELLA proteins were ever SUMOylated, which could not explain the accumulation of the unmodified
DELLA proteins. Conti et al. (2014) proposed a model whereby SUMOylated DELLA proteins bind
to GID1 but are not degraded, and by binding to GID1 the SUMOylated DELLA proteins sequester
the receptor, preventing it from targeting the pool of unmodified DELLA proteins for degradation thus
acting as an inhibitor of GID1. The ability of SUMOylated DELLAs to bind to GID1 was shown using
co-immunoprecipitation of SUMOylated RGA with GID1a and the interaction with the SUMOylated
DELLA protein was shown to be independent of GA. The results presented by Conti et al. (2014)
showed the GA pathway in plants can be regulated independently of GA and shows that there is crosstalk
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between the GA pathway and the SUMO cascade process, revealing previously unknown complexity in
the regulation of plant growth and development.
A number of questions remain open with regards to the mechanism of protection of DELLA proteins
by the small pool of SUMOylated DELLA proteins and although a model of SUMOylated DELLA
proteins sequestering GID1 has been proposed, there is as of yet no direct evidence of the mechanism
and a number of alternative processes could be responsible. One of the most important requirements
for the sequestering of GID1 by SUMOylated DELLAs is that the binding affinity of the two molecules
is strong enough to allow a small pool of SUMOylated DELLA to have such a large inhibitory effect.
Additionally it would be important to test if there was any difference in the affinity between the hormone
bound GID1 complex and unbound GID1. To answer these questions, quantitative data on the interaction
kinetics is required to test this model and the results would inform the direction of future research into
the GA pathway.
The original goal of the work presented in this chapter was to investigate the binding kinetics of
GID1a with SUMOylated RGA using surface plasmon resonance (SPR) to generate the data required
to test the model proposed by Conti et al. (2014). However, the task of producing sufficient amounts of
RGA proved to be technically challenging and rather this chapter presents methods to produce purified
RGA protein and an in vitro cell free method to SUMOylate the protein which may be used in work to
investigate the binding kinetics with GID1.
4.2 Chapter aims
• Find the site of RGA SUMOylation
• Produce and characterise SUMOylated RGA protein
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4.3 Results
4.3.1 Analysis of RGA protein sequences
Previous work had shown that the DELLA proteins RGA and GAI were SUMOylated (Conti et al., 2014;
Nelis, 2011) but the site of modification was not identified. In order to explore the role of SUMOylated
RGA and other DELLA proteins, the SUMOylated lysine needed to be identified in order to gener-
ate a non SUMOylatable mutated version of the protein and to analyse the structural consequences of
SUMOylation.
All five Arabidopsis DELLA proteins and various DELLA proteins from other species were aligned
and the peptide sequences were analysed with SUMOsp 2.0 (Ren et al., 2009) to identify putative SUMO
sites (Figure 4.1). A conserved lysine in the DELLA domain of the protein was identified which was
predicted to be a SUMO site in all protein orthologs, corresponding to K65 in RGA or K49 in GAI. This
was the only lysine within all the DELLA proteins that was consistently predicted to be a SUMO site
and based on the structure of GAI was surface exposed, making it the best candidate lysine for further
analysis.
AtRGA    44 DELLAVLGYKVRSSEMAEVALKLEQLETMM 73
AtGAI    28 DELLAVLGYKVRSSEMADVAQKLEQLEVMM 57
AtRGL1   32 DELLVVLGYKVRSSDMADVAHKLEQLEMVL 61
AtRGL2   44 DELLAVLGYKVRSSEMAEVAQKLEQLEMVL 73
AtRGL3   34 DEFLAVLGYKVRSSDMADVAQKLEQLEMVL 63
VvGAI1   35 DELLAVLGYNVKASDMAEVAQKLEQLEEVI 79
SlGAI    42 DELLAVLGYKVKSSDMADVAQKLEQLEMAM 86
HvSLN1   39 DELLAALGYKVRASDMADVAQKLEQLEMAM 68
TaRHT1   38 DELLAALGYKVRASDMADVAQKLEQLEMAM 67
OsSLR    39 DELLAALGYKVRSSDMADVAQKLEQLEMAM 68
ZmD8     38 DELLAALGYKVRSSDMADVAQKLEQLEMAM 67
α1 α2
Figure 4.1: Alignment of DELLA proteins showing the predicted SUMO site within the conserved
DELLA domain. DELLA proteins from a wide evolutionary range of species show strong conservation
(grey bars below alignment). The predicted SUMOylatable lysine lies within α helix 2 of the protein,
within the domain that interacts with GID1. The location of the alpha helices within the protein are
shown in blue and are based on the crystal structure of AtGAI from Murase et al. (2008). Species used:
Vv = grape, Sl = tomato, Hv = barley, Ta = wheat, Os = rice, Zm = maize.
The predicted SUMO site lysine lies within a highly conserved region of the DELLA protein, which
shows very few sequence differences even in monocotyledonous plants, suggesting functional import-
ance for this region. The DELLA domain of the DELLA proteins forms the surface that interacts
with the GID1 GA complex and the identified lysine lies within the α-helix 2 of the protein which
both makes contact with GID1 and forms a salt bridge with α-helix 4 within the protein (Murase et al.,
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2008). SUMOylation of this lysine would almost certainly prevent DELLA-GID1 binding through steric
hindrance of binding conformation, suggesting that SUMOylation of the DELLA proteins inhibits direct
interaction with hormone bound GID1.
4.3.2 Lysine 65 in RGA is the site of SUMOylation
Based on bioinformatic analysis of multiple DELLA protein sequences, lysine 65 in AtRGA was a
strong candidate as the site of SUMOylation. To determine if this was indeed the site of SUMOylation
and the only SUMO site within the RGA, RGA and rga K65R clones in the plasmid pENTR were ac-
quired from a collaborator to test SUMOylation at this site. N-terminal His tag fusions were generated
by recombination of the pENTR clones with pDEST17 and these were transformed to the E. coli recon-
stituted SUMOylation system (Okada et al., 2009) using SAE1a + SAE2 as the E1 heterodimer, SCE1
as the E2. Two forms of AtSUM1 were used, an active form (SUM1-GG) and a form with the terminal
diglycine mutated to diarginine (SUM1-AA) which cannot be ligated to other proteins as a negative
control for the assay.
The RGA proteins were expressed in the reconstituted system for 2 hours at 30ºC and then total cell
lysates were analysed by western blotting using αRGA antibodies to visualise the proteins. The assay
(Figure 4.2) showed that in the reconstituted E. coli system, rga K65R was not SUMOylated while the
wild type protein was showing that lysine 65 is the SUMOylated residue in RGA.
His:RGA
His:rga K65R
His:AtSUM1-GG
His:AtSUM1-AA
+
-
-
-
-
-
-
-
-+
+
+
+
+
+
+
130
100
70 His:RGA / 
His:rga K65R 
WB αRGA
Figure 4.2: Reconstituted SUMOylation assay of RGA. RGA is SUMOylated while the mutagenised
rga K65R is not, indicating that lysine 65 is the site of SUMOylation in vitro. SUM1-GG is the native
active form of SUMO1 while the non-ligating SUM1-AA is used as a negative control for the assay.
Arrows indicate SUMOylated RGA, with the higher band corresponding to poly-SUMOylation. All
lanes contain total bacterial lysates from each expression reaction. Results published in (Conti et al.,
2014). WB: western blot.
While this assay suggests that K65 is a major SUMO site in RGA, the behaviour in planta may be
different and it is possible that secondary SUMO sites may exist, especially since an E3 is not used in
the reconstituted assay. However, there is a high degree of confidence that K65 is the primary SUMO
site based on the high levels of SUMOylation at this site in the in vitro assay. Further analysis of the
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SUMOylation state of RGA in planta should be performed to confirm the results from the reconstituted
system using a sensitive technique such as MALDI-TOF mass-spectrometry of purified RGA proteins.
4.3.3 N-terminal fusion tags are not present in recombinant RGA
The original aim of this work was to purify large amounts of SUMOylated RGA and investigate the
interaction of the SUMOylated form using a method that would provide quantitative binding data in
order to test whether binding kinetics support the model of SUMOylated RGA inhibiting GID1 mediated
degradation of the DELLA proteins. In order to achieve this aim, soluble SUMOylated RGA protein
needed to be purified. Affinity tag chromatography was chosen for RGA purification as large amounts of
protein could be produced. Antibody affinity chromatography was deemed to be prohibitively expensive
and only small amounts of protein could be purified due to limited amounts of the bespoke αRGA
antibody being available. The reconstituted SUMOylation system used His tagged AtSUM1 and SAE2,
so an alternative tag was required for RGA to purify it from the free His:AtSUM1 and His:SAE2. The
GST fusion tag was selected as a suitable tag which allowed cost effective purification. RGA was
subcloned into pDEST15 to add an N-terminal GST fusion to the protein for use as an affinity tag,
however, all attempts to purify the protein using glutathione sepharose beads failed suggesting that
expressed protein was either insoluble or there was an issue with the tag.
To investigate this issue, both N-terminal His and GST tagged fusion proteins were expressed as
before and then the soluble and insoluble fractions were separated and analysed on a western blot. The
blot was probed with αGST and αHis antibodies to show whether the soluble tagged proteins were
present. However, the probed western blot showed no immunoreactivity against the expressed proteins
(Figure 4.3) at their expected sizes. Control proteins excluded any issues related to the antibodies
or western blotting procedure. While the GST fusion showed no immunoreactivity at the expected
GST:RGA size, a small fragment corresponding to the size of free GST was detected in the soluble
fraction of the bacterial lysate. These data suggested that either there was premature termination of
translation or that the protein tag was cleaved from the newly synthesised RGA. Later experiments
(Figure 4.4) showed that RGA protein was expressed from the GST:RGA plasmid but the protein only
corresponded to the size of RGA and not to the full fusion protein, which excludes premature termination
of translation as the tag was at the N-terminal of the protein which would have been synthesised first.
The His fusion, like the GST, showed no reactivity at expected size either, again suggesting that
the tag was not present. Whether this tag was cleaved or not could not be discerned from the results
as the cleaved His fragment would be too small to detect on the gel used in the assay. Interestingly,
comparing the His tagged protein to the GST tagged protein in a later experiment (Figure 4.4), the His
tagged version was larger than the GST version which is somewhat surprising given that the His tagged
protein was expected to be smaller. If both tags were being cleaved from RGA, the smaller size of the
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Figure 4.3: No immunoreactivity against N-terminal tagged RGA proteins. GST tagged (pDEST15)
and His tagged (pDEST17) RGA N-terminal fusions were probed with αGST and αHis antibodies re-
spectively but no protein of the expected size was detected for either protein. The GST:RGA lane shows
a band corresponding to the size of free GST. All lanes, including control lanes, contain total bacterial
lysates. Control proteins GID1a and OTS1 were expressed in the vectors pDEST15 and pDEST17
respectively. WB: western blot.
GST:RGA protein suggests that tag cleavage occurs at different sites in the two proteins. However, there
is no direct evidence of His tag cleavage in these data.
The fact that purification of GST:RGA failed and that both His and GST tagged RGA could not be
detected on a western blot indicated that there was a systematic issue with either the protein itself or
the DNA construct that prevented fusion of stable N-terminal tags. Sequencing of the original RGA
pENTR plasmid did not show any mutation within the gene or any misalignments with the open reading
frame that would have caused issue. The lack of an N-terminal tag meant that purification of RGA, and
therefore SUMOylated RGA was not possible and alternative methods for purification were investigated.
4.3.4 SUMOylated RGA produced in E. coli is insoluble
In order to purify SUMOylated RGA using the reconstituted E. coli system, the SUMOylated form of
RGA needed to be in the soluble fraction of the bacterial lysate as functional protein was required for
purification and interaction assays with GID1. To test the solubility of the SUMOylated form, both
the GST:RGA and His:RGA plasmids were transformed into the reconstituted E. coli SUMOylation
system as described earlier and the protein fractions from the lysates were analysed by western blot
using αRGA antibodies to detect the proteins. The western blot showed that the SUMOylated versions
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of both the RGA proteins expressed in the His and GST plasmids were exclusively insoluble (Figure
4.4) while the unmodified RGA protein was present in both fractions. This result was very surprising
given that SUMO fusions are widely used to enhance the solubility of difficult to express proteins (Butt
et al., 2005; Marblestone et al., 2006; Zuo et al., 2005), though SUMOylation occurs via an isopeptide
bond and may behave differently to translational fusions.
His:SUM1-GG
His:SUM1-AA
His:RGA
GST:RGA
Fraction
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+ +- - - -
+ + + + - -
- - - -
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Figure 4.4: SUMOylated RGA produced in the reconstituted E. coli system is insoluble. While part of
the RGA protein fraction is soluble, SUMOylated RGA is only found in the insoluble fraction of E. coli
lysate. RGA was expressed in both pDEST17 (N-terminal His tag) and pDEST15 (N-terminal GST tag)
but neither improved the solubility of SUMOylated RGA. Furthermore RGA expressed in pDEST15 did
not show an increase in molecular weight corresponding to the addition of GST but was in fact slightly
smaller the RGA expressed in pDEST17. Additionally a small low molecular weight band is present in
the soluble lane, corresponding to the size of free GST. This suggests that the GST portion of the fusion
is expressed but a stable GST:RGA fusion is not produced.
The fact that SUMOylated RGA was insoluble meant that unless modifications could be found to
the SUMOylation conditions that would render the SUMOylated protein soluble, this system could not
be used to produce SUMOylated RGA. N-terminal tag instability added to the difficulties as protein
fusions that might improve solubility could not be added at the N-terminus. As an alternative to using
the reconstituted system, the use of in vitro SUMOylation using purified enzymes could be used but
this would again require purified RGA protein. Using in vitro SUMOylation also raised the issue of
yield as SUMOylation using enzymes is somewhat less efficient. Nevertheless alternative methods of
RGA expression in the yeast Pichia pastoris (P. pastoris) and using C-terminal fusions were investigated
which are discussed in the next subsections.
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4.3.5 RGA expression in Pichia pastoris
Protein misfolding, formation of inclusion bodies (insoluble protein), tag cleavage, premature transla-
tion termination, protein degradation and lack of post-translational modification are major issues en-
countered when trying to express eukaryotic genes in bacteria. The use of eukaryotic systems such
as yeast or insect cells can alleviate these issues experienced with bacterial expression (Vincentelli
et al., 2005). Due to the issues experienced with RGA tag cleavage in E. coli and the large amount of
expressed protein forming inclusion bodies, expression in the yeast Pichia pastoris (P. pastoris) was
investigated. P. pastoris was selected as it is an easily transformed eukaryotic system which can pro-
duce large amounts of recombinant protein with relative ease compared to other eukaryotic expression
systems. Expression vectors can be designed to include an α-factor peptide to secrete proteins into the
expression media allowing separation of the recombinant protein from most yeast proteins. Using P.
pastoris to secrete recombinant protein also avoids the issue of yeast cell lysis which is more difficult
and less efficient compared to bacteria.
An additional construct was designed to address issues experienced with producing SUMOylated
protein. A translational fusion of AtSUM1 and rga K65R was created by a collaborator, S1:rga K65R. It
was hypothesised that protein produced by this gene would behave in a similar manner to SUMOylated
RGA. This construct was included in the P. pastoris protein expression experiments.
For the expressed protein to be excreted from P. pastoris, an α-factor signal peptide needs to be
fused to the recombinant protein which targets the protein to the Golgi apparatus leading to exocytosis.
During this process the α-factor is cleaved by endogenous peptidases producing a recombinant protein
with minimal additional amino acid sequence. The pGAPZα B plasmid system and the protease deficient
strain SMD1168 from Life Technologies were used for expression of RGA and rga K65R. The pGAPZα
B plasmid introduces an N-terminal α-factor peptide and a C-terminal His tag to an expressed protein.
DNA sequences coding the RGA, rga K65R and S1:rga K65R were amplified from pENTR plasmids
containing these genes and restriction sites were introduced to subclone in-frame inserts into pGAPZα
B plasmids using the restriction enzymes XbaI and SfiI (see materials and methods chapter for full
details). These plasmids were transformed into E. coli. For each construct 5 bacterial colonies were
analysed for the presence of the correct insert in the pGAPZα plasmid and all were found to contain the
correct size insert (Figure 4.5). Plasmid was extracted from these clones and then sequenced to confirm
the correct DNA sequence and subsequently cloned into SMD1168.
For each construct, five yeast colonies were selected and a small scale (10 ml) expression screen was
performed to test the expression of the proteins in P. pastoris. To test whether His tagged RGA proteins
could be purified, 5 ml of the supernatant from the yeast cultures was used in a trial purification using
nickel affinity HIS-Select columns (Sigma Aldrich) to isolate His-tagged RGA and rga K65R proteins.
Bradford reagent was used to quantify protein from the purification, however, there was no detectable
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Figure 4.5: Restriction digest of RGA constructs in pGAPZαB to confirm gene insertion. Purified
plasmid DNA from 5 independent clones for each construct was digested with XbaI and SfiI to release
the cloned gene fragment and confirm insert size. All clones contained the correct insert size and two
clones for each construct were selected for sequencing.
protein in any of the eluates. 27 μl of each eluate was then analysed by western blot with αHis antibodies
and again no protein was detected, even when the X-ray film was exposed for an extended period of time
(Figure 4.6). This trial purification suggested that either no His tagged RGA protein was produced or
the protein was expressed but was not excreted into the extracellular media.
Construct
Clone #
RGA:His rga K65R:His S1:rga K65R:His
1 2 3 4 51 2 3 4 51 2 3 4
70
55k
Da
WB αHis
Figure 4.6: Small scale nickel IMAC purification of RGA:His, rga K65R:His and S1:rga K65R:His from
P. pastoris extracellular media. Arrow indicates expected size of RGA protein. No protein was detected
for the RGA:His construct while trace amounts were detected for the other two constructs. Overall no
appreciable amounts of protein were purified from the extracellular media. WB: western blot.
To investigate lack of purified RGA from the nickel affinity spin columns, the RGA and rga K65R ex-
pression was repeated and both the cellular and extracellular total fractions were analysed using αRGA
antibodies to test whether any RGA protein was expressed. The two fractions were treated with a strong
denaturing lysis buffer and analysed by western blot and RGA was detected in most of the cellular
extracts but not the extracellular extracts. This indicated that secretion did not occur (Figure 4.7). Al-
though two secretion samples showed a band, the corresponding expression cultures evaporated during
incubation due to loose fitting covers on the Erlenmeyer flasks used for expression. The samples are
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marked with the letter ’b’ in Figure 4.7. It is likely that the protein bands seen are due to proteins
released from lysed cells in these samples and not from secretion. The RGA proteins observed in the
cellular faction migrated at two different molecular weights, both larger than the expected size of 67.4
kDa for RGA after α-factor cleavage. The lower of the two observed bands corresponded to the expec-
ted size of RGA fused to the α-factor of 76.8 kDa suggesting that no cleavage of the α-factor peptide
occurred. The reason for the presence of the larger band at 100 kDa is not known but may be due to post
translational modifications of the protein such as glycosylation as RGA contains a number of predicted
glycosylation sites.
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Figure 4.7: RGA expression in P. pastoris. RGA constructs in pGAPZαB were expressed in P. pastoris
and the cellular and secreted fraction was analysed. RGA protein was expressed in the cellular fraction.
All cellular RGA proteins migrated with higher molecular weight than the expected RGA size, this
discrepancy in size for the lower band is equal to the size of the excretion α-factor fusion. The high
band may be due to additional PTMs. The band with the ’a’ was due to accidental loading of the RGA
control protein with P. pastoris lysate in the same lane and should be disregarded. Very little protein
was observed in the secreted fractions. Lanes labelled with ’b’ showed protein but during expression the
yeast media evaporated due to poorly fitting flask covers. The lanes marked with ’b’ probably contain
contaminant RGA from lysed cells. WB: western blot.
The results of the trial expressions indicated that RGA protein was expressed but was retained within
yeast cells. Next a large scale expression of the best expressing yeast clone for the RGA:His was
performed (clone 1 for RGA:His) in 500 ml of media and to test whether large scale expression had an
affect on secretion, both the cellular and extracellular fractions were analysed. After the yeast culture
had grown to saturation, the cells and expression media were separated by centrifugation and the cells
were frozen in liquid nitrogen for later processing. The expression media from the expression was
then filtered through an 0.4 μm filter and imidazole and NaCl were added to prepare the media for
purification on 1ml nickel nitrilotriacetic acid (NTA) His-Trap columns (GE Life Sciences) capable of
purifying milligram amounts of protein. The prepared expression media was passed through the His-
Trap columns at a rate of 1 ml/min in a cold-room (approximately 8 hours). The column was then
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washed and the bound protein was eluted into 1 ml fractions. A Bradford assay was used to test which
fractions contained protein, however, no detectable protein was present. Aliquots were taken from the
elution fractions expected to contain protein for later analysis.
The frozen yeast pellet was then lysed using the non-denaturing detergent lysis reagent Y-PER Plus
(Pierce) and the lysate was clarified by centrifugation and then filtered through a 0.4 μm membrane.
After adjusting the media composition by adding imidazole and NaCl, the cellular lysate was then pur-
ified using a 1 ml His-Trap column and eluted into 1 ml fractions. Bradford assays showed that a low
amount of protein was present in a number of the fractions and these were pooled then concentrated us-
ing an Amicon spin column (Millipore) and the concentration of the protein was determined by infrared
spectroscopy. A yield of around 50 μg of protein was calculated which was significantly less than the
milligram scale yield expected for an expression volume of 500 ml. Background protein was expected
in His column purifications from yeast cells as a number of yeast proteins are known to bind to nickel
columns. Since the amount of protein purified was so low, it was suspected that the protein present was
yeast background protein rather than recombinant protein.
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Figure 4.8: Analysis of P. pastoris intracellular and extracellular nickel IMAC protein purification. No
RGA protein was detected in the elution from the nickel IMAC column suggesting the His tag is either
not present or obscured. WB: western blot.
Aliquots of the elution from both the extracellular and cellular fraction were then analysed by west-
ern blot using αRGA antibodies. No RGA protein was detectable in either sample indicating that no,
or very little, RGA protein was purified (Figure 4.8). The inability to purify RGA or rga K65R protein
from either the cellular or extracellular fraction indicated that there was an issue with the C-terminal His
tag of the proteins. The issue is not known but the most likely reasons could be tag removal or prema-
ture termination of translation, with the latter well documented in yeast expression systems (Henikoff
& Cohen, 1984). Additionally, the expressed protein did not appear to be secreted into the extracel-
lular media, this combined with lack of α-factor secretion peptide cleavage suggested the recombinant
protein was not correctly processed in the Golgi apparatus within the yeast cells. Interestingly, in yeast
two-hybrid experiments performed in Saccharomyces cerevisiae (S. cerevisiae) as described in Chapter
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5, it was noted that yeast cells expressing RGA fused to the GAL4 activation domain (AD) were less
viable and if the cells were left on agar plates for two weeks, the RGA containing plasmid was lost.
This suggests that RGA may be toxic to the yeast cells. Also, if RGA was fused to the GAL4 DNA
binding domain (BD) alongside an unfused AD, the reporter gene for yeast two-hybrid assay was activ-
ated, indicating that RGA may be binding to the AD. Given the role of DELLA proteins as transcription
factor inhibitors in plants, it is possible that the capacity for RGA to bind to transcription factors ex-
tends to yeast proteins and this is responsible for the reduction in viability seen in S. cerevisiae. This
phenomenon may also be responsible for the lack of protein processing seen in P. pastoris caused by
RGA binding to and disrupting yeast transcription factors. However, additional experiments would be
required to confirm whether this was actually the case.
The issue of the lack of protein purified via the His tag could have been further explored to determine
whether the His tag was actually present and the pGAPZα B vectors could have been redesigned to
remove AT rich regions which are known to interfere with yeast translation of exogenous proteins.
However, based on the effort and the additional issue that the α-factor secretion signal peptide was not
processed correctly, it was decided that alternative bacterial expression methods would be investigated
instead.
4.3.6 Redesigned E. coli expression vector for RGA
Attempts to express and purify soluble RGA using affinity tags failed in both E. coli and P. pastoris
expression systems and the RGA clone was analysed to identify the cause of the expression issues.
Alternative C-terminal fusion tags were also investigated as an alternative strategy to produce tagged
RGA that could be purified.
The original RGA clone was acquired from a collaborating research group, though the sequence had
not been verified independently for our work. The pENTR D/TOPO cloning system uses blunt end
cloning and allows insertion of a DNA fragment with the only requirement that the sequence CACC is
appended to the 5’ end of the sequence to be inserted and therefore allows cloning of DNA sequences
with very little additional sequence. The pENTR plasmid is used in the Gateway cloning system to move
cloned sequences into pDEST plasmids using homologous recombination to generate tagged expression
vectors. The RGA clone was expected to only contain the coding sequence for the gene. To verify this
the plasmid was sequenced and additional sequence was found upstream of the RGA coding sequence
which was found to be part of the 5’ untranslated region (UTR) from the RGA gene. The sequence of the
plasmid is shown in Figure 4.9 alongside the expected sequence for blunt end cloning. The additional
5’ untranslated sequence introduced a frameshift as it was 47 bases long and also encodes for a stop
codon for the sequence in frame with the RGA gene showing that any translational fusions introduced
by the Gateway system would be out of frame with the N-terminal fusion tags and translation would
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Original   AGCAGGCTCCGCGGCCGCCCCCTTCACCCTAGATCCAAGATCAGACCTAATCTAATCGAA
New        AGCAGGCTCCGCGGCCGCCCCCTTCACC--------------------------------
                                          R  S  K  I  R  P  N  L  I  E                                  
Original   ACTCATAGCTGAAAAATGAAGAGAGATCATCACCAATTCCAAGGTCGATTGTCCAAC...
New        ---------------ATGAAGAGAGATCATCACCAATTCCAAGGTCGATTGTCCAAC...
            T  H  S  *  K  M  K  R  D  H  H  Q  F  Q  G  R  L  S  N
Original   ...CTCTCGACGGCGGCGTACAAGGGTGGGCGCGCCGACCCAGCTTTCTTGTACAAAGTT
New        ...CTCTCGACGGCGGCGTACAAGGGTGGGCGCGCCGACCCAGCTTTCTTGTACAAAGTT
               L  S  T  A  A  Y  K  G  G  R  A  D  P  A  F  L  Y  K  V                                                    
5ʹ end of RGA gene:
3ʹ end of RGA gene:
pENTR D/TOPO plasmid
pENTR D TOPO plasmid
extra sequence
RGA
RGA
extra sequence
RBS
Figure 4.9: DNA sequences of original and new RGA pENTR D/TOPO vectors. The original vector
contained an extra sequence from the 5’ untranslated region of the RGA gene while the new vector
contained only the RGA coding sequence. The additional promotor sequence introduces a frame shift
and stop codon into the sequence upstream of the RGA gene and also includes a predicted bacterial
ribosome binding site which may have been used as an alternative translation initiation site from in old
vector.
be terminated before the RGA gene. This result was surprising given that this clone had been used to
express RGA protein (albeit without an N-terminal tag) which was detected using αRGA antibodies and
was of the expected size for RGA. Furthermore, the expression of the tag alone could not account for
the size of recombinant protein since the largest tag used was GST with a size of 35 kDa while RGA is
68 kDa.
One hypothesis to explain the observed results was that bacterial translation initiated both at the
start of the fusion tag and also at the start of the RGA gene from a single mRNA molecule generated
by the original RGA clone in an expression vector. This would require a ribosome binding site (RBS)
upstream of the RGA start codon and analysis of the sequence found a putative site, ATAGCT, 6 bp
upstream of the RGA start codon that conforms to an E. coli RBS (Shultzaberger et al., 2001). If such a
situation had occurred, a single mRNA generated from an expression plasmid with an N-terminal fusion
tag would produce two separate proteins. One protein would be produced for the tag which would be
terminated within the extra 5’ UTR sequence as this contains a stop codon when in frame with the
fusion tag in pDEST plasmids. Another protein would be produced for the RGA gene initiated at the
alternative RBS. For expression of this clone in pDEST15 which adds a GST, Figure 4.4 shows two
proteins corresponding to RGA and GST which is in concordance with this hypothesis. The putative
GST band in this figure is results from cross-reactivity to the αRGA antibodies. Figure 4.3 shows that
this band is reactive against αGST antibodies.
A new pENTR RGA plasmid was created without any additional non-coding sequence, correspond-
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Figure 4.10: Expression of RGA with N-terminal His and GST tags. Two different RGA constructs were
inserted into pDEST15 (GST:N) and pDEST17 (His:N) to produce four different expression vectors.
None of the vectors produced soluble tagged proteins and only one vector His:RGA using the new
construct produced insoluble tagged protein.
ing to the new sequence shown in Figure 4.9 and the sequence was confirmed by DNA sequencing.
Unlike the original RGA plasmid, expression vectors derived from the new RGA clone would be in
frame with any tags and would not contain any premature stop codons. The RGA gene from the new
clone was transferred into pDEST15 and pDEST17 to generate N-terminal GST and His tagged vectors,
and with pET DEST 55 to generate a C-terminal His tagged vector (which also introduces an N-terminal
StrepII tag, though this tag was not used). The expression of these new vectors was compared to vec-
tors derived from the old RGA clone and both the soluble and insoluble fractions were analysed. The
results of the N-terminal tagged protein expressions are shown in Figure 4.10 and compared to the old
GST tagged vector (pDEST15), the new vector shows the expected increase in protein size. However
the protein was not detected by αGST antibodies, the reason for this in not known. In a repeat of the
GST:RGA expression using the new clones, GST:RGA was detected with αGST antibodies however,
almost all of the protein was insoluble (Figure 4.14). The His tagged protein (pDEST17) on the other
hand did show immunoreactivity against αHis antibodies, however, this protein was only present in the
insoluble fraction. Nevertheless these results indicated that the new N-terminal expression vector did
produce His and GST tagged RGA protein.
The results for the C-terminal His tagged RGA expression vectors are shown Figure 4.11 comparing
vectors generated from the old and new RGA clones. Both vectors produce His tagged RGA that can
be detected with αHis antibodies showing that C-terminal His tags are stable in RGA. Importantly the
C-terminal His tagged RGA proteins are present in the soluble fractions of the bacterial lysates. This
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Figure 4.11: Expression of RGA with a C-terminal His tag. The two RGA clones were inserted into
pET DEST 55 which added an N-terminal strepII tag and a C-terminal His tag. Soluble C-terminal
His tagged protein was produced for both RGA constructs. (a) Although there is no band for insoluble
RGA:His in these lanes, it is probably due to loss of protein pellet during fraction purification. (b) Cross
reactivity of the αRGA with the His:OTS1 lane in the His control lane. WB: Western blot.
indicates that soluble tagged RGA protein was produced and that the C-terminal His tagged expression
vector derived from the new RGA clone could be used to produce purified RGA protein.
The results from this section show that the problems experienced with trying to express tagged RGA
in E. coli were due a pENTR vector containing an additional sequence that introduced a frameshift muta-
tion and premature stop codons in all reading frames which made N-terminal protein fusions impossible.
By removing this extra sequence, N-terminal tags could be added to RGA but no useful soluble protein
was produced from these expressions. Ultimately expression vectors derived from pET DEST 55 with
a C-terminal fusion tag resulted in production of soluble, His tagged protein which could be purified by
IMAC.
4.3.7 Cell free in vitro enzymatic SUMOylation of RGA
After a method to produce soluble, tagged RGA had been developed, a method to produce SUMOylated
RGA in vitro was developed. Since SUMOylated RGA produced in the reconstituted E. coli SUMOyla-
tion system (Okada et al., 2009) became completely incorporated into inclusion bodies, this method
could not be used, instead a free enzyme system was developed using E1, E2 and SUMO proteins based
on a modified method by Park-Sarge & Sarge (2009).
Expression vectors for AtSUM1 and an E1 heterodimer consisting of a dual vector containing SAE1a
and SAE2 were used from the reconstituted system from Okada et al. (2009). The E2 enzyme, SCE1, was
cloned from Arabidopsis cDNA into pDEST17 and the pET DEST 55 vector containing RGA described
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Figure 4.12: Purified proteins for in vitro SUMOylation assay. The E1 heterodimer was expressed as
a dual insert construct and the full dimer was co-purified via the His tagged SAE1a as the association
of the SAE2 protein is strong to maintain the complex during purification. Two different SCE1 clones
were expressed and both produced enzyme. His tagged and StrepII SUMO were also purified. RGA:His
was purified but showed a large amount of degradation products which was expected based on results
from earlier expression tests. The expressed proteins all matched their expected sizes.
earlier was used. All vectors were expressed in BL21 CodonPlus (DE3) RIL E. coli cells (Agilent Tech-
nologies) and purified using nickel NTA His:Trap columns. His:SEA1a and S:SAE2 were coexpressed,
and due to the affinity of the two protein subunits to each other, S:SAE2 copurified with His:SAE1a.
All purified proteins were then concentrated and buffer exchanged into a 50 mM Tris buffer at pH 7.6.
Aliquots of the purified proteins were analysed by SDS-PAGE (Figure 4.12) which confirmed the ex-
pected size of the proteins. The purified RGA:His showed partial degradation of the protein, though a
significant proportion was intact. The RGA protein was also found to irreversibly precipitate at high
concentrations of the protein (1 mg/ml) at low temperatures so the protein concentration was main-
tained at 1 mg/ml for storage.
For the SUMOylation assay, 20 μl reactions were set up using 50 ng E1, 50 ng E2, 5 μg RGA:His,
5 μg His:SUM1, 1 U pyrophosphatase, 20 mM ATP in reaction buffer (50 mM Tris, 50 mM KCl, 5 mM
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MgCl, pH 7.6). Control reactions were set up lacking either ATP, His:SUM1 or RGA:His. The reactions
were incubated at 37°C for 1 hour and the reactions were stopped by the addition of 7 μl 4x SDS
PAGE sample buffer and were then analysed by western blotting. RGA:His protein was successfully
SUMOylated in the assay but only a small amount of protein was SUMOylated which could only be
observed using the more sensitive αAtSUM1 antibodies (Figure 4.13). The RGA protein itself showed
significant degradation during the assay with only a small pool of protein of the expected size of around
70 kDa remaining after the reaction, this was at least one factor responsible for the small amount of
SUMOylated RGA present after the reaction. Nevertheless these data show that SUMOylated RGA
can be produced using cell free in vitro SUMOylation, however, the method needs to be improved to
produce useful amounts of SUMOylated RGA for interaction assays.
Stability of the RGA protein during purification and the SUMOylation reaction was the most signi-
ficant issue that resulted in low yield. A number of modifications to the methods used could be made
to alleviate the stability issue of the protein. Carry over of trace amounts of proteases could contribute
to the degradation of RGA and more stringent purification of the RGA protein could reduce protease
mediated degradation. Tandem affinity purification using two tags can be used to achieve higher purity
as fewer background bacterial proteins are able to bind to the two different affinity media. The pET
DEST 55 vector used to express RGA adds both an N-terminal StrepII tag and a C-terminal His tag and
tandem affinity purification against these two tags could be used. This method would also remove partial
RGA fragments from the expression, as only full length protein would have both tags required for puri-
fication. The integrity of the N-terminal StrepII would need to be tested on RGA. This was investigated,
however, the StrepII antibodies used were found to non-specifically bind to a bacterial protein of around
70 kDa, the same size as RGA, so the results from this experiment were inconclusive, though the data
did suggest that the RGA protein was StrepII tagged as soluble degradation products were seen in the
StrepII:RGA sample but not the control (Figure 4.14). However, different αStrepII antibodies, which do
not cross-react with bacterial proteins need to be used to confirm whether or not soluble RGA is StrepII
tagged.
The rate of SUMOylation in the assay could also be increased by including a SUMO E3 ligase in the
reaction mix. At least four SUMO E3 ligases have been identified in Arabidopsis (Novatchkova et al.,
2012) with SIZ1 and HYP2 the most studied (Ishida et al., 2012) and Miura et al. (2009) showed that
recombinant SIZ1 protein enhances the rate of SUMOylation of ABI5 in vitro, making SIZ1 a good
candidate E3 as it has been shown that the functional enzyme can be expressed in E. coli.
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Figure 4.13: In vitro enzymatic SUMOylation of RGA. SUMOylation of RGA:His was observed when
all AtSUM1 and ATP were present. The amount of SUMOylated RGA produced was low and could only
be detected using αAtSUM1 antibodies. Incubation of RGA:His in the SUMOylation reactions lead to
a high degree of degradation of the protein which was responsible for the low yield of SUMOylated
protein. WB: Western blot.
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Figure 4.14: Expression of new RGA clone in pET DEST 55 and pDEST15. pET DEST 55 adds an N-
terminal StrepII tag and a C-terminal His tag to RGA (StrepII:RGA:His). pDEST15 adds an N-terminal
GST tag to RGA (GST:RGA). The αStrepII antibody cross-reacted with a bacterial band at 70 kDa,
the same size as StrepII:RGA:His. Due to the cross-reactivity, it could not be demonstrated definitively
that RGA with a StrepII was produced, though the band was much stronger for the StrepII:RGA:His
lanes (b) than the non specific bands (a). GST tagged RGA was detected, however, almost all of this
GST:RGA was insoluble. WB: Western blot.
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4.4 Discussion
The work presented in this chapter demonstrates that the DELLA protein RGA is SUMOylated and the
site of SUMOylation is K65. The SUMOylated lysine found in RGA is conserved in the other DELLA
paralogs in Arabidopsis and in orthologs in both eudicot and monocot plant species suggesting a con-
served role for SUMOylation in the DELLA proteins. While Arabidopsis has five DELLA paralogs,
most plant species only have a single DELLA gene. There is a degree of functional diversification in the
Arabidopsis DELLA proteins which is mostly due to differential expression rather than biochemical dif-
ferences (Gallego-Bartolomé et al., 2010) suggesting that the function of SUMOylation in the different
Arabidopsis paralogs should play a similar role. The conservation of the DELLA domain of the DELLA
proteins could alternatively be due to the functional role of this domain in binding to the GA receptor
GID1. Based on structural evidence (Murase et al., 2008) the SUMO site motif in the DELLA proteins
is surface exposed. The high degree of sequence conservation of the SUMO site suggests that this site is
the target for SUMOylation in all Arabidopsis paralogs and in orthologs in other species. SUMOylation
has been demonstrated for Arabidopsis RGA and GAI (Nelis, 2011) so far.
The SUMO site in the DELLA proteins in the second α-helix forms one of the binding surfaces
that interact with the receptor GID1. Based on the crystal structure of GAI and GID1a binding, the
SUMOylated lysine (K48 in GAI) does not participate directly in the interaction with GID1. The loc-
ation of an attached SUMO moiety at this site could quite reasonably interfere with the DELLA-GID1
interaction by obscuring binding surfaces in the DELLA protein. Interference would need to be tested
experimentally to confirm whether this is the case. However, if the model that the SUMO moiety in-
teracts with a SIM in GID1 is correct, a typical interaction assay would not be able to test whether
SUMOylation of DELLA proteins blocks their typical binding to GID1. Previous work using Y2H
experiments to investigate SUMOylation and SIM binding has found that by mutating amino acids in
the binding groove of SUMO, SIM interaction can be abolished (Kroetz & Hochstrasser, 2009). Using
a DELLA protein SUMOylated by a non-interacting mutant of SUMO in an interaction assay could
overcome the issue of SUMO binding to GID1 and specifically test the DELLA-GID interaction of
SUMOylated DELLA proteins.
4.4.1 Expression of RGA
Expression of recombinant DELLA proteins proved to be difficult with issues encountered with introdu-
cing fusion tags and with protein solubility. Furthermore SUMOylated RGA produced in a reconstituted
SUMOylation system in E. coli was completely insoluble. There are very few examples of recombinant
DELLA expression in bacteria in the literature. Most work with DELLA proteins used tagged RGA
expressed in plants using both stable transgenic lines or transient expression using Agrobacterium tume-
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faciens to transform plant cells (Gallego-Bartolomé et al., 2012). Studies on the ubiquitin E3 ligase
F-box protein SLY1 required for DELLA degradation used recombinant SLY1 to pulldown RGA from
plant extracts (Dill et al., 2004) and the original GA dependent binding of the RGA-GID1a interaction
studies used recombinant GST-GID1a from E. coli to pull down RGA from plant extracts (Griffiths
et al., 2006). While the majority of research on the DELLA proteins has used plant protein, His tagged
RGA (Tyler et al., 2004) and GAI (Qin et al., 2014) has been reported, however, details of the expres-
sion plasmids were not reported so the strategy these authors used to produce tagged DELLA proteins
is unknown. Recently Wang et al. (2009) successfully expressed RGA in E. coli using an N-terminal
maltose binding protein (MBP) tag and purified the protein using dextran affinity chromatography. For
some difficult to express proteins, the addition of an MBP tag can increase the amount of expressed
protein in the soluble fraction (Kapust & Waugh, 1999).
The initial problems encountered with RGA expression in E. coli were due to the inclusion of 5’
UTR DNA in the vector received from a collaborator which prevented the fusion of N-terminal tags due
to the introduction of stop codons in the open reading frame of the expressed gene. After this issue was
corrected by constructing a new expression vector, soluble protein with an N-terminal tag could still
not be produced. GST fusions were undetectable and His fusions were insoluble. Using a C-terminal
His tag was successful and was used to produce and purify soluble RGA. It is unclear whether the
issues encountered with N-terminal tags are due the protein or the Gateway expression system used.
The Gateway expression system introduces short peptide linkers at the N- and C-terminal regions of the
expressed proteins and it is possible that these may be incompatible with the RGA gene. If this was the
case, expression using a different plasmid system may alleviate this issue.
Expression in P. pastoris was also investigated and it was found that the fused α-secretion factor
was not cleaved from the protein and the protein was not secreted as desired into the expression media.
Furthermore, the protein could not be purified through nickel IMAC which was likely due to the lack of
a His tag on the protein.
4.4.2 Production of recombinant SUMOylated RGA
The reconstituted E. coli SUMOylation system (Okada et al., 2009) would have been an ideal system
for producing large amounts of SUMOylated RGA protein if it were not for the fact that SUMOylated
RGA produced by this system formed inclusion bodies. Other groups have reported using a reconstit-
uted SUMOylation system in E. coli to produce SUMOylated protein and separation of the modified and
unmodified protein was achieved by using different affinity tags on the SUMO and target proteins (Lens
et al., 2011). In an attempt to address the fact that SUMOylated RGA in the E. coli system forms inclu-
sion bodies, SUMOylation of RGA using a cell free system was investigated. It was demonstrated that
RGA could be SUMOylated using AtSUM1 and purified E1 and E2 enzymes, however, the efficiency
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of the reaction appeared to be low, with little SUMOylated RGA produced. Degradation of RGA during
the SUMOylation reaction was partially responsible for the low efficiency. Though SUMOylation RGA
was produced, the yield of this method would need to be significantly improved to produce large enough
amounts of SUMOylated RGA for use in other assays.
The issue of degradation of RGA which may be due to small amounts of proteases remaining in the
purified protein samples used in the reaction would need to be addressed in future work. More stringent
purification procedures could be used to reduce the levels of protease carryover, though this would
probably reduce the protein yield as well. Proteins were purified using nickel IMAC, and using both
a higher wash volume and higher concentration of imidazole in the wash buffer than the concentration
used (30 mM imidazole) could be used to increase the purification stringency. Alternatively using a
different protein tag for RGA at the C-terminus giving better purity could be used such as GST or
StrepII tags.
The cell free SUMOylation reaction efficiency could also be improved by including a SUMO E3
ligase to the reaction. Inclusion of an E3 in a reconstituted E. coli SUMOylation system has been
shown to significantly increase the level of SUMOylated protein produced (Weber et al., 2014). The
use of an E3 ligase may also reduce the reaction time which would lead to less degradation of the RGA
protein. Improving the purity of the protein and the use of an E3 together may allow useful amounts of
SUMOylated RGA to be produced by a cell free system.
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5.1 Introduction
The gibberellin (GA) phytohormones are perceived by the soluble receptor GIBBERELLIN INSENS-
ITIVE DWARF1 (GID1) in plants (Ueguchi-Tanaka et al., 2005). GID1 has a high sequence similarity
to hormone sensitive lipases (HSLs) which are found across eukaryotic species and play an active role
in lipid biochemistry, however, GID1 has lost its catalytic ability and the active site of this protein has
been adapted to bind to GA instead. The co-opting of HSLs as receptors for GA appears to have begun
with the divergence of the angiosperms, with these plant species showing sensitivity and specificity in
response to GA application. The gross structure of GID1 has remained very similar to that of the HSLs,
with both containing a substrate binding pocket in the major protein domain with a smaller lid domain
enclosing the pocket (Shimada et al., 2008). In the case of GID1, the pocket is responsible for GA bind-
ing. While a large number of different GA forms have been found and characterised, GID1 only binds
to a small number of bioactive GAs including GA1, GA3, GA4 and GA7, all of which contain specific
functional groups required for interaction. The binding of bioactive GAs to GID1 leads to closing and
stabilisation of the lid domain over the hormone bound pocket and this conformational state recognises
and is able to bind to the DELLA repressor proteins (Murase et al., 2008).
The recognition of the DELLA proteins by hormone bound GID1 (Ueguchi-Tanaka et al., 2007)
targets the DELLA proteins for degradation and is the mechanism by which GA regulates DELLA sta-
bility (Fu et al., 2002) and gene expression by releasing numerous transcription factors from inhibition
by DELLAs. The N-terminal domain of the DELLA proteins containing a VHYNP and DELLA motif
is required for recognition by activated GID1, binding to the closed GID1 lid domain (Sun et al., 2010).
The binding of the DELLA proteins to GID1 initiates degradation of the DELLA proteins via the 26S
proteasome. A SKP1–CULLIN–F-box (SCF) ubiquitin E3 ligase complex containing the F-box protein
SLY1 (Dill et al., 2004) specifically detects the bound GID1-GA-DELLA complex and recruits molecu-
lar machinery that polyubiquitinate the DELLA protein which is subsequently degraded (Griffiths et al.,
2006; Fu et al., 2002). Although GID1 mediated degradation of DELLA proteins is the major mech-
anism behind GA signalling, Ariizumi et al. (2008) found that the action of GID1 binding to DELLAs
alone is sufficient to release downstream transcription factors from repression. Overexpression of GID1
in a sly1 mutant background, which cannot degrade DELLAs, partially rescues the dwarf phenotype
of sly1, however, to what extent the effect of GID1 mediated DELLA repression plays a role in GA
signalling remains unknown.
The amount of GID1 present in the cell determines the sensitivity of the cell to GA, with higher
levels of GID1 degrading DELLA proteins at a higher rate for a given level of GA (Ueguchi-Tanaka
et al., 2005). GID1 sits at the centre of a very complex network with many feedback loops that regulate
plant growth and development. While DELLA proteins block plant growth responses, they promote
the transcription of GID1 and GA biosynthesis genes leading to a negative feedback loop that stabilises
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DELLA repression (Middleton et al., 2012). There is also crosstalk between the GA pathway and
other hormone pathways including auxin (Roumeliotis et al., 2012), jasmonic acid (Hou et al., 2010)
and salicylic acid (Alonso-Ramírez et al., 2009). This complex regulatory network allows the plant to
coordinate robust responses to environmental cues. One well studied example is the stress response
observed under drought or high salt conditions where DELLA mediated restraint of growth has been
shown to improve a plant’s overall ability to survive these conditions (Achard et al., 2006). Growth
restraint under stress conditions conserves vital resources that prolongs the ability of the plant to survive
while stress conditions persist. The circadian cycle also regulates GA signalling by modulating the
levels of GID1, promoting GID1 transcription during the night leading to enhanced GA signalling, with
the opposite occurring during the day. Regulation of GID1 by the circadian cycle is responsible for daily
rhythmic cycles of plant growth (Arana et al., 2011).
While most agriculturally relevant plant species have a single GID1 gene, Arabidopsis has three
functional paralogs, GID1a, b and c. These paralogs have a high degree of functional overlap and
single knockdown mutants show very subtle phenotypes. Double knockdowns on the other other hand
show more noticeable phenotypes that are not explained by gene dose effects alone, suggesting a de-
gree of functional specialisation for the Arabidopsis GID1 paralogs. The gid1a gid1c mutant shows
partial dwarfism while gid1a gid1b has reproductive organ deformities and lower seed yield suggesting
tissue or organ specialisation for the Arabidopsis GID1 paralogs. As expected, triple knockdowns of
all three GID1 genes show a severe dwarf phenotype that is GA insensitive (Iuchi et al., 2007). Na-
kajima et al. (2006) investigated the biochemical differences between the Arabidopsis GID1 proteins
and demonstrated that while all were able to interact with all five of the Arabidopsis DELLA proteins,
they exhibited different optimal pH values for GA binding and different overall GA binding affinities.
GID1b showed both the narrowest pH binding range and the highest binding affinity for GA, ten times
that of GID1a or GID1c. Differences in GA binding affinities of the GID1 proteins are partly respons-
ible for functional diversification of the Arabidopsis GID1 proteins, with transcriptional regulation also
playing a role (Suzuki et al., 2009).
The results of Chapter 4 demonstrated that the DELLA protein RGA is SUMOylated and a model
was proposed whereby SUMOylated DELLA proteins inhibit the ability of GID1 proteins to target
DELLA proteins for degradation. One possible mechanism by which SUMOylated DELLA proteins
could inhibit GID1 is through direct binding to GID1 in an alternative conformation that is not targeted
for degradation. Based on the structure of the proteins and the site of SUMOylation in RGA, the posi-
tion of the attached SUMO moiety or SUMO chain in the DELLA domain of the protein may prevent
binding to GID1 in the typical conformation through steric hindrance suggesting that binding would
occur with an alternative conformation. Work by other co-authors on the paper submitted on DELLA
SUMOylation demonstrated binding of SUMOylated RGA to GID1a in vitro and that this interaction
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was GA independent. SUMOylated RGA for these experiment was purified from plant cell lysates
(Conti et al., 2014). This is in contrast to the interaction with non-modified RGA which requires the
presence of GA (Griffiths et al., 2006). While these results do not show that SUMOylated DELLA
binding to GID1 occurs in vivo, they do support the proposed model. Since GID1a is able to bind to
SUMOylated DELLA in a GA independent manner it was hypothesised that this protein could contain
a SUMO interacting motif (SIM) which would be responsible for the observed binding. This chapter
describes work that identified and characterised a SIM region in the Arabidopsis GID1a protein and
investigated the effect of overexpressing versions of GID1a with reduced AtSUM1 affinity in order to
test predictions from the proposed model of SUMOylated DELLA inhibition of GID1.
5.2 Chapter aims
• Show that AtSUM1 can interact with GID1a.
• Identify the location of the SUMO interacting motif in GID1a.
• Generate a GID1a mutant that cannot bind to SUMO but retains GA dependant DELLA binding.
• Characterise the phenotype of overexpressing a GID1a SIM mutant in Arabidopsis.
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5.3 Results
5.3.1 SUMO interacts with GID1a
For the proposed model of SUMOylated DELLA proteins inhibiting GID1, it was hypothesised that
GID1 could bind to the attached SUMO moiety or SUMO chain in SUMOylated DELLA proteins.
To test whether GID1a could bind to AtSUM1, a co-immunoprecipitation (co-IP) using GST:GID1a
and His:AtSUM1 was performed. To test whether the phytohormone GA plays a role in the interac-
tion, an additional co-IP with 10 μM GA3 in all assay solutions was included. The co-IP (Figure 5.1)
demonstrated that His:AtSUM1 interacted with GST:GID1a but not GST alone. AtSUM1 interacted
with GST:GID1a in both the presence and absence of GA3, demonstrating that GA3 is not required for
the interaction. These results suggest that SUMO plays a hormone independent role in GID1 regula-
tion. Although there was a slight difference in the intensity of the AtSUM1 bands in the co-IP result
with and without GA3, it is possible that this difference is due to variability between the different co-IP
assays. Quantitative measurements of the interaction would be required to determine whether or not the
presence of GA had an effect on the strength of interaction with GID1a.
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Figure 5.1: Co-IP of His:AtSUM1 with GST:GID1a. His:AtSUM1 was found to interact with
GST:GID1a both in the presence and absence of the phytohormone GA3 demonstrating that the inter-
action is GA independent. GST:GID1a was immobilised to αGST antibody coated paramagnetic beads
and His:AtSUM1 was used as the bait. GST was used as a negative control for the assay and shows that
the interaction of His:AtSUM1 was specific to the GID1a component of the GST:GID1a fusion. Results
published in Conti et al. (2014). WB: western blot.
5.3.2 Bioinformatic analysis of GID1 proteins
Since GID1a had been shown to interact with AtSUM1, it was expected that GID1a would contain one
or more SIMs which would be responsible for the affinity of the protein to AtSUM1. The primary and
tertiary structure of GID1a were investigated to identify putative SIM sites in the protein that could be
tested and mutagenised to generate SIM deficient mutants of GID1a.
The major defining feature of SIMs is their hydrophobic core enriched for leucine, isoleucine and
valine. Depending on the SIM orientation, this core has the motif structure of either ΨΨxΨ or ΨxΨΨ
which is flanked by either charged or polar residues (Song et al., 2005). To identify putative SIMs in
GID1a, regions matching the hydrophobic core motif were identified. The primary sequence of GID1a
was screened for sequences consisting of the motif ΨΨxΨ or ΨxΨΨ and 19 such subsequences were
found. Two of the subsequences overlapped and were removed since the hydrophobic region would
have been too long for this sequence to be a SIM, which left 17 putative subsequences.
For SIMs to be functional they need to be surface exposed and part of unstructured, flexible regions
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of a protein. To further eliminate subsequences, the location of the putative SIMs in the 3D structure
of GID1a was analysed using the structure resolved by Murase et al. (2008) of GID1a bound to GA3
and the GAI DELLA domain. The majority of the putative SIM-like sequences were found to be within
the core of the protein or within secondary structures. All of these sequences were ruled out as SIMs
leaving just three SIMs that were surface exposed. The hydrophobic core of SIMs is generally enriched
for the amino acids leucine, isoleucine or valine and of the remaining putative SIMs had enrichment
of these amino acids. The conservation of these remaining sequences was investigated using all three
Arabidopsis GID1 paralogs (GID1a, GID1b and GID1c) and homologs from rice, wheat and maize.
Two of the remaining putative SIM sequences were found to lie within a highly conserved region of
the proteins while the hydrophobic sequence of the third was not conserved in the monocot species.
The two putative SIMs in the conserved regions were taken as the best candidates to investigate further.
These putative SIMs were named SIM A and SIM B and the cores of the sequences were at positions
15V-18L and 21W-24I respectively.
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GID1a
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GID1a GA3 complex
a b
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x B
Figure 5.2: Mapping of SIM-like hydrophobic cores onto the 3D structure of GID1a. a) Diagrammatic
representation of the two conformational states of GID1a based on GA stabilising model showing loc-
ation of the two putative SIMs. b) 3D structure of GID1a with hydrophobic SIM-like patches shown
in blue. Most of these regions were within the core of the protein and were excluded (light blue) while
the best two candidate SIMs were in the lid domain of the protein and are shown in dark blue. GID1a
structure from Murase et al. (2008).
The two identified SIM-like sequences lie next to each other in the lid domain of GID1a and these
are shown in blue in Figure 5.2. The putative SIM B is within α-helix B of GID1a which is in complex
with GA3. Using molecular simulations Hao et al. (2013) demonstrated that the lid domain, including
α-helix B, has a high degree of conformational flexibility when GID1 is in the unbound state. Although
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this SIM B was within a secondary structure, this putative SIM was retained due to the conformational
flexibility of this domain. Due to the conformational flexibility it was speculated that this region might
be flexible enough to form an interaction with SUMO.
5.3.3 GID1a SIM peptides bind to AtSUM1
Once the two strong candidate SIM regions in GID1a were identified, oligopeptides of these sequences
were tested for interaction with AtSUM1 using far-western blotting. Based on a similar experiment by
Namanja et al. (2012), 13-mer peptides were designed consisting of the 4-mer hydrophobic core plus
six amino acids downstream and three amino acids upstream of this core as the sequences were thought
to be reverse type SIMs similar to those investigated by Namanja et al. (2012). Namanja et al. (2012)
demonstrated that SIM interaction with HsSUM1 and 3 could be abolished by disrupting the SIM core
region by substituting one of the large hydrophobic residues with a small hydrophobic amino acid such
alanine. Based on these data, mutagenised versions of the two SIMs were generated by replacing the
second amino acid within the hydrophobic SIM cores with alanine with the intention of creating mutant
peptides which do not interact with AtSUM1.
High purity samples of these peptides were then synthesised by Cambridge Research Biochemicals
and the peptides were purified by high performance liquid chromatography (HPLC) which was also
used to demonstrate sample homogeneity. 1 μg of each peptide was then spotted onto a nitrocellulose
membrane and then tested for interaction with AtSUM1 by far-western blotting (Figure 5.3b). The
results are shown in Figure 5.3a and demonstrate that the first peptide (SIM A) did not interact but the
second (SIM B) did and the mutagenised version (SIM B V8A or V22A in full length protein) showed
weaker interaction rather than abolishing the interaction altogether. This far-western blot was repeated
twice more with similar results, with SIM B V8A consistently showing weaker interaction. To confirm
that SIM B was functionally conserved, the corresponding peptides in a number of GID1 homologues
were synthesised, this time using using the SPOT peptide array synthesis method (see Materials and
Methods section; the peptide array was synthesised by a collaborating group at Glasgow University and
not by myself). The SIM B region of GID1a was highly conserved, with very few differences between
the evolutionarily distant monocot species; the far-western blotting assay of these peptides showed that
all of the peptides interacted with AtSUM1 (Figure 5.3c) suggesting that SUMO binding capacity of
this region of GID1 was conserved and that it may serve an important biochemical role.
Based on previous research by Namanja et al. (2012), the V8A mutation to SIM B was expected to
completely abolish AtSUM1 interaction and initially the reason for the partial interaction was unknown.
Later, as progress was made on the large scale SIM peptide screen detailed in Chapter 3 and AtSUM1
SIM sequences were better characterised, it was realised that the functionally important core sequence
may not have been the residues originally identified (amino acids 7-10 in peptide) but rather hydrophobic
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residues towards the N-terminal of the SIM B (amino acids 1-4) and that the SIM peptide conformed
to SIM type A rather than type R. The random forest SIM predictor described in Chapter 3 supported
this notion with a high confidence (predicted FPR = 0.08) that the conformed to type A. For type A
SIMs, amino acids after the carboxy end of the hydrophobic core are important in establishing polar
interactions or charged interaction with SUMO and the V8A mutation was in this region in the updated
model of SIM B. The fact that the V8A mutation does not abolish AtSUM1 interaction supports the
notion that this amino acid is not part of the SIM core but rather upstream of it and the reduction in
interaction can be attributed to interference of a non-essential region of the SIM. However, this re-
evaluation of the residues that constitute the SIM core do not invalidate the interaction results but rather
it was a refinement of the GID1a SIM model and the V8A weakly interacting mutant was used to
investigate the effect of a weak SIM in planta.
AtGID1a   9 LIESRTVVPLNTWVLISNFKVAYNILR 35
AtGID1c   9 LIESKTVVPLNTWVLISNFKLAYNLLR 35
AtGID1b   9 LNECKRIVPLNTWVLISNFKLAYKVLR 35
OsGID1    9 RNECKTVVPLHTWVLISNFKLSYNILR 35
TaGID1    9 RNECKTVVPLHTWVLISNFKVSYHMLR 35
ZmGID1a   9 RNECKGAVPIHTWVLISNFKLAYNMLR 35
              *.:  **::*********::*::**
AtGID1a 9 LIESRTVVPLNTWVLISNFKVAYNILR 35
SIM A     LIESRTVVPLNTW 
SIM B           VVPLNTWVLISNF
SIM A SIM B
SIM B V8ASIM A V8A
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Figure 5.3: Interaction of GID1 SIMs with SUMO1. (a) Far-western blot of AtSUM1 against two
putative SIMs and mutagenised versions of these peptides. SIM B was found to interact with AtSUM1
and the V8A mutation reduced this interaction. (b) Far-western blotting method. AtSUM1 was used as
a probe and two antibodies were then used to detect any interaction of the probe protein with peptides
immobilised on a support matrix. (c) Far-western blot of SIM B from various GID1 homologs all
showing interaction with AtSUM1 indicating that the SUMO binding capacity of this region of GID1 is
conserved. Species used: At = Arabidopsis thaliana, Os = Oryza sativa (rice), Ta = Triticum aestivum
(wheat) and Zm = Zea mays (maize).
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5.3.4 GID1a SIM mutants maintain receptor function
The mutant SIM B V8A peptide had been shown to be a weaker AtSUM1 interactor and the mutation
was introduced into a clone of the full GID1a coding sequence generating the mutant gid1a V22A. V22
lies within a highly conserved region of the GID1a lid component and alanine scanning analysis of the
rice GID1 homolog by Ueguchi-Tanaka et al. (2007) has shown that disruption of this region can abolish
the GA dependant interaction with the DELLA proteins; a triple alanine substitution of residues 20T -
22V was found to abolish interaction with the rice DELLA protein SLR. Additionally Yamamoto et al.
(2010) showed that the P99S mutation in the rice GID1 leads to GA independent binding of the receptor
to DELLA proteins. The binding of the mutant gid1a V22A to RGA was investigated with a yeast two-
hybrid (Y2H) assay to test whether DELLA binding was abolished and whether the receptor maintains
GA dependent binding. Another mutant, gid1a V22S which was generated as an alternative to the V22A
mutation was also tested. The mutant gid1a V22S was predicted to also have weaker interaction with
SUMO.
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RGA empty
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Figure 5.4: The SIM mutants gid1a V22A and gid1a V22S maintain GA dependant binding to RGA. All
three proteins only interacted with RGA in the presence of GA3. The HIS3 reporter gene inhibitor 3-AT
was used to increase the interaction assay stringency. All constructs were grown on minimal nutrient
agar lacking leucine and tryptophan (-L -W) media to select for the two plasmids containing each gene.
Interaction was shown by growing the yeast on media lacking leucine, tryptophan and histidine (-L
-W -H) supplemented with X-α-gal which turns the yeast colonies blue upon activation of the MEL1
galactosidase reporter gene.
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The Y2H assay included yeast clones grown on agar plates with and without GA3 to test GA depend-
ance. The wild type protein showed the expected GA dependant interaction with RGA which was not
affected by the addition of the reporter gene inhibitor 3-Amino-1,2,4-triazole (3-AT) (Figure 5.4). The
two GID1 mutants also interacted with RGA and exhibited GA dependance in the interaction, however,
addition of 3AT resulted in a slight reduction in the colony size of gid1a V22A and very large reduction
for gid1a V22S. The Y2H assay was repeated twice more using yeast cells from different transformation
events and the assays gave similar results. Although Y2H experiments are semiquantitative, the results
from these assays suggest that although gid1a V22A interacts with RGA in a GA dependant manner, the
interaction is weaker than the wild type and the interaction with the gid1a V22S mutant is even weaker
still. Since gid1a V22A retained GA dependant binding to the DELLA protein RGA and the interaction
was stronger than gid1a V22S, this mutant was used for further investigation in planta.
5.3.5 Investigating GID1a interactions using SPR
To investigate the binding strength of AtSUM1 and RGA to GID1a and the two mutant forms of the pro-
tein, surface plasmon resonance (SPR) was used. The GID1a sequences in the vector pENTR D/TOPO
were subcloned into the plasmid pDEST15 to generate N-terminal GST fusion clones and the pro-
teins were expressed in CodonPlus RIL (DE3) E. coli cells and purified using a glutathione sepharose
column. Figure 5.5 shows an SDS-PAGE gel of the purified recombinant GID1a proteins. His:AtSUM1
and RGA:His protein from work described in Chapter 4 was used (Figure 4.12). A major problem en-
countered with the GID1a proteins was degradation of the protein which liberated a small free GST
fragment (confirmed by western blot analysis with αGST antibodies). To purify sufficient amounts of
protein, the purification procedure time had to be kept to a minimum and all purification steps had to be
performed on ice to keep the protein and solutions close to 0°C.
For the SPR assay, the proteins were covalently coupled to a CM5 SPR sensor chip (GE Life Sci-
ences). All reactions were carried out in a 20 mM phosphate buffer pH 7.4 with 150 mM NaCl. In order
to bind the proteins to the chip, the pH of the protein buffer solution was optimised to attract the proteins
to the chip surface through electrostatic attraction. The GID1a and mutant gid1a protein solutions ap-
peared to have a biphasic response with peaks at pH 4.5 and 5.0 compared with the GST control protein
which had a single peak at pH 4.5. The predicted isoelectric point for GID1a is 6.6 and for GST is 4-5.
Therefore for the GID1a solutions it was hypothesised that the lower value pH peak corresponded to
free GST while the higher to GST:GID1a or GID1a protein and the higher pH values for these proteins
were used with the coupling reaction. Despite scouting for optimal pH values, the capture efficiency of
GID1a and the mutant proteins was very low and below the target binding of 2000 response units (RU).
The final covalent protein binding results are shown in table 5.1.
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Figure 5.5: GID1a mutant protein purification. GST:GID1a, GST:gid1a V22A, GST:gid1a V22S
and GST proteins were purified using a GSTrap glutathione affinity column and moderate levels of
GST:GID1a degradation products are present. The band for the wild type GID1a protein is weaker as
less protein was loaded onto the gel in error due to different concentration of this sample.
The poor coupling observed for GID1a and the mutant proteins could have been due to the complex
mixture of intact proteins and degradation products. Ideally the GST should have had an RU of 40%
of the GST:GID1a proteins, as this corresponded to the proportion of GST by mass in the GST:GID1a
fusion proteins. The GST control channel was used as a control and subtracted from the GST:GID1a
protein channels. Subtracting this channel from the others removed the interaction signal from non-
specific interactions with the GST protein and from the CM5 chip surface. The significantly higher
level of bound GST protein compared to GST:GID1a protein compromised the accurate removal of non-
specific interaction signals. Nevertheless the interaction with the proteins in table 5.2 was investigated
to test whether GA dependance with RGA could be observed and whether AtSUM1 could interfere with
the GID1a-RGA interaction. The response values for each protein were normalised by the total amount
of immobilised protein bound and then the GST channel was subtracted from the three GID1a protein
channels. These results were then normalised by the original amount of GID1a immobilised.
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Ligand pH Final protein response (RU)
GID1a 4.8 376.4
gid1a V22A 5.2 433.9
gid1a V22S 5.2 316.6
GST 4.5 2314.9
Table 5.1: GID1a mutant protein coupling to the CM5 chip for SPR analysis. The coupling of GID1a,
gid1a V22A and gid1a V22S was poor and below the target of 2000 RU while the coupling of GST was
satisfactory.
After normalisation, apparent binding signals could be seen for all ligands tested and these are shown
in Figure 5.6. However, all of the ligand binding treatments show the same trend, with GID1a and gid1a
V22S showing the same response and gid1a V22A showing a weaker response. The addition of GA3
to the samples had no effect on the responses and RGA in the absence of GA3 still produced the same
strength signal. These observations strongly suggested that the response seen in this SPR assay was not
from ligand binding to the various GID1a proteins but rather non-specific binding. Due to the difficulties
encountered with immobilising the GID1a proteins to the CM5 chip, it is possible that little or no GID1
protein was immobilised to the chip. The response signal seen is most likely due to mismatched non-
specific interaction subtraction resulting from incorrect proportions of GST to GST:GID1a bound to the
CM5 chip.
Run # Protein(s) 100 μM GA3
1 AtSUM1 no
2 AtSUM1 yes
3 RGA no
4 RGA yes
5 RGA + AtSUM1 no
6 RGA + AtSUM1 yes
Table 5.2: Interactors tested against GID1a and GID1a mutant proteins. Each assay condition was
repeated once with similar response results.
Should this experiment be repeated in the future, purification of a homogenous GID1a sample could
alleviate the issues encountered. The degradation of the GST:GID1a fusion which decouples the tag
from the fusion protein was the greatest issue encountered with the stability of this protein. Using a
specific protease cleavage site to remove the fusion tag during purification would allow the preparation
of GID1a without the GST tag which may improve the stability of the protein and would reduce the
number of protein species in the sample. Additionally size exclusion chromatography could be used to
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separate full length proteins from degraded protein fragments allowing the purification of a homogenous
protein sample.
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Figure 5.6: SPR sensograms of the binding between the various GID1a proteins and AtSUM1 and RGA.
The expected molecular interactions were not observed including GA independent binding of RGA.
Based on these observations and from the number of technical difficulties experienced with this assay,
it is likely the interaction results observed in these sensograms are due to non-specific interactions. No
conclusions were drawn from these data regarding the interactions of the proteins investigated.
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5.3.6 Exposure of Arabidopsis to a synthetic SIM peptide
SUMOylation plays an important regulatory role in a myriad of cellular processes. It was hypothes-
ised that SUMO regulated processes could be interfered with by introducing large amounts of SUMO
binding peptides into plant cells. Short peptides containing SIMs were proposed to act as competit-
ive inhibitors of SUMO-SIM interactions, reducing the interactions between SUMOylated and SUMO
binding proteins. The GID1 SIM peptides screened in Figure 5.3c had been shown to interact with
AtSUM1 and an experiment was set up to test whether applying large amounts of free SIM peptide to
developing Arabidopsis seedlings would induce a phenotype caused by dysregulation of SUMO con-
trolled processes. SUMO plays a dominant role in stress responses and levels of SUMOylation increase
in response to stresses. Various concentrations of hydrogen peroxide (H2O2) were used to induce oxid-
ative stress which has been shown to cause accumulation of SUMOylated proteins (Kurepa et al., 2003).
It was expected that by interfering with SUMO-SIM interactions, stress responses and repair mechan-
isms would be compromised and SIM peptide treated plants would display a more severe phenotype to
the oxidative stress inducer H2O2.
Large amounts of SIM peptides from a number of GID1 homologs were synthesised by Bayer Crop
Science. The synthesised peptides are a patented invention of Durham University (2014) [UK patent
WO2014083301 (A1)]. Initially the AtGID1a SIM peptide was going to be used in this assay but the
purity of this sample was lower than the other peptides that were manufactured. Instead the wheat GID1
SIM peptide was used, which differed by a single amino acid (sequence: VVPLHTWVLISNF) and had
been shown to interact with AtSUM1 (Figure 5.3c). Arabidopsis seedlings were grown in a 96 well
plate with 100 μl of ½ Murashige and Skoog (MS) agar by placing two seeds in each well. 6 days after
vernalisation the wells were supplemented with 100 μl 15 μM SIM peptide or H2O mock treatment then
two days later the wells were treated with a series of H2O2 concentrations. This regime was designed
to allow the plants to first absorb the SIM peptide and allow its effect to become established before
challenging the plants with the oxidative stress agent. After 10 days of H2O2 exposure, data were
collected from this 96 well plate experiment and size of the plants was estimated by measuring the
colour density of the blue channel of an image of the 96 well plate. The plants strongly absorbed blue
light giving a good contrast against the agar and 96 well plate and this was used as a proxy for plant
size.
The results from the assay in Figure 5.7 show the expected decline in plant size with increasing
H2O2 levels, with the highest concentration killing and bleaching the plants. The peptide treatments
however, did not show any effect at any concentration of H2O2 suggesting that in this assay, the capacity
of the plants to cope with oxidative stress had not been compromised.
While the lack of observed effect could be due to the SIM peptide not having an effect on cellular
function, it could also be due to insufficient peptide entering and/or remaining within the plant cells
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to elicit an effect. The SIM peptides are relatively large, high molecular weight molecules and uptake
through the plant tissues and into the cells may be inhibited by the size of these molecules. Additionally
the stability of the peptide both internally and externally is not known and the peptide may be degraded
by a number of processes including by endogenous peptidases. If the SIM peptide was degraded, the half
life of the molecule may be too short to observe an effect. Cellular uptake and peptide stability would
need to be investigated before any definitive conclusions can be made about the effect of introducing
SIM binding peptide into a plant cell.
141
CHAPTER 5. IDENTIFICATION OF A SIM IN GID1A
a
+
-
0
+
+
+
-
-
-
10 20 40 80 160
H2O2 concentration (mM)
+ -Treatment:         15 µM SIM peptide           H2O mock
b
0
10
20
30
40
50
0 10 20 40 80 160
H2O2 concentration (mM)
R
el
at
iv
e 
pl
an
t s
iz
e
peptide NO YES
Figure 5.7: Synthetic SIM peptide does not affect plant growth under stress. Plants treated with H2O2
show expected decrease in size but treatment with SIM peptide has no effect. (a) Two Arabidopsis plants
were planted on 100 μl of ½ MS agar and allowed to germinate. The wells were treated with a various
H2O2 concentrations and either 15 μM SIM peptide or a water mock treatment. (b) Graph of plant size
estimated using the inverse blue value for each well in the 96 well plate image. n = 8.
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5.3.7 Phenotype of GID1a SIM mutants in Arabidopsis
Once the GID1a SIM B peptide with the V8A mutation had been shown to be a weak interactor of
AtSUM1 and that the mutation introduced into the full length GID1a protein, gid1a V22A, was still able
to bind to RGA in a GA dependant manner, the effect of expressing these two proteins was investigated.
The coding sequences (CDS) for GID1a and gid1a V22A were subcloned from pENTR D/TOPO into the
plant expression vector pEarlyGate 201 to generate N-terminal HA fusion genes under the strong 35S
promoter of the cauliflower mosaic virus. These vectors were transformed into the Col-0 Arabidopsis
ecotype and into the SUMO protease mutant ots1 ots2 using the floral dip method (ots1 ots2 knock-
downs were confirmed by PCR, Figure A.1 in the Appendices). The ots1 ots2 line was included as
these plants hyper-accumulate SUMOylated proteins and it was hypothesised that overexpression of
the GID1a proteins in these lines may produce a stronger phenotype. During screening the ots1 ots2
lines, overexpression of 35S:HA:gid1a V22A resulted in a severe dwarf phenotype and in these plants
the development of the majority of siliques terminated before seeds were produced. Additionally no
homozygous lines for ots1 ots2 35S:HA:GID1a were isolated in screening. Furthermore, in both the
35S:HA:gid1a V22A homozygous T4 lines in the ots1 ots2 background, there were no detectable levels
of the transgenic proteins (Figure 5.8). Expression levels for ots1 ots2 35S:HA:GID1a were not tested
as there were no homozygous lines for this genotype. Work on hemizygous T2 ots1 ots2 transgenic lines
published in Conti et al. (2008) showed protein expression of the GID1a and gid1a V22A transgenes.
It is likely that the transgenes have been silenced in the T4 homozygous ots1 ots2 35S:HA:gid1a V22A
lines which would explain the lack of expression. The transgenes in the wild-type Col-0 lines on the
other hand did not have the issues observed with ots1 ots2 lines and therefore only overexpressors in the
wild-type background were investigated further.
Phenotyping the germination rate of GID1a and gid1a V22A overexpressing lines was performed
on both hemizygous and homozygous lines. The germination assay using the hemizygous lines was
performed as a preliminary screen which was followed up using seeds from homozygous lines. The res-
ults of both experiments are presented as the effects between the hemizygous and homozygous lines are
different, possibly due to higher gene dose effects in the homozygous lines. Equal transgene expression
in the lines used was confirmed by western blot of the plant extracts (Figure 5.8). Lines 1 and 2 for
35S:HA:GID1a and lines 2 and 3 for 35S:HA:GID1a V22A showed similar expression and were used
for the germination assay.
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Figure 5.8: Protein expression analysis of transgenic GID1a and gid1a V22A overexpressing plant lines.
Two lines for each construct, 35S:HA:GID1a and 35S:HA:gid1a V22A, were identified with similar
expression levels in the wild-type Col-0 background. No transgene expression was detected in the ots1
ots2 background lines. Coomassie staining of the blot shows equal protein loading in each lane. WB:
western blot.
GA signalling positively regulates seed germination and the effect of the overexpressing transgenes
on the germination rate was investigated. Germination rate was used as a proxy for GA signalling as
it is regulated by this hormone. It was hypothesised that by overexpressing GID1a the rate of DELLA
protein degradation would be increased leading to lower amounts of these transcriptional repressors.
GA signalling would be enhanced with lower DELLA levels which would lead to a higher germination
rate. A similar effect was hypothesised for the gid1a V22A lines but the effect was expected to be
larger thus there would be a higher germination rate. The gid1a V22A mutant protein is expected to
have a lower affinity to SUMOylated DELLA proteins which were predicted to inhibit GID1 function.
As the gid1a V22A mutant was predicted to be less inhibited by SUMOylated DELLA proteins it was
predicted to target more DELLA proteins for degradation compared to overexpression of GID1a alone.
The gid1a V22A overexpressing lines were then expected to have enhanced GA signalling compared
to overexpressing GID1a lines. The GA biosynthesis inhibitor paclobutrazol (PAC) was included at
two concentrations to lower the levels of endogenous GA in the germinating seeds. PAC treatment of
germinating seeds leads to lower germination rates (Lee et al., 2002) and this inhibitor was used to test
whether the overexpression of GID1a and gid1a V22A could reverse the lower germination phenotype
observed with PAC treatment.
The germination rates of second generation transgenic (T2) seeds were tested on PAC concentrations
of 0, 0.1 and 0.5 μM. The seeds had been collected from T1 parents with a single transgene insertion
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event and seeds contained a mix of segregating no-transgene:hemizygous:homozygous seeds with an
expected ratio 1:2:1 so the observed phenotype resulted from a mix of those genotypes. The results of
the assay using the segregating seeds are shown in Figure 5.9 which shows a slightly lower germination
rate for the GID1a overexpressing lines. However, the trend for line GID1a #1 is reverse to what was
expected with increasing PAC levels and this result was considered to be anomalous. Comparing the
other GID1a overexpressing line #2 to the wild-type shows no significant difference. Overexpression of
the gid1a V22A protein on the other hand led to significantly higher germination rates compared to both
the GID1a overexpressing lines and to the wild-type (Chi squared test with post-hoc analysis; p < 0.05).
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Figure 5.9: Germination rates for over-expressing GID1a and gid1a V22A segregating lines. One
35S:HA:GID1a line shows lower germination rates to the control while the other line is similar. The
35S:HA:gid1a V22A lines show significantly higher germination rates compared to the wild-type con-
trol and the 35S:HA:GID1a lines (Chi squared test with post hoc analysis; p < 0.05). The results for
35S:HA:GID1a line #1 are anomalous as they display the reverse trend expected for increasing PAC
concentrations, the reason for this anomaly in not known. n ≈ 200 - number of seeds used for each
group.
This assay was repeated again once the homozygous lines had been isolated. The effect of the
transgene was expected to be stronger due to a higher overall gene dose effect and that all seeds were
transgenic. The results for this assay are shown in Figure 5.10 and both the GID1a and the gid1a V22A
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overexpressing lines have close to 100% germination under all concentrations of PAC, significantly
higher than the wild-type control (p < 0.05). Furthermore, the two different transgenic constructs are
not distinguishable from each other, nor were the germination rates between the different PAC treatment
levels for the transgenic lines. This suggests that over-expression of both GID1a and gid1a V22A is
able to reverse the decrease in germination rate caused by PAC. Interestingly, to further support these
results, one of the lines which showed no protein expression (35S:HA:gid1a V22A #1; Figure 5.8) was
tested and showed similar germination rates to the Col-0 wild-type line (data not shown) demonstrating
that observed effects can be attributed to the presence of the overexpressed transgenes.
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Figure 5.10: Germination rates for over-expressing GID1a and gid1a V22A homozygous lines. All
transgenic lines show germination rates close to 100% for all PAC treatments and the germination rates
are significantly higher than the wild-type control Col-0 (Chi squared test with post-hoc analysis; p <
0.05). n = 100 - number of seeds used for each group.
Taking the homozygous lines alone, no difference between the two transgenes can be observed but
the data from the segregating lines suggests that the effect of the GID1a overexpressing lines is less
than that of gid1a V22A lines. Taking both experiments into consideration it could be concluded that
overexpression of gid1a V22A has a strong effect on increasing germination rates while overexpression
of GID1a has an intermediate effect between wild-type seeds and gid1a V22A overexpressing seeds.
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The germination experiment using the homozygous lines did not show consistent differences between
the different PAC treatments and the use of higher concentrations would be required to show differences
between the treatment levels and confirm whether the effect of overexpression of GID1a is intermediate
between wild type and gid1a V22A.
5.4 Discussion
The purpose of this work was to investigate whether the GA receptor GID1 contained a SIM and
could bind to SUMO to test the model of GA independent signalling proposed by Conti et al. (2014).
This model proposes that the DELLA proteins are SUMOylated under stress conditions and these
SUMOylated forms of DELLA are able to bind to and inhibit the action of GID1 and that the mechan-
ism is GA independent. In Chapter 4 it was demonstrated that the Arabidopsis DELLA protein RGA is
SUMOylated at K65 and this is the only site of SUMOylation in in vitro experiments. Research conduc-
ted by other colleagues demonstrated that SUMOylated RGA purified from plants could interact with
GID1a in a GA independent manner using a co-IP assay; the same experiment demonstrated that the
unmodified form of this protein required GA for the interaction with GID1a to occur (Conti et al., 2008)
supporting the SUMOylation model of GA independent signalling.
The work described in this chapter complemented the results from the SUMOylated RGA inter-
action experiment by demonstrating that GID1 can interact with free SUMO, as the model predicted
that SUMOylated DELLAs would interact with GID1 via binding of the SUMO group attached to the
DELLA proteins to a SIM or group of SIMs in GID1. Bioinformatic analysis suggested that there was
at least one SIM in the lid domain of GID1 and the predicted regions were highly conserved in both Ar-
abidopsis paralogs and in orthologs in cereal plant species. Interaction with these predicted SIM regions
was confirmed using short peptides of these sequences. A single region named SIM B covering residues
V15 to F27 in the GID1 proteins tested interacted with AtSUM1 and peptides from all species were
shown to interact with AtSUM1. These results suggested that the SUMO binding capacity of this region
is conserved across a wide evolutionary range of plant species. Later analysis using the HyperSUMO
sequence feature predictor strongly suggested that a hydrophobic tetrad required for SUMO interaction
consisted of the first four residues of SIM B (V15-L18) and that the SIM was of type A with the im-
portant charged or polar amino acids lying upstream of the hydrophobic core. SIM B lies within the
lid domain of GID1, within an unstructured loop region and part of α-helix B. Generally SIMs cannot
be part of secondary structures such as α-helices, however, the structure of GID1a was resolved using
the hormone and DELLA bound form of the protein and it is likely that the protein takes on a different
structure in the unbound state. Simulation of the dynamics of GID1a in the unbound state, GID1a-GA4
and GID1a-GA4-DELLA has shown that the secondary structure of α-helix B in GID1a is stabilised by
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both the binding of GA and the DELLA protein and suggests that in the unbound state the lid domain of
GID1a has much greater conformational flexibility (Hao et al., 2013). Given the conformational flexib-
ility of the GID1a α-helix B in the unbound state, it is plausible that SUMO binding can occur. These
structural data suggest that the hormone bound state of GID1 may not be suitable for SUMO binding to
SIM B but rather binding occurs in the conformation of the unbound state.
Attempts to generate mutant SIM versions which lacked SIM binding were only partially success-
ful, identifying the weakly interacting SIM B V8A peptide. The inability to generate complete loss
of interaction mutants was probably due to targeting the incorrect amino acids for mutagenesis, as the
peptide sequence at positions 7W-10I (respective to the position in the peptide, not GID1a) were ori-
ginally thought to form the hydrophobic core of the SIM. Later, using results from the work described
in Chapter 3 this hypothesis was updated to residues 1V-L4 instead. Targeting these residues for muta-
genesis instead may have resulted in complete loss of SUMO interaction. The weakly interacting V8A
mutant was investigated further and introduced into the full length sequence of a GID1a clone, generat-
ing gid1a V22A. A Y2H screen confirmed that the gid1a V22A mutant was functional and could bind to
RGA in a GA dependent manner, though the interaction appeared to be weaker. An alternative mutant
was also generated, gid1a V22S, and this mutant too was able to bind to RGA in a GA dependent man-
ner but the strength of the interaction was lower than that of gid1a V22A. The ability of the gid1a V22S
mutant to interact with SUMO was not confirmed.
Although the mutagenised SIM B V8A peptide had been shown to be a weaker interactor of At-
SUM1, the interaction of the corresponding mutation in GID1a was not tested and remains an important
outstanding experiment that needs to be performed in future work. This experiment is required to con-
firm whether the affinity of full length gid1a V22A protein for AtSUM1 is weaker. Originally it was
planned to investigate and measure the binding kinetics of native GID1a and the two SIM mutant forms
with both AtSUM1 and RGA using SPR but due to technical issues the assay failed. These data would
have confirmed whether the GID1a SIM mutants did indeed have a lower binding affinity for AtSUM1.
The SPR binding data was also going to be used to test whether the model of SUMOylated DELLA pro-
teins inhibiting GID1 was plausible from a kinetics point of view by modelling the proposed pathway.
Immobilisation of GID1a and the two mutagenised versions to an SPR sensor chip proved to be very
inefficient despite screening for optimal pH for binding. For the control GST protein on the other hand,
there were no issues with immobilisation.
Though only a small amount of protein from the GID1a samples was immobilised, the interaction
assay was performed with AtSUM1 and RGA. The measurements obtained however, appeared to be due
to background binding rather than actual GID1a protein interaction as no differential responses were
seen between the RGA runs with and without GA. A stronger signal was expected from the GID1a-GA-
RGA run than from the GID1a-RGA run as RGA binding has been demonstrated to be GA dependant.
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This expected difference in binding was not seen, indicating that the expected molecular interactions
were not occurring. One possible explanation could be that the wrong protein species were captured
from the heterogeneous GID1a samples which contained a number of break down products and a protein
fragment without a functional GID1a domain could have been preferentially captured. Another group
investigating the interaction of RGA and AtSUM1 with GID1a were able to show interaction using
SPR (Woodcock, 2014). They used protein samples donated by myself for the interaction assay that
were expressed and purified in the same manner as the samples described in this chapter. Woodcock
(2014) used a lower pH of 4.5 for the immobilisation of GID1a suggesting that the higher pH levels
used in the SPR assay described here were not appropriate for capturing GID1a. However, Woodcock
(2014) used buffers lacking salts to achieve binding and could not show GA dependance for the GID1a-
RGA interaction. It was suggested that the recombinant RGA protein behaved differently to the natural
protein and showed uncharacteristic binding to GID1a in the absence of GA. This assumption was made
because RGA bound to GID1a displayed a very slow dissociation from GID1a. Overall these results
suggest that there remains a major technical issue in the interaction assay that prevents the measurement
of the binding kinetics of both AtSUM1 to GID1a and RGA to GID1a.
The issue of degradation of the GST:GID1a fusion, which was used in this assay, was noted by
Murase et al. (2008) during their preparation of GID1a for crystallisation and they also found that
the protein was less stable in the absence of GA. Murase et al. (2008) proposed that this was due
to more solvent exposed protein chains in the GA free sample of GID1a they used which allowed
more favourable conditions for protease digestion. The GID1a samples described in this chapter were
expressed and purified in the absence of GA which was likely to have enhanced the rate of degradation
of this protein. To alleviate the problems with sample heterogeneity, the removal of the GST tag by
protease cleavage at a specific recognition site followed by size exclusion chromatography would allow
isolation of a homogeneous sample. Immobilisation of GID1a from such a sample with a single protein
species would eliminate the issue of immobilising a degradation fragment.
The observed binding signal in the SPR experiments could be explained by the signal from non-
specific interactions which had not been completely subtracted from the final SPR sensogram. The
signal from the GST channel was subtracted from the signal from the GID1a, gid1a V22A and gid1a
V22S channels but had to be scaled since the protein amounts in each channel were not a 1:1 molar ratio.
Rather the GST control was significantly higher. It is possible that due to the large difference in molar
ratios and errors in the scaling calculations, the signal from non-specific binding was not completely
subtracted.
Although reduced AtSUMO interaction for gid1a V22A full length protein had not been confirmed,
overexpression experiments in Arabidopsis were carried out which supported reduced SUMO binding.
With all other variables being equal, the amount of GID1 protein in the cell determines the stability of the
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DELLA proteins. Overexpression of GID1 would be expected to reduce the amount of DELLA proteins
and enhance GA signalling and this has been demonstrated by a number of groups (Ueguchi-Tanaka
et al., 2005; Conti et al., 2014). It has been shown that a small pool of DELLA proteins are always
SUMOylated, which increases under stress conditions (Conti et al., 2014). The model of SUMOylated
DELLA inhibition of GID1a then predicts that there is always a certain level of GID1 inhibition, which
is enhanced under stress conditions. Overexpression of GID1 protein lacking or having reduced SUMO
binding would be expected to have a stronger effect on reducing DELLA protein levels as the GID1a
inhibitory effect would be reduced. This would lead to enhanced GA signalling compared to overex-
pressing wild-type GID1a. Based on these hypotheses it was predicted that overexpression of the weak
AtSUM1 interacting mutant gid1a V22A would lead to stronger GA signalling than the overexpression
of GID1a alone. Germination was used as a proxy for GA signalling as the process is strongly de-
pendant on GA signalling (Ogawa et al., 2003). In concordance with previously published results, the
overexpression of GID1a was demonstrated to enhance the germination rate of Arabidopsis seeds. The
effect was found to be significantly higher for overexpression of gid1a V22A, however, the effect was
only observed in segregating lines as the strength of the effect of both homozygous overexpressors led
to almost complete germination of the seeds tested. To observe differences in the strength of effect in
homozygous overexpressing lines, higher levels of the GA biosynthesis inhibitor PAC could be used to
provide more challenging assay conditions.
The results from the overexpression assays support predictions made from the model of
SUMOylated DELLA induced GID1 inhibition which predicted enhanced GA signalling in GID1 SIM
mutant overexpressors. Although the results from the work described in this chapter support the model
and no results have been obtained that disprove the model, there are a number of critical aspects that
have not been tested. Most importantly the model predicts that SUMOylated DELLA is responsible
for GID1 inhibition, however, it has not been demonstrated experimentally that it is actually the case
and alternatively there could be some other SUMOylated target other than the DELLA proteins that is
inhibiting GID1. Stress induced SUMOylation results in the SUMOylation of a large number of protein
targets and one or more of these could be inhibiting GID1. Determining the identity of the SUMOylated
target which inhibits GID1 activity should be the next area of research into the role of SUMOylation in
GA signalling.
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The purpose of the work presented in the thesis was to expand the understanding of SUMO-SIM
interactions in plants and to develop a set of tools to predict SIMs in protein sequences. Two separate
areas of research were presented in this thesis, the first was a large investigation into the amino acid
composition of SIMs that bind to AtSUM1 andHsSUM1 while the latter part investigated a specific role
of a SUMO-SIM interaction in gibberellin receptor GID1.
The results of this work demonstrate distinct differences in the binding properties of plant and animal
SUMO proteins. Phosphorylation of the SIMs was shown to have either an activating or a deactivating
effect in SIMs depending on the location of the modification and the amino acid composition of the
SIM. Large datasets of SIM interactions with both AtSUM1 and HsSUM1 were generated and the data
were used to construct SIM predictors using random forest models. A SUMO site predictor was also
developed using random forest models and both the SIM and SUMO site predictors were combined to
develop a web-based SUMO-related sequence feature predictor with a graphical user interface to make
the predictor available to the wider research community. The plant SIM predictor that was developed
was used to perform a large-scale screen for conserved SUMO binding proteins (SBPs) in Arabidopsis.
The predicted SBPs form a group of novel proteins whose function could be regulated by SUMO and
these proteins are good candidates for further research into the role of SUMOylation. The predicted
SBPs were enriched for biological processes that are known to be regulated by SUMO, such as DNA
and RNA maintenance as well as for novel processes such as cell wall metabolism.
Investigation into the role of SUMO in the GA pathway was initiated by the finding that the DELLA
repressor protein RGA is a target for SUMOylation. A model was proposed whereby SUMOylated
RGA inhibits the action of the GA receptor GID1 which targets the DELLA proteins for degradation in
the presence of GA. SUMOylated DELLA inhibition of GID1 was proposed to occur through binding of
the SUMO moiety of SUMOylated RGA to GID1 via a SIM, blocking the action of GID1. The results
presented in Chapter 5 demonstrate that GID1 can bind to SUMO and that the model of SUMOylated
DELLA inhibition of GID1 is plausible.
6.1 Analysis of SIM sequences
Research in animal models has shown that SUMO isoforms have different affinities for SIMs depending
on the amino acid sequence. SUMO isoform binding differences were observed between human iso-
forms of SUMO (Tatham et al., 2005) so inter-species differences were expected to exist. To what extent
plant and human SUMO isoforms differed in their binding properties was unknown prior to this work.
Though plant SBPs had been identified, prior to the publication of the research described in this thesis
by Conti et al. (2014), no plant SIMs had been described so no data was available for characterising
plant SUMO binding preferences.
152
CHAPTER 6. DISCUSSION
In order to investigate the binding properties of plant SUMO, a randomly generated peptide library
was designed to identify AtSUM1 binding peptides. Namanja et al. (2012) used a large-scale peptide
library to investigate the binding differences between HsSUM1 and HsSUM3, though their approach
is different to that taken in this work. For two known human SIMs, Namanja et al. (2012) generated
all possible single amino acid substitutions of 13-residue sequences and used these sequences to gener-
ate peptide arrays. Although this peptide library screened hundreds of SIMs, they were all very similar,
with any two peptides differing by at most two amino acids. For the purpose of their work, this approach
was appropriate as they were interested in identifying important amino acid residues within those spe-
cific SIMs. However, using the same strategy to generate de novo data to characterise SUMO binding
properties would result in a very constrained dataset that would not sample very much peptide sequence
variety. To overcome this issue, random sequences from a defined distribution were generated. The
distribution that the SIMs were drawn from was constrained to a limited set of amino acids at certain
positions to ensure that the peptide resembled the general motif of known SIMs. Three types of SIM
motif are known (Vogt & Hofmann, 2012) and peptides resembling each type were generated. The
advantage of this approach was that the peptides generated had a greater variety and sampled a more
diverse range of peptide sequences. Although there was no replication of the peptides on the arrays,
there was position specific replication of amino acids in the peptide library, which allowed trends in
amino acid binding preferences to be observed.
The constraints imposed upon the amino acids at the different peptide positions were quite stringent
and limited the variety of the peptides in the set. Importantly only a limited number of amino acids were
screened at the most constrained hydrophobic core positions of the peptides and it is possible that some
features of SIMs could have been missed using this dataset. The stringency was set high to ensure that
enough interacting peptides were identified. A peptide library with higher diversity would sample more
peptide diversity but have a lower proportion of interacting peptides and due to limited library size, too
few SUMO interactors would have been identified to be useful. A balance between peptide variety and
positive interactions had to be met.
The approach of using a randomly generated SIM-like peptide library produced an acceptable ratio
of interacting to non-interacting peptides, allowing trends in the peptide sequences to be observed.
AtSUM1 binding preferences were compared with those of HsSUM1, and the binding properties of the
two SUMO isoforms were found to be very different with only a minority of the library peptides being
able to bind to both SUMO isoforms. The major differences in binding were found to be due to the
amino acids immediately next to the hydrophobic cores of the SIMs, with the influence of the position
on binding having less of an effect the further from the core it was. Furthermore, phosphorylation
of polar amino acids within certain SIMs was shown to act as interaction switches either activating or
deactivating the interaction. In a biological context, this is an important observation showing that effects
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of SUMOylation can be regulated by protein kinase cascades.
These results demonstrate that there are large differences in SUMO binding behaviour in distantly
related species. The peptide sequence requirements for SUMO isoforms from distantly related species
needs to therefore be determined independently as the binding preferences vary significantly. Further-
more, these results show that any predictors of SIMs will need to be trained using species and SUMO
paralog specific data. This is in contrast to the prediction of SUMO sites that do not show species or
SUMO isoform differences.
6.2 SUMO-related sequence predictor
The large SIM datasets were used to build specific SIM predictors for both AtSUM1 and HsSUM1
isoforms. Random forest methods had been used previously to predict SUMO sites within proteins by
Teng et al. (2012). Areas for improvement in these authors’ methodology were identified to improve the
performance of the predictors. A new SUMO site predictor was built using training data from Xue et al.
(2006), using the improved random forest method. The performance of the SUMO site predictor was
significantly improved by this new method. This increase in performance was achieved by converting
amino acid factor variables into numeric PCA dimensions, by performing variable selection and by
performing parameter optimisation.
The resulting SUMO site predictors outperformed previously published predictors and offered both
better sensitivity and specificity. The SIM predictors had lower performance because of limited training
data. The performance of the SIM predictors could be improved by using training datasets with more
observations. Future work should focus on building larger SIM datasets and should include additional
SUMO paralogs from Arabidopsis including AtSUM2 and AtSUM3. AtSUM1 and AtSUM2 share a
high sequence similarity (Castaño-Miquel et al., 2011) and it would interesting to see to what degree,
if any, the SIM binding preferences differ between these two proteins. Future work could also use
quantitative interaction methods, such as using fluorescently labelled SUMO proteins. This would allow
more complex models of SUMO interaction to be incorporated into a SIM predictor. Chapter 3 discusses
some other minor technical issues with the peptide synthesis quality and methods for addressing these
issues.
The AtSUM1 SIM predictor, along with structural and evolutionary information, was used to
identify putative SBPs containing at least two predicted SIMs in Arabidopsis using a genome wide
screen of sequences. The screen focused on evolutionarily conserved proteins having predicted ortho-
logous proteins in other plant species. The SBPs identified in this screen agree well with the role of
SUMOylation in DNA and RNA maintenance and repair (Elrouby et al., 2013; Xu et al., 2013; Mazur
& van den Burg, 2012). While the false positive rate for the predicted SBPs is unknown, this set of pro-
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teins is expected to contain an enrichment of true SBPs, as the set contains the expected enrichment for
DNA/RNA related processes. The identified proteins complement work by Miller et al. (2012) who have
used genome wide screens to identify protein targets for SUMOylation, and some of these SUMOylated
proteins may be the interacting partners for the predicted SBPs. Co-localisation and co-expression
studies of the identified SUMOylated proteins and predicted SBPs could be used to identify putative
interacting SBP-SUMOylated protein pairs. There is also likely to be some overlap in the predicted
SBPs and other large scale screens for SUMOylated proteins. SUMOylated proteins often contain SIMs
which promote SUMOylation of these proteins (Jentsch & Psakhye, 2013) and these proteins could also
be identified in the SBP screen.
6.3 The role of SUMOylated DELLAs
DELLA proteins in the GA pathway are responsible for negatively regulating GA responses in the
absence of the hormone GA. In the presence of GA, the GA receptor GID1 binds to the DELLA proteins
and targets them for degradation leading to the activation of GA signalling. The demonstration that the
DELLA proteins are SUMOylated (Conti et al., 2014) was the first evidence for the role of SUMO in
the GA pathway.
The model of SUMOylated DELLA inhibition of the receptor GID1a through the binding of
SUMOylated DELLA to GID1 via the SUMO moiety was proposed as the function for this modification.
In this model, increased levels of SUMOylated DELLA proteins lead to more binding of SUMOylated
DELLAs to GID1. These SUMOylated DELLA proteins are not targeted for degradation by GID1, and
the binding of SUMOylated DELLA inhibits the activity of GID1 against non-modified DELLAs. This
model then predicts that when SUMOylated levels of DELLA proteins increase, such as in response
to stress, inhibition of GID1 occurs allowing higher levels of DELLA proteins to accumulate, which
in turn represses GA signalling and restrains plant growth. It is predicted that increasing the levels of
GID1 through overexpression would reduce DELLA levels, and enhance GA signalling, leading to in-
creased growth. Furthermore, overexpression of a GID1 mutant protein lacking SUMO binding would
be expected to have a stronger effect on reducing DELLA protein levels as it would not be subject to
inhibition by the pool of SUMOylated DELLAs.
Results from Chapter 5 demonstrated that GID1a protein is able to bind to SUMO and a putative
SIM was identified in the lid region of the protein. Co-IP assays performed by another collaborating re-
searcher demonstrated that SUMOylated RGA could bind to GID1a in a GA independent manner (Conti
et al., 2014). These experiments demonstrated that SUMOylated DELLA binding to GID1a could occur
in vitro. Overexpression lines were used to test the two hypotheses regarding overexpression of GID1
and a GID1 SIM mutant. Germination assays confirmed that overexpression of a SIM mutant of GID1,
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gid1 V22A, was able to increase seed germination rate, which was used as a proxy for GA signalling.
The results for overexpression of GID1a alone were inconclusive, as an assay using hemizygous lines
did not show an increase in germination rate, while in an assay using homozygous lines overexpressing
GID1a and gid1a V22A resulted in almost complete germination of the seeds tested, even when exposed
to the GA biosynthesis inhibitor PAC. Nevertheless these plant overexpression experiments support the
proposed hypotheses regarding GA signalling.
Although a number of experiments have provided evidence for an inhibitory effect of SUMOylated
RGA on GID1a activity, no direct evidence of the mechanism has been demonstrated in planta. The
interaction between SUMOylated DELLA and GID1a needs to be tested in plant cells to further test
this model. Förster resonance energy transfer (FRET) is commonly used to demonstrate the interaction
of two proteins in vivo and recent advances in methodology (Wallrabe et al., 2012) and results analysis
(Hoppe et al., 2013) have allowed interaction of more than two proteins to be investigated. Each pro-
tein is fused to a different fluorescent molecule and each pair of possible interactions can be tested by
exciting different fluorophores and observing the emission spectra. Using three different fluorophores
to tag a DELLA protein, SUMO1 and GID1a would allow the association of the three molecules to be
tested. Demonstrating interaction of these three proteins in vivo would provide important direct evid-
ence for the interaction of SUMOylated DELLA proteins with GID1. The SUMOylation of DELLA
proteins may be a critical mechanism regulating growth restraint during periods of stress. Understand-
ing of plant hormonal regulation in Arabidopsis could inform research into developing new crop plant
biotechnologies.
6.4 Concluding remarks
The research presented in this thesis has provided the first detailed investigation of SIMs in plant mod-
els. The data from the SIM work was used to build a predictor for SIMs that bind to both AtSUM1
and HsSUM1 and will be of use to researchers investigating SUMOylation in both plant and animal
models. A genome-wide screen for SIM containing proteins in Arabidopsis has provided a novel set of
predicted SBPs, which may help elucidate the role of SUMOylation alongside previous work identify-
ing SUMOylated proteins by other groups. Finally, the role of SUMOylation of the DELLA proteins
was investigated and a functional SIM in the GA receptor was identified indicating that the GA pathway
is regulated by SUMO.
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A.1 DNA primers for PCR
Name Sequence (5’ - 3’) Ta (°C)
D_AttB1-F ACAAGTTTGTACAAAAAAGCAGGCT 55
D_AttB2-R ACCACTTTGTACAAGAAAGCTGGGT 55
E_RGA-F CAGGCCCAGCCGGCCATGAAGAGAGATCATCACCAATTCCAAG 58
E_SUM1-F CAGGCCCAGCCGGCCATGTCTGCAAACCAGGAGGAAGAC 58
E_RGA-R GCTACTTCTAGAATGTACGCCGCCGTCGAGAGTTTC 58
C_RGA-F CACCATGAAGAGAGATCATCACCAATT 58
C_RGA-R GTACGCCGCCGTCGAGAGTTT 58
C_SCE1-F CACCATGGCTAGTGGAATCGCT 60
C_SCE1-R TTAGACAAGAGCAGGATACTGC 60
M13 (-20)-F GTAAAACGACGGCCAG 55
M13-R CAGGAAACAGCTATGAC 55
M_GID1a_V22A-F GTGGTTCCTCTCAATACATGGGCTTTAATATCCAACTTCAAAGTA 55
M_GID1a_V22A-R TACTTTGAAGTTGGATATTAAAGCCCATGTATTGAGAGGAACCAC 55
M_GID1a_V22S-F ACAGTGGTTCCTCTCAATACATGGAGTTTAATATCCAACTTCAAAGTAGC 55
M_GID1a_V22S-R GCTACTTTGAAGTTGGATATTAAACTCCATGTATTGAGAGGAACCACTGT 55
D_OTS1-F CACCATGACGAAGAGGAAGAAGGA 60
D_OTS1-R TTACTCTGTCTGGTCACTGACAC 60
D_OTS2-F CACCATGAAGAGACAAAGAGCAATCG 60
D_OTS2-R TTAATCTGTTTGGTTACCCTTGC 60
D_T-DNA-R TGGTTCACGTAGTGGGCCATCG 60
D_ots1-F CGACAAGAAGTGGTTTAGACC 60
D_ots2-F GACAGGGATGCATATTTTGTGAAG 60
Table A.1: DNA primers used for PCR.
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A.2 Genotyping of ots1 ots2 T-DNA insertion lines
T-DNA insertion knock-down of ots1-1 ots2-1 were confirmed by PCR. Primers for the full length
genes were used to confirm absence of the functional OTS1 and OTS2 genes. T-DNA insertions were
confirmed using a left border primer for the T-DNA insertion plasmid pROK 2 and a gene specific primer
for OTS1 or OTS2. The line ots1-1 ots2-1 displayed the expected lack of OTS1 or OTS2 fragments and
the expected T-DNA insert fragments for ots1-1 and ots2-1 (see Figure A.1).
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Figure A.1: Confirmation of the ots1-1 ots2-1 knock-down plant line.
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B.1 Areas of images sampled for baseline subtraction assessment
SIM array, 
part 1
SIM array, 
part 2
Phosphorylated
SIM array
x
y
Image areas used to assess baseline subtraction
AtSUM1 interaction images
Figure B.1: Peptide array image areas used to assess baseline flattening for the AtSUM1 interaction
far-western blot.
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SIM array, 
part 1
SIM array, 
part 2
Phosphorylated
SIM array
x
y
Image areas used to assess baseline subtraction
AtSUM1 control images
Figure B.2: Peptide array image areas used to assess baseline flattening for the AtSUM1 control far-
western blot.
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SIM array, 
part 1
SIM array, 
part 2
Phosphorylated
SIM array
x
y
Image areas used to assess baseline subtraction
HsSUM1 interaction images
Figure B.3: Peptide array image areas used to assess baseline flattening for the HsSUM1 interaction
far-western blot.
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SIM array, 
part 1
SIM array, 
part 2
Phosphorylated
SIM array
x
y
Image areas used to assess baseline subtraction
HsSUM1 control images
Figure B.4: Peptide array image areas used to assess baseline flattening for the HsSUM1 control far-
western blot.
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B.2 SIM peptide sequences
Table B.1: SIM peptide interaction values. NA indicates data that was removed
due to quality issues. A lowercase ’p’ before an amino acid indicates a phos-
phorylated amino acid. See Table 3.1 for explanation of peptide classes. Peptide
classes not in this table are control peptides from known SIMs.
Peptide Class AtSUM1 HsSUM1
FEILDLTIGEWRT B4 0.03 -0.03
GKPVDLTPEQEEV B1 0.00 -0.01
GWIWGWEEEAIDV A3 NA NA
SWTYDLTSDPLEN B1 NA NA
CSLSESELDLLIS R1 NA 0.39
PIMPTVSSSFDLK A3 0.00 -0.01
YLLVNIGSGVSMI A1 NA NA
LRVVDLTILGFLF B1 0.51 NA
KKLMDIKNRVTSR A1 0.18 NA
DMIILVSKHVTFK A1 0.01 NA
SKVINLSEDIFAG A2 0.16 0.00
DLVLDLCKQMELK B4 1.03 0.00
GDKQDESFEPFIP R3 0.05 -0.02
PLPPSPSDSFNSV A3 NA NA
EAIVSVSSDSEIP A2 NA NA
SVKGSSSLPLWFS R3 0.59 -0.01
KPLLFLSSSSSFS A2 0.80 0.08
DFSDESDLNMLWS R2 NA NA
QLVIDLTRNKGMR B1 0.37 NA
RSLMMLSRDSSFK A1 0.92 NA
PMMIVVECNPKGD A1 0.00 0.01
AMKNTSHVLLLSL R1 0.67 0.03
GFSPDLTTFNIRA B2 0.99 NA
LILPDLTSGAESK B2 0.00 0.00
LNYVRLSESSFAS A3 0.44 0.16
KSILYLNRHQTEE A1 0.13 0.14
PLPFNYDEDDEKD A3 0.00 0.02
RKLMFLSDDGIMF A2 0.55 0.06
YHYIDLSKNEISG B3 0.00 0.65
ELELDLSSNAKVQ B4 0.00 0.03
KPLVIVCNKTDLM A1 0.00 NA
LIESRTVVPLNTW GID1a-SIM-A 0.57 -0.01
SFRPDLYSWPSLP B2 NA NA
TDAESEELRVMRE R3 0.00 -0.02
VCLLDLEYGLPVQ B4 NA NA
SVAIDLCGMTQAE B3 0.92 NA
IQSAEGSVDVLMD R1 NA NA
QNPISLSSSVSFQ A2 0.99 NA
RHMIPVSEENMYP A1 0.00 NA
TCIVDLYTHLPKV B1 0.00 0.01
ADYIDLTDLTVHD B1 NA 0.91
NKVVIMSSSHSSI A3 0.16 0.00
VNHIDLYRLDFQT B1 0.20 0.01
CAVPGCDVKVMSD R1 0.04 0.00
DDIIKLDEEALKA A2 0.00 -0.02
EFKLDLTCGINPS B2 0.29 0.00
DPSVDLSERPMMY B3 NA NA
SHCVDLEMLDEVK B4 0.00 0.56
KMIVDLEPPRFDN B3 0.00 0.00
IAYWRNHVVVVIL R1 0.56 0.02
HIPIVVGSQQRYE A1 0.52 0.01
RVIIDLDFKTQFE B3 0.74 0.25
ETQDSSSLTPFYD R3 NA NA
KWMDTRDVLIVNP R1 0.00 -0.03
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Peptide Class AtSUM1 HsSUM1
DGFLLVEESLRIK A3 0.06 0.37
DSDKESSLNLILR R2 0.68 NA
SDMIAMTNEDLNK A1 0.00 -0.03
VAEEESELCMLME R2 NA NA
EEMKESSISMVEA R2 0.00 -0.04
PVPFDLTPRLSNK B2 0.42 NA
CEIFDLDSEHVRI A3 0.00 NA
IVPLNTWVLISNF GID1a-SIM-B 0.39 NA
ESIVFMEDDEVKE A3 0.00 -0.04
PPAVDLELEKVLG B3 0.00 -0.03
VTLLRVQDSQNRS A1 0.71 0.44
KKEFETQMEVVGK R1 -0.01 0.01
LQSFDLSSNKFNG B4 0.00 0.06
QGLMFVGESALSL A1 NA NA
DRILGVSDEKKPI A2 0.00 -0.02
LCLLVMKNSQVSK A1 0.00 -0.02
WSDQDSSLWMIPC R2 NA NA
LLLVSLCDHKTLS A1 0.00 0.14
NDVLQISDHLSKQ A1 0.00 -0.01
GEEVDLYMDQSSG B2 NA NA
GILIDLEPARTED B3 NA NA
TNPTSSSFSFPLT R3 0.47 NA
ATVVDLYRTRYKY B1 0.69 -0.03
RDMIVVGESGLFT A1 NA NA
TQDTSSSVLLFFD R3 NA NA
TGMLKMEEEFVDS A2 0.01 -0.02
VVVAGNRLSLIAR R1 0.99 NA
AKVLEESLEIMSE R2 0.00 0.01
HLVMELCEGGELF A1 0.59 NA
DPKPDLTLGVPEH B2 0.00 -0.02
RSVFDLYFRKNPF B2 1.00 NA
WEVINLTEDNHPL A1 0.00 0.80
PSIVDLDLNVFDK B4 0.00 -0.02
HPLPSLSSSTKPH A3 0.00 -0.02
ALEPDLTPFPANR B4 0.00 NA
ACKVDLTREERSN B3 0.00 0.76
KGSSTESIAVVEK R1 0.00 0.01
LIESRTVVPLNTW GID1a-SIM-A 0.62 -0.03
LLFPSSEPDLWRL R3 0.00 -0.03
IKTMEDDYAVPVS R3 0.00 0.06
TFLPDLTEIMTEI B2 NA NA
PFMIDLYPYYAYR B1 0.68 0.04
NVLLSIESDKTDE A2 0.00 0.06
IILPNLSSETTDL A3 NA NA
SFGNSEDPAPWSK R3 0.00 -0.01
TRVLDLYNKNCSA B2 0.28 0.03
QEPLLVEEEAACL A2 NA NA
VTPEESSLVVYLI R3 0.23 NA
DRVIYLDSDIIVV A2 NA NA
DDVIVVESEERAR A2 0.00 NA
EPIYSPSSDDHNL A3 0.00 -0.03
DDVVTLSEDEEET A2 NA NA
RHLLVLSSDDNGC A2 NA NA
KRILKLNEGFDRF A1 0.98 NA
LPPVDLTDLSSST B1 NA NA
KRVVDLCAAPGSW B3 0.00 -0.04
DDDDDDDPDYVEE R3 NA NA
GFLLRISKQDIKK A1 0.44 -0.01
ESKLDLTDTIKDG B2 0.00 -0.05
AKMIDLSDNELTG B3 0.00 -0.03
VAISSSSVKVLKI R3 0.60 -0.03
RNMITMSEEVANS A2 NA NA
AGKKSDSLPVFDD R3 0.00 -0.01
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PEHIDLDQISVIH B3 0.00 -0.02
IPCYDLTSSAPFL B4 NA 0.94
DDVLDLSWSRSQL B4 0.64 NA
MAPIKINGDKKLY A1 0.00 -0.04
DNEKECIIVWEKK M-IR2 0.00 0.23
LIVPRFEEDYWIR A3 0.04 NA
LAVVVVSESYPIS A2 NA NA
VPKYDLSCLPSNI B3 0.00 0.08
IDKYDLYGQVAMP B1 0.00 0.00
PSEVDLYSSGENG B1 NA NA
SRPIPFDDDNKEV A3 0.10 -0.02
RSLLEVEESLIQE A3 NA NA
SRGSSDDISVMLI R2 NA NA
PKFVDLTAPDHRP B1 NA NA
QKIVVVDSEMPSG A2 0.00 -0.03
ALYVRFSSSCEKT A3 0.00 0.03
KTTYDLSKKISWQ B3 0.00 -0.03
TDSYDLFVISLIT B3 0.22 NA
DVPLFLDEDVPLL A3 NA NA
VGEADLSVARRKN B4 0.23 0.35
TDIISIEDSESED A2 NA NA
GTPVDLTRPSKKV B1 0.01 0.04
RAMVDLDNAGVRG B3 0.00 0.00
QEEEEEEVVVIGD R2 NA NA
LPLSRSRVLMVMN R1 1.05 NA
IKAADLTSGKGKI B2 0.09 0.02
VEIVDVKCGNPDR A1 0.00 0.80
VAHLDLSKVFLQN B4 0.09 0.00
NMKVDLTKLDMAA B1 0.00 -0.03
MFPLLVCTRESTP A1 NA NA
QVMVAIDESECSK A1 0.00 -0.03
WTQTDSEVEVMVI R1 NA NA
EQVYDLTEVKPNE B3 0.00 -0.01
ISIICVCHGTSFS A1 0.00 0.11
AVPIHTWVLISNF ZmGID1a 0.65 -0.03
EVLLKLEEEYIEN A3 0.00 -0.01
GRPMNVSDSSPLA A2 NA NA
FRLPPISSSADVA A3 NA NA
ASLLDICEKVLSL A1 0.00 0.02
PFRKGNNILVMCD R1 0.12 0.03
DPAVKGTLNVLNS R1 0.00 0.19
ELIIDLTTSKIAS B4 0.02 0.19
DVFWDLSSAKFGS B4 0.59 -0.02
NDFLTLDESRLID A3 0.00 0.04
EMKECTGLEVLPT R1 0.00 0.00
SGFLDLYTDKDTT B4 0.03 0.08
LEYVDLYLIHWPA B1 0.00 -0.03
QELVTVRNEALHT A1 0.24 -0.02
SGAMSSSLSLLVN R2 0.79 NA
NLTPDLTTLDSFG B2 NA NA
EKTIDLTGRVGQE B2 0.00 -0.03
RSESNGKLQLVYL R1 0.05 -0.02
QFLVSVSESRSSI A3 0.82 0.27
DSNFDEDLPLPPW R3 NA NA
YCLNKESVEVVKL R1 0.04 NA
SSLLCLESEEARM A3 NA 0.53
EALLDLTNSVVSS B2 NA NA
RALDSSDVELVKL R2 0.00 0.03
DSILDLFLESVRI B4 0.62 NA
EQLLALDSDKYSR A2 0.00 -0.03
LVPKDESVKVLAE R3 0.00 -0.04
PTIVEVSSSNMYD A3 NA NA
PSQFDSSISPMRM R3 0.12 0.26
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RLIIDLYGISKKP B2 0.28 0.02
LIESRTVVPLNTW GID1a-SIM-A 0.66 -0.04
WVLPEDDLILLAI R2 0.15 NA
KFDKSESPRLVHR R3 0.25 NA
LDPLVWDDEVAAY A3 NA NA
SMRSESDLELLNK R2 0.00 -0.04
AQTFDLTPQNVDL B2 NA NA
GAGKTTQLRIITG R1 0.75 NA
GEAMDLFQRMEKD B4 0.08 0.00
RPILLLDSSAING A3 NA NA
RHGSSESISFPIR R3 0.80 NA
INDLEEKMKLVKK R1 0.01 -0.02
FRHSSSSLPILQQ R2 0.67 0.33
KSVLGVSSEPSPR A2 0.00 0.01
KMQKKQRMSLVVS R1 0.05 0.00
SRKLEGKVALITG R1 0.31 -0.01
NVLIDLYKKCGRI B2 0.05 NA
AAIMAMDESVLDD A2 NA NA
KNMICFESSPNLM A3 0.00 0.68
PSMVDLTTLKLLN B3 0.80 0.15
QLGVDESYTLMVS R3 NA NA
PAILSVEDSKGNT A2 0.00 -0.03
TSVIGIDSSLPAL A2 NA NA
ASILNPEESWKLC A3 0.00 -0.03
AEILEVEEEGMSI A2 NA NA
EGELDLTSDPWPQ B2 NA NA
EIRERDGLFLMLQ R1 0.87 NA
ACLSSSSVKVIKI R2 0.02 -0.03
GCLVDLYARAGRL B2 0.40 NA
RNELESDYVIVCF R3 NA NA
NNVVVMDSDSAVK A2 0.00 0.07
TTMLSLSEDQHII A2 0.00 -0.01
RVNIEDDLSVLGN R2 NA NA
SDVWDLTLRSHEL B2 0.06 -0.01
YRYVDLTVINGNV B1 NA NA
PCLVPLGTSSIEN A1 NA 0.30
SDKADSRIGLVIG R1 0.28 0.44
LKAYDLTNLSEFL B1 0.13 0.00
AVFIPIEEEEDCP A3 NA NA
STAVSDSVLLLFG R2 0.74 NA
LKVLVVGGGDGGV A1 0.05 -0.01
RVLLNICQEAFEG A1 NA NA
LNTIDLSSNNFEG B4 NA NA
YSVVVVNKENANG A1 0.42 0.12
WALPEDELILLAI R2 0.19 NA
ETTIDLSAKNNRG B3 0.00 NA
NLLVDLYEDCCNG B1 NA NA
NRFYGLSSSSSSS A3 0.76 0.48
FPLPDLTVTHENV B2 0.00 -0.03
DWKYDLFPNPNFA B3 0.56 -0.04
FGNHTEEVRLVWK R1 0.00 0.01
PHFADLTSLRVID B2 0.21 0.00
NIYVDEDMYILRD R1 NA NA
WKELDLESKIPNY B4 0.00 -0.02
SSLIDLYCKCGFV B1 0.00 -0.01
MIVMAPSDEAELF A3 NA NA
EAPNEEEVQLLLE R2 NA NA
VPIILVSSSSMAY A2 0.87 NA
ISLSEDSVDVLED R2 NA NA
TSLITLRSNNIKE A1 1.00 NA
STSIDLTRFMIQT B1 0.98 NA
LGVLKVDESLRAE A2 0.02 0.05
VRLWDLYTETPLF B2 0.00 -0.02
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FDLRSESFTFIGL R3 0.75 NA
LVAKEDEIKMLKA R2 0.00 -0.01
FGVYDLTTKTCTM B1 0.00 0.00
EKFLDLTVSVICK B2 0.00 0.01
YHKKQETLKILRQ R1 0.49 NA
MYTIDLYDMTFRE B1 0.05 0.00
FYVCDLEMLPCVL B4 NA NA
DVMVILDNHKTVP A1 0.00 -0.01
AHQVDLYLLSQVA B1 0.11 0.01
KSPLSLSDDEYVQ A2 0.00 0.00
SSVIDSDMVLLLD R1 NA NA
SCLVTPSSEETND A3 NA 0.32
KVEMDLYLVRKLV B4 0.06 0.01
VGRADLTLSGSFA B2 NA NA
FWSHDEDPSPLPP R3 0.00 0.00
KIIARKNLELVKW R1 0.00 -0.02
LFYFDSSYRPVPL R3 0.17 0.06
CPFFKMEEDHERI A3 0.00 NA
TAMLKMEEEFVDS A3 0.00 0.00
LESLQREVELLEQ R1 0.00 -0.01
VKVWDLTAGKLLT B4 0.00 0.01
LSRYDLFHGHLFL B3 0.76 0.01
SIDGSDSLNYVNE R3 NA NA
DIPPDISDSDKYF A3 0.00 -0.01
KMLIFLSESQSRQ A3 0.39 0.10
SHMLDVEDDFEAF A3 0.00 -0.01
VELLNMDDDDDGD A2 NA NA
LQVVDLYSNAISG B1 NA NA
TELPPLSESGLDW A3 NA NA
QTVFRPDDDVVIQ A3 NA NA
DDPFALESSTAGL A3 NA NA
GSKADLFLEPGDK B4 0.01 -0.01
LSLLSLKTSLSGP A1 0.58 0.09
FLSGHQTLQLMRK R1 0.54 NA
LTLMYLKTESEVI A1 0.05 0.01
GSLSSSDLPLLRP R3 0.00 0.01
ATSDSSEPDLLWQ R3 NA NA
RLANDDDIMLLDW R2 NA NA
GRAIDLTRSECYE B1 0.00 0.03
IPLVVVETRREVD A1 0.04 0.00
IEFMDLYSYLIPV B4 NA NA
FILVCSSLDVLPH R1 0.00 0.30
HHGHDEELHVLAV R3 0.00 -0.01
KRKVDLTNDDVEG B1 -0.01 0.00
FEESSESPPPMPN R3 NA NA
SLSVDLTTDAPNK B1 0.01 0.05
WAEVEDSLIVINQ R2 NA NA
EYAEEEDMVLVDW R3 NA NA
CVRADLTDKCEAH B2 0.00 -0.01
TPVIDLETVSGCD B4 0.45 NA
LNIVCLCGHIFCW A1 0.00 -0.02
IQRFDLTNINSAI B2 0.68 0.11
IPLLQLSDSPRII A2 0.51 0.03
DGFVDSDPIPIPI R3 NA NA
NSTIDLTKDPGHV B2 0.01 -0.01
GTATSSELNLIDS R2 0.00 -0.02
LHMFVWSSSASPV A3 0.00 0.03
CGECDLFSMNEVL S1ref753 0.39 0.28
GQKLNGSISVLGN R1 0.00 0.07
DRLIDLEGREMQL B4 NA NA
IFWGEDELSMIRC R1 0.00 -0.01
IPLLKERMNVLNP R1 0.45 NA
SFIDSSSLWIVMP R2 NA NA
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EVMIGYSDSGKDA A3 0.00 -0.01
IISLDLSKSGLNG B4 0.01 -0.01
PKFVDIDSDDKDP A3 0.00 -0.01
KQGQGERINLLLE R1 0.47 NA
KKTEENQLALMKP R1 0.00 0.02
VAKASEEWGIFQV R3 0.00 -0.01
MLSEDEEVRLLIS R2 NA NA
VVQKNGGIGLIYV R1 0.10 0.00
GPYLTYEDSFLAI A3 0.16 NA
LQHKNHDLELLCD R1 0.60 0.06
ARRRGRGVSVLSG R1 0.34 NA
RRRRSSSLALVPG R2 0.37 NA
FAVYDLTTRTARH B1 1.00 0.11
YTSQSSSMQILRA R2 1.00 0.68
EERKKKTIVVMLP R1 0.21 NA
IDMVLLDSSGTKI A2 0.00 0.00
KYAGSEEMEVMLV R2 0.00 0.05
KLAREESVILLPG R2 0.03 -0.01
RDEIDLTQKKLPK B1 0.00 0.03
EQVFDLTEVKPHE B4 0.00 -0.01
LFVYDLETASAIY B4 NA NA
RVLPQSSVHIVVT R1 0.84 0.45
KYMIDLEHRIKFL B3 0.50 0.01
LPVIDLSLLHQPF B3 0.80 0.03
LRSVDLSPASWLA B3 0.00 -0.01
MMMMKMESEWVGA A2 0.00 -0.03
SPEIDLTTNSEVT B1 NA NA
LVAPESSVDLVTV R2 NA NA
HRPPPPSSSTSRR A3 0.39 NA
RTMIALEEKGVKY A1 0.00 -0.03
CVPVIISDDIELP A2 NA 0.37
NATVDLSFNNLTG B3 0.48 NA
TQLADLYSSEGLS B2 NA NA
NRKVDLSMSKSKE B4 0.03 0.02
ALFFDLTQAYRHT B2 0.91 0.02
LQSLDLSQNRLSG B4 0.84 0.05
QPKDDSSLRPYSQ R3 0.00 0.16
DRLIAICEDLYAA A1 NA NA
MTLLKVDSEKVNK A2 0.00 0.04
EAIKESRISIVIL R1 0.39 0.07
NSIPSPSDETKDS A3 -0.01 -0.02
LVLISDSVVLIST R2 0.14 NA
VFYVDLSECVVCT B3 0.53 -0.02
VAVVAMKEEDAGE A1 0.00 -0.02
IMIVLLEESEDVQ A2 NA 0.24
AFEKEDSVHIIDL R2 0.00 -0.01
VSRCDSSVSVFSA R3 NA 0.73
KKVVALESEIVEL A2 -0.01 -0.01
GLLVHIEDSHLTR A2 0.00 0.10
SDAVDLYEAMEKT B1 0.00 -0.01
DSPLLLSSSHSLI A2 0.13 0.00
FKTGENCMEMVNF R1 0.00 0.03
MTFASDSMKLVVT R3 0.00 -0.02
QGQPDLDIHRIRN B4 0.32 NA
SKMMIVDDEYIII A2 0.02 0.03
KLIFDIEEEPLQG A3 0.10 0.04
LENKKRNVSVLRE R1 0.01 NA
VSELDLYSPEEEI B2 NA NA
KKKLEEEVTILRS R2 0.09 NA
AKAVDLTGKAPKS B1 0.00 0.21
FDIYDLELTAVNN B3 NA NA
KSLVGMKKTLVFY A1 0.03 -0.01
LNLVMLCQGVYDF A1 0.00 -0.01
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EVKCSEDIGLIGV R2 -0.01 0.37
TALLDLYAKCGMI B2 0.01 -0.01
RYSPDLTMFASGD B2 NA NA
SAVIPYEESGWYD A3 NA NA
WSMIDLYELIGRY B1 0.05 -0.01
EKIVDIREEILRK A1 0.30 NA
YNIWNVSSDDDDE A3 NA NA
AFADSSDVLLMIC R2 NA NA
QHLADLSFINRGG B4 0.17 NA
ELPMREELGLMYV R1 -0.01 -0.01
PELYEEDYNVLVD R3 NA NA
ERPISVEEEESGF A2 NA NA
KQIIDLYDQISKL B1 0.10 0.02
RRECDLDEKDVFL B4 0.01 0.98
MNFKSSSIVVMKA R2 0.02 0.03
VSSPDLTKEVLLT B2 0.01 -0.01
FIDEDEKVAVVFD R1 0.88 -0.01
GASIDLEVCLPPE B3 NA NA
PAVLRLEDESRVL A2 0.00 -0.01
FQGGEEDIIIIST R3 0.15 NA
PVPLDEEVKLMIT R3 0.00 0.01
WKKVDLTKIGIPS B3 0.16 0.02
SLLLLISTSVTTS A1 0.79 NA
INGTEEEVDLLRE R2 -0.01 -0.01
FLQFDSDLTLIDP R3 NA NA
SGYLDLYQRLRNR B2 0.91 NA
RWYLKPDDSSIFF A3 0.05 0.01
VEADDDSVQMLDN R2 NA NA
NFKVSEEYGYPKN R3 0.00 0.03
GSKVDLSDASMKG B3 0.00 -0.01
REEWEESIKVYTE R3 0.00 0.00
GPPLRVSSSQFPD A2 NA NA
VFIVHMSSSLAST A2 0.18 0.01
TKDPSESMPVMVF R2 0.00 -0.01
GIAVDLSDESAYA B3 NA NA
QHLSEDELQLLCE R2 0.33 0.00
FHQIDLYGKLLGL B4 0.85 0.00
EGVVVVDSEEIRR A2 0.00 NA
LNVYDLTPVNNYL B3 NA NA
ESVPDRKVVILGA R1 0.02 0.02
PDIFDLTVAKPSN B2 0.00 0.00
DAILNIRKSYGFP A1 0.96 NA
KETVDLENVPIEE B3 0.00 -0.02
KNLVGVSDESYRL A2 0.00 -0.01
APVSDDEVVPVED R3 NA NA
ANLVVMDDCELQG A1 0.20 NA
GGLVVLTGTAVVA A1 0.58 NA
QAMIDLDKTEKKS A1 -0.01 0.00
GEKDESELLVVVG R3 0.02 -0.01
IVAIDSEIYVLGG R3 NA NA
EICDSETVGIIMS R1 NA 0.67
KVPVRLSESVKLW A2 0.14 0.01
SPRVEESMSVVNN R2 NA NA
TFDSEESVDMVLH R2 -0.01 -0.02
LLAVDLTDYCYRV B1 0.00 -0.02
SLDASSDLFILNK R2 0.10 0.03
LDELDLTDCLVLK B2 0.06 0.02
YTDDEDDMMMVGD R2 NA NA
KALLGLEEDDLNG A2 0.00 -0.01
YAEYDLYEIIRHH B1 0.03 0.00
VDVYDLEDKMLFL B3 0.00 0.00
AIYPDLTKNIEAF B2 0.00 0.00
QAFGEDELAYLPD R3 NA NA
181
APPENDIX B. SIM PEPTIDE ARRAYS
Peptide Class AtSUM1 HsSUM1
FAFVYMEDERDAE A3 NA NA
SVILDLTALYGIA B4 0.13 NA
GDSFDLYYGLFLY B2 NA NA
GFYVQISDSLNST A3 NA NA
RTFVDLSTATMIV B4 0.23 0.05
DKQADLYLDARPN B2 -0.01 0.02
EWSLDSDYLLVGS R3 NA NA
ASPNEEELVVVGC R2 NA NA
TRADNSKMTLMHY R1 0.00 -0.01
MVLMLPSDSARQW A3 -0.01 -0.02
TCLISEELDFLKS R3 0.00 0.12
LRLIGVEDSVGID A2 NA NA
PMMLQLGSGNEGN A1 NA NA
TSMIEFDSSESCE A3 NA NA
HPLMLVESESLTD A2 NA NA
SQPLPISSENKES A2 0.00 -0.01
TTLIDLYVKCGCL B1 0.01 -0.03
FGYTRKDVILIGV R1 0.62 0.13
RPVSEDEVALMAK R2 -0.01 0.01
GSNESSSMSIVMY R2 NA NA
DTVFDLTTAISKL B4 0.06 0.10
FDLQSEEMNLLKE R2 0.00 -0.01
GCSSSNTISLLLL R1 0.72 NA
VMIMDVEKKGSII A1 0.00 0.00
NQSVDLSSASDGN B4 NA NA
MNIASSSLPIPHN R3 0.00 -0.01
SYLVTLSQQSGNV A1 0.93 0.15
KCIIELTKDGDLR A1 0.00 0.38
LPPSESEFIVFKL R3 0.36 NA
MREHSSDLFMMTL R3 0.00 0.00
ILTRDEELGVISD R2 NA NA
WAFIDLTAGPFSW B1 NA NA
ETQPEDSVHLVTW R1 0.00 -0.01
SCLLESEVRILPD R2 NA 0.91
TLVMDLTLCLSSI B2 NA NA
NDQNESSMLILQE R1 NA NA
RQIYDLYGEEGLK B2 0.03 -0.01
GGIVDLEDIAGKA B3 0.00 -0.01
LSLLLLSSSFSSV A2 0.70 NA
ILTLDLFSQLAPV B4 0.63 NA
IDEDESSLELIQI R3 NA NA
GKLLDLSDDPLWT A3 0.00 -0.01
SEAVDLESVAVHE B3 0.00 -0.01
EKALDLYYKMLNS B2 0.47 0.00
QKKLDLTKDGAVS B4 0.00 0.03
TGQDSSSVSIMNP R2 NA NA
KHWIDLTRILPLS B1 0.93 0.12
KAEARDQMPLVIQ R1 0.00 0.00
ALALDLFRKMEER B4 0.88 NA
QDLMSLDDDILDF A2 NA NA
IAKQEEDIGFYAG R3 0.08 -0.01
LSRSSDDWQYMGI R3 NA NA
IYMLPLGKGVSKA A1 0.15 0.02
GKVGEDEFGYMLA R3 -0.01 -0.01
IDVFDYSDEDDRV A3 0.00 -0.01
AYILYLEESLRGL A2 0.00 NA
SVLLRVKEDHDGA A1 0.00 -0.01
DYHVDLESRLGKT B4 0.00 0.00
RVLAKRGVRVVMA R1 0.71 NA
RDVREEEITLMMA R2 0.00 -0.01
DRLLAMSEDDLPY A1 NA NA
EKEKDDDVNIVIH R2 0.01 0.00
EGFLDLTDVDIRL B2 0.61 NA
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ELLEKQQVFIVEG R1 0.00 -0.01
FGYSSEDVQMVIE R2 NA NA
YLIMSIGESCDPV A1 NA NA
TGVFGPSSSSTNA A3 NA NA
CSSKSEGLNLLIY R1 0.00 0.39
GRIVNLSSEAHRF A2 0.31 NA
SWMMHVSSSLRLL A2 1.03 NA
ETRSSSSMALITV R2 0.42 0.07
QRSVDLYEDLIRC B3 -0.01 -0.02
STPVALDDSSYSF A2 NA NA
LYMYDDEVPIPRK R3 0.00 0.08
TTLVDLYAKCGDM S1ref779 0.00 -0.01
VVVADLTKSKETT B2 0.00 -0.02
LNVYDLTPMNVYG B1 NA NA
TPSIDLSVRKPSQ B3 0.02 NA
AGIKEDDLLIMSD R2 0.01 0.00
IPILPVEDDDIAM A3 NA NA
FAKPHKEVPMIFG R1 -0.01 -0.01
VPILAVDSDGLVN A3 0.71 NA
SLEIDLTRGKSVN B1 0.01 NA
FSYFHNGVHVVSE R1 0.03 0.01
HETGSTEIVVLCH R1 0.00 0.00
LCLESDEVKMIGI R3 -0.01 0.65
LAERTGHVMLLHL R1 0.19 -0.01
RLVIIIGCSVLGF A1 0.01 0.00
NWMKEDSLLFVHY R3 0.39 -0.01
IKVSSSELSVLDE R3 -0.01 -0.01
KHLVDLEMKLQIA B3 0.00 0.00
VPAVSNGLIILYV R1 0.52 NA
HPLLSLSSSPSSV A2 NA NA
GFPPFYSEEPLAT A3 NA NA
TYVIGLEDEEENK A2 0.14 0.09
NKEADLEPGLDKA B4 -0.01 -0.02
ELSGSSSLSVVFL R2 0.72 NA
LLMEEDEIDFVAD R3 NA NA
QETKESDIKILRK R3 0.04 0.05
KTSLSSSLMLVRL R2 0.89 NA
LIGFSSSYSFVNF R3 0.94 0.21
QQQVDLYDQHLAS B4 -0.01 -0.01
PYVIKISRHHHRI A1 0.60 NA
NKILTVNGEFPGP A1 -0.01 -0.01
IDEVEEDMSLIGS R1 NA NA
DQVLHISTSPLHR A1 0.36 0.04
DFLVEISDSNQTR A2 1.02 NA
LKIIDLYVVFAVF B3 0.65 0.09
YFRWDLYPYYRAF B4 0.86 0.03
VTLADLTKKLKDW B2 0.00 -0.01
EDEDEDDIPLVFK R3 0.00 0.03
KYVLFLDDDVRLH A3 0.04 0.01
EKVLEMEDSLESG A2 -0.01 -0.01
AEVLGISSDSTII A2 NA NA
SSLILIKSEVAQS A1 0.75 0.00
LSSQDSEPKPVNN R3 -0.01 -0.01
LKIREEDLCVLVE R2 -0.01 0.03
AAFVDLTPWHRFG B1 0.43 NA
VWSEEDEISLLQA R2 NA NA
DGVISIESSSTSE A2 NA NA
MDEDEEEFELWLQ R3 0.00 -0.01
STIVDLTKVGKYK B1 0.00 -0.01
FGFYDLTTGEAHH B1 0.00 0.00
RILPRPSDSVLKY A3 0.40 0.05
HLFAESELRILID R2 0.10 0.01
LVLESSDLMLMGF R2 NA NA
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KIKESEDISILKA R2 0.00 0.00
FYCLDLTLLLMGA B2 NA NA
IRRYDLTQDPLHS B3 0.06 0.04
LETLDLSNNLALQ B4 NA NA
PLNPSENLLLLLQ R1 0.76 NA
IPEVDLYKCEPWD B1 -0.01 -0.02
RSPVLMSSSVFAL A3 0.96 0.16
SSQVDLDNIDETE B3 NA NA
FAIWIMSSSQDDS A3 0.07 -0.01
IVLIAVGNEITSF A1 NA NA
VEIYDLEENLVID B3 NA 0.35
EKPLVIEDEQVIL A3 -0.01 -0.01
VHIIDLDIMQGLQ B3 0.06 0.09
QPQIDLTSNSGEY B1 NA NA
IGVVVVSDENGEP A2 NA NA
VTPVDLFYKRNHG B3 1.06 0.01
KRLVMMGDDTWTQ A1 0.04 -0.01
LPVIDLYRNIEHE B3 0.00 -0.01
QSPIDLTDERVSL B3 NA NA
KRFVDEELVLVGT R2 0.04 0.00
IPTIDLEEVNDQI B3 0.00 0.36
AYGYSDEYSFVFK R3 0.31 NA
KLPTRGSMKIIVK R1 0.16 0.03
ISLYAISEERLPN A3 0.02 0.04
VAPPSSSPMIVQK R3 0.00 0.00
LVYIDLTSERLYK B1 0.02 0.03
GQFVDLTRKLHTL B1 0.96 NA
QRLMQLQQQQLLK A1 0.14 NA
TEKYDLSSIRVVK B3 0.99 NA
PSIADLDMDTYDK B4 0.00 -0.01
HQVITVEENSAEH A1 0.00 0.00
VQPIDLSGVGVPE B3 NA NA
KMIVLMSSDGQSF A2 0.00 -0.01
RGRFSESLQLYKR R3 0.98 NA
MRDMQDQLGILVR R1 0.32 NA
SRSSESSVNILCL R2 0.00 0.00
PLPVMYSSSLKRL A3 1.00 0.10
IEKVDLSAKLTGQ B4 0.00 -0.01
NVEDEDSIKIVET R2 0.00 -0.01
LFILFVSTGRVIA A1 0.74 0.34
QLPLDSSVVLVRD R1 0.00 0.00
TSSCDLYRACGPF B2 0.00 -0.02
PVIFSTNWLLVIN lat62-1 NA NA
KCLLKQVLLEDDM lat12-1 0.00 0.24
GELLKIKSEKLPK A1 0.01 0.05
PGLFDLSVSAEpYI B4 NA NA
PGLFDLpSVSAEYI B4 NA NA
PGLFDLpSVSAEpYI B4 NA NA
PGLFDLpSVpSAEYI B4 0.14 NA
PGLFDLpSVpSAEpYI B4 NA NA
PGLFDLSVSAEYI B4 0.37 NA
EKASGKKIPLVMA R1 0.00 0.03
EKApSGKKIPLVMA R1 0.00 0.09
FKCIDLDGDGVIT B4 0.01 0.48
FKCIDLDGDGVIpT B4 0.00 0.71
ISPIFISGGCEWF A1 0.00 -0.06
IpSPIFISGGCEWF A1 0.00 -0.05
ISPIFIpSGGCEWF A1 0.00 -0.07
IpSPIFIpSGGCEWF A1 -0.01 0.02
RALADLFLLpSNQR B4 0.10 NA
RALADLFLLSNQR B4 1.10 NA
LQKLDLSNNRLTG B4 0.01 NA
LQKLDLpSNNRLTG B4 0.00 NA
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LQKLDLSNNRLpTG B4 0.00 -0.02
LQKLDLpSNNRLpTG B4 0.00 0.00
ASPLTIRSRLEEE A1 0.03 0.00
ASPLpTIRSRLEEE A1 0.00 0.00
ASPLTIRpSRLEEE A1 0.00 -0.02
ApSPLpTIRSRLEEE A1 0.04 0.00
ASPLpTIRpSRLEEE A1 0.00 -0.01
ApSPLpTIRpSRLEEE A1 0.00 -0.02
SNEPDLTPALLGP B4 0.00 -0.02
pSNEPDLTPALLGP B4 NA NA
SNEPDLpTPALLGP B4 NA NA
pSNEPDLpTPALLGP B4 NA NA
DVFSENKIDLLPL R1 0.00 -0.02
DVFpSENKIDLLPL R1 0.00 -0.01
LGMIYVGSCNEEV A1 NA NA
LGMIpYVGSCNEEV A1 NA NA
LGMIYVGpSCNEEV A1 1.05 0.22
LGMIpYVGpSCNEEV A1 0.15 NA
ILLLFISSQVAIA A1 0.59 0.03
ILLLFISpSQVAIA A1 0.06 -0.02
ILLLFIpSpSQVAIA A1 0.01 -0.03
ILLLFIpSSQVAIA A1 0.01 -0.05
NLNSDKRLRLLSS R1 0.38 NA
NLNSDKRLRLLSpS R1 0.00 NA
NLNSDKRLRLLpSpS R1 0.00 NA
NLNpSDKRLRLLSpS R1 0.01 NA
NLNpSDKRLRLLpSpS R1 0.00 NA
NLNpSDKRLRLLSS R1 0.73 NA
SVEFDLDKTKRLL B4 0.00 NA
pSVEFDLDKTKRLL B4 0.00 NA
pSVEFDLDKpTKRLL B4 0.01 NA
SVEFDLDKpTKRLL B4 0.00 0.51
DLVLDLSAISEAG B4 0.45 -0.01
DLVLDLpSAISEAG B4 0.00 -0.03
DLVLDLpSAIpSEAG B4 0.60 -0.02
DLVLDLSAIpSEAG B4 0.03 -0.01
PQLLLIDTGSDLT A1 0.00 -0.02
PQLLLIDTGSDLpT A1 0.00 -0.02
PQLLLIDpTGSDLT A1 0.00 0.00
PQLLLIDpTGSDLpT A1 NA NA
KPLLFLSSSSSFS LAT17 0.81 0.11
KPLLFLSSSSSFS LAT17 0.81 0.03
FEILDLTIGEWRT LAT1 0.26 NA
PQLLLIDpTGpSDLT A1 NA NA
PQLLLIDpTGpSDLpT A1 NA NA
LFRFDLEAKCPPS B4 0.01 -0.02
LFRFDLEAKCPPpS B4 0.01 -0.02
LSPVIVQTSRWAN A1 0.80 0.00
LSPVIVQTpSRWAN A1 0.05 0.32
LSPVIVQpTSRWAN A1 0.06 0.39
LSPVIVQpTpSRWAN A1 0.00 NA
LpSPVIVQTpSRWAN A1 0.00 NA
LpSPVIVQpTpSRWAN A1 0.00 NA
LETMDLTEILRQK B4 0.00 NA
LEpTMDLTEILRQK B4 0.00 NA
LEpTMDLpTEILRQK B4 0.00 NA
LETMDLpTEILRQK B4 0.00 NA
GLKWDLSNTEMRF B4 0.00 -0.05
GLKWDLpSNTEMRF B4 0.00 NA
GLKWDLpSNpTEMRF B4 0.00 NA
GLKWDLSNpTEMRF B4 0.00 0.01
GLLLCVTKEDNIR A1 0.00 0.46
GLLLCVpTKEDNIR A1 0.00 0.17
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ASYYDLSFHSISS B4 0.09 0.09
ASYYDLSFHSIpSS B4 0.70 0.15
ASYpYDLSFHpSISS B4 0.00 0.00
ASYpYDLSFHSISpS B4 0.00 -0.02
ApSYYDLpSFHSISpS B4 0.20 0.04
ASYYDLSFHpSISS B4 0.81 0.34
ESIVKIGEGTYGE A1 0.00 -0.02
KPLLFLSSSSSFS LAT17 0.85 0.13
FEILDLTIGEWRT LAT1 0.33 0.02
KPLLFLSSSSSFS LAT17 0.56 0.04
EpSIVKIGEGTYGE A1 0.00 -0.01
EpSIVKIGEGpTYGE A1 0.00 0.01
ESIVKIGEGpTpYGE A1 0.00 -0.02
EpSIVKIGEGpTpYGE A1 0.00 -0.02
ESIVKIGEGTpYGE A1 0.00 -0.03
TKIEGQNLVVLGD R1 0.00 -0.03
pTKIEGQNLVVLGD R1 0.00 -0.05
KSPVWLKNDIERR A1 0.00 NA
KpSPVWLKNDIERR A1 0.03 NA
DRVLALQGNGSVN A1 0.00 -0.08
DRVLALQGNGpSVN A1 0.00 -0.11
AEEVDLSTDVQQW B4 0.01 -0.10
AEEVDLpSTDVQQW B4 0.00 -0.09
AEEVDLpSpTDVQQW B4 0.00 -0.09
AEEVDLSpTDVQQW B4 0.00 -0.06
GGHCDLELYPDFI B4 0.00 -0.02
GGHCDLELpYPDFI B4 0.00 0.00
YSVPDLDMLSVPD B4 0.82 -0.03
YpSVPDLDMLSVPD B4 0.00 -0.03
YSVPDLDMLpSVPD B4 0.86 -0.02
pYpSVPDLDMLSVPD B4 0.00 -0.03
pYpSVPDLDMLpSVPD B4 -0.01 -0.03
YpSVPDLDMLpSVPD B4 -0.01 -0.02
ITLLSLGSGEAPL A1 0.04 -0.01
IpTLLSLGSGEAPL A1 0.00 -0.04
ITLLpSLGSGEAPL A1 0.01 -0.02
ITLLpSLGpSGEAPL A1 NA NA
IpTLLpSLGSGEAPL A1 NA NA
IpTLLpSLGpSGEAPL A1 NA NA
LIPVSVKEGDNVL A1 0.00 -0.02
LIPVpSVKEGDNVL A1 0.00 -0.02
MDMKEKKLTVIGT R1 0.00 0.02
MDMKEKKLpTVIGT R1 0.00 -0.02
MDMKEKKLTVIGpT R1 0.00 -0.01
MDMKEKKLpTVIGpT R1 0.00 -0.01
WSGGKTEVRLLFF R1 0.35 0.12
WSGGKpTEVRLLFF R1 0.72 0.09
WpSGGKpTEVRLLFF R1 0.82 0.06
WpSGGKTEVRLLFF R1 0.31 NA
LSLLRLGSTREPN A1 0.71 NA
LSLLRLGpSTREPN A1 0.01 NA
LpSLLRLGSTREPN A1 0.88 NA
LpSLLRLGSpTREPN A1 0.01 NA
LpSLLRLGpSpTREPN A1 0.00 NA
LpSLLRLGpSTREPN A1 0.03 NA
FELLDLSQPNFNN B4 0.00 0.04
FELLDLpSQPNFNN B4 -0.01 -0.02
PEPLRVGEKKEYD A1 0.00 -0.03
PEPLRVGEKKEpYD A1 0.00 -0.03
KKVVMVSEGFKHR A1 0.00 NA
KKVVMVpSEGFKHR A1 0.00 0.15
MTSFDLSILHIQI B4 0.04 -0.01
MTSFDLpSILHIQI B4 0.59 0.03
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MpTSFDLSILHIQI B4 0.18 -0.02
MTpSFDLpSILHIQI B4 0.77 0.04
MpTpSFDLpSILHIQI B4 0.87 0.13
MpTSFDLpSILHIQI B4 0.67 0.14
TGLMGMNRGSLSF A1 0.00 NA
TGLMGMNRGSLpSF A1 0.00 -0.01
pTGLMGMNRGSLSF A1 0.00 NA
TGLMGMNRGpSLpSF A1 0.00 -0.01
pTGLMGMNRGSLpSF A1 0.00 -0.01
pTGLMGMNRGpSLpSF A1 NA NA
pSMLFDLSRPARDL B4 0.16 NA
SMLFDLpSRPARDL B4 0.00 NA
pSMLFDLpSRPARDL B4 0.00 NA
SMLFDLSRPARDL B4 0.47 NA
NMPLLVHGEVTDP A1 0.00 -0.05
NMPLLVHGEVpTDP A1 0.00 -0.05
ENHLQHSLTIIPK R1 0.00 NA
ENHLQHpSLTIIPK R1 0.00 NA
ENHLQHSLpTIIPK R1 0.00 NA
ENHLQHpSLpTIIPK R1 0.00 NA
DTLVKMKNTVLHQ A1 0.00 -0.04
DpTLVKMKNTVLHQ A1 0.00 -0.01
DTLVKMKNpTVLHQ A1 0.00 0.02
DpTLVKMKNpTVLHQ A1 0.00 -0.02
SNTPTRSLSLISV R1 0.00 0.03
pSNTPTRSLSLISV R1 0.04 0.05
SNTPpTRSLSLISV R1 0.05 0.11
SNTPTRSLpSLIpSV R1 0.00 0.06
SNpTPpTRpSLSLISV R1 NA NA
SNTPpTRSLSLIpSV R1 0.00 -0.01
SVLLDLRSGAKRA A1 0.02 NA
pSVLLDLRSGAKRA A1 0.13 NA
SVLLDLRpSGAKRA A1 0.04 0.53
pSVLLDLRpSGAKRA A1 0.01 NA
SEVIHLKEQLYEA A1 0.00 -0.03
pSEVIHLKEQLYEA A1 0.00 -0.03
SEVIHLKEQLpYEA A1 0.00 -0.02
pSEVIHLKEQLpYEA A1 0.00 -0.01
TGFLSRDVRLLSD R1 0.07 0.11
TGFLSRDVRLLpSD R1 0.00 -0.01
pTGFLSRDVRLLSD R1 0.05 0.10
TGFLpSRDVRLLpSD R1 0.00 0.03
pTGFLSRDVRLLpSD R1 0.01 0.02
pTGFLpSRDVRLLpSD R1 0.00 -0.01
GERLDLYEAARGK B4 0.00 0.32
GERLDLpYEAARGK B4 0.00 NA
KFILEKSVFLVVS R1 0.74 0.05
KFILEKSVFLVVpS R1 0.01 -0.03
KFILEKpSVFLVVpS R1 0.04 -0.04
KFILEKpSVFLVVS R1 0.63 0.01
HKVLHLNRTDTRL A1 0.21 NA
HKVLHLNRTDpTRL A1 0.07 NA
HKVLHLNRpTDpTRL A1 0.00 NA
HKVLHLNRpTDTRL A1 0.00 NA
LSIMAVCTSNERR A1 0.00 0.87
LSIMAVCpTSNERR A1 0.00 NA
LSIMAVCTpSNERR A1 0.01 NA
LpSIMAVCpTSNERR A1 0.01 NA
LpSIMAVCTpSNERR A1 0.00 NA
LpSIMAVCpTpSNERR A1 0.00 NA
CVLLLLSSHDNSR A1 0.01 NA
CVLLLLSSHDNpSR A1 0.00 NA
CVLLLLSpSHDNpSR A1 0.00 NA
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CVLLLLpSSHDNpSR A1 0.01 NA
CVLLLLpSpSHDNpSR A1 0.00 0.84
CVLLLLSpSHDNSR A1 0.00 0.54
QSELDLSYGQRYQ B4 0.18 -0.01
QSELDLSYGQRpYQ B4 0.00 0.01
QpSELDLSpYGQRYQ B4 0.01 NA
QSELDLpSYGQRpYQ B4 0.00 0.01
QpSELDLpSpYGQRYQ B4 0.01 NA
QpSELDLSYGQRYQ B4 0.13 -0.01
AQLLEISESKVSQ A1 0.00 -0.02
AQLLEIpSESKVSQ A1 0.00 -0.03
AQLLEISEpSKVSQ A1 0.00 -0.01
AQLLEIpSESKVpSQ A1 0.00 -0.03
AQLLEIpSEpSKVSQ A1 0.00 -0.02
AQLLEIpSEpSKVpSQ A1 0.00 -0.03
RAIRESRIAVVVL R1 0.12 0.09
RAIREpSRIAVVVL R1 0.14 0.00
ELVMAIEEEFSIE A1 0.00 -0.03
ELVMAIEEEFpSIE A1 0.00 -0.01
LHELDNSVDIINQ R1 0.00 0.03
LHELDNpSVDIINQ R1 0.00 -0.01
AIVLDVGSGSVCH A1 0.03 -0.01
AIVLDVGpSGSVCH A1 0.57 0.01
AIVLDVGSGpSVCH A1 0.99 0.01
AIVLDVGpSGpSVCH A1 0.99 0.05
RKTFDLSYYQLVL B4 0.05 0.01
RKpTFDLSYYQLVL B4 0.03 -0.01
RKTFDLSYpYQLVL B4 0.02 -0.05
RKTFDLpSYpYQLVL B4 0.04 0.01
RKpTFDLSpYpYQLVL B4 0.00 0.03
RKTFDLpSpYYQLVL B4 0.26 0.10
LPQLDLFKSEIMS B4 0.26 -0.03
LPQLDLFKpSEIMS B4 0.00 -0.02
LPQLDLFKpSEIMpS B4 0.00 -0.03
LPQLDLFKSEIMpS B4 0.00 -0.02
EVGPETNVLVMGA R1 0.00 -0.01
EVGPEpTNVLVMGA R1 0.00 -0.03
FVVVVLSENYPTS A1 0.00 0.00
FVVVVLSENYPTpS A1 0.00 -0.02
FVVVVLSENpYPTS A1 0.00 -0.03
FVVVVLpSENYPTpS A1 0.01 -0.01
FVVVVLSENpYPTpS A1 0.00 -0.02
FVVVVLpSENpYPpTS A1 0.00 -0.02
PEMWDLFRREMIpS B4 0.02 0.09
PEMWDLFRREMIS B4 0.16 0.04
TILIDLDTKQVIE A1 0.11 0.06
TILIDLDpTKQVIE A1 0.00 -0.02
pTILIDLDpTKQVIE A1 0.00 -0.02
pTILIDLDTKQVIE A1 0.59 0.05
LRRLDLENVTKCL B4 0.00 -0.02
LRRLDLENVpTKCL B4 0.00 -0.03
IIKGTEKVLLIQE R1 0.00 -0.03
IIKGpTEKVLLIQE R1 0.00 -0.03
SPVESGRLAILAS R1 0.03 -0.02
pSPVESGRLAILAS R1 0.03 -0.02
SPVEpSGRLAILApS R1 0.00 -0.02
pSPVEpSGRLAILAS R1 0.01 -0.02
pSPVEpSGRLAILApS R1 0.00 -0.01
SPVEpSGRLAILAS R1 0.10 0.02
LCLVPMENTVGVA A1 0.00 0.17
LCLVPMENpTVGVA A1 NA 0.27
GKKMDLTYSVQWI B4 0.00 -0.04
GKKMDLpTYSVQWI B4 0.00 -0.03
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GKKMDLTYpSVQWI B4 0.00 -0.02
GKKMDLpTpYSVQWI B4 0.00 -0.02
GKKMDLpTpYpSVQWI B4 0.00 -0.02
GKKMDLTpYpSVQWI B4 0.00 -0.03
GELLKIKpSEKLPK A1 0.00 0.06
LAQLDLSYNKLTG B4 0.00 -0.01
LAQLDLpSYNKLTG B4 0.00 0.14
LAQLDLpSYNKLpTG B4 0.00 -0.01
LAQLDLSpYNKLpTG B4 0.00 -0.02
LAQLDLpSpYNKLpTG B4 0.00 -0.02
LAQLDLSYNKLpTG B4 0.00 -0.01
AKILGVDSRKSCV A1 0.00 -0.02
AKILGVDSRKpSCV A1 0.00 -0.02
AKILGVDpSRKpSCV A1 0.00 -0.02
AKILGVDpSRKSCV A1 0.00 -0.03
YLPPDLESEILSR B4 0.00 0.01
YLPPDLESEILpSR B4 0.00 NA
pYLPPDLESEILSR B4 0.00 -0.02
YLPPDLEpSEILpSR B4 0.00 NA
pYLPPDLEpSEILSR B4 0.00 -0.01
pYLPPDLEpSEILpSR B4 0.00 NA
DKVIDLSKDEKIE B4 0.00 0.28
DKVIDLpSKDEKIE B4 0.00 -0.03
AQLpYDLSGVPPER B4 0.00 -0.02
AQLYDLpSGVPPER B4 0.00 -0.02
AQLpYDLpSGVPPER B4 0.00 -0.02
AQLYDLSGVPPER B4 0.00 -0.01
IYIGTCEVGIVSV R1 0.00 0.02
IYIGTCEVGIVpSV R1 0.00 0.57
IYIGpTCEVGIVSV R1 0.00 0.14
IpYIGTCEVGIVpSV R1 0.00 0.62
IpYIGpTCEVGIVSV R1 0.03 0.21
IpYIGpTCEVGIVpSV R1 0.00 0.71
GCELDLSSAKGpYH B4 0.00 0.31
GCELDLpSSAKGYH B4 0.00 0.58
GCELDLpSpSAKGYH B4 0.00 0.42
GCELDLSpSAKGpYH B4 0.00 0.61
GCELDLpSpSAKGpYH B4 0.00 0.57
GCELDLSSAKGYH B4 0.00 0.30
LQTQESNIAIVGD R1 0.00 -0.02
LQTQEpSNIAIVGD R1 0.00 -0.02
LQpTQEpSNIAIVGD R1 0.00 -0.02
LQpTQESNIAIVGD R1 0.00 -0.02
FLAMTDEVRVIIV R1 0.00 -0.01
FLAMpTDEVRVIIV R1 0.00 0.02
PpTILDLFRNLGNV B4 0.00 NA
PTILDLFRNLGNV B4 0.03 NA
NGDDKTDIGMVVI R1 0.00 -0.04
NGDDKpTDIGMVVI R1 0.04 -0.04
GNIIGVDTGGVEK A1 0.00 -0.04
GNIIGVDpTGGVEK A1 0.00 -0.04
QQRLDLpYTSAAGL B4 0.00 -0.04
QQRLDLYpTSAAGL B4 0.00 -0.03
QQRLDLpYTpSAAGL B4 0.00 -0.05
QQRLDLpYpTSAAGL B4 0.00 -0.07
QQRLDLpYpTpSAAGL B4 0.00 -0.04
QQRLDLYTSAAGL B4 0.00 0.16
VETADLSDKALVpS B4 0.00 -0.05
VETADLpSDKALVS B4 0.00 -0.04
VEpTADLpSDKALVS B4 0.00 -0.04
VETADLpSDKALVpS B4 0.00 -0.03
VEpTADLpSDKALVpS B4 0.00 -0.03
VETADLSDKALVS B4 0.00 -0.03
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ADVVVIGSGIGGL A1 0.04 0.01
ADVVVIGpSGIGGL A1 0.00 -0.02
LNLVYICQCNGLP A1 0.02 -0.03
LNLVpYICQCNGLP A1 0.00 -0.03
IVILEIRTEFGHK A1 0.54 0.03
IVILEIRpTEFGHK A1 0.07 0.00
ATLISGTVCLLVE R1 0.00 -0.03
ATLIpSGTVCLLVE R1 0.00 -0.02
ApTLISGpTVCLLVE R1 0.00 -0.02
ApTLIpSGTVCLLVE R1 0.00 -0.02
ApTLIpSGpTVCLLVE R1 0.00 -0.02
ATLISGpTVCLLVE R1 0.00 -0.03
ADVLDLCVDNpYES B4 0.18 0.29
ADVLDLCVDNYEpS B4 0.94 0.37
ADVLDLCVDNpYEpS B4 0.03 0.03
ADVLDLCVDNYES B4 1.07 0.11
VRILRVSNEGRES A1 0.29 NA
VRILRVpSNEGRES A1 0.00 -0.02
VRILRVSNEGREpS A1 0.00 NA
VRILRVpSNEGREpS A1 0.00 -0.03
DKRYDLFRTMSGK B4 0.01 NA
DKRYDLFRpTMSGK B4 0.00 NA
DKRYDLFRpTMpSGK B4 0.00 NA
DKRpYDLFRTMpSGK B4 0.00 NA
DKRpYDLFRpTMpSGK B4 0.00 NA
DKRYDLFRTMpSGK B4 0.00 NA
NpSKWDLTRQIANV B4 0.00 NA
NSKWDLpTRQIANV B4 0.00 NA
NpSKWDLpTRQIANV B4 0.00 NA
NSKWDLTRQIANV B4 0.03 0.06
KRGGGGRIILLTS R1 0.00 0.01
KRGGGGRIILLpTS R1 0.01 0.17
KRGGGGRIILLTpS R1 0.09 0.14
KRGGGGRIILLpTpS R1 0.17 NA
CVLLCVSQRKLQN A1 0.01 0.05
CVLLCVpSQRKLQN A1 0.00 0.02
RVLLHMCETSDLF A1 0.01 0.18
RVLLHMCEpTSDLF A1 0.00 0.23
RVLLHMCETpSDLF A1 0.01 0.31
RVLLHMCEpTpSDLF A1 0.00 0.14
CRSLDLTIISAED B4 0.00 0.22
CRSLDLpTIISAED B4 0.00 0.35
CRpSLDLpTIISAED B4 NA NA
CRSLDLpTIIpSAED B4 0.00 0.75
CRpSLDLpTIIpSAED B4 NA 0.30
CRpSLDLTIISAED B4 0.19 NA
LHFTDHEISLLPR R1 0.29 NA
LHFpTDHEISLLPR R1 0.00 NA
LHFTDHEIpSLLPR R1 0.04 NA
LHFpTDHEIpSLLPR R1 0.00 NA
VDPWDLDTSIPLR B4 0.00 NA
VDPWDLDpTSIPLR B4 0.00 NA
VDPWDLDpTpSIPLR B4 0.00 NA
VDPWDLDTpSIPLR B4 0.00 NA
MPRQHGDLNIIYD R1 0.03 -0.01
MPRQHGDLNIIpYD R1 0.00 -0.03
AVDVTSELFLICL R1 0.00 -0.03
AVDVpTSELFLICL R1 0.00 -0.02
AVDVTpSELFLICL R1 0.00 -0.02
AVDVpTpSELFLICL R1 0.00 -0.03
GSLIVLRKDLGAP A1 0.18 NA
GpSLIVLRKDLGAP A1 0.28 0.20
KIEFDLDLLTLEP B4 0.99 0.00
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KIEFDLDLLpTLEP B4 1.11 0.00
PSPLVVSGQYQDV A1 0.06 -0.02
PSPLVVpSGQYQDV A1 0.00 -0.02
PpSPLVVSGQYQDV A1 0.00 -0.02
PSPLVVpSGQpYQDV A1 0.00 -0.02
PpSPLVVpSGQpYQDV A1 NA NA
PpSPLVVSGQpYQDV A1 NA NA
KELLNMRSSSKRT A1 0.03 0.02
KELLNMRSpSSKRT A1 0.01 0.09
KELLNMRpSSSKRT A1 0.16 0.07
KELLNMRpSSpSKRT A1 0.02 0.12
KELLNMRpSpSSKRpT A1 0.00 NA
KELLNMRSpSpSKRT A1 0.01 0.04
VKTCHGSVSVVVY R1 0.22 0.04
VKTCHGpSVSVVVY R1 0.08 0.18
VKTCHGSVpSVVVY R1 0.00 0.44
VKTCHGSVpSVVVpY R1 0.00 0.63
VKTCHGpSVSVVVpY R1 0.00 0.29
VKpTCHGSVpSVVVpY R1 0.00 0.75
RYLNEDSLRMLLS R1 0.02 NA
RYLNEDSLRMLLpS R1 0.00 0.23
RpYLNEDpSLRMLLS R1 0.00 NA
RpYLNEDSLRMLLpS R1 0.00 0.01
RpYLNEDpSLRMLLpS R1 0.00 NA
RpYLNEDSLRMLLS R1 0.00 -0.01
VEPVRVKTELAEK A1 0.00 -0.02
VEPVRVKpTELAEK A1 0.00 -0.01
CSFFDLYLIYHSF B4 0.00 -0.02
CSFFDLYLIYHpSF B4 0.00 -0.01
CpSFFDLYLIYHpSF B4 0.01 -0.02
CSFFDLpYLIpYHSF B4 0.22 0.01
CSFFDLpYLIpYHpSF B4 0.07 0.02
CSFFDLYLIpYHSF B4 -0.01 0.00
ITSLDLSSSGLTG B4 0.00 -0.02
ITpSLDLSSSGLTG B4 0.00 -0.01
IpTSLDLSSSGLpTG B4 0.00 -0.02
ITSLDLSpSSGLpTG B4 0.00 -0.02
ITSLDLpSpSpSGLTG B4 0.00 -0.02
IpTSLDLSSSGLTG B4 0.04 -0.03
PYVTEDELKLMLR R1 1.14 NA
PpYVTEDELKLMLR R1 0.70 NA
PYVpTEDELKLMLR R1 0.00 -0.01
PpYVpTEDELKLMLR R1 0.00 -0.02
WAVVLLESEPEVL A1 0.00 -0.03
WAVVLLEpSEPEVL A1 0.00 -0.01
VGPVDLSSSAWSN A1 0.00 -0.06
VGPVDLSSpSAWSN A1 0.00 -0.05
VGPVDLSpSSAWpSN A1 0.00 -0.08
VGPVDLpSpSSAWSN A1 0.00 -0.08
VGPVDLpSpSSAWpSN A1 0.00 -0.05
VGPVDLpSSSAWSN A1 0.00 -0.03
ESMADLSLKpTNVP B4 0.00 -0.02
ESMADLpSLKTNVP B4 0.00 -0.02
ESMADLpSLKpTNVP B4 0.00 -0.03
EpSMADLSLKpTNVP B4 0.00 -0.02
EpSMADLpSLKpTNVP B4 0.00 -0.02
ESMADLSLKTNVP B4 0.00 -0.02
EVILCVDNRQNMY A1 0.00 0.00
EVILCVDNRQNMpY A1 0.00 0.08
NFKHSHQISVLVA R1 0.40 -0.01
NFKHpSHQISVLVA R1 0.84 0.01
NFKHSHQIpSVLVA R1 0.31 -0.01
NFKHpSHQIpSVLVA R1 0.08 -0.01
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TDQIDLSKRSDST B4 0.00 -0.02
TDQIDLSKRSDSpT B4 0.00 -0.01
pTDQIDLSKRSDST B4 0.00 -0.02
TDQIDLSKRpSDpST B4 0.00 -0.01
TDQIDLpSKRSDpSpT B4 0.00 -0.02
TDQIDLSKRSDpSpT B4 0.00 -0.01
QGSLDLSAINPNQ B4 0.06 -0.01
QGpSLDLSAINPNQ B4 0.00 -0.02
QGpSLDLpSAINPNQ B4 0.00 -0.03
QGSLDLpSAINPNQ B4 0.00 -0.02
GSTADLTLDIASR B4 0.01 -0.02
GSTADLpTLDIASR B4 0.00 0.19
GSTADLTLDIApSR B4 0.00 0.51
GSTADLpTLDIApSR B4 0.00 0.33
GSpTADLpTLDIApSR B4 0.44 NA
GpSTADLTLDIApSR B4 0.00 0.04
VKLKRESLDLVNA R1 0.00 0.13
VKLKREpSLDLVNA R1 0.00 0.01
VGNQTREIKLLHR R1 0.20 NA
VGNQpTREIKLLHR R1 0.28 NA
LGQFKTCVLLLGN R1 0.00 -0.02
LGQFKpTCVLLLGN R1 0.00 -0.01
LKILDLpSFNKLNG B4 0.03 NA
LKILDLSFNKLNG B4 0.01 NA
DVNNKQQVTVVAE R1 0.00 -0.01
DVNNKQQVpTVVAE R1 0.00 -0.03
SHYYDLETLESSF B4 0.00 -0.01
SHpYYDLETLESSF B4 0.00 -0.01
SHYpYDLETLESSF B4 0.00 -0.02
pSHYpYDLETLESSF B4 0.00 -0.02
SHYpYDLEpTLESpSF B4 0.01 -0.02
pSHYYDLETLESpSF B4 0.03 -0.01
LPVLPVRRKTLLT A1 0.32 NA
LPVLPVRRKpTLLT A1 0.22 NA
LPVLPVRRKTLLpT A1 0.15 NA
LPVLPVRRKpTLLpT A1 0.00 NA
NLLVSSKLDVLKN R1 0.00 0.04
NLLVSpSKLDVLKN R1 0.00 0.00
NLLVpSpSKLDVLKN R1 0.00 0.00
NLLVpSSKLDVLKN R1 0.00 0.01
IPILDIDDSEFLH A1 0.00 -0.01
IPILDIDDpSEFLH A1 0.00 -0.01
VGLMDIGECDDAY A1 0.00 0.05
VGLMDIGECDDApY A1 0.00 0.04
LLPVEVKEQRVSN A1 0.00 -0.04
LLPVEVKEQRVpSN A1 0.00 -0.06
SRVLSIDTRVERA A1 0.14 NA
pSRVLSIDTRVERA A1 0.26 NA
SRVLpSIDTRVERA A1 0.00 0.09
pSRVLSIDpTRVERA A1 0.01 NA
pSRVLpSIDpTRVERA A1 0.00 NA
pSRVLpSIDTRVERA A1 0.00 0.00
EMEPTSSISLVAA R1 0.00 -0.02
EMEPTpSSISLVAA R1 0.00 -0.02
EMEPTSSIpSLVAA R1 0.00 -0.02
EMEPpTpSSISLVAA R1 0.00 -0.01
EMEPpTpSSIpSLVAA R1 0.00 -0.02
EMEPTpSSIpSLVAA R1 0.00 -0.02
ESSGKCGVAMMAS R1 0.00 0.09
ESSGKCGVAMMApS R1 0.00 0.22
KDYADLCFERFGD B4 1.00 0.08
KDpYADLCFERFGD B4 1.11 0.22
YELCDLFGMYMID B4 0.05 -0.02
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pYELCDLFGMYMID B4 0.03 -0.01
YELCDLFGMpYMID B4 0.01 0.20
pYELCDLFGMpYMID B4 0.00 0.31
YEGAKTSIGIVPN R1 0.00 0.08
YEGAKTpSIGIVPN R1 0.00 -0.01
YEGAKpTpSIGIVPN R1 0.00 -0.02
pYEGAKpTSIGIVPN R1 0.00 -0.03
pYEGAKpTpSIGIVPN R1 0.00 -0.02
YEGAKpTSIGIVPN R1 0.00 0.01
YQAADLTKCGSQD B4 0.00 -0.02
YQAADLpTKCGSQD B4 0.00 -0.02
pYQAADLTKCGpSQD B4 0.00 0.10
YQAADLpTKCGpSQD B4 0.00 0.35
pYQAADLpTKCGpSQD B4 0.00 0.42
YQAADLTKCGpSQD B4 0.00 0.47
RSYSSSQLFIVII R1 0.51 0.07
RSYpSSSQLFIVII R1 0.45 0.04
RSpYSpSSQLFIVII R1 0.34 0.02
RSpYSSpSQLFIVII R1 0.40 0.02
RpSpYSSpSQLFIVII R1 0.34 0.00
RpSYSSSQLFIVII R1 0.69 0.00
pTSKPDLTSISSSP B4 0.00 -0.02
TpSKPDLTSISSSP B4 0.00 -0.02
TSKPDLTpSISSpSP B4 0.00 -0.02
TSKPDLpTpSISSSP B4 0.00 -0.01
pTSKPDLTpSISSpSP B4 0.00 -0.02
TSKPDLTSISSSP B4 0.00 -0.01
KRLREKTLEVIWQ R1 0.08 -0.01
KRLREKpTLEVIWQ R1 0.23 -0.03
VFGFDSSVHVVTG R1 0.97 0.01
VFGFDpSSVHVVTG R1 0.01 -0.02
VFGFDpSSVHVVpTG R1 0.00 -0.02
VFGFDSpSVHVVpTG R1 0.00 -0.03
VFGFDpSpSVHVVpTG R1 0.00 -0.02
VFGFDSSVHVVpTG R1 0.00 -0.03
QEIIGLTTKNANG A1 0.00 -0.01
QEIIGLpTTKNANG A1 0.00 0.00
QEIIGLTpTKNANG A1 0.00 0.16
QEIIGLpTpTKNANG A1 0.00 0.27
YALLTERIILVDN R1 0.00 0.01
pYALLTERIILVDN R1 0.00 -0.02
YALLpTERIILVDN R1 0.00 -0.02
pYALLpTERIILVDN R1 0.00 -0.04
SLATDHHLQMIGL R1 0.00 -0.03
pSLATDHHLQMIGL R1 0.00 0.03
SLApTDHHLQMIGL R1 0.00 -0.02
pSLApTDHHLQMIGL R1 0.00 -0.03
GQKVDLTRRIREV B4 0.05 NA
GQKVDLpTRRIREV B4 0.04 NA
MSVMEMSHRGKEF A1 0.00 0.00
MpSVMEMSHRGKEF A1 0.00 -0.01
MSVMEMpSHRGKEF A1 0.00 0.02
MpSVMEMpSHRGKEF A1 0.00 0.03
ESSLCKQLGIVPR R1 0.00 0.53
ESpSLCKQLGIVPR R1 0.00 0.63
EpSpSLCKQLGIVPR R1 0.00 NA
EpSSLCKQLGIVPR R1 0.00 0.70
VPRLDLDNRHFTE B4 0.20 0.05
VPRLDLDNRHFpTE B4 0.00 -0.01
VVSVSNGIPMLMR R1 0.06 NA
VVpSVSNGIPMLMR R1 0.00 NA
VVSVpSNGIPMLMR R1 0.00 NA
VVpSVpSNGIPMLMR R1 0.00 NA
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NACADLpTTEELGK B4 0.00 0.22
NACADLTpTEELGK B4 0.00 0.46
NACADLpTpTEELGK B4 0.00 0.28
NACADLTTEELGK B4 0.00 0.36
GSPLLLEKRHNCL A1 0.01 -0.01
GpSPLLLEKRHNCL A1 0.04 0.04
WAYPDLDFIRWPI B4 0.00 -0.03
WApYPDLDFIRWPI B4 0.00 -0.03
RGMVSISGEPIQR A1 0.00 NA
RGMVpSISGEPIQR A1 0.00 0.05
RGMVSIpSGEPIQR A1 0.00 0.17
RGMVpSIpSGEPIQR A1 0.00 NA
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B.3 Predicted SIM containing proteins
Table B.2: Top 500 predicted SIM containing proteins in Arabidopsis.
Accession ID Short name Description
AT5G39040 ABCB27, ALS1,
AtALS1, ATTAP2,
TAP2
transporter associated with antigen processing protein 2
AT4G39850 ABCD1, ACN2,
AtABCD1, CTS,
PED3, PXA1
peroxisomal ABC transporter 1
AT3G20320 ABCI15, TGD2 trigalactosyldiacylglycerol2
AT5G04895 ABO6 DEA(D/H)-box RNA helicase family protein
AT3G57330 ACA11 autoinhibited Ca2+-ATPase 11
AT4G37640 ACA2 calcium ATPase 2
AT3G05420 ACBP4, AtACBP4 acyl-CoA binding protein 4
AT5G49460 ACLB-2 ATP citrate lyase subunit B 2
AT4G33300 ADR1-L1 ADR1-like 1
AT1G12820 AFB3 auxin signaling F-box 3
AT2G24540 AFR Galactose oxidase/kelch repeat superfamily protein
AT5G57090 AGR, AGR1, ATPIN2,
EIR1, MM31, PIN2,
WAV6
Auxin eﬄux carrier family protein
AT1G17260 AHA10 autoinhibited H(+)-ATPase isoform 10
AT5G62670 AHA11, HA11 H(+)-ATPase 11
AT4G30190 AHA2, HA2, PMA2 H(+)-ATPase 2
AT4G00730 AHDP, ANL2 Homeobox-leucine zipper family protein / lipid-binding
START domain-containing protein
AT2G34680 AIR9 Outer arm dynein light chain 1 protein
AT1G69850 AIT1, ATNRT1:2,
NRT1.2, NRT1:2,
NTL1
nitrate transporter 1:2
AT5G35220 AMOS1, EGY1 Peptidase M50 family protein
AT4G32410 ANY1, AtCESA1,
CESA1, RSW1
cellulose synthase 1
AT1G60780 AP1M2, HAP13 Clathrin adaptor complexes medium subunit family protein
AT1G56590 AP3M, ZIP4 Clathrin adaptor complexes medium subunit family protein
AT4G16130 ARA1, ATISA1, ISA1 arabinose kinase
AT2G44900 ARABIDILLO-1,
ARABIDILLO1
ARABIDILLO-1
AT3G19180 ARC6H, ATCDP1,
CDP1, PARC6
paralog of ARC6
AT1G68370 ARG1 Chaperone DnaJ-domain superfamily protein
AT2G16090 ARI2, ATARI2 RING/U-box superfamily protein
AT4G34940 ARO1 armadillo repeat only 1
AT3G27000 ARP2, ATARP2,
WRM
actin related protein 2
AT1G18450 ARP4, ATARP4 actin-related protein 4
AT4G30510 ATATG18B, ATG18B homolog of yeast autophagy 18 (ATG18) B
AT1G54710 ATATG18H, ATG18H homolog of yeast autophagy 18 (ATG18) H
AT5G63810 AtBGAL10, BGAL10 beta-galactosidase 10
AT4G39400 ATBRI1, BIN1, BRI1,
CBB2, DWF2
Leucine-rich receptor-like protein kinase family protein
AT2G46020 ATBRM, BRM,
CHA2, CHR2
transcription regulatory protein SNF2, putative
AT2G02560 ATCAND1, CAND1,
ETA2, HVE, TIP120
cullin-associated and neddylation dissociated
AT3G18480 AtCASP, CASP CCAAT-displacement protein alternatively spliced product
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AT5G05170 ATCESA3, ATH-B,
CESA3, CEV1, ELI1,
IXR1, MRE1
Cellulose synthase family protein
AT5G17420 ATCESA7, CESA7,
IRX3, MUR10
Cellulose synthase family protein
AT4G18780 ATCESA8, CESA8,
IRX1, LEW2
cellulose synthase family protein
AT3G11130 AtCHC1, CHC1 Clathrin, heavy chain
AT3G06010 ATCHR12, CHR12 Homeotic gene regulator
AT2G13620 ATCHX15, CHX15,
CHX15
cation/hydrogen exchanger 15
AT5G64660 ATCMPG2, CMPG2 CYS, MET, PRO, and GLY protein 2
AT5G53130 ATCNGC1, CNGC1 cyclic nucleotide gated channel 1
AT2G24610 ATCNGC14, CNGC14 cyclic nucleotide-gated channel 14
AT3G17700 ATCNGC20, CNBT1,
CNGC20
cyclic nucleotide-binding transporter 1
AT5G54250 ATCNGC4, CNGC4,
DND2, HLM1
cyclic nucleotide-gated cation channel 4
AT4G21670 ATCPL1, CPL1,
FRY2, SHI4
C-terminal domain phosphatase-like 1
AT2G46700 ATCRK3, CRK3 CDPK-related kinase 3
AT5G17020 ATCRM1, ATXPO1,
HIT2, XPO1, XPO1A
exportin 1A
AT4G31590 ATCSLC05,
ATCSLC5, CSLC05,
CSLC5
Cellulose-synthase-like C5
AT3G07330 ATCSLC06,
ATCSLC6, CSLC06,
CSLC6
Cellulose-synthase-like C6
AT4G07960 ATCSLC12, CSLC12,
CSLC12
Cellulose-synthase-like C12
AT2G33100 ATCSLD1, CSLD1,
CSLD1
cellulose synthase-like D1
AT3G03050 ATCSLD3, CSLD3,
KJK, RHD7
cellulose synthase-like D3
AT4G38190 ATCSLD4, CSLD4 cellulose synthase like D4
AT1G02730 ATCSLD5, CSLD5,
CSLD5, SOS6
cellulose synthase-like D5
AT4G02570 ATCUL1, AXR6,
CUL1
cullin 1
AT1G26830 ATCUL3, ATCUL3A,
CUL3, CUL3A
cullin 3
AT5G46210 ATCUL4, CUL4 cullin4
AT5G66750 ATDDM1, CHA1,
CHR01, CHR1,
DDM1, SOM1, SOM4
chromatin remodeling 1
AT1G55350 ATDEK1, DEK1,
EMB1275, EMB80
calpain-type cysteine protease family
AT5G05980 ATDFB, DFB, FPGS1 DHFS-FPGS homolog B
AT1G73360 AtEDT1, ATHDG11,
EDT1, HDG11
homeodomain GLABROUS 11
AT5G27640 ATEIF3B-1,
ATTIF3B1, EIF3B,
EIF3B-1, TIF3B1
translation initiation factor 3B1
AT3G56150 ATEIF3C-1,
ATTIF3C1, EIF3C,
EIF3C-1, TIF3C1
eukaryotic translation initiation factor 3C
AT1G79940 ATERDJ2A DnaJ / Sec63 Brl domains-containing protein
AT1G66340 AtETR1, EIN1, ETR,
ETR1
Signal transduction histidine kinase, hybrid-type, ethylene
sensor
AT1G33390 ATFAS4, FAS4 RNA helicase family protein
196
APPENDIX B. SIM PEPTIDE ARRAYS
Accession ID Short name Description
AT4G35930 AtFBS4, FBS4 F-box family protein
AT2G30390 ATFC-II, FC-II, FC2 ferrochelatase 2
AT5G15250 ATFTSH6, FTSH6 FTSH protease 6
AT3G01640 ATGLCAK, GLCAK glucuronokinase G
AT1G42540 ATGLR3.3, GLR3.3 glutamate receptor 3.3
AT1G05200 ATGLR3.4, GLR3.4,
GLUR3
glutamate receptor 3.4
AT4G01950 ATGPAT3, GPAT3 glycerol-3-phosphate acyltransferase 3
AT5G07830 AtGUS2, GUS2 glucuronidase 2
AT2G34710 ATHB-14, ATHB14,
PHB, PHB-1D
Homeobox-leucine zipper family protein / lipid-binding
START domain-containing protein
AT1G52150 ATHB-15, ATHB15,
CNA, ICU4
Homeobox-leucine zipper family protein / lipid-binding
START domain-containing protein
AT4G37270 ATHMA1, HMA1 heavy metal atpase 1
AT5G52640 ATHS83, AtHsp90-1,
ATHSP90.1, HSP81-1,
HSP81.1, HSP83,
HSP90.1
heat shock protein 90.1
AT5G56000 AtHsp90.4, Hsp81.4 HEAT SHOCK PROTEIN 81.4
AT2G04030 AtHsp90.5, AtHsp90C,
CR88, EMB1956,
Hsp88.1, HSP90.5
Chaperone protein htpG family protein
AT5G52910 ATIM timeless family protein
AT3G16630 ATKINESIN-13A,
KINESIN-13A
P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT5G05810 ATL43 RING/U-box superfamily protein
AT1G62830 ATLSD1, ATSWP1,
LDL1, LSD1, SWP1
LSD1-like 1
AT3G44200 ATNEK6, IBO1,
NEK6
NIMA (never in mitosis, gene A)-related 6
AT1G60800 AtNIK3, NIK3 NSP-interacting kinase 3
AT1G73590 ATPIN1, PIN1 Auxin eﬄux carrier family protein
AT5G57880 ATPRD2, MPS1,
PRD2
multipolar spindle 1
AT5G53890 AtPSKR2, PSKR2 phytosylfokine-alpha receptor 2
AT1G60190 AtPUB19, PUB19 ARM repeat superfamily protein
AT3G08850 ATRAPTOR1B,
RAPTOR1,
RAPTOR1B
HEAT repeat ;WD domain, G-beta repeat protein protein
AT3G49750 AtRLP44, RLP44 receptor like protein 44
AT3G05530 ATS6A.2, RPT5A regulatory particle triple-A ATPase 5A
AT1G22620 ATSAC1 Phosphoinositide phosphatase family protein
AT3G10380 ATSEC8, SEC8 subunit of exocyst complex 8
AT3G01680 AtSEOR1, SEOb,
SEOR1
CONTAINS InterPro DOMAIN/s: Mediator complex subunit
Med28 (InterPro:IPR021640);
AT4G04920 AtSFR6, IEN1,
MED16, SFR6
sensitive to freezing 6
AT1G09020 ATSNF4, SNF4 homolog of yeast sucrose nonfermenting 4
AT5G20280 ATSPS1F, SPS1F,
SPSA1
sucrose phosphate synthase 1F
AT1G04920 ATSPS3F, SPS3F sucrose phosphate synthase 3F
AT3G43190 ATSUS4, SUS4 sucrose synthase 4
AT1G05500 ATSYTE,
NTMC2T2.1,
NTMC2TYPE2.1,
SYT5, SYTE
Calcium-dependent lipid-binding (CaLB domain) family
protein
AT1G06950 ATTIC110, TIC110 translocon at the inner envelope membrane of chloroplasts 110
AT3G20780 ATTOP6B, BIN3,
HYP6, RHL3, TOP6B
topoisomerase 6 subunit B
AT1G78580 ATTPS1, TPS1, TPS1 trehalose-6-phosphate synthase
AT4G17770 ATTPS5, TPS5, TPS5 trehalose phosphatase/synthase 5
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AT1G06410 ATTPS7, ATTPSA,
TPS7, TPS7
trehalose-phosphatase/synthase 7
AT2G03530 ATUPS2, UPS2 ureide permease 2
AT1G14360 ATUTR3, UTR3 UDP-galactose transporter 3
AT3G59360 ATUTR6, UTR6 UDP-galactose transporter 6
AT2G05170 ATVPS11, VPS11 vacuolar protein sorting 11
AT1G54560 ATXIE, XIE Myosin family protein with Dil domain
AT1G03190 ATXPD, UVH6 RAD3-like DNA-binding helicase protein
AT3G13750 BGAL1, BGAL1 beta galactosidase 1
AT1G77410 BGAL16 beta-galactosidase 16
AT4G36360 BGAL3 beta-galactosidase 3
AT5G20710 BGAL7 beta-galactosidase 7
AT2G28470 BGAL8 beta-galactosidase 8
AT5G24630 BIN4, MID double-stranded DNA binding
AT4G03080 BSL1 BRI1 suppressor 1 (BSU1)-like 1
AT2G27210 BSL3 BRI1 suppressor 1 (BSU1)-like 3
AT1G05940 CAT9 cationic amino acid transporter 9
AT3G19820 CBB1, DIM, DIM1,
DWF1, EVE1
cell elongation protein / DWARF1 / DIMINUTO (DIM)
AT1G65320 CBSX6 Cystathionine beta-synthase (CBS) family protein
AT5G44030 CESA4, IRX5, NWS2 cellulose synthase A4
AT2G02090 CHA19, CHR19, ETL1 SNF2 domain-containing protein / helicase domain-containing
protein
AT5G14170 CHC1 SWIB/MDM2 domain superfamily protein
AT3G47860 CHL chloroplastic lipocalin
AT1G05490 chr31 chromatin remodeling 31
AT2G18760 CHR8 chromatin remodeling 8
AT3G52080 chx28 cation/hydrogen exchanger 28
AT1G05750 CLB19, PDE247 Tetratricopeptide repeat (TPR)-like superfamily protein
AT5G60600 CLB4, CSB3, GCPE,
HDS, ISPG
4-hydroxy-3-methylbut-2-enyl diphosphate synthase
AT3G02130 CLI1, RPK2, TOAD2 receptor-like protein kinase 2
AT1G06220 CLO, GFA1, MEE5 Ribosomal protein S5/Elongation factor G/III/V family protein
AT4G24460 CLT2 CRT (chloroquine-resistance transporter)-like transporter 2
AT2G22125 CSI1, POM2 binding
AT1G63900 DAL1, SP1 E3 Ubiquitin ligase family protein
AT5G36950 DEG10, DegP10 DegP protease 10
AT5G40200 DEG9, DegP9 DegP protease 9
AT5G66680 DGL1 dolichyl-diphosphooligosaccharide-protein glycosyltransferase
48kDa subunit family protein
AT2G47420 DIM1A Ribosomal RNA adenine dimethylase family protein
AT5G66360 DIM1B Ribosomal RNA adenine dimethylase family protein
AT1G18260 EBS5, HRD3A HCP-like superfamily protein
AT1G61140 EDA16 SNF2 domain-containing protein / helicase domain-containing
protein / zinc finger protein-related
AT1G79350 EMB1135 RING/FYVE/PHD zinc finger superfamily protein
AT3G18110 EMB1270 Pentatricopeptide repeat (PPR) superfamily protein
AT5G49930 emb1441 zinc knuckle (CCHC-type) family protein
AT1G79490 EMB2217 Pentatricopeptide repeat (PPR) superfamily protein
AT3G48470 EMB2423 embryo defective 2423
AT4G11150 emb2448, TUF, TUFF,
VHA-E1
vacuolar ATP synthase subunit E1
AT1G20200 EMB2719, HAP15 PAM domain (PCI/PINT associated module) protein
AT1G13980 EMB30, GN, VAN7 sec7 domain-containing protein
AT5G18700 EMB3013, RUK Protein kinase family protein with ARM repeat domain
AT5G64580 EMB3144 AAA-type ATPase family protein
AT4G31820 ENP, MAB4, NPY1 Phototropic-responsive NPH3 family protein
AT4G02680 EOL1 ETO1-like 1
AT5G01400 ESP4 HEAT repeat-containing protein
AT4G26750 EXT-like hydroxyproline-rich glycoprotein family protein
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AT3G14270 FAB1B phosphatidylinositol-4-phosphate 5-kinase family protein
AT1G71010 FAB1C FORMS APLOID AND BINUCLEATE CELLS 1C
AT1G22770 FB, GI gigantea protein (GI)
AT3G10390 FLD Flavin containing amine oxidoreductase family protein
AT2G30950 FTSH2, VAR2 FtsH extracellular protease family
AT1G13440 GAPC-2, GAPC2 glyceraldehyde-3-phosphate dehydrogenase C2
AT1G16300 GAPCP-2 glyceraldehyde-3-phosphate dehydrogenase of plastid 2
AT3G01040 GAUT13 galacturonosyltransferase 13
AT2G46180 GC4 golgin candidate 4
AT1G55325 GCT, MAB2 RNA polymerase II transcription mediators
AT5G58960 GIL1 Plant protein of unknown function (DUF641)
AT1G31070 GlcNAc1pUT1 N-acetylglucosamine-1-phosphate uridylyltransferase 1
AT5G24280 GMI1 gamma-irradiation and mitomycin c induced 1
AT2G13650 GONST1 golgi nucleotide sugar transporter 1
AT1G07290 GONST2 golgi nucleotide sugar transporter 2
AT1G32750 GTD1, HAC13,
HAF01, HAF1, TAF1
HAC13 protein (HAC13)
AT1G64990 GTG1 GPCR-type G protein 1
AT1G10760 GWD, GWD1, SEX1,
SOP, SOP1
Pyruvate phosphate dikinase, PEP/pyruvate binding domain
AT5G46880 HB-7, HDG5 homeobox-7
AT1G05230 HDG2 homeodomain GLABROUS 2
AT4G01690 HEMG1, PPO1, PPOX Flavin containing amine oxidoreductase family
AT2G06990 HEN2 RNA helicase, ATP-dependent, SK12/DOB1 protein
AT1G63440 HMA5 heavy metal atpase 5
AT3G05040 HST, HST1 ARM repeat superfamily protein
AT1G64790 ILA ILITYHIA
AT5G13460 IQD11 IQ-domain 11
AT3G49260 iqd21 IQ-domain 21
AT2G26180 IQD6 IQ-domain 6
AT4G38440 IYO LOCATED IN: chloroplast;
AT3G13682 LDL2 LSD1-like2
AT1G02910 LPA1 tetratricopeptide repeat (TPR)-containing protein
AT1G14030 LSMT-L Rubisco methyltransferase family protein
AT4G35920 MCA1 PLAC8 family protein
AT2G20980 MCM10 minichromosome maintenance 10
AT5G46280 MCM3 Minichromosome maintenance (MCM2/3/5) family protein
AT2G16440 MCM4 Minichromosome maintenance (MCM2/3/5) family protein
AT5G44635 MCM6 minichromosome maintenance (MCM2/3/5) family protein
AT4G02060 MCM7, PRL Minichromosome maintenance (MCM2/3/5) family protein
AT2G14050 MCM9 minichromosome maintenance 9
AT2G14820 MEL3, NPY2 Phototropic-responsive NPH3 family protein
AT5G17520 MEX1, RCP1 root cap 1 (RCP1)
AT2G29990 NDA2 alternative NAD(P)H dehydrogenase 2
AT4G28220 NDB1 NAD(P)H dehydrogenase B1
AT1G30010 nMAT1 Intron maturase, type II family protein
AT2G43040 NPG1 tetratricopeptide repeat (TPR)-containing protein
AT4G28600 NPGR2 no pollen germination related 2
AT5G43050 NPQ6 Protein of unknown function (DUF565)
AT1G14850 NUP155 nucleoporin 155
AT3G57430 OTP84 Tetratricopeptide repeat (TPR)-like superfamily protein
AT2G48120 PAC pale cress protein (PAC)
AT4G14210 PDE226, PDS, PDS3 phytoene desaturase 3
AT3G06960 PDE320, TGD4 pigment defective 320
AT3G25800 PDF1, PP2AA2, PR 65 protein phosphatase 2A subunit A2
AT4G04890 PDF2 protodermal factor 2
AT5G64070 PI-4KBETA1,
PI4KBETA1
phosphatidylinositol 4-OH kinase beta1
AT1G72560 PSD ARM repeat superfamily protein
AT5G42340 PUB15 Plant U-Box 15
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Accession ID Short name Description
AT1G49780 PUB26 plant U-box 26
AT1G31830 PUT2 Amino acid permease family protein
AT3G19553 PUT5 Amino acid permease family protein
AT5G22750 RAD5, RAD5A DNA/RNA helicase protein
AT3G55510 RBL Noc2p family
AT3G51460 RHD4 Phosphoinositide phosphatase family protein
AT5G57280 RID2 S-adenosyl-L-methionine-dependent methyltransferases
superfamily protein
AT5G44180 RLT2 Homeodomain-like transcriptional regulator
AT2G46710 ROPGAP3 Rho GTPase activating protein with
PAK-box/P21-Rho-binding domain
AT4G29040 RPT2a regulatory particle AAA-ATPase 2A
AT5G58290 RPT3 regulatory particle triple-A ATPase 3
AT1G58520 RXW8 lipases;hydrolases, acting on ester bonds
AT2G35800 SAMTL mitochondrial substrate carrier family protein
AT3G56640 SEC15A exocyst complex component sec15A
AT4G02350 SEC15B exocyst complex component sec15B
AT1G21650 SECA2 Preprotein translocase SecA family protein
AT4G00800 SETH5 transducin family protein / WD-40 repeat family protein
AT5G48170 SLY2, SNE F-box family protein
AT3G52490 SMXL3 Double Clp-N motif-containing P-loop nucleoside triphosphate
hydrolases superfamily protein
AT1G03060 SPI Beige/BEACH domain ;WD domain, G-beta repeat protein
AT5G42390 SPP Insulinase (Peptidase family M16) family protein
AT2G02480 STI AAA-type ATPase family protein
AT1G22150 SULTR1;3 sulfate transporter 1;3
AT2G19580 TET2 tetraspanin2
AT5G64510 TIN1 unknown protein;
AT3G24660 TMKL1 transmembrane kinase-like 1
AT3G01780 TPLATE ARM repeat superfamily protein
AT4G31600 UTr7 UDP-N-acetylglucosamine (UAA) transporter family
AT3G13290 VCR varicose-related
AT3G03660 WOX11 WUSCHEL related homeobox 11
AT2G35610 XEG113 xyloglucanase 113
AT4G11800 Calcineurin-like metallo-phosphoesterase superfamily protein
AT4G10080 unknown protein;
AT1G07590 Tetratricopeptide repeat (TPR)-like superfamily protein
AT5G43745 Protein of unknown function (DUF1012)
AT1G73950 Transmembrane Fragile-X-F-associated protein
AT3G07210 unknown protein;
AT3G14170 Plant protein of unknown function (DUF936)
AT2G28480 RNA-binding CRS1 / YhbY (CRM) domain protein
AT3G13670 Protein kinase family protein
AT3G18020 Pentatricopeptide repeat (PPR) superfamily protein
AT1G10330 Tetratricopeptide repeat (TPR)-like superfamily protein
AT1G12790 CONTAINS InterPro DOMAIN/s: RuvA domain 2-like
(InterPro:IPR010994);
AT3G12020 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT2G26780 ARM repeat superfamily protein
AT1G45688 unknown protein;
AT1G62020 Coatomer, alpha subunit
AT2G32970 unknown protein;
AT5G06130 chaperone protein dnaJ-related
AT1G12380 unknown protein;
AT3G43240 ARID/BRIGHT DNA-binding domain-containing protein
AT3G49810 ARM repeat superfamily protein
AT4G24840 FUNCTIONS IN: molecular_function unknown;
AT5G58510 unknown protein;
AT1G30630 Coatomer epsilon subunit
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Accession ID Short name Description
AT1G12500 Nucleotide-sugar transporter family protein
AT1G30290 Tetratricopeptide repeat (TPR)-like superfamily protein
AT5G42560 Abscisic acid-responsive (TB2/DP1, HVA22) family protein
AT4G02750 Tetratricopeptide repeat (TPR)-like superfamily protein
AT4G21660 proline-rich spliceosome-associated (PSP) family protein
AT4G22990 Major Facilitator Superfamily with SPX (SYG1/Pho81/XPR1)
domain-containing protein
AT3G11320 Nucleotide-sugar transporter family protein
AT5G40250 RING/U-box superfamily protein
AT1G22860 Vacuolar sorting protein 39
AT3G08650 ZIP metal ion transporter family
AT5G47940 unknown protein;
AT2G45540 WD-40 repeat family protein / beige-related
AT2G45990 unknown protein;
AT5G15610 Proteasome component (PCI) domain protein
AT3G02710 ARM repeat superfamily protein
AT3G56570 SET domain-containing protein
AT1G59710 Protein of unknown function (DUF569)
AT1G55535 unknown protein;
AT2G24240 BTB/POZ domain with WD40/YVTN repeat-like protein
AT1G33420 RING/FYVE/PHD zinc finger superfamily protein
AT5G35970 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT1G08760 Plant protein of unknown function (DUF936)
AT1G77460 Armadillo/beta-catenin-like repeat ; C2 calcium/lipid-binding
domain (CaLB) protein
AT4G13330 S-adenosyl-L-methionine-dependent methyltransferases
superfamily protein
AT1G06590 unknown protein;
AT5G03250 Phototropic-responsive NPH3 family protein
AT4G02400 U3 ribonucleoprotein (Utp) family protein
AT4G27680 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT1G28690 Tetratricopeptide repeat (TPR)-like superfamily protein
AT4G29960 unknown protein;
AT3G25805 unknown protein;
AT3G26782 Tetratricopeptide repeat (TPR)-like superfamily protein
AT5G48130 Phototropic-responsive NPH3 family protein
AT5G48660 B-cell receptor-associated protein 31-like
AT1G05020 ENTH/ANTH/VHS superfamily protein
AT2G47010 unknown protein;
AT5G14260 Rubisco methyltransferase family protein
AT5G28850 Calcium-binding EF-hand family protein
AT5G43310 COP1-interacting protein-related
AT1G32460 unknown protein;
AT4G15840 BTB/POZ domain-containing protein
AT4G37920 unknown protein;
AT2G01460 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT2G28315 Nucleotide/sugar transporter family protein
AT4G11120 translation elongation factor Ts (EF-Ts), putative
AT5G39250 F-box family protein
AT3G07510 unknown protein;
AT5G15710 Galactose oxidase/kelch repeat superfamily protein
AT2G43320 S-adenosyl-L-methionine-dependent methyltransferases
superfamily protein
AT5G15070 Phosphoglycerate mutase-like family protein
AT2G47390 Prolyl oligopeptidase family protein
AT3G19990 unknown protein;
AT2G22120 RING/FYVE/PHD zinc finger superfamily protein
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Accession ID Short name Description
AT5G38520 alpha/beta-Hydrolases superfamily protein
AT2G26270 FUNCTIONS IN: molecular_function unknown;
AT3G03940 Protein kinase family protein
AT1G02040 C2H2-type zinc finger family protein
AT1G60560 SWIM zinc finger family protein
AT4G24160 alpha/beta-Hydrolases superfamily protein
AT5G12260 BEST Arabidopsis thaliana protein match is:
glycosyltransferase family protein 2 (TAIR:AT5G60700.1);
AT1G15290 Tetratricopeptide repeat (TPR)-like superfamily protein
AT2G17930 Phosphatidylinositol 3- and 4-kinase family protein with FAT
domain
AT2G42910 Phosphoribosyltransferase family protein
AT5G44860 unknown protein;
AT1G68710 ATPase E1-E2 type family protein / haloacid
dehalogenase-like hydrolase family protein
AT1G73920 alpha/beta-Hydrolases superfamily protein
AT5G43020 Leucine-rich repeat protein kinase family protein
AT5G65750 2-oxoglutarate dehydrogenase, E1 component
AT4G24610 unknown protein;
AT5G16210 HEAT repeat-containing protein
AT5G35430 Tetratricopeptide repeat (TPR)-like superfamily protein
AT5G59740 UDP-N-acetylglucosamine (UAA) transporter family
AT1G48360 zinc ion binding;nucleic acid binding;hydrolases, acting on
acid anhydrides, in phosphorus-containing anhydrides
AT2G01690 ARM repeat superfamily protein
AT5G39450 F-box family protein
AT5G49960 unknown protein;
AT3G49350 Ypt/Rab-GAP domain of gyp1p superfamily protein
AT4G19006 Proteasome component (PCI) domain protein
AT3G60860 SEC7-like guanine nucleotide exchange family protein
AT4G31480 Coatomer, beta subunit
AT5G13500 unknown protein;
AT5G58160 actin binding
AT1G66330 senescence-associated family protein
AT3G03790 ankyrin repeat family protein / regulator of chromosome
condensation (RCC1) family protein
AT5G22780 Adaptor protein complex AP-2, alpha subunit
AT1G14330 Galactose oxidase/kelch repeat superfamily protein
AT1G20540 Transducin/WD40 repeat-like superfamily protein
AT5G42740 Sugar isomerase (SIS) family protein
AT1G03440 Leucine-rich repeat (LRR) family protein
AT1G45150 unknown protein;
AT1G13820 alpha/beta-Hydrolases superfamily protein
AT2G42700 FUNCTIONS IN: molecular_function unknown;
AT1G27660 basic helix-loop-helix (bHLH) DNA-binding superfamily
protein
AT2G25760 Protein kinase family protein
AT2G40400 Protein of unknown function (DUF399 and DUF3411)
AT2G16760 Calcium-dependent phosphotriesterase superfamily protein
AT2G29670 Tetratricopeptide repeat (TPR)-like superfamily protein
AT3G22800 Leucine-rich repeat (LRR) family protein
AT3G49142 Tetratricopeptide repeat (TPR)-like superfamily protein
AT4G01210 glycosyl transferase family 1 protein
AT5G05570 transducin family protein / WD-40 repeat family protein
AT1G73430 sec34-like family protein
AT3G12650 unknown protein;
AT3G24480 Leucine-rich repeat (LRR) family protein
AT5G19640 Major facilitator superfamily protein
AT1G17500 ATPase E1-E2 type family protein / haloacid
dehalogenase-like hydrolase family protein
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Accession ID Short name Description
AT2G02170 Remorin family protein
AT3G45850 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT4G34310 alpha/beta-Hydrolases superfamily protein
AT5G28350 Quinoprotein amine dehydrogenase, beta chain-like; RIC1-like
guanyl-nucleotide exchange factor
AT1G19835 Plant protein of unknown function (DUF869)
AT1G70280 NHL domain-containing protein
AT5G42760 Leucine carboxyl methyltransferase
AT3G52870 IQ calmodulin-binding motif family protein
AT1G14390 Leucine-rich repeat protein kinase family protein
AT4G18820 AAA-type ATPase family protein
AT1G22850 SNARE associated Golgi protein family
AT1G50020 unknown protein;
AT2G15860 unknown protein;
AT3G44330 INVOLVED IN: protein processing;
AT5G06120 ARM repeat superfamily protein
AT4G34450 coatomer gamma-2 subunit, putative / gamma-2 coat protein,
putative / gamma-2 COP, putative
AT1G07970 CONTAINS InterPro DOMAIN/s: Cytochrome B561-related,
N-terminal (InterPro:IPR019176);
AT2G40280 S-adenosyl-L-methionine-dependent methyltransferases
superfamily protein
AT4G39050 Kinesin motor family protein
AT5G08420 RNA-binding KH domain-containing protein
AT5G61450 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT1G03010 Phototropic-responsive NPH3 family protein
AT2G26690 Major facilitator superfamily protein
AT2G41770 Protein of unknown function (DUF288)
AT4G16470 Tetratricopeptide repeat (TPR)-like superfamily protein
AT5G11720 Glycosyl hydrolases family 31 protein
AT1G63850 BTB/POZ domain-containing protein
AT3G10210 SEC14 cytosolic factor family protein / phosphoglyceride
transfer family protein
AT1G50450 Saccharopine dehydrogenase
AT3G55060 unknown protein;
AT4G21300 Tetratricopeptide repeat (TPR)-like superfamily protein
AT3G56120 S-adenosyl-L-methionine-dependent methyltransferases
superfamily protein
AT4G25030 unknown protein;
AT5G16610 unknown protein;
AT1G50440 RING/FYVE/PHD zinc finger superfamily protein
AT2G40980 Protein kinase superfamily protein
AT1G70160 unknown protein;
AT5G08720 CONTAINS InterPro DOMAIN/s: Streptomyces
cyclase/dehydrase (InterPro:IPR005031);
AT2G03270 DNA-binding protein, putative
AT2G27610 Tetratricopeptide repeat (TPR)-like superfamily protein
AT1G71060 Tetratricopeptide repeat (TPR)-like superfamily protein
AT1G67930 Golgi transport complex protein-related
AT1G06890 nodulin MtN21 /EamA-like transporter family protein
AT3G01720 unknown protein;
AT4G32750 unknown protein;
AT4G04670 Met-10+ like family protein / kelch repeat-containing protein
AT5G49665 Zinc finger (C3HC4-type RING finger) family protein
AT2G32415 Polynucleotidyl transferase, ribonuclease H fold protein with
HRDC domain
AT1G76140 Prolyl oligopeptidase family protein
AT5G19540 unknown protein;
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AT3G48770 DNA binding;ATP binding
AT5G51150 Mitochondrial import inner membrane translocase subunit
Tim17/Tim22/Tim23 family protein
AT1G01930 zinc finger protein-related
AT2G25430 epsin N-terminal homology (ENTH) domain-containing
protein / clathrin assembly protein-related
AT4G38200 SEC7-like guanine nucleotide exchange family protein
AT4G36180 Leucine-rich receptor-like protein kinase family protein
AT5G37490 ARM repeat superfamily protein
AT1G53345 unknown protein;
AT2G04360 unknown protein;
AT3G59340 Eukaryotic protein of unknown function (DUF914)
AT5G16680 RING/FYVE/PHD zinc finger superfamily protein
AT4G30400 RING/U-box superfamily protein
AT4G32272 Nucleotide/sugar transporter family protein
AT3G05990 Leucine-rich repeat (LRR) family protein
AT4G15890 binding
AT4G19380 Long-chain fatty alcohol dehydrogenase family protein
AT3G17740 unknown protein;
AT3G54190 Transducin/WD40 repeat-like superfamily protein
AT5G08540 unknown protein;
AT5G63100 S-adenosyl-L-methionine-dependent methyltransferases
superfamily protein
AT1G12470 zinc ion binding
AT4G02900 ERD (early-responsive to dehydration stress) family protein
AT3G01580 Tetratricopeptide repeat (TPR)-like superfamily protein
AT3G04480 endoribonucleases
AT2G35840 Sucrose-6F-phosphate phosphohydrolase family protein
AT3G17030 Nucleic acid-binding proteins superfamily
AT4G37030 unknown protein;
AT2G22400 S-adenosyl-L-methionine-dependent methyltransferases
superfamily protein
AT3G27550 RNA-binding CRS1 / YhbY (CRM) domain protein
AT3G28040 Leucine-rich receptor-like protein kinase family protein
AT4G28890 RING/U-box superfamily protein
AT2G33680 Tetratricopeptide repeat (TPR)-like superfamily protein
AT3G62360 Carbohydrate-binding-like fold
AT4G33970 Leucine-rich repeat (LRR) family protein
AT5G25265 unknown protein;
AT1G16860 Ubiquitin-specific protease family C19-related protein
AT4G13970 zinc ion binding
AT5G64270 splicing factor, putative
AT5G56220 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT5G43530 Helicase protein with RING/U-box domain
AT5G64090 FUNCTIONS IN: molecular_function unknown;
AT3G59910 Ankyrin repeat family protein
AT3G47530 Pentatricopeptide repeat (PPR) superfamily protein
AT2G38000 chaperone protein dnaJ-related
AT3G49650 P-loop containing nucleoside triphosphate hydrolases
superfamily protein
AT3G50780 BEST Arabidopsis thaliana protein match is: BTB/POZ
domain-containing protein (TAIR:AT1G63850.1);
AT3G07950 rhomboid protein-related
AT4G34220 Leucine-rich repeat protein kinase family protein
AT1G12800 Nucleic acid-binding, OB-fold-like protein
AT3G58480 calmodulin-binding family protein
AT2G32730 26S proteasome regulatory complex, non-ATPase subcomplex,
Rpn2/Psmd1 subunit
AT5G02550 unknown protein;
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AT5G21070 unknown protein;
AT5G60700 glycosyltransferase family protein 2
AT2G01600 ENTH/ANTH/VHS superfamily protein
AT5G42930 alpha/beta-Hydrolases superfamily protein
AT3G13600 calmodulin-binding family protein
AT4G15820 BEST Arabidopsis thaliana protein match is: embryo defective
1703 (TAIR:AT3G61780.1);
AT2G34250 SecY protein transport family protein
AT5G11710 ENTH/VHS family protein
AT1G16220 Protein phosphatase 2C family protein
AT2G07360 SH3 domain-containing protein
AT5G65290 LMBR1-like membrane protein
AT5G11700 LOCATED IN: vacuole;
AT1G12600 UDP-N-acetylglucosamine (UAA) transporter family
AT2G39910 ARM repeat superfamily protein
AT4G32140 EamA-like transporter family
AT4G28080 Tetratricopeptide repeat (TPR)-like superfamily protein
AT5G66960 Prolyl oligopeptidase family protein
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B.4 SIM containing protein gene ontology analysis
Table B.3: Full molecular function gene ontology analysis of SIM containing
proteins.
Molecular function GO term Observed
frequency (%)
Expected
frequency (%)
Ratio p-value
hydrolase activity, acting on acid anhydrides 12.05 6.54 1.84 7.89E-13
hydrolase activity, acting on acid anhydrides,
in phosphorus-containing anhydrides
12.05 6.56 1.84 7.89E-13
nucleoside-triphosphatase activity 14.55 8.84 1.65 7.89E-13
pyrophosphatase activity 2.50 0.65 3.86 1.53E-12
cellulose synthase activity 4.09 0.57 7.24 2.59E-08
glucosyltransferase activity 1.36 0.09 14.99 2.59E-08
ATPase activity 11.59 5.68 2.04 9.94E-08
transporter activity 39.55 32.51 1.22 2.88E-07
substrate-specific transporter activity 5.00 2.23 2.24 6.97E-07
ATPase activity, coupled 12.05 6.07 1.98 4.69E-06
substrate-specific transmembrane transporter
activity
1.14 0.11 10.26 6.78E-06
calmodulin binding 2.50 0.15 17.09 7.04E-06
hydrolase activity 2.95 0.64 4.58 1.10E-05
ion transmembrane transporter activity 12.50 6.96 1.80 2.60E-05
ATP binding 11.36 3.01 3.78 4.26E-05
adenyl ribonucleotide binding 11.36 3.03 3.75 4.49E-05
ATPase activity, coupled to transmembrane
movement of ions, phosphorylative mechanism
11.14 2.87 3.87 4.62E-05
purine nucleoside binding 3.64 0.70 5.23 4.62E-05
adenyl nucleotide binding 11.59 5.66 2.05 4.62E-05
transferase activity, transferring hexosyl groups 1.14 0.14 7.98 4.62E-05
transmembrane transporter activity 1.59 0.34 4.68 4.62E-05
ATPase activity, coupled to transmembrane
movement of ions
4.55 1.28 3.55 4.68E-05
binding 12.05 6.06 1.99 4.68E-05
nucleoside binding 1.36 0.13 10.45 4.68E-05
beta-galactosidase activity 11.14 2.99 3.72 4.90E-05
galactosidase activity 1.36 0.08 18.15 1.19E-04
helicase activity 9.55 3.55 2.69 1.59E-04
purine ribonucleoside triphosphate binding 2.50 0.64 3.90 2.64E-04
ribonucleotide binding 20.00 11.62 1.72 2.71E-04
purine ribonucleotide binding 2.50 0.64 3.90 2.71E-04
purine nucleotide binding 2.95 0.85 3.46 3.23E-04
DNA-dependent ATPase activity 12.05 4.97 2.42 5.76E-04
nucleotide-sugar transmembrane transporter
activity
8.18 3.05 2.68 8.17E-04
nucleotide binding 0.91 0.04 22.99 8.17E-04
transferase activity, transferring glycosyl
groups
4.09 1.65 2.48 9.17E-04
protein binding 2.95 0.85 3.48 1.03E-03
P-P-bond-hydrolysis-driven transmembrane
transporter activity
5.00 1.94 2.58 1.68E-03
primary active transmembrane transporter
activity
10.91 6.10 1.79 1.71E-03
ATPase activity, coupled to movement of
substances
1.82 0.17 10.69 1.92E-03
ATPase activity, coupled to transmembrane
movement of substances
8.86 3.84 2.31 1.92E-03
clathrin binding 6.59 1.70 3.89 2.05E-03
hydrolase activity, acting on acid anhydrides,
catalyzing transmembrane movement of
substances
5.00 1.26 3.96 2.05E-03
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Molecular function GO term Observed
frequency (%)
Expected
frequency (%)
Ratio p-value
active transmembrane transporter activity 6.36 2.18 2.92 4.72E-03
cation transmembrane transporter activity 47.50 36.72 1.29 4.93E-03
cation-transporting ATPase activity 2.05 0.24 8.48 5.40E-03
ion channel activity 12.05 6.56 1.84 8.95E-03
catalytic activity 12.05 6.09 1.98 9.83E-03
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Table B.4: Full biological process gene ontology analysis of SIM containing
proteins.
Biological process GO term Observed
frequency (%)
Expected
frequency (%)
Ratio p-value
cellular component organization or biogenesis 13.93 5.13 2.71 3.12E-09
developmental process 17.12 7.22 2.37 3.12E-09
plant-type cell wall biogenesis 2.74 0.20 13.68 1.10E-07
cell wall biogenesis 2.97 0.25 11.76 1.10E-07
cellular component organization or biogenesis
at cellular level
10.73 3.79 2.83 1.10E-07
cellular component organization 10.96 4.08 2.69 2.30E-07
developmental process involved in
reproduction
9.36 3.23 2.90 4.38E-07
anatomical structure morphogenesis 5.94 1.49 3.99 8.93E-07
cellular developmental process 5.94 1.51 3.92 1.14E-06
cellular cell wall organization or biogenesis 3.65 0.60 6.04 3.36E-06
cell morphogenesis 4.57 0.99 4.61 3.69E-06
cellular component morphogenesis 4.57 0.99 4.61 3.69E-06
reproductive process 9.36 3.61 2.59 4.70E-06
cell morphogenesis involved in differentiation 3.42 0.56 6.06 6.11E-06
transport 14.16 6.94 2.04 8.01E-06
establishment of localization 14.16 6.99 2.02 9.67E-06
DNA-dependent DNA replication initiation 1.37 0.04 31.08 1.47E-05
cellular component organization at cellular
level
7.53 2.77 2.72 2.30E-05
plant-type cell wall organization or biogenesis 2.97 0.47 6.28 2.30E-05
carbohydrate biosynthetic process 4.11 0.96 4.29 2.80E-05
cell wall organization or biogenesis 3.88 0.95 4.11 9.66E-05
organelle organization 6.16 2.16 2.85 9.98E-05
polysaccharide biosynthetic process 2.51 0.39 6.40 1.21E-04
disaccharide metabolic process 1.83 0.19 9.70 1.71E-04
embryo development 5.02 1.65 3.04 2.77E-04
polysaccharide metabolic process 2.97 0.62 4.78 2.77E-04
cellular carbohydrate metabolic process 5.25 1.80 2.91 3.27E-04
carbohydrate metabolic process 7.76 3.37 2.30 3.53E-04
response to radiation 5.48 1.98 2.77 4.20E-04
oligosaccharide metabolic process 1.83 0.23 8.00 4.87E-04
cell growth 3.65 1.01 3.63 5.46E-04
response to light stimulus 5.25 1.91 2.75 6.64E-04
cellular component biogenesis 2.97 0.71 4.21 7.28E-04
cellular component biogenesis at cellular level 2.97 0.71 4.21 7.28E-04
cellular carbohydrate biosynthetic process 2.97 0.71 4.16 7.90E-04
embryo development ending in seed dormancy 4.34 1.42 3.05 8.05E-04
growth 3.88 1.18 3.30 8.18E-04
cellulose biosynthetic process 1.37 0.12 11.03 9.09E-04
intracellular transport 4.57 1.57 2.90 9.09E-04
response to gravity 1.60 0.19 8.31 1.00E-03
unidimensional cell growth 2.97 0.76 3.92 1.21E-03
cellulose metabolic process 1.37 0.14 10.06 1.29E-03
developmental growth 3.20 0.88 3.64 1.29E-03
establishment of localization in cell 4.79 1.79 2.68 1.50E-03
DNA unwinding involved in replication 0.91 0.04 22.80 1.58E-03
pollen germination 1.37 0.14 9.50 1.60E-03
protein complex assembly 2.28 0.48 4.71 1.88E-03
cellular process 42.69 33.96 1.26 1.98E-03
root development 2.51 0.59 4.24 1.98E-03
developmental growth involved in
morphogenesis
2.97 0.83 3.60 2.24E-03
anatomical structure development 5.48 2.31 2.37 2.48E-03
establishment of protein localization 4.11 1.49 2.76 2.86E-03
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Biological process GO term Observed
frequency (%)
Expected
frequency (%)
Ratio p-value
gravitropism 1.37 0.17 8.14 2.86E-03
intracellular protein transport 3.42 1.09 3.13 2.86E-03
protein transport 4.11 1.49 2.76 2.86E-03
cellular protein complex assembly 2.05 0.42 4.84 2.90E-03
DNA duplex unwinding 0.91 0.06 16.28 3.42E-03
DNA geometric change 0.91 0.06 16.28 3.42E-03
positive regulation of post-embryonic
development
1.37 0.18 7.77 3.42E-03
vacuole organization 0.91 0.06 16.28 3.42E-03
protein complex subunit organization 2.28 0.55 4.16 3.73E-03
pattern specification process 2.05 0.46 4.46 4.62E-03
trichome morphogenesis 1.14 0.12 9.50 4.67E-03
response to abiotic stimulus 9.59 5.45 1.76 5.50E-03
cell tip growth 1.83 0.38 4.85 5.61E-03
organ development 2.97 0.95 3.13 6.10E-03
positive regulation of developmental process 1.37 0.20 6.70 6.10E-03
tropism 1.37 0.21 6.58 6.61E-03
Golgi organization 0.68 0.03 24.42 7.54E-03
pollen tube growth 1.60 0.30 5.25 7.74E-03
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C.1 Peptide array image analysis software
Software with a graphical user interface (GUI) was used to analyse SIM peptide array images. The GUI
allows a grid to be specified over the desired image and the intensity values under the grid can then be
calculated. An example of the interface is shown in Figure C.1. The main GUI code is stored in the file
Array_Tool.m and depends on the functions shown in Table C.1.
Figure C.1: Peptide array analysis GUI interface.
Function name Purpose
calcGrid.m Calculates the coordinates of grid points based on grid size,
spacing and offset.
discCalc.m Calculates pixel coordinates for all pixels within a circle with
specified radius and centre-point, then calculates either the
mean, median or sum of pixel values within the disc.
drawCircles.m Draws circles onto peptide array image based on results radii
and circle midpoint coordinates.
drawDots.m Draws dots onto peptide array image based on grid centre-point
coordinates.
drawFigure.m Redraws peptide array image, removing anything that was
drawn over image previously.
generateResults.m Iterates the discCalc.m over all points in the grid and outputs
the data as a table.
getmidpointcircle.m Calculate discretised pixel coordinates around a centre point
using the get mid point circle algorithm. Source code from
Tinevez (2013), retrieved from MATLAB Central File
Exchange.
Array_Tool.m Main function for generating GUI, Calls other functions to
perform actions.
Table C.1: Function files from the peptide image analysis software tool.
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C.1.1 CalcGrid.m function
1 function calcGrid(hObject)
2 %Draws mid-points of circles
3
4 %Variables
5 handles = guidata(gcbo);
6 xOr = str2num(get(handles.gridX, 'string'));
7 yOr = str2num(get(handles.gridY, 'string'));
8 xN = str2num(get(handles.nCols, 'string'));
9 yN = str2num(get(handles.nRows, 'string'));
10 xSp = str2num(get(handles.cellSizeX, 'string'));
11 ySp = str2num(get(handles.cellSizeY, 'string'));
12 startOf = str2num(get(handles.startOff, 'string'));
13 endOf = str2num(get(handles.endOff, 'string'));
14 refX = str2num(get(handles.refX, 'string'));
15 refY = str2num(get(handles.refY, 'string'));
16
17 %Generate grid
18 [X Y] = meshgrid(1:xN, 1:yN);
19 X = X';
20 Y = Y';
21 X = X(:)*xSp + xOr - xSp;
22 Y = Y(:)*ySp + yOr - ySp;
23
24 %Remove offset
25 X = X((1+startOf):(length(X)-endOf));
26 Y = Y((1+startOf):(length(Y)-endOf));
27
28 %Plot points on graph
29 %hold on
30 %plot(X, Y, '+')
31 %plot(refX, refY, '+', 'color', 'magenta')
32 %hold off
33
34 %Save new data
35 handles.X = X;
36 handles.Y = Y;
37 guidata(hObject, handles);
C.1.2 discCalc.m function
1 function [result n] = discCalc(image, x, y, r, mode)
2 %DISCCALC calculates the sum, mean or median of pixels in a disc
3 % mode can be: 'mean' result = mean
4 % 'median' result = median
5 % 'sum' result = sum
6 % 'raw' result = vector of values
7 % n in output is the number of points that satisfy the
8 % disc criteria
9
10 [columnsInImage rowsInImage] = meshgrid(1:size(image,2), 1:size(image,1));
11 % Next create the circle in the image.
12 circlePixels = logical((rowsInImage - y).^2 ...
13 + (columnsInImage - x).^2 <= r.^2);
14 % circlePixels is a 2D "logical" array.
15 % Now, display it.
16 n = sum(sum(circlePixels));
17
18 if strcmp(mode, 'mean'),
19 result = mean(image(circlePixels));
20 elseif strcmp(mode, 'median'),
21 result = median(image(circlePixels));
22 elseif strcmp(mode, 'sum'),
23 result = sum(image(circlePixels));
24 elseif strcmp(mode, 'raw'),
25 result = image(circlePixels);
26 else
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27 error('Invalid type specified in input paramters')
28 end
29
30 end
C.1.3 drawCircles.m function
1 function drawCircles(hObject)
2 calcGrid(hObject)
3 %Draws circles
4 %Variables
5 handles = guidata(gcbo);
6 initRadius = str2double(get(handles.initCircSize, 'string'));
7 threshold = str2double(get(handles.threshold, 'string'));
8 limit = str2double(get(handles.limit, 'string'));
9 n = length(handles.X);
10 sizeOptimise = get(handles.sizeOptimise, 'value');
11 X = round(handles.X);
12 Y = round(handles.Y);
13 invImg = imcomplement(handles.img);
14 refX = str2num(get(handles.refX, 'string'));
15 refY = str2num(get(handles.refY, 'string'));
16
17 %initialise radii variable with minimum circle size
18 radii = ones(n, 1) * initRadius;
19
20 %Make circles
21 switch sizeOptimise
22 case 0
23 %No size optimisation
24 for i = 1:n,
25 hold on
26 [x y] = getmidpointcircle(X(i), Y(i), radii(i));
27 plot(x, y)
28 hold off
29 end
30 case 1
31 %With size optimisation
32 for i = 1:n,
33 [x y] = getmidpointcircle(X(i), Y(i), radii(i));
34 while mean(invImg(sub2ind(size(invImg),y,x))) > ...
35 threshold && radii(i) < limit,
36 radii(i) = radii(i) + 1;
37 [x y] = getmidpointcircle(X(i), Y(i), radii(i));
38 end
39 hold on
40 plot(x, y)
41 hold off
42 end
43 otherwise
44 error('Critical error')
45 end
46
47 [x y] = getmidpointcircle(refX, refY, initRadius);
48 hold on
49 plot(x, y, 'color', 'magenta')
50 hold off
51
52 %Save data
53 handles.radii = radii;
54 guidata(hObject, handles)
C.1.4 drawDots.m function
1 function drawDots(hObject)
2 %Draws mid-points of circles
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3 calcGrid(hObject)
4
5 %Variables
6 handles = guidata(gcbo);
7 refX = str2num(get(handles.refX, 'string'));
8 refY = str2num(get(handles.refY, 'string'));
9
10 %Plot points on graph
11 hold on
12 plot(handles.X, handles.Y, '+')
13 plot(refX, refY, '+', 'color', 'magenta')
14 hold off
C.1.5 drawFigure.m function
1 function drawFigure
2 handles = guidata(gcbo);
3 imshow(handles.img);
C.1.6 generateResults.m function
1 function generateResults(hObject)
2 %Variables
3 handles = guidata(gcbo);
4 invImg = double(imcomplement(handles.img));
5 X = round(handles.X);
6 Y = round(handles.Y);
7 radii = handles.radii;
8 temp = get(handles.measType,{'String','Value'});
9 measureType = temp{1}{temp{2}};
10 n = length(X);
11 output = zeros(n,1);
12 refSub = get(handles.refSub, 'value');
13 refX = str2num(get(handles.refX, 'string'));
14 refY = str2num(get(handles.refY, 'string'));
15 initRadius = str2double(get(handles.initCircSize, 'string'));
16
17 switch refSub
18 case 0
19 for i = 1:n,
20 output(i) = discCalc(invImg, X(i), Y(i), radii(i), measureType);
21 end
22 case 1
23 switch measureType
24 case 'mean'
25 background = discCalc(invImg, refX, refY, ...
26 initRadius, measureType);
27 for i = 1:n,
28 output(i) = discCalc(invImg, X(i), Y(i), ...
29 radii(i), measureType) - background;
30 end
31 case 'median'
32 background = discCalc(invImg, refX, refY, ...
33 initRadius, measureType);
34 for i = 1:n,
35 output(i) = discCalc(invImg, X(i), Y(i), ...
36 radii(i), measureType) - background;
37 end
38 case 'sum'
39 [background bPixls] = discCalc(invImg, refX, refY, ...
40 initRadius, measureType);
41 background = background/bPixls;
42 for i = 1:n,
43 [output(i) pixls] = discCalc(invImg, X(i), Y(i), ...
44 radii(i), measureType);
45 output(i) = output(i) - background*pixls;
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46 end
47 otherwise
48 error('Critical error')
49 end
50 otherwise
51 error('Critical error')
52 end
53
54
55
56 set(handles.resultsTable, 'Data', output)
57 guidata(hObject, handles);
C.1.7 getmidpointcircle.m function
The following function was written by Tinevez (2013) and was retrieved from the MATLAB Central
File Exchange.
1 function [xc, yc] = getmidpointcircle(x0, y0, radius)
2 %% GETMIDPOINTCIRCLE return the x,y pixel coordinates of a circle
3 %
4 % [x y] = GETMIDPOINTCIRCLE(x0, y0, radius) returns the pixel coordinates
5 % of the circle centered at pixel position [x0 y0] and of the given integer
6 % radius. The mid-point circle algorithm is used for computation
7 % (http://en.wikipedia.org/wiki/Midpoint_circle_algorithm).
8 %
9 % This function is aimed at image processing applications, where the
10 % integer pixel coordinates matter, and for which one pixel cannot be
11 % missed or duplicated. In that view, using rounded trigonometric
12 % coordinates generated using cosine calls are inadequate. The mid-point
13 % circle algorithm is the answer.
14 %
15 % Accent is made on performance. We compute in advance the number of point
16 % that will be generated by the algorithm, to pre-allocate the coordinates
17 % arrays. I have tried to do this using a MATLAB class implementing the
18 % iterator pattern, to avoid computing the number of points in advance and
19 % still be able to iterate over circle points. However, it turned out that
20 % repeated function calls is extremely expansive, and the class version of
21 % this function is approximately 1000 times slower. With this function, you
22 % can get the pixel coordinates of a circle of radius 1000 in 0.16 ms, and
23 % this time will scale linearly with increasing radius (e.g. it takes
24 % 0.16 s for a radius of 1 million).
25 %
26 % Also, this functions ensure that sorted coordinates are returned. The
27 % mid-point algorithm normally generates a point for the 8 circles octants
28 % in one iteration. If they are put in an array in that order, the [x y]
29 % points will jump from one octant to another. Here, we ensure that they
30 % are returned in order, starting from the top point, and going clockwise.
31 %
32 % EXAMPLE
33 %
34 % n_circles = 20;
35 % color_length = 100;
36 % image_size = 128;
37 % max_radius = 20;
38 %
39 % I = zeros(image_size, image_size, 3, 'uint8');
40 % colors = hsv(color_length);
41 %
42 % for i = 1 : n_circles
43 %
44 % x0 = round( image_size * rand);
45 % y0 = round( image_size * rand);
46 % radius = round( max_radius * rand );
47 %
48 % [x y] = getmidpointcircle(x0, y0, radius);
49 %
50 % index = 1 ;
51 % for j = 1 : numel(x)
52 % xp = x(j);
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53 % yp = y(j);
54 %
55 % if ( xp < 1 || yp < 1 || xp > image_size || yp > image_size )
56 % continue
57 % end
58 % I(xp, yp, :) = round( 255 * colors(index, :) );
59 % index = index + 1;
60 % if index > color_length
61 % index = 1;
62 % end
63 % end
64 %
65 % end
66 %
67 % imshow(I, []);
68 %
69 %
70 % Jean-Yves Tinevez <jeanyves.tinevez@gmail.com> - Nov 2011 - Feb 2012
71
72 % Compute first the number of points
73 octant_size = floor((sqrt(2)*(radius-1)+4)/2);
74 n_points = 8 * octant_size;
75
76 % Iterate a second time, and this time retrieve coordinates.
77 % We "zig-zag" through indices, so that we reconstruct a continuous
78 % set of of x,y coordinates, starting from the top of the circle.
79
80 xc = NaN(n_points, 1);
81 yc = NaN(n_points, 1);
82
83 x = 0;
84 y = radius;
85 f = 1 - radius;
86 dx = 1;
87 dy = - 2 * radius;
88
89 % Store
90
91 % 1 octant
92 xc(1) = x0 + x;
93 yc(1) = y0 + y;
94
95 % 2nd octant
96 xc(8 * octant_size) = x0 - x;
97 yc(8 * octant_size) = y0 + y;
98
99 % 3rd octant
100 xc(4 * octant_size) = x0 + x;
101 yc(4 * octant_size) = y0 - y;
102
103 % 4th octant
104 xc(4 * octant_size + 1) = x0 - x;
105 yc(4 * octant_size + 1) = y0 - y;
106
107 % 5th octant
108 xc(2 * octant_size) = x0 + y;
109 yc(2 * octant_size) = y0 + x;
110
111 % 6th octant
112 xc(6 * octant_size + 1) = x0 - y;
113 yc(6 * octant_size + 1) = y0 + x;
114
115 % 7th octant
116 xc(2 * octant_size + 1) = x0 + y;
117 yc(2 * octant_size + 1) = y0 - x;
118
119 % 8th octant
120 xc(6 * octant_size) = x0 - y;
121 yc(6 * octant_size) = y0 - x;
122
123
124 for i = 2 : n_points/8
125
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126 % We update x & y
127 if f > 0
128 y = y - 1;
129 dy = dy + 2;
130 f = f + dy;
131 end
132 x = x + 1;
133 dx = dx + 2;
134 f = f + dx;
135
136 % 1 octant
137 xc(i) = x0 + x;
138 yc(i) = y0 + y;
139
140 % 2nd octant
141 xc(8 * octant_size - i + 1) = x0 - x;
142 yc(8 * octant_size - i + 1) = y0 + y;
143
144 % 3rd octant
145 xc(4 * octant_size - i + 1) = x0 + x;
146 yc(4 * octant_size - i + 1) = y0 - y;
147
148 % 4th octant
149 xc(4 * octant_size + i) = x0 - x;
150 yc(4 * octant_size + i) = y0 - y;
151
152 % 5th octant
153 xc(2 * octant_size - i + 1) = x0 + y;
154 yc(2 * octant_size - i + 1) = y0 + x;
155
156 % 6th octant
157 xc(6 * octant_size + i) = x0 - y;
158 yc(6 * octant_size + i) = y0 + x;
159
160 % 7th octant
161 xc(2 * octant_size + i) = x0 + y;
162 yc(2 * octant_size + i) = y0 - x;
163
164 % 8th octant
165 xc(6 * octant_size - i + 1) = x0 - y;
166 yc(6 * octant_size - i + 1) = y0 - x;
167
168 end
169
170 end
C.1.8 Array_Tool.m GUI function
1 function varargout = Array_Tool(varargin)
2 % ARRAY_TOOL MATLAB code for Array_Tool.fig
3 % ARRAY_TOOL, by itself, creates a new ARRAY_TOOL or raises the existing
4 % singleton*.
5 %
6 % H = ARRAY_TOOL returns the handle to a new ARRAY_TOOL or the handle to
7 % the existing singleton*.
8 %
9 % ARRAY_TOOL('CALLBACK',hObject,eventData,handles,...) calls the local
10 % function named CALLBACK in ARRAY_TOOL.M with the given input arguments.
11 %
12 % ARRAY_TOOL('Property','Value',...) creates a new ARRAY_TOOL or raises the
13 % existing singleton*. Starting from the left, property value pairs are
14 % applied to the GUI before Array_Tool_OpeningFcn gets called. An
15 % unrecognized property name or invalid value makes property application
16 % stop. All inputs are passed to Array_Tool_OpeningFcn via varargin.
17 %
18 % *See GUI Options on GUIDE's Tools menu. Choose "GUI allows only one
19 % instance to run (singleton)".
20 %
21 % See also: GUIDE, GUIDATA, GUIHANDLES
22
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23 % Edit the above text to modify the response to help Array_Tool
24
25 % Last Modified by GUIDE v2.5 17-Mar-2014 01:45:50
26
27 % Begin initialization code - DO NOT EDIT
28 gui_Singleton = 1;
29 gui_State = struct('gui_Name', mfilename, ...
30 'gui_Singleton', gui_Singleton, ...
31 'gui_OpeningFcn', @Array_Tool_OpeningFcn, ...
32 'gui_OutputFcn', @Array_Tool_OutputFcn, ...
33 'gui_LayoutFcn', [] , ...
34 'gui_Callback', []);
35 if nargin && ischar(varargin{1})
36 gui_State.gui_Callback = str2func(varargin{1});
37 end
38
39 if nargout
40 [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:});
41 else
42 gui_mainfcn(gui_State, varargin{:});
43 end
44 % End initialization code - DO NOT EDIT
45
46
47 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
48 %%% Update graph with centre points after text change %%%
49 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
50
51 function nRows_Callback(hObject, eventdata, handles) %#ok<*DEFNU,*INUSD>
52 drawFigure
53 drawDots(hObject)
54
55 function startOff_Callback(hObject, eventdata, handles)
56 drawFigure
57 drawDots(hObject)
58
59 function nCols_Callback(hObject, eventdata, handles)
60 drawDots(hObject)
61
62 function endOff_Callback(hObject, eventdata, handles)
63 drawFigure
64 drawDots(hObject)
65
66
67 function gridX_Callback(hObject, eventdata, handles)
68 drawFigure
69 drawDots(hObject)
70
71 function refX_Callback(hObject, eventdata, handles)
72 drawFigure
73 drawDots(hObject)
74
75 function cellSizeX_Callback(hObject, eventdata, handles)
76 drawFigure
77 drawDots(hObject)
78
79 function gridY_Callback(hObject, eventdata, handles)
80 drawFigure
81 drawDots(hObject)
82
83 function refY_Callback(hObject, eventdata, handles)
84 drawFigure
85 drawDots(hObject)
86
87
88 function cellSizeY_Callback(hObject, eventdata, handles)
89 drawFigure
90 drawDots(hObject)
91
92 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
93 %%% Other callbacks %%%
94 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
95
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96 % Draw cirles of measruing area over dots
97 function genCirc_Callback(hObject, eventdata, handles)
98 drawFigure
99 drawCircles(hObject)
100
101 % Draw points after button click
102 function test_Callback(hObject, eventdata, handles)
103 drawFigure
104 drawDots(hObject)
105
106 % Generates intensity results on button click
107 function pushbutton3_Callback(hObject, eventdata, handles)
108 generateResults(hObject)
109
110 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
111 %%% User defined functions %%%
112 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
113
114 % Load new image
115 function opFile_ClickedCallback(hObject, eventdata, handles)
116 handles = guidata(gcbo);
117
118 [filename path] = uigetfile(...
119 {'*.jpg; *.jpeg; *.tif; *.tif; *.raw; *.png; *.bmp; *.txt', ...
120 'All Image Files'; ...
121 '*.*', 'All Files'}, 'Open image file', handles.currentPath);
122
123 if filename ~= 0,
124 handles.img = imread([path filename]);
125 imshow(handles.img);
126 end
127
128 %Save fold location
129 handles.currentPath = path;
130
131 % Update handles structure
132 guidata(hObject, handles);
133
134
135 % -------------------------------------------------------------------------
136 % END OF USER DEFINED FUNCTIONS
137 % The following code is machine generated and is required for GUI
138 % -------------------------------------------------------------------------
139
140 % --- Executes just before Array_Tool is made visible.
141 function Array_Tool_OpeningFcn(hObject, eventdata, handles) %#ok<*INUSL>
142 handles.output = hObject;
143 handles.img = imread('sampleImage.jpg');
144 imshow(handles.img)
145 handles.currentPath = [];
146 guidata(hObject, handles);
147
148 % --- Outputs from this function are returned to the command line.
149 function varargout = Array_Tool_OutputFcn(hObject, eventdata, handles)
150 varargout{1} = handles.output;
151
152 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
153 %%% Executes during object creation, after setting all properties. %%%
154 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
155 function edit2_CreateFcn(hObject, eventdata, handles)
156 if ispc && isequal(get(hObject,'BackgroundColor'), ...
157 get(0,'defaultUicontrolBackgroundColor'))
158 set(hObject,'BackgroundColor','white');
159 end
160
161 function startOff_CreateFcn(hObject, eventdata, handles)
162
163 if ispc && isequal(get(hObject,'BackgroundColor'), ...
164 get(0,'defaultUicontrolBackgroundColor'))
165 set(hObject,'BackgroundColor','white');
166 end
167
168 function nCols_CreateFcn(hObject, eventdata, handles)
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169 if ispc && isequal(get(hObject,'BackgroundColor'), ...
170 get(0,'defaultUicontrolBackgroundColor'))
171 set(hObject,'BackgroundColor','white');
172 end
173
174 function endOff_CreateFcn(hObject, eventdata, handles)
175
176 if ispc && isequal(get(hObject,'BackgroundColor'), ...
177 get(0,'defaultUicontrolBackgroundColor'))
178 set(hObject,'BackgroundColor','white');
179 end
180
181 function gridX_CreateFcn(hObject, eventdata, handles)
182
183 if ispc && isequal(get(hObject,'BackgroundColor'), ...
184 get(0,'defaultUicontrolBackgroundColor'))
185 set(hObject,'BackgroundColor','white');
186 end
187
188 function refX_CreateFcn(hObject, eventdata, handles)
189 if ispc && isequal(get(hObject,'BackgroundColor'), ...
190 get(0,'defaultUicontrolBackgroundColor'))
191 set(hObject,'BackgroundColor','white');
192 end
193
194 function cellSizeX_CreateFcn(hObject, eventdata, handles)
195 if ispc && isequal(get(hObject,'BackgroundColor'), ...
196 get(0,'defaultUicontrolBackgroundColor'))
197 set(hObject,'BackgroundColor','white');
198 end
199
200 function gridY_CreateFcn(hObject, eventdata, handles)
201
202 if ispc && isequal(get(hObject,'BackgroundColor'), ...
203 get(0,'defaultUicontrolBackgroundColor'))
204 set(hObject,'BackgroundColor','white');
205 end
206
207 function refY_CreateFcn(hObject, eventdata, handles)
208
209 if ispc && isequal(get(hObject,'BackgroundColor'), ...
210 get(0,'defaultUicontrolBackgroundColor'))
211 set(hObject,'BackgroundColor','white');
212 end
213
214 function cellSizeY_CreateFcn(hObject, eventdata, handles)
215 if ispc && isequal(get(hObject,'BackgroundColor'), ...
216 get(0,'defaultUicontrolBackgroundColor'))
217 set(hObject,'BackgroundColor','white');
218 end
219
220 function initCircSize_CreateFcn(hObject, eventdata, handles)
221 if ispc && isequal(get(hObject,'BackgroundColor'), ...
222 get(0,'defaultUicontrolBackgroundColor'))
223 set(hObject,'BackgroundColor','white');
224 end
225
226 function measType_CreateFcn(hObject, eventdata, handles)
227 if ispc && isequal(get(hObject,'BackgroundColor'), ...
228 get(0,'defaultUicontrolBackgroundColor'))
229 set(hObject,'BackgroundColor','white');
230 end
231
232 function limit_CreateFcn(hObject, eventdata, ~)
233 if ispc && isequal(get(hObject,'BackgroundColor'), ...
234 get(0,'defaultUicontrolBackgroundColor'))
235 set(hObject,'BackgroundColor','white');
236 end
237
238 function threshold_CreateFcn(hObject, eventdata, handles)
239 if ispc && isequal(get(hObject,'BackgroundColor'), ...
240 get(0,'defaultUicontrolBackgroundColor'))
241 set(hObject,'BackgroundColor','white');
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242 end
243
244 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
245 %%% Unused callback functions %%%
246 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
247 function togglebutton1_Callback(hObject, eventdata, handles)
248 function nRows_CreateFcn(hObject, eventdata, handles)
249 function mainGraph_CreateFcn(hObject, eventdata, handles)
250 function refSub_Callback(hObject, eventdata, handles)
251 function nRows_ButtonDownFcn(hObject, eventdata, handles)
252 function initCircSize_Callback(hObject, eventdata, handles)
253 function measType_Callback(hObject, eventdata, handles)
254 function sizeOptimise_Callback(hObject, eventdata, handles)
255 function limit_Callback(hObject, eventdata, handles)
256 function threshold_Callback(hObject, eventdata, handles)
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C.2 Sequence analysis functions
C.2.1 Sequence similarity
The following C source code is for the sequence similarity shared library used by R to calculate sequence
similarity using the sum of pairs method.
1 /* C code for an object to be used by R for efficiently calculating
2 * protein conservation using a substation matrix to score amino acid pairs.
3 *
4 * Object accepts pointers to R objects to be operated on.
5 *
6 * The R objects are 1 dimensional arrays that were coerced from
7 * 2 dimensional R arrays. The arrays are kept as 1 dimensional arrays and
8 * and 1 dimensional indices are calculated from 2 dimensional indices.
9 */
10
11 #include <stdio.h>
12 #include <stdlib.h>
13
14 /* Recursive function to calculate binomial coefficients
15 * This function is used to calculate the number of of amino-
16 * acid substitution pairs. If there are N sequences, there
17 * (N choose 2) pair substations.
18 */
19 int nchoosek(int n, int k)
20 {
21 if (k == 0) return 1;
22 if (n == 0) return 0;
23 return(nchoosek(n-1, k-1) + nchoosek(n-1, k));
24 }
25
26 void HSDS_conservation_C(int *nLetters, int *nSequences, int *nSmoothing,
27 char **chAlignment, double *dOutput, double *dSCORE,
28 char **chAlphabet, int *nAlphabetsize)
29 {
30 /* Convert alignment matrix into an index matrix for dSCORE.
31 * This will allow using alignment values to directly index the
32 * substitution matrix, rather than having to look up values.
33 */
34
35 // Allocate memory for the index matrix, nAlignment
36 int **nAlignment;
37 nAlignment = malloc(nSequences[0] * sizeof(int *));
38 for (int i = 0; i < nSequences[0]; i++)
39 {
40 nAlignment[i] = malloc(nLetters[0] * sizeof(int));
41 }
42
43 // Convert amino acids into their respective integer index values and
44 // populate the nAlignment matrix with these values
45 for (int i = 0; i < nSequences[0]; i++)
46 {
47 for (int j = 0; j < nLetters[0]; j++)
48 {
49 for (int k = 0; k < nAlphabetsize[0]; k++)
50 {
51 if (chAlignment[(i * nLetters[0]) + j][0] == chAlphabet[k][0])
52 {
53 nAlignment[i][j] = k;
54 }
55 }
56 }
57 }
58
59
60 /*
61 * Calculate conservation
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62 */
63
64 // Calculate the number pair substitutions, N, to, which will be used in
65 // the mean calculation.
66 double fDenominator = (double)nchoosek(nSequences[0], 2);
67
68 // For each position in the alignment, calculate the sum of possible
69 // pair substitution then divide by N.
70 for (int i = 0; i < nLetters[0]; i++)
71 {
72 for (int j = 0; j < (nSequences[0] - 1); j++)
73 {
74 for (int k = j + 1; k < nSequences[0]; k++)
75 {
76 dOutput[i] += dSCORE[ (nAlignment[j][i] * nAlphabetsize[0]) +
77 nAlignment[k][i] ];
78 }
79 }
80 dOutput[i] /= fDenominator;
81 }
82
83
84 // Smooth data, averages each position by a window nSmoothing characters
85 // upstream and downstream of each position
86 if (nSmoothing[0] > 0)
87 {
88 double *dTemp = malloc(nLetters[0] * sizeof(double));
89 for (int i = 0; i < nLetters[0]; i++)
90 {
91 dTemp[i] = dOutput[i];
92 }
93
94 int a, b;
95 double dSum;
96 for (int i = 0; i < nLetters[0]; i++)
97 {
98 a = i - nSmoothing[0];
99 b = i + nSmoothing[0];
100 dSum = 0.0;
101 if (a < 0)
102 a = 0;
103 if (b >= nLetters[0])
104 b = nLetters[0] - 1;
105 for (int j = a; j <= b; j++)
106 {
107 dSum += dTemp[j];
108 }
109 dOutput[i] = dSum / (double)(b - a + 1);
110 }
111 }
112 }
R wrapper function for the C shared library function:
1 HSDS_conservation <- function(alignment, nSmoothing = 0, useCompiled = TRUE,
2 matrix_dir = "Simplant/Data/",
3 c_dir = "Simplant/Executables/"){
4 # The data file for the score matrix needs to present in matrix_dir.
5 # To use the C compiled version function which is much faster,
6 # either the 'HSDS_conservation_C.so' or 'HSDS_conservation_C.c'
7 # needs to be present in the c_dir directory.
8 if (is.null(alignment)) return(1)
9
10 # Check whether the HSDS matrix is loaded, if not
11 # try find it and load it.
12 #HSDS <- NULL
13 if(!exists("HSDS")){
14 if (file.exists("Data/HSDS_matrix.rds")){
15 HSDS <- readRDS("Data/HSDS_matrix.rds")
16 }else if(file.exists(paste0(matrix_dir, "HSDS_matrix.rds"))){
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17 HSDS <- readRDS(paste0(matrix_dir, "HSDS_matrix.rds"))
18 }else{
19 stop("Can find HSDS matrix file. Check the 'matrix_dir' folder name.")
20 }
21 }
22
23 # Variables
24 nLetters <- ncol(alignment$ali)
25 nSequences <- nrow(alignment$ali)
26 output <- rep(0, nLetters)
27
28 # If there is only 1 sequence present, return output of zeros here
29 if(nSequences == 1){
30 return(output)
31 }
32
33 # If using compiled, check if possible,
34 # if standard library file can't be
35 # found, a warning is issued and function
36 # jumps to R code instead.
37 if(useCompiled == TRUE){
38 # First check if .so is loaded
39 if (!is.loaded("HSDS_conservation_C")){
40
41 # If not check for the .so file then load it
42 if(file.exists("Executables/HSDS_conservation_C.so")){
43 dyn.load("Executables/HSDS_conservation_C.so")
44 }else if(file.exists(paste0(c_dir, "HSDS_conservation_C.so"))){
45 dyn.load(paste0(c_dir, "HSDS_conservation_C.so"))
46
47 # If there is no .so file, check for the .c file
48 # and try to compile it and then load .so file
49 }else if(file.exists("Executables/HSDS_conservation_C.c")){
50 system("R CMD SHLIB Executables/HSDS_conservation_C.c")
51 dyn.load("Executables/HSDS_conservation_C.so")
52 }else if(file.exists(paste0(c_dir, "HSDS_conservation_C.so"))){
53 system(paste0("R CMD SHLIB ", c_dir, "HSDS_conservation_C.c"))
54 dyn.load(paste0(c_dir, "HSDS_conservation_C.c"))
55
56 # If the .c file cant be found, issue a warning and use
57 # use R coded part of the function instead
58 }else{
59 warning(paste("Can't find shared object file, using slower R",
60 "code function instead.",
61 "Check that the directory is correct and the",
62 "'HSDS_conservation_C.c' file is present."))
63 useCompiled <- FALSE
64 }
65 }
66 }
67
68 if(useCompiled == TRUE){
69 ### Do C version
70 #nLetters <- ncol(alignment$ali)
71 #nSequences <- nrow(alignment$ali)
72 #output <- rep(0, nLetters)
73
74 output <- .C("HSDS_conservation_C",
75 nLetters = as.integer(ncol(alignment$ali)),
76 nSequences = as.integer(nrow(alignment$ali)),
77 nSmoothing = as.integer(nSmoothing),
78 chAlignment = as.vector(t(alignment$ali)),
79 dOutput = as.numeric(rep(0, ncol(alignment$ali))),
80 dSCORE = as.vector(HSDS),
81 chAlphabet = rownames(HSDS),
82 nAlphabetsize = as.integer(length(rownames(HSDS)))
83 )$dOutput
84
85 }else{
86 ### Do R version
87 # Conservation scoring
88 n <- choose(nSequences, 2)
89 for (i in 1:nLetters){
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90 for(j in 1:(nSequences - 1)){
91 for(k in (j+1):nSequences){
92 output[i] <- output[i] +
93 HSDS[alignment$ali[j, i], alignment$ali[k, i]]
94 }
95 }
96 output[i] <- output[i]/n
97 }
98
99 #Smoothing
100 if(nSmoothing > 0){
101 temp <- output
102 for(i in 1:nLetters){
103 a <- i - nSmoothing
104 b <- i + nSmoothing
105 if (a < 1) a <- 1
106 if (b > nLetters) b <- nLetters
107 output[i] <- mean(temp[a:b])
108 }
109 }
110 }
111
112 return(output)
113 }
114
115 # Complile function to bytecode
116 HSDS_conservation <- cmpfun(HSDS_conservation)
C.2.2 Preference logo
The following function is written in R.
1 preferenceLogo <- function(alignment, background = "arabidopsis",
2 plot = TRUE, output = FALSE, title="",
3 MCcorrection = "none", font = "Arial",
4 fontsize = 0.7){
5 ### Plot a preference logo
6 # Plot is based on a Berry style logo as an alternative to
7 # sequence logos. This logo displays amino acid frequencies
8 # relative to a background frequency. This is in contrast
9 # sequence logos which display absolute frequencies scaled
10 # by information content at each position.
11 # The purpose of the preference logo is compare the
12 # distribution of two sets of sequences. The background
13 # set frequencies are subtracted from the test set
14 # ("alignment" variable) and amino acid comparisons with
15 # too small data amount are excluded using a Poisson test
16 # where the p value is greater than 0.05. This solves issues
17 # when comparing datasets with a small number of observations.
18 #
19 # Parameters:
20 # alignment: Test set of aligned, non gapped sequences. This
21 # must be a matrix of characters corresponding to
22 # the single letter amino alphabet. Matrix rows
23 # represent individual sequences and columns
24 # represent sequence posisitions.
25 # background: This can either be a matrix of background
26 # sequences or a character string specifing
27 # species specific amino acid frequencies. If
28 # a matrix is used, the must have the same number
29 # of columns (positions) as the alignment matrix.
30 # Current strings for default frequencies are
31 # c("arabidopsis", "human").
32 # MCRcorrection: A multiple comparison correction can be applied
33 # to the p value from the Poisson test. The defualt is
34 # "none", the methods are c("holm", "hochberg",
35 # "hommel", "bonferroni", "BH", "BY", "fdr"). See
36 # the help topic on p.adjust from the {stats} package
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37 # for futher explanation
38
39 # Required packages
40 require("rms.gof") # for the Poisson test
41
42 # Single letter amino acid alphabet and corresponding
43 # hydrophobicity colour scheme
44 alphabet <- c("I", "V", "L", "F", "C",
45 "M", "A", "G", "T", "S",
46 "W", "Y", "P", "H", "N",
47 "D", "E", "Q", "K", "R")
48 alphCols <- c(colorRampPalette(c(rgb(.7,.3,0,.6),rgb(.7,.7,0,.6)))(7),
49 colorRampPalette(c(rgb(0,0.5,.8,.6),rgb(0,0,.8,.6)))(13))
50
51 # Amino acid frequency tables for plant and human
52 AtFreqs <- matrix(c(3468,4417,6079,2756,1329,
53 1745,3986,4116,3328,5731,
54 823,1912,3259,1504,2822,
55 3471,4210,2216,4312,3516)/65000,
56 1, 20, dimnames = list("", alphabet))
57 HsFreqs <- matrix(c(5.6, 6.6, 9.1, 3.9, 1.9,
58 2.2, 7.8, 7.2, 5.9, 6.8,
59 1.4, 3.2, 5.2, 2.3, 5.3,
60 6.3, 4.3, 4.2, 5.9, 5.1)/100,
61 1, 20, dimnames = list("", alphabet))
62 #zeroFreqs
63
64 # Calculate variables
65 nSequences <- dim(alignment)[1]
66 nPositions <- dim(alignment)[2]
67 nLetters <- length(alphabet)
68
69 # countTable function takes an input sequence matrix and returns the counts
70 # for each amino acid at each position. The returned data is in a matrix
71 countTable <- function(fastaMatrix){
72 output <- matrix(-1, nPositions, nLetters,
73 dimnames = list(NULL, alphabet))
74 for(i in 1:nPositions){
75 for(j in 1:nLetters){
76 output[i,j] <- sum(fastaMatrix[,i] == alphabet[j])
77 }
78 }
79 return(output)
80 }
81
82 # Make baground counts table
83 # The background counts table is scaled to have
84 # so that the column sums are the same as the number of sequences in
85 # the input alignment matrix, this is required for the later relative
86 # counts calculation.
87 if (background[1] == "arabidopsis"){
88 background <- matrix(0, nPositions, 20,
89 dimnames = list(rep("", nPositions),alphabet))
90 AtFreqs <- AtFreqs * nSequences
91 for (i in 1:nPositions){
92 background[i,] <- AtFreqs
93 }
94 } else if (background[1] == "human"){
95 background <- matrix(0, nPositions, 20,
96 dimnames = list(rep("", nPositions),alphabet))
97 HsFreqs <- HsFreqs * nSequences
98 for (i in 1:nPositions){
99 background[i,] <- HsFreqs
100 }
101 }else{
102 if (nPositions != dim(background)[2]) error(
103 "Wrong backgound string or matrix of wrong size supplied")
104 n = dim(background)[1]
105 background <- (countTable(background)/n)*nSequences
106 }
107
108 # Calculate frequency differences
109 alignFreqs <- countTable(alignment)
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110 freqDiff <- (alignFreqs - background)/nSequences
111
112 # Do Poisson test and remove non-significant amino acids
113 sig <- matrix(0, nPositions, nLetters, dimnames = list(NULL, alphabet))
114 for (i in 1:nPositions){
115 for (j in 1:nLetters){
116 p <- poisson.test(alignFreqs[i,j], r = background[i,j])$p.value
117 p <- p.adjust(p, method = MCcorrection, n = nLetters)
118 sig[i,j] <- p
119 if (p > 0.05) freqDiff[i,j] <- NaN
120 }
121 }
122
123 # Remove infinite values
124 freqDiff[freqDiff == Inf | freqDiff == -Inf] <- NaN
125
126 # Calculate plotting parameters
127 ymin <- min(c(freqDiff, -0.1), na.rm = TRUE)
128 ymax <- max(c(freqDiff, 0.5), na.rm = TRUE)
129 xmin <- 1
130 xmax <- dim(freqDiff)[1]
131
132 #Function for sizing letters based on p value
133 sig_size <- function(p){
134 output <- 1/(-p*100-1) + 1
135 return(output)
136 }
137
138 # Draw graph
139 if(plot){
140 par(mar=c(4,2,2,1))
141 plot(c(xmin, xmax), c(ymin, ymax), type = "n", xlab="",
142 ylab="", main = title, family = font,
143 cex.axis = fontsize, las = 1)
144 axis(side = 1, at = seq(xmin, xmax, by = 1),
145 labels = FALSE, tcl = -0.2)
146 grid(ny = NA)
147 abline(c(0,0), c(0,5), col = "gray")
148 for(i in 1:dim(freqDiff)[2]){
149 plotIndex <- !is.nan(freqDiff[,i])
150 x <- (1:xmax)[plotIndex]
151 y <- freqDiff[,i][plotIndex]
152 ps <- sig[,i][plotIndex]
153 points(x, y, pch = alphabet[i], col = alphCols[i],
154 cex = 1.2-sig_size(ps), font = 2)
155 }
156 }
157
158 if (output) return(freqDiff)
159 }
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